AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|EVENT_TYPE|POPULATION|RACE|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-14|3.4|3.7|3.6|1943|Incidence|54370170|All Races|Male and Female|Acute Lymphocytic|1999|||
0-14|3.5|3.8|3.7|1995|Incidence|54659806|All Races|Male and Female|Acute Lymphocytic|2000|||
0-14|3.6|4.0|3.8|2164|Incidence|57293473|All Races|Male and Female|Acute Lymphocytic|2001|||
0-14|3.5|3.8|3.6|2122|Incidence|58853101|All Races|Male and Female|Acute Lymphocytic|2002|||
0-14|3.4|3.7|3.5|2147|Incidence|60910921|All Races|Male and Female|Acute Lymphocytic|2003|||
0-14|3.6|3.9|3.8|2324|Incidence|61011791|All Races|Male and Female|Acute Lymphocytic|2004|||
0-14|3.5|3.8|3.7|2251|Incidence|60953039|All Races|Male and Female|Acute Lymphocytic|2005|||
0-14|3.7|3.9|3.8|11852|Incidence|306722950|All Races|Male and Female|Acute Lymphocytic|2005-2009|||
0-14|3.6|3.9|3.8|2329|Incidence|61022964|All Races|Male and Female|Acute Lymphocytic|2006|||
0-14|3.7|4.0|3.8|2393|Incidence|61294588|All Races|Male and Female|Acute Lymphocytic|2007|||
0-14|3.8|4.1|3.9|2459|Incidence|61569505|All Races|Male and Female|Acute Lymphocytic|2008|||
0-14|3.7|4.0|3.8|2377|Incidence|60804105|All Races|Male and Female|Acute Lymphocytic|2009|||
0-14|0.6|0.8|0.7|375|Incidence|54370170|All Races|Male and Female|Acute Myeloid|1999|||
0-14|0.5|0.7|0.6|322|Incidence|54659806|All Races|Male and Female|Acute Myeloid|2000|||
0-14|0.6|0.7|0.7|384|Incidence|57293473|All Races|Male and Female|Acute Myeloid|2001|||
0-14|0.6|0.7|0.7|398|Incidence|58853101|All Races|Male and Female|Acute Myeloid|2002|||
0-14|0.6|0.7|0.6|392|Incidence|60910921|All Races|Male and Female|Acute Myeloid|2003|||
0-14|0.6|0.8|0.7|423|Incidence|61011791|All Races|Male and Female|Acute Myeloid|2004|||
0-14|0.6|0.7|0.6|391|Incidence|60953039|All Races|Male and Female|Acute Myeloid|2005|||
0-14|0.6|0.7|0.7|2036|Incidence|306722950|All Races|Male and Female|Acute Myeloid|2005-2009|||
0-14|0.6|0.7|0.7|415|Incidence|61022964|All Races|Male and Female|Acute Myeloid|2006|||
0-14|0.6|0.7|0.7|409|Incidence|61294588|All Races|Male and Female|Acute Myeloid|2007|||
0-14|0.6|0.8|0.7|432|Incidence|61569505|All Races|Male and Female|Acute Myeloid|2008|||
0-14|0.6|0.7|0.6|381|Incidence|60804105|All Races|Male and Female|Acute Myeloid|2009|||
0-14|14.3|14.9|14.6|7904|Incidence|54370170|All Races|Male and Female|All Cancer Sites Combined|1999|||
0-14|14.5|15.2|14.9|8105|Incidence|54659806|All Races|Male and Female|All Cancer Sites Combined|2000|||
0-14|15.2|15.9|15.5|8897|Incidence|57293473|All Races|Male and Female|All Cancer Sites Combined|2001|||
0-14|15.0|15.6|15.3|9035|Incidence|58853101|All Races|Male and Female|All Cancer Sites Combined|2002|||
0-14|14.7|15.3|15.0|9198|Incidence|60910921|All Races|Male and Female|All Cancer Sites Combined|2003|||
0-14|15.4|16.1|15.7|9676|Incidence|61011791|All Races|Male and Female|All Cancer Sites Combined|2004|||
0-14|15.0|15.6|15.3|9390|Incidence|60953039|All Races|Male and Female|All Cancer Sites Combined|2005|||
0-14|15.4|15.7|15.5|48164|Incidence|306722950|All Races|Male and Female|All Cancer Sites Combined|2005-2009|||
0-14|15.2|15.8|15.5|9540|Incidence|61022964|All Races|Male and Female|All Cancer Sites Combined|2006|||
0-14|15.4|16.0|15.7|9752|Incidence|61294588|All Races|Male and Female|All Cancer Sites Combined|2007|||
0-14|15.5|16.2|15.9|9888|Incidence|61569505|All Races|Male and Female|All Cancer Sites Combined|2008|||
0-14|15.0|15.6|15.3|9415|Incidence|60804105|All Races|Male and Female|All Cancer Sites Combined|2009|||
0-14|0.7|0.8|0.7|403|Incidence|54370170|All Races|Male and Female|Bones and Joints|1999|||
0-14|0.6|0.8|0.7|373|Incidence|54659806|All Races|Male and Female|Bones and Joints|2000|||
0-14|0.6|0.8|0.7|410|Incidence|57293473|All Races|Male and Female|Bones and Joints|2001|||
0-14|0.6|0.8|0.7|421|Incidence|58853101|All Races|Male and Female|Bones and Joints|2002|||
0-14|0.6|0.8|0.7|424|Incidence|60910921|All Races|Male and Female|Bones and Joints|2003|||
0-14|0.7|0.8|0.7|453|Incidence|61011791|All Races|Male and Female|Bones and Joints|2004|||
0-14|0.6|0.8|0.7|419|Incidence|60953039|All Races|Male and Female|Bones and Joints|2005|||
0-14|0.7|0.7|0.7|2122|Incidence|306722950|All Races|Male and Female|Bones and Joints|2005-2009|||
0-14|0.7|0.8|0.7|441|Incidence|61022964|All Races|Male and Female|Bones and Joints|2006|||
0-14|0.6|0.8|0.7|424|Incidence|61294588|All Races|Male and Female|Bones and Joints|2007|||
0-14|0.6|0.8|0.7|418|Incidence|61569505|All Races|Male and Female|Bones and Joints|2008|||
0-14|0.6|0.8|0.7|416|Incidence|60804105|All Races|Male and Female|Bones and Joints|2009|||
0-14|3.1|3.4|3.2|1753|Incidence|54370170|All Races|Male and Female|Brain and Other Nervous System|1999|||
0-14|3.2|3.5|3.4|1836|Incidence|54659806|All Races|Male and Female|Brain and Other Nervous System|2000|||
0-14|3.2|3.5|3.3|1888|Incidence|57293473|All Races|Male and Female|Brain and Other Nervous System|2001|||
0-14|3.3|3.6|3.5|2032|Incidence|58853101|All Races|Male and Female|Brain and Other Nervous System|2002|||
0-14|3.2|3.4|3.3|2006|Incidence|60910921|All Races|Male and Female|Brain and Other Nervous System|2003|||
0-14|3.3|3.6|3.5|2130|Incidence|61011791|All Races|Male and Female|Brain and Other Nervous System|2004|||
0-14|3.1|3.4|3.3|1995|Incidence|60953039|All Races|Male and Female|Brain and Other Nervous System|2005|||
0-14|3.3|3.4|3.4|10363|Incidence|306722950|All Races|Male and Female|Brain and Other Nervous System|2005-2009|||
0-14|3.2|3.5|3.4|2060|Incidence|61022964|All Races|Male and Female|Brain and Other Nervous System|2006|||
0-14|3.3|3.6|3.5|2136|Incidence|61294588|All Races|Male and Female|Brain and Other Nervous System|2007|||
0-14|3.3|3.6|3.4|2129|Incidence|61569505|All Races|Male and Female|Brain and Other Nervous System|2008|||
0-14|3.1|3.4|3.3|1990|Incidence|60804105|All Races|Male and Female|Brain and Other Nervous System|2009|||
0-14|0.5|0.6|0.5|297|Incidence|54370170|All Races|Male and Female|Hodgkin Lymphoma|1999|||
0-14|0.5|0.7|0.6|325|Incidence|54659806|All Races|Male and Female|Hodgkin Lymphoma|2000|||
0-14|0.5|0.7|0.6|338|Incidence|57293473|All Races|Male and Female|Hodgkin Lymphoma|2001|||
0-14|0.5|0.6|0.6|328|Incidence|58853101|All Races|Male and Female|Hodgkin Lymphoma|2002|||
0-14|0.5|0.7|0.6|361|Incidence|60910921|All Races|Male and Female|Hodgkin Lymphoma|2003|||
0-14|0.5|0.6|0.5|325|Incidence|61011791|All Races|Male and Female|Hodgkin Lymphoma|2004|||
0-14|0.5|0.7|0.6|361|Incidence|60953039|All Races|Male and Female|Hodgkin Lymphoma|2005|||
0-14|0.6|0.6|0.6|1777|Incidence|306722950|All Races|Male and Female|Hodgkin Lymphoma|2005-2009|||
0-14|0.6|0.7|0.6|370|Incidence|61022964|All Races|Male and Female|Hodgkin Lymphoma|2006|||
0-14|0.5|0.6|0.5|326|Incidence|61294588|All Races|Male and Female|Hodgkin Lymphoma|2007|||
0-14|0.6|0.7|0.6|378|Incidence|61569505|All Races|Male and Female|Hodgkin Lymphoma|2008|||
0-14|0.5|0.6|0.6|337|Incidence|60804105|All Races|Male and Female|Hodgkin Lymphoma|2009|||
0-14|0.8|0.9|0.8|453|Incidence|54370170|All Races|Male and Female|Kidney and Renal Pelvis|1999|||
0-14|0.8|1.0|0.9|484|Incidence|54659806|All Races|Male and Female|Kidney and Renal Pelvis|2000|||
0-14|0.8|1.0|0.9|502|Incidence|57293473|All Races|Male and Female|Kidney and Renal Pelvis|2001|||
0-14|0.8|0.9|0.8|498|Incidence|58853101|All Races|Male and Female|Kidney and Renal Pelvis|2002|||
0-14|0.8|0.9|0.9|526|Incidence|60910921|All Races|Male and Female|Kidney and Renal Pelvis|2003|||
0-14|0.7|0.9|0.8|506|Incidence|61011791|All Races|Male and Female|Kidney and Renal Pelvis|2004|||
0-14|0.8|0.9|0.8|517|Incidence|60953039|All Races|Male and Female|Kidney and Renal Pelvis|2005|||
0-14|0.8|0.9|0.9|2717|Incidence|306722950|All Races|Male and Female|Kidney and Renal Pelvis|2005-2009|||
0-14|0.8|0.9|0.8|523|Incidence|61022964|All Races|Male and Female|Kidney and Renal Pelvis|2006|||
0-14|0.8|0.9|0.9|538|Incidence|61294588|All Races|Male and Female|Kidney and Renal Pelvis|2007|||
0-14|0.8|1.0|0.9|565|Incidence|61569505|All Races|Male and Female|Kidney and Renal Pelvis|2008|||
0-14|0.8|1.0|0.9|563|Incidence|60804105|All Races|Male and Female|Kidney and Renal Pelvis|2009|||
0-14|4.4|4.8|4.6|2490|Incidence|54370170|All Races|Male and Female|Leukemia|1999|||
0-14|4.4|4.8|4.6|2499|Incidence|54659806|All Races|Male and Female|Leukemia|2000|||
0-14|4.7|5.0|4.9|2768|Incidence|57293473|All Races|Male and Female|Leukemia|2001|||
0-14|4.5|4.9|4.7|2763|Incidence|58853101|All Races|Male and Female|Leukemia|2002|||
0-14|4.3|4.7|4.5|2743|Incidence|60910921|All Races|Male and Female|Leukemia|2003|||
0-14|4.7|5.0|4.9|2989|Incidence|61011791|All Races|Male and Female|Leukemia|2004|||
0-14|4.5|4.8|4.7|2880|Incidence|60953039|All Races|Male and Female|Leukemia|2005|||
0-14|4.7|4.9|4.8|15019|Incidence|306722950|All Races|Male and Female|Leukemia|2005-2009|||
0-14|4.7|5.0|4.8|2980|Incidence|61022964|All Races|Male and Female|Leukemia|2006|||
0-14|4.7|5.0|4.9|3028|Incidence|61294588|All Races|Male and Female|Leukemia|2007|||
0-14|4.8|5.1|5.0|3116|Incidence|61569505|All Races|Male and Female|Leukemia|2008|||
0-14|4.6|4.9|4.8|2958|Incidence|60804105|All Races|Male and Female|Leukemia|2009|||
0-14|0.8|1.0|0.9|477|Incidence|54370170|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|||
0-14|0.9|1.0|0.9|509|Incidence|54659806|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|||
0-14|0.8|1.0|0.9|521|Incidence|57293473|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|||
0-14|0.8|1.0|0.9|529|Incidence|58853101|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|||
0-14|0.8|1.0|0.9|546|Incidence|60910921|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|||
0-14|0.9|1.0|0.9|572|Incidence|61011791|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|||
0-14|0.8|1.0|0.9|553|Incidence|60953039|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|||
0-14|0.9|1.0|0.9|2833|Incidence|306722950|All Races|Male and Female|Non-Hodgkin Lymphoma|2005-2009|||
0-14|0.8|1.0|0.9|549|Incidence|61022964|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|||
0-14|0.9|1.1|1.0|597|Incidence|61294588|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|||
0-14|0.9|1.0|0.9|572|Incidence|61569505|All Races|Male and Female|Non-Hodgkin Lymphoma|2008|||
0-14|0.9|1.0|0.9|559|Incidence|60804105|All Races|Male and Female|Non-Hodgkin Lymphoma|2009|||
0-14|2.8|3.1|2.9|1573|Incidence|54370170|All Races|Male and Female|Other|1999|||
0-14|2.7|3.0|2.9|1562|Incidence|54659806|All Races|Male and Female|Other|2000|||
0-14|3.2|3.5|3.3|1912|Incidence|57293473|All Races|Male and Female|Other|2001|||
0-14|3.0|3.3|3.2|1874|Incidence|58853101|All Races|Male and Female|Other|2002|||
0-14|3.1|3.4|3.3|2013|Incidence|60910921|All Races|Male and Female|Other|2003|||
0-14|3.2|3.5|3.4|2096|Incidence|61011791|All Races|Male and Female|Other|2004|||
0-14|3.2|3.5|3.3|2054|Incidence|60953039|All Races|Male and Female|Other|2005|||
0-14|3.2|3.3|3.3|10203|Incidence|306722950|All Races|Male and Female|Other|2005-2009|||
0-14|3.1|3.4|3.3|2026|Incidence|61022964|All Races|Male and Female|Other|2006|||
0-14|3.1|3.4|3.3|2062|Incidence|61294588|All Races|Male and Female|Other|2007|||
0-14|3.1|3.4|3.3|2051|Incidence|61569505|All Races|Male and Female|Other|2008|||
0-14|3.0|3.3|3.2|1973|Incidence|60804105|All Races|Male and Female|Other|2009|||
0-14|0.8|0.9|0.8|458|Incidence|54370170|All Races|Male and Female|Soft Tissue|1999|||
0-14|0.9|1.0|0.9|517|Incidence|54659806|All Races|Male and Female|Soft Tissue|2000|||
0-14|0.9|1.1|1.0|558|Incidence|57293473|All Races|Male and Female|Soft Tissue|2001|||
0-14|0.9|1.1|1.0|590|Incidence|58853101|All Races|Male and Female|Soft Tissue|2002|||
0-14|0.9|1.0|0.9|579|Incidence|60910921|All Races|Male and Female|Soft Tissue|2003|||
0-14|0.9|1.1|1.0|605|Incidence|61011791|All Races|Male and Female|Soft Tissue|2004|||
0-14|0.9|1.1|1.0|611|Incidence|60953039|All Races|Male and Female|Soft Tissue|2005|||
0-14|1.0|1.0|1.0|3130|Incidence|306722950|All Races|Male and Female|Soft Tissue|2005-2009|||
0-14|0.9|1.0|1.0|591|Incidence|61022964|All Races|Male and Female|Soft Tissue|2006|||
0-14|0.9|1.1|1.0|641|Incidence|61294588|All Races|Male and Female|Soft Tissue|2007|||
0-14|1.0|1.1|1.0|659|Incidence|61569505|All Races|Male and Female|Soft Tissue|2008|||
0-14|0.9|1.1|1.0|619|Incidence|60804105|All Races|Male and Female|Soft Tissue|2009|||
0-14|0.3|0.4|0.3|194|Mortality|59955368|All Races|Male and Female|Acute Lymphocytic|1999|||
0-14|0.3|0.4|0.4|234|Mortality|60300602|All Races|Male and Female|Acute Lymphocytic|2000|||
0-14|0.3|0.4|0.3|208|Mortality|60566200|All Races|Male and Female|Acute Lymphocytic|2001|||
0-14|0.3|0.4|0.4|217|Mortality|60764336|All Races|Male and Female|Acute Lymphocytic|2002|||
0-14|0.4|0.5|0.4|246|Mortality|60910921|All Races|Male and Female|Acute Lymphocytic|2003|||
0-14|0.3|0.4|0.3|202|Mortality|61011791|All Races|Male and Female|Acute Lymphocytic|2004|||
0-14|0.3|0.4|0.3|188|Mortality|60953039|All Races|Male and Female|Acute Lymphocytic|2005|||
0-14|0.3|0.3|0.3|924|Mortality|306722950|All Races|Male and Female|Acute Lymphocytic|2005-2009|||
0-14|0.2|0.3|0.3|174|Mortality|61022964|All Races|Male and Female|Acute Lymphocytic|2006|||
0-14|0.3|0.4|0.3|212|Mortality|61294588|All Races|Male and Female|Acute Lymphocytic|2007|||
0-14|0.2|0.3|0.3|176|Mortality|61569505|All Races|Male and Female|Acute Lymphocytic|2008|||
0-14|0.2|0.3|0.3|174|Mortality|61882854|All Races|Male and Female|Acute Lymphocytic|2009|||
0-14|0.2|0.3|0.2|141|Mortality|59955368|All Races|Male and Female|Acute Myeloid|1999|||
0-14|0.2|0.3|0.2|145|Mortality|60300602|All Races|Male and Female|Acute Myeloid|2000|||
0-14|0.2|0.3|0.3|157|Mortality|60566200|All Races|Male and Female|Acute Myeloid|2001|||
0-14|0.2|0.3|0.2|131|Mortality|60764336|All Races|Male and Female|Acute Myeloid|2002|||
0-14|0.2|0.3|0.2|142|Mortality|60910921|All Races|Male and Female|Acute Myeloid|2003|||
0-14|0.2|0.3|0.2|147|Mortality|61011791|All Races|Male and Female|Acute Myeloid|2004|||
0-14|0.2|0.3|0.2|137|Mortality|60953039|All Races|Male and Female|Acute Myeloid|2005|||
0-14|0.2|0.2|0.2|636|Mortality|306722950|All Races|Male and Female|Acute Myeloid|2005-2009|||
0-14|0.2|0.2|0.2|124|Mortality|61022964|All Races|Male and Female|Acute Myeloid|2006|||
0-14|0.2|0.2|0.2|129|Mortality|61294588|All Races|Male and Female|Acute Myeloid|2007|||
0-14|0.2|0.2|0.2|127|Mortality|61569505|All Races|Male and Female|Acute Myeloid|2008|||
0-14|0.2|0.2|0.2|119|Mortality|61882854|All Races|Male and Female|Acute Myeloid|2009|||
0-14|2.4|2.6|2.5|1498|Mortality|59955368|All Races|Male and Female|All Cancer Sites Combined|1999|||
0-14|2.4|2.7|2.5|1526|Mortality|60300602|All Races|Male and Female|All Cancer Sites Combined|2000|||
0-14|2.3|2.6|2.5|1494|Mortality|60566200|All Races|Male and Female|All Cancer Sites Combined|2001|||
0-14|2.4|2.7|2.5|1548|Mortality|60764336|All Races|Male and Female|All Cancer Sites Combined|2002|||
0-14|2.4|2.7|2.5|1543|Mortality|60910921|All Races|Male and Female|All Cancer Sites Combined|2003|||
0-14|2.3|2.6|2.5|1492|Mortality|61011791|All Races|Male and Female|All Cancer Sites Combined|2004|||
0-14|2.3|2.5|2.4|1452|Mortality|60953039|All Races|Male and Female|All Cancer Sites Combined|2005|||
0-14|2.2|2.3|2.2|6881|Mortality|306722950|All Races|Male and Female|All Cancer Sites Combined|2005-2009|||
0-14|2.1|2.4|2.2|1360|Mortality|61022964|All Races|Male and Female|All Cancer Sites Combined|2006|||
0-14|2.2|2.4|2.3|1395|Mortality|61294588|All Races|Male and Female|All Cancer Sites Combined|2007|||
0-14|2.1|2.3|2.2|1354|Mortality|61569505|All Races|Male and Female|All Cancer Sites Combined|2008|||
0-14|2.0|2.3|2.1|1320|Mortality|61882854|All Races|Male and Female|All Cancer Sites Combined|2009|||
0-14|0.1|0.2|0.1|82|Mortality|59955368|All Races|Male and Female|Bones and Joints|1999|||
0-14|0.1|0.2|0.1|83|Mortality|60300602|All Races|Male and Female|Bones and Joints|2000|||
0-14|0.1|0.2|0.1|88|Mortality|60566200|All Races|Male and Female|Bones and Joints|2001|||
0-14|0.1|0.2|0.1|85|Mortality|60764336|All Races|Male and Female|Bones and Joints|2002|||
0-14|0.1|0.2|0.1|82|Mortality|60910921|All Races|Male and Female|Bones and Joints|2003|||
0-14|0.1|0.2|0.1|75|Mortality|61011791|All Races|Male and Female|Bones and Joints|2004|||
0-14|0.1|0.2|0.1|88|Mortality|60953039|All Races|Male and Female|Bones and Joints|2005|||
0-14|0.1|0.1|0.1|347|Mortality|306722950|All Races|Male and Female|Bones and Joints|2005-2009|||
0-14|0.1|0.1|0.1|59|Mortality|61022964|All Races|Male and Female|Bones and Joints|2006|||
0-14|0.1|0.1|0.1|61|Mortality|61294588|All Races|Male and Female|Bones and Joints|2007|||
0-14|0.1|0.1|0.1|62|Mortality|61569505|All Races|Male and Female|Bones and Joints|2008|||
0-14|0.1|0.2|0.1|77|Mortality|61882854|All Races|Male and Female|Bones and Joints|2009|||
0-14|0.7|0.8|0.7|431|Mortality|59955368|All Races|Male and Female|Brain and Other Nervous System|1999|||
0-14|0.7|0.8|0.7|440|Mortality|60300602|All Races|Male and Female|Brain and Other Nervous System|2000|||
0-14|0.6|0.8|0.7|416|Mortality|60566200|All Races|Male and Female|Brain and Other Nervous System|2001|||
0-14|0.7|0.8|0.8|463|Mortality|60764336|All Races|Male and Female|Brain and Other Nervous System|2002|||
0-14|0.7|0.8|0.8|458|Mortality|60910921|All Races|Male and Female|Brain and Other Nervous System|2003|||
0-14|0.7|0.8|0.7|446|Mortality|61011791|All Races|Male and Female|Brain and Other Nervous System|2004|||
0-14|0.6|0.8|0.7|426|Mortality|60953039|All Races|Male and Female|Brain and Other Nervous System|2005|||
0-14|0.7|0.7|0.7|2105|Mortality|306722950|All Races|Male and Female|Brain and Other Nervous System|2005-2009|||
0-14|0.6|0.8|0.7|422|Mortality|61022964|All Races|Male and Female|Brain and Other Nervous System|2006|||
0-14|0.6|0.8|0.7|426|Mortality|61294588|All Races|Male and Female|Brain and Other Nervous System|2007|||
0-14|0.6|0.8|0.7|429|Mortality|61569505|All Races|Male and Female|Brain and Other Nervous System|2008|||
0-14|0.6|0.7|0.7|402|Mortality|61882854|All Races|Male and Female|Brain and Other Nervous System|2009|||
0-14|~|~|~|~|Mortality|59955368|All Races|Male and Female|Hodgkin Lymphoma|1999|||
0-14|~|~|~|~|Mortality|60300602|All Races|Male and Female|Hodgkin Lymphoma|2000|||
0-14|~|~|~|~|Mortality|60566200|All Races|Male and Female|Hodgkin Lymphoma|2001|||
0-14|~|~|~|~|Mortality|60764336|All Races|Male and Female|Hodgkin Lymphoma|2002|||
0-14|~|~|~|~|Mortality|60910921|All Races|Male and Female|Hodgkin Lymphoma|2003|||
0-14|~|~|~|~|Mortality|61011791|All Races|Male and Female|Hodgkin Lymphoma|2004|||
0-14|~|~|~|~|Mortality|60953039|All Races|Male and Female|Hodgkin Lymphoma|2005|||
0-14|0.0|0.0|0.0|27|Mortality|306722950|All Races|Male and Female|Hodgkin Lymphoma|2005-2009|||
0-14|~|~|~|~|Mortality|61022964|All Races|Male and Female|Hodgkin Lymphoma|2006|||
0-14|~|~|~|~|Mortality|61294588|All Races|Male and Female|Hodgkin Lymphoma|2007|||
0-14|~|~|~|~|Mortality|61569505|All Races|Male and Female|Hodgkin Lymphoma|2008|||
0-14|~|~|~|~|Mortality|61882854|All Races|Male and Female|Hodgkin Lymphoma|2009|||
0-14|0.1|0.1|0.1|54|Mortality|59955368|All Races|Male and Female|Kidney and Renal Pelvis|1999|||
0-14|0.1|0.1|0.1|46|Mortality|60300602|All Races|Male and Female|Kidney and Renal Pelvis|2000|||
0-14|0.1|0.1|0.1|58|Mortality|60566200|All Races|Male and Female|Kidney and Renal Pelvis|2001|||
0-14|0.1|0.1|0.1|42|Mortality|60764336|All Races|Male and Female|Kidney and Renal Pelvis|2002|||
0-14|0.1|0.1|0.1|54|Mortality|60910921|All Races|Male and Female|Kidney and Renal Pelvis|2003|||
0-14|0.1|0.1|0.1|51|Mortality|61011791|All Races|Male and Female|Kidney and Renal Pelvis|2004|||
0-14|0.1|0.1|0.1|54|Mortality|60953039|All Races|Male and Female|Kidney and Renal Pelvis|2005|||
0-14|0.1|0.1|0.1|217|Mortality|306722950|All Races|Male and Female|Kidney and Renal Pelvis|2005-2009|||
0-14|0.1|0.1|0.1|43|Mortality|61022964|All Races|Male and Female|Kidney and Renal Pelvis|2006|||
0-14|0.0|0.1|0.1|36|Mortality|61294588|All Races|Male and Female|Kidney and Renal Pelvis|2007|||
0-14|0.1|0.1|0.1|46|Mortality|61569505|All Races|Male and Female|Kidney and Renal Pelvis|2008|||
0-14|0.0|0.1|0.1|38|Mortality|61882854|All Races|Male and Female|Kidney and Renal Pelvis|2009|||
0-14|0.7|0.8|0.8|451|Mortality|59955368|All Races|Male and Female|Leukemia|1999|||
0-14|0.7|0.9|0.8|490|Mortality|60300602|All Races|Male and Female|Leukemia|2000|||
0-14|0.8|0.9|0.8|503|Mortality|60566200|All Races|Male and Female|Leukemia|2001|||
0-14|0.7|0.8|0.7|441|Mortality|60764336|All Races|Male and Female|Leukemia|2002|||
0-14|0.8|0.9|0.8|505|Mortality|60910921|All Races|Male and Female|Leukemia|2003|||
0-14|0.7|0.8|0.7|455|Mortality|61011791|All Races|Male and Female|Leukemia|2004|||
0-14|0.6|0.8|0.7|417|Mortality|60953039|All Races|Male and Female|Leukemia|2005|||
0-14|0.6|0.7|0.7|2060|Mortality|306722950|All Races|Male and Female|Leukemia|2005-2009|||
0-14|0.6|0.7|0.7|411|Mortality|61022964|All Races|Male and Female|Leukemia|2006|||
0-14|0.7|0.8|0.7|441|Mortality|61294588|All Races|Male and Female|Leukemia|2007|||
0-14|0.6|0.7|0.7|402|Mortality|61569505|All Races|Male and Female|Leukemia|2008|||
0-14|0.6|0.7|0.6|389|Mortality|61882854|All Races|Male and Female|Leukemia|2009|||
0-14|0.1|0.1|0.1|55|Mortality|59955368|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|||
0-14|0.1|0.1|0.1|55|Mortality|60300602|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|||
0-14|0.0|0.1|0.1|40|Mortality|60566200|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|||
0-14|0.1|0.2|0.1|74|Mortality|60764336|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|||
0-14|0.1|0.1|0.1|50|Mortality|60910921|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|||
0-14|0.1|0.1|0.1|44|Mortality|61011791|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|||
0-14|0.1|0.1|0.1|55|Mortality|60953039|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|||
0-14|0.1|0.1|0.1|216|Mortality|306722950|All Races|Male and Female|Non-Hodgkin Lymphoma|2005-2009|||
0-14|0.1|0.1|0.1|44|Mortality|61022964|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|||
0-14|0.0|0.1|0.1|40|Mortality|61294588|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|||
0-14|0.0|0.1|0.1|39|Mortality|61569505|All Races|Male and Female|Non-Hodgkin Lymphoma|2008|||
0-14|0.0|0.1|0.1|38|Mortality|61882854|All Races|Male and Female|Non-Hodgkin Lymphoma|2009|||
0-14|0.5|0.6|0.5|328|Mortality|59955368|All Races|Male and Female|Other|1999|||
0-14|0.5|0.6|0.6|333|Mortality|60300602|All Races|Male and Female|Other|2000|||
0-14|0.4|0.6|0.5|297|Mortality|60566200|All Races|Male and Female|Other|2001|||
0-14|0.5|0.6|0.6|342|Mortality|60764336|All Races|Male and Female|Other|2002|||
0-14|0.5|0.6|0.5|311|Mortality|60910921|All Races|Male and Female|Other|2003|||
0-14|0.5|0.6|0.5|317|Mortality|61011791|All Races|Male and Female|Other|2004|||
0-14|0.5|0.6|0.5|318|Mortality|60953039|All Races|Male and Female|Other|2005|||
0-14|0.5|0.5|0.5|1477|Mortality|306722950|All Races|Male and Female|Other|2005-2009|||
0-14|0.4|0.5|0.5|296|Mortality|61022964|All Races|Male and Female|Other|2006|||
0-14|0.4|0.6|0.5|306|Mortality|61294588|All Races|Male and Female|Other|2007|||
0-14|0.4|0.5|0.5|286|Mortality|61569505|All Races|Male and Female|Other|2008|||
0-14|0.4|0.5|0.4|271|Mortality|61882854|All Races|Male and Female|Other|2009|||
0-14|0.1|0.2|0.1|87|Mortality|59955368|All Races|Male and Female|Soft Tissue|1999|||
0-14|0.1|0.1|0.1|71|Mortality|60300602|All Races|Male and Female|Soft Tissue|2000|||
0-14|0.1|0.2|0.1|86|Mortality|60566200|All Races|Male and Female|Soft Tissue|2001|||
0-14|0.1|0.2|0.2|95|Mortality|60764336|All Races|Male and Female|Soft Tissue|2002|||
0-14|0.1|0.2|0.1|78|Mortality|60910921|All Races|Male and Female|Soft Tissue|2003|||
0-14|0.1|0.2|0.2|98|Mortality|61011791|All Races|Male and Female|Soft Tissue|2004|||
0-14|0.1|0.2|0.1|83|Mortality|60953039|All Races|Male and Female|Soft Tissue|2005|||
0-14|0.1|0.2|0.1|432|Mortality|306722950|All Races|Male and Female|Soft Tissue|2005-2009|||
0-14|0.1|0.2|0.1|80|Mortality|61022964|All Races|Male and Female|Soft Tissue|2006|||
0-14|0.1|0.2|0.1|82|Mortality|61294588|All Races|Male and Female|Soft Tissue|2007|||
0-14|0.1|0.2|0.1|89|Mortality|61569505|All Races|Male and Female|Soft Tissue|2008|||
0-14|0.1|0.2|0.2|98|Mortality|61882854|All Races|Male and Female|Soft Tissue|2009|||
0-19|2.5|2.8|2.7|938|Incidence|35359689|All Races|Female|Acute Lymphocytic|1999|2.5|2.8|2.7
0-19|2.7|3.0|2.8|1011|Incidence|35585399|All Races|Female|Acute Lymphocytic|2000|2.7|3.0|2.8
0-19|2.8|3.1|2.9|1088|Incidence|37294501|All Races|Female|Acute Lymphocytic|2001|2.7|3.1|2.9
0-19|2.6|2.9|2.7|1042|Incidence|38330396|All Races|Female|Acute Lymphocytic|2002|2.6|2.9|2.7
0-19|2.5|2.8|2.7|1055|Incidence|39731700|All Races|Female|Acute Lymphocytic|2003|2.5|2.8|2.7
0-19|2.6|2.9|2.7|1100|Incidence|39908757|All Races|Female|Acute Lymphocytic|2004|2.6|2.9|2.8
0-19|2.6|2.9|2.7|1097|Incidence|40041255|All Races|Female|Acute Lymphocytic|2005|2.6|2.9|2.7
0-19|2.8|2.9|2.9|5853|Incidence|202012800|All Races|Female|Acute Lymphocytic|2005-2009|2.8|3.0|2.9
0-19|2.6|3.0|2.8|1135|Incidence|40202922|All Races|Female|Acute Lymphocytic|2006|2.7|3.0|2.8
0-19|2.8|3.1|2.9|1193|Incidence|40435594|All Races|Female|Acute Lymphocytic|2007|2.8|3.1|3.0
0-19|2.9|3.2|3.0|1247|Incidence|40609057|All Races|Female|Acute Lymphocytic|2008|2.9|3.2|3.1
0-19|2.7|3.0|2.8|1156|Incidence|39998778|All Races|Female|Acute Lymphocytic|2009|2.7|3.1|2.9
0-19|0.6|0.8|0.7|241|Incidence|35359689|All Races|Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.7|0.6|224|Incidence|35585399|All Races|Female|Acute Myeloid|2000|0.5|0.7|0.6
0-19|0.6|0.7|0.7|247|Incidence|37294501|All Races|Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.6|0.8|0.7|257|Incidence|38330396|All Races|Female|Acute Myeloid|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|249|Incidence|39731700|All Races|Female|Acute Myeloid|2003|0.6|0.7|0.6
0-19|0.5|0.7|0.6|243|Incidence|39908757|All Races|Female|Acute Myeloid|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.6|262|Incidence|40041255|All Races|Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.7|0.7|0.7|1405|Incidence|202012800|All Races|Female|Acute Myeloid|2005-2009|0.7|0.7|0.7
0-19|0.6|0.8|0.7|288|Incidence|40202922|All Races|Female|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|274|Incidence|40435594|All Races|Female|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|292|Incidence|40609057|All Races|Female|Acute Myeloid|2008|0.6|0.8|0.7
0-19|0.6|0.8|0.7|279|Incidence|39998778|All Races|Female|Acute Myeloid|2009|0.6|0.8|0.7
0-19|14.5|15.3|14.9|5244|Incidence|35359689|All Races|Female|All Cancer Sites Combined|1999|14.4|15.2|14.8
0-19|15.0|15.8|15.4|5466|Incidence|35585399|All Races|Female|All Cancer Sites Combined|2000|15.0|15.8|15.4
0-19|15.7|16.6|16.2|6024|Incidence|37294501|All Races|Female|All Cancer Sites Combined|2001|15.7|16.6|16.2
0-19|15.2|16.0|15.6|5993|Incidence|38330396|All Races|Female|All Cancer Sites Combined|2002|15.2|16.0|15.6
0-19|15.6|16.4|16.0|6393|Incidence|39731700|All Races|Female|All Cancer Sites Combined|2003|15.7|16.5|16.1
0-19|15.9|16.7|16.3|6537|Incidence|39908757|All Races|Female|All Cancer Sites Combined|2004|16.0|16.8|16.4
0-19|15.8|16.5|16.1|6523|Incidence|40041255|All Races|Female|All Cancer Sites Combined|2005|15.9|16.7|16.3
0-19|16.1|16.4|16.3|33182|Incidence|202012800|All Races|Female|All Cancer Sites Combined|2005-2009|16.2|16.6|16.4
0-19|15.5|16.3|15.9|6465|Incidence|40202922|All Races|Female|All Cancer Sites Combined|2006|15.7|16.5|16.1
0-19|16.1|16.9|16.5|6740|Incidence|40435594|All Races|Female|All Cancer Sites Combined|2007|16.3|17.1|16.7
0-19|16.2|16.9|16.5|6794|Incidence|40609057|All Races|Female|All Cancer Sites Combined|2008|16.3|17.1|16.7
0-19|15.8|16.6|16.2|6542|Incidence|39998778|All Races|Female|All Cancer Sites Combined|2009|16.0|16.8|16.4
0-19|0.7|0.9|0.8|276|Incidence|35359689|All Races|Female|Bones and Joints|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|283|Incidence|35585399|All Races|Female|Bones and Joints|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|309|Incidence|37294501|All Races|Female|Bones and Joints|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|294|Incidence|38330396|All Races|Female|Bones and Joints|2002|0.7|0.9|0.8
0-19|0.8|0.9|0.8|338|Incidence|39731700|All Races|Female|Bones and Joints|2003|0.8|0.9|0.9
0-19|0.8|1.0|0.9|354|Incidence|39908757|All Races|Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.7|0.9|0.8|320|Incidence|40041255|All Races|Female|Bones and Joints|2005|0.7|0.9|0.8
0-19|0.8|0.8|0.8|1590|Incidence|202012800|All Races|Female|Bones and Joints|2005-2009|0.7|0.8|0.8
0-19|0.7|0.9|0.8|328|Incidence|40202922|All Races|Female|Bones and Joints|2006|0.7|0.9|0.8
0-19|0.7|0.9|0.8|308|Incidence|40435594|All Races|Female|Bones and Joints|2007|0.7|0.9|0.8
0-19|0.7|0.9|0.8|321|Incidence|40609057|All Races|Female|Bones and Joints|2008|0.7|0.9|0.8
0-19|0.7|0.9|0.8|310|Incidence|39998778|All Races|Female|Bones and Joints|2009|0.7|0.9|0.8
0-19|2.6|2.9|2.7|969|Incidence|35359689|All Races|Female|Brain and Other Nervous System|1999|2.6|2.9|2.7
0-19|2.6|3.0|2.8|1000|Incidence|35585399|All Races|Female|Brain and Other Nervous System|2000|2.6|3.0|2.8
0-19|2.7|3.0|2.8|1058|Incidence|37294501|All Races|Female|Brain and Other Nervous System|2001|2.7|3.0|2.8
0-19|2.6|2.9|2.8|1055|Incidence|38330396|All Races|Female|Brain and Other Nervous System|2002|2.6|2.9|2.8
0-19|2.8|3.1|2.9|1159|Incidence|39731700|All Races|Female|Brain and Other Nervous System|2003|2.8|3.1|2.9
0-19|2.9|3.3|3.1|1234|Incidence|39908757|All Races|Female|Brain and Other Nervous System|2004|2.9|3.3|3.1
0-19|2.7|3.1|2.9|1158|Incidence|40041255|All Races|Female|Brain and Other Nervous System|2005|2.7|3.1|2.9
0-19|2.8|3.0|2.9|5900|Incidence|202012800|All Races|Female|Brain and Other Nervous System|2005-2009|2.8|3.0|2.9
0-19|2.7|3.0|2.9|1159|Incidence|40202922|All Races|Female|Brain and Other Nervous System|2006|2.7|3.1|2.9
0-19|2.9|3.2|3.1|1244|Incidence|40435594|All Races|Female|Brain and Other Nervous System|2007|2.9|3.3|3.1
0-19|2.8|3.1|2.9|1196|Incidence|40609057|All Races|Female|Brain and Other Nervous System|2008|2.8|3.1|2.9
0-19|2.6|3.0|2.8|1119|Incidence|39998778|All Races|Female|Brain and Other Nervous System|2009|2.6|3.0|2.8
0-19|1.0|1.2|1.1|376|Incidence|35359689|All Races|Female|Hodgkin Lymphoma|1999|1.0|1.2|1.1
0-19|1.1|1.3|1.2|429|Incidence|35585399|All Races|Female|Hodgkin Lymphoma|2000|1.1|1.3|1.2
0-19|1.1|1.3|1.2|449|Incidence|37294501|All Races|Female|Hodgkin Lymphoma|2001|1.1|1.3|1.2
0-19|1.1|1.3|1.2|466|Incidence|38330396|All Races|Female|Hodgkin Lymphoma|2002|1.1|1.3|1.2
0-19|1.1|1.3|1.2|465|Incidence|39731700|All Races|Female|Hodgkin Lymphoma|2003|1.1|1.3|1.2
0-19|1.1|1.3|1.2|474|Incidence|39908757|All Races|Female|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.1|1.3|1.2|491|Incidence|40041255|All Races|Female|Hodgkin Lymphoma|2005|1.1|1.3|1.2
0-19|1.2|1.3|1.2|2450|Incidence|202012800|All Races|Female|Hodgkin Lymphoma|2005-2009|1.2|1.3|1.2
0-19|1.1|1.3|1.2|475|Incidence|40202922|All Races|Female|Hodgkin Lymphoma|2006|1.1|1.3|1.2
0-19|1.0|1.2|1.1|454|Incidence|40435594|All Races|Female|Hodgkin Lymphoma|2007|1.0|1.2|1.1
0-19|1.2|1.4|1.3|531|Incidence|40609057|All Races|Female|Hodgkin Lymphoma|2008|1.2|1.4|1.3
0-19|1.1|1.3|1.2|491|Incidence|39998778|All Races|Female|Hodgkin Lymphoma|2009|1.1|1.3|1.2
0-19|0.6|0.8|0.7|254|Incidence|35359689|All Races|Female|Kidney and Renal Pelvis|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|259|Incidence|35585399|All Races|Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.7|0.8|0.8|279|Incidence|37294501|All Races|Female|Kidney and Renal Pelvis|2001|0.7|0.8|0.7
0-19|0.6|0.7|0.7|254|Incidence|38330396|All Races|Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.7
0-19|0.7|0.9|0.8|308|Incidence|39731700|All Races|Female|Kidney and Renal Pelvis|2003|0.7|0.9|0.8
0-19|0.6|0.8|0.7|270|Incidence|39908757|All Races|Female|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|295|Incidence|40041255|All Races|Female|Kidney and Renal Pelvis|2005|0.7|0.8|0.7
0-19|0.7|0.8|0.8|1558|Incidence|202012800|All Races|Female|Kidney and Renal Pelvis|2005-2009|0.7|0.8|0.8
0-19|0.6|0.8|0.7|284|Incidence|40202922|All Races|Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|323|Incidence|40435594|All Races|Female|Kidney and Renal Pelvis|2007|0.7|0.9|0.8
0-19|0.7|0.9|0.8|330|Incidence|40609057|All Races|Female|Kidney and Renal Pelvis|2008|0.7|0.9|0.8
0-19|0.7|0.9|0.8|323|Incidence|39998778|All Races|Female|Kidney and Renal Pelvis|2009|0.7|0.9|0.8
0-19|3.4|3.8|3.6|1284|Incidence|35359689|All Races|Female|Leukemia|1999|3.4|3.8|3.6
0-19|3.6|4.0|3.8|1343|Incidence|35585399|All Races|Female|Leukemia|2000|3.6|4.0|3.8
0-19|3.8|4.2|4.0|1480|Incidence|37294501|All Races|Female|Leukemia|2001|3.8|4.2|4.0
0-19|3.6|4.0|3.8|1454|Incidence|38330396|All Races|Female|Leukemia|2002|3.6|4.0|3.8
0-19|3.4|3.8|3.6|1435|Incidence|39731700|All Races|Female|Leukemia|2003|3.4|3.8|3.6
0-19|3.5|3.9|3.7|1486|Incidence|39908757|All Races|Female|Leukemia|2004|3.5|3.9|3.7
0-19|3.5|3.9|3.7|1506|Incidence|40041255|All Races|Female|Leukemia|2005|3.6|4.0|3.8
0-19|3.8|4.0|3.9|7977|Incidence|202012800|All Races|Female|Leukemia|2005-2009|3.9|4.0|3.9
0-19|3.7|4.1|3.9|1577|Incidence|40202922|All Races|Female|Leukemia|2006|3.7|4.1|3.9
0-19|3.8|4.2|4.0|1620|Incidence|40435594|All Races|Female|Leukemia|2007|3.8|4.2|4.0
0-19|3.9|4.3|4.1|1671|Incidence|40609057|All Races|Female|Leukemia|2008|3.9|4.3|4.1
0-19|3.7|4.0|3.8|1562|Incidence|39998778|All Races|Female|Leukemia|2009|3.7|4.1|3.9
0-19|0.6|0.8|0.7|247|Incidence|35359689|All Races|Female|Non-Hodgkin Lymphoma|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|277|Incidence|35585399|All Races|Female|Non-Hodgkin Lymphoma|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|297|Incidence|37294501|All Races|Female|Non-Hodgkin Lymphoma|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|299|Incidence|38330396|All Races|Female|Non-Hodgkin Lymphoma|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|294|Incidence|39731700|All Races|Female|Non-Hodgkin Lymphoma|2003|0.7|0.8|0.7
0-19|0.7|0.9|0.8|314|Incidence|39908757|All Races|Female|Non-Hodgkin Lymphoma|2004|0.7|0.9|0.8
0-19|0.7|0.9|0.8|314|Incidence|40041255|All Races|Female|Non-Hodgkin Lymphoma|2005|0.7|0.9|0.8
0-19|0.7|0.8|0.8|1550|Incidence|202012800|All Races|Female|Non-Hodgkin Lymphoma|2005-2009|0.7|0.8|0.8
0-19|0.7|0.8|0.8|303|Incidence|40202922|All Races|Female|Non-Hodgkin Lymphoma|2006|0.7|0.8|0.8
0-19|0.7|0.9|0.8|318|Incidence|40435594|All Races|Female|Non-Hodgkin Lymphoma|2007|0.7|0.9|0.8
0-19|0.7|0.8|0.8|306|Incidence|40609057|All Races|Female|Non-Hodgkin Lymphoma|2008|0.7|0.8|0.8
0-19|0.7|0.9|0.8|307|Incidence|39998778|All Races|Female|Non-Hodgkin Lymphoma|2009|0.7|0.9|0.8
0-19|4.1|4.6|4.3|1524|Incidence|35359689|All Races|Female|Other|1999|4.1|4.5|4.3
0-19|4.1|4.5|4.3|1528|Incidence|35585399|All Races|Female|Other|2000|4.1|4.5|4.3
0-19|4.6|5.0|4.8|1783|Incidence|37294501|All Races|Female|Other|2001|4.6|5.0|4.8
0-19|4.5|4.9|4.7|1792|Incidence|38330396|All Races|Female|Other|2002|4.5|4.9|4.7
0-19|4.7|5.2|5.0|1981|Incidence|39731700|All Races|Female|Other|2003|4.8|5.2|5.0
0-19|4.7|5.1|4.9|1978|Incidence|39908757|All Races|Female|Other|2004|4.7|5.2|5.0
0-19|4.8|5.3|5.0|2051|Incidence|40041255|All Races|Female|Other|2005|4.9|5.3|5.1
0-19|4.8|5.0|4.9|10057|Incidence|202012800|All Races|Female|Other|2005-2009|4.9|5.1|5.0
0-19|4.5|5.0|4.7|1943|Incidence|40202922|All Races|Female|Other|2006|4.6|5.1|4.8
0-19|4.7|5.1|4.9|2017|Incidence|40435594|All Races|Female|Other|2007|4.8|5.2|5.0
0-19|4.6|5.0|4.8|1999|Incidence|40609057|All Races|Female|Other|2008|4.7|5.1|4.9
0-19|4.7|5.2|5.0|2014|Incidence|39998778|All Races|Female|Other|2009|4.8|5.3|5.0
0-19|0.8|1.0|0.9|314|Incidence|35359689|All Races|Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|347|Incidence|35585399|All Races|Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|369|Incidence|37294501|All Races|Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|379|Incidence|38330396|All Races|Female|Soft Tissue|2002|0.9|1.1|1.0
0-19|0.9|1.1|1.0|413|Incidence|39731700|All Races|Female|Soft Tissue|2003|0.9|1.1|1.0
0-19|1.0|1.2|1.1|427|Incidence|39908757|All Races|Female|Soft Tissue|2004|1.0|1.2|1.1
0-19|0.9|1.1|1.0|388|Incidence|40041255|All Races|Female|Soft Tissue|2005|0.9|1.1|1.0
0-19|1.0|1.1|1.0|2100|Incidence|202012800|All Races|Female|Soft Tissue|2005-2009|1.0|1.1|1.0
0-19|0.9|1.1|1.0|396|Incidence|40202922|All Races|Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|456|Incidence|40435594|All Races|Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|1.0|1.2|1.1|440|Incidence|40609057|All Races|Female|Soft Tissue|2008|1.0|1.2|1.1
0-19|0.9|1.1|1.0|416|Incidence|39998778|All Races|Female|Soft Tissue|2009|0.9|1.1|1.0
0-19|3.2|3.6|3.4|1257|Incidence|37188457|All Races|Male|Acute Lymphocytic|1999|3.2|3.6|3.4
0-19|3.2|3.6|3.4|1277|Incidence|37431805|All Races|Male|Acute Lymphocytic|2000|3.2|3.6|3.4
0-19|3.4|3.7|3.5|1380|Incidence|39251872|All Races|Male|Acute Lymphocytic|2001|3.3|3.7|3.5
0-19|3.3|3.7|3.5|1398|Incidence|40327357|All Races|Male|Acute Lymphocytic|2002|3.3|3.7|3.5
0-19|3.2|3.5|3.3|1390|Incidence|41753613|All Races|Male|Acute Lymphocytic|2003|3.2|3.5|3.3
0-19|3.5|3.9|3.7|1563|Incidence|41911213|All Races|Male|Acute Lymphocytic|2004|3.5|3.9|3.7
0-19|3.3|3.7|3.5|1485|Incidence|42031490|All Races|Male|Acute Lymphocytic|2005|3.4|3.7|3.5
0-19|3.6|3.7|3.6|7759|Incidence|211925010|All Races|Male|Acute Lymphocytic|2005-2009|3.6|3.7|3.7
0-19|3.5|3.8|3.6|1547|Incidence|42186878|All Races|Male|Acute Lymphocytic|2006|3.5|3.9|3.7
0-19|3.5|3.8|3.7|1566|Incidence|42421376|All Races|Male|Acute Lymphocytic|2007|3.5|3.9|3.7
0-19|3.5|3.9|3.7|1578|Incidence|42588547|All Races|Male|Acute Lymphocytic|2008|3.5|3.9|3.7
0-19|3.5|3.9|3.7|1558|Incidence|41939120|All Races|Male|Acute Lymphocytic|2009|3.5|3.9|3.7
0-19|0.7|0.9|0.8|293|Incidence|37188457|All Races|Male|Acute Myeloid|1999|0.7|0.9|0.8
0-19|0.6|0.8|0.7|251|Incidence|37431805|All Races|Male|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.7|0.8|0.8|295|Incidence|39251872|All Races|Male|Acute Myeloid|2001|0.7|0.8|0.8
0-19|0.7|0.8|0.8|306|Incidence|40327357|All Races|Male|Acute Myeloid|2002|0.7|0.8|0.8
0-19|0.7|0.8|0.7|308|Incidence|41753613|All Races|Male|Acute Myeloid|2003|0.7|0.8|0.7
0-19|0.8|0.9|0.8|355|Incidence|41911213|All Races|Male|Acute Myeloid|2004|0.8|0.9|0.8
0-19|0.6|0.7|0.7|281|Incidence|42031490|All Races|Male|Acute Myeloid|2005|0.6|0.8|0.7
0-19|0.7|0.7|0.7|1485|Incidence|211925010|All Races|Male|Acute Myeloid|2005-2009|0.7|0.7|0.7
0-19|0.6|0.8|0.7|300|Incidence|42186878|All Races|Male|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|304|Incidence|42421376|All Races|Male|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.7|0.9|0.8|328|Incidence|42588547|All Races|Male|Acute Myeloid|2008|0.7|0.9|0.8
0-19|0.6|0.7|0.6|268|Incidence|41939120|All Races|Male|Acute Myeloid|2009|0.6|0.7|0.6
0-19|16.4|17.3|16.8|6250|Incidence|37188457|All Races|Male|All Cancer Sites Combined|1999|16.4|17.2|16.8
0-19|16.7|17.6|17.2|6412|Incidence|37431805|All Races|Male|All Cancer Sites Combined|2000|16.7|17.6|17.1
0-19|17.3|18.2|17.7|6965|Incidence|39251872|All Races|Male|All Cancer Sites Combined|2001|17.3|18.2|17.7
0-19|17.7|18.5|18.1|7310|Incidence|40327357|All Races|Male|All Cancer Sites Combined|2002|17.7|18.5|18.1
0-19|16.8|17.6|17.2|7193|Incidence|41753613|All Races|Male|All Cancer Sites Combined|2003|16.8|17.6|17.2
0-19|17.8|18.6|18.2|7658|Incidence|41911213|All Races|Male|All Cancer Sites Combined|2004|17.9|18.7|18.3
0-19|17.4|18.3|17.8|7565|Incidence|42031490|All Races|Male|All Cancer Sites Combined|2005|17.6|18.4|18.0
0-19|17.8|18.2|18.0|38546|Incidence|211925010|All Races|Male|All Cancer Sites Combined|2005-2009|18.0|18.4|18.2
0-19|17.7|18.5|18.1|7691|Incidence|42186878|All Races|Male|All Cancer Sites Combined|2006|17.8|18.6|18.2
0-19|17.7|18.6|18.1|7786|Incidence|42421376|All Races|Male|All Cancer Sites Combined|2007|17.9|18.8|18.4
0-19|17.9|18.7|18.3|7882|Incidence|42588547|All Races|Male|All Cancer Sites Combined|2008|18.1|18.9|18.5
0-19|17.3|18.1|17.7|7481|Incidence|41939120|All Races|Male|All Cancer Sites Combined|2009|17.4|18.2|17.8
0-19|0.9|1.1|1.0|379|Incidence|37188457|All Races|Male|Bones and Joints|1999|0.9|1.1|1.0
0-19|0.8|1.0|0.9|352|Incidence|37431805|All Races|Male|Bones and Joints|2000|0.8|1.0|0.9
0-19|1.0|1.2|1.1|431|Incidence|39251872|All Races|Male|Bones and Joints|2001|1.0|1.2|1.1
0-19|1.0|1.2|1.1|446|Incidence|40327357|All Races|Male|Bones and Joints|2002|1.0|1.2|1.1
0-19|0.9|1.0|0.9|398|Incidence|41753613|All Races|Male|Bones and Joints|2003|0.9|1.1|1.0
0-19|0.9|1.1|1.0|410|Incidence|41911213|All Races|Male|Bones and Joints|2004|0.9|1.1|1.0
0-19|0.9|1.1|1.0|422|Incidence|42031490|All Races|Male|Bones and Joints|2005|0.9|1.1|1.0
0-19|1.0|1.1|1.0|2155|Incidence|211925010|All Races|Male|Bones and Joints|2005-2009|1.0|1.1|1.0
0-19|1.0|1.2|1.1|464|Incidence|42186878|All Races|Male|Bones and Joints|2006|1.0|1.2|1.1
0-19|0.9|1.1|1.0|433|Incidence|42421376|All Races|Male|Bones and Joints|2007|0.9|1.1|1.0
0-19|0.9|1.1|1.0|413|Incidence|42588547|All Races|Male|Bones and Joints|2008|0.9|1.1|1.0
0-19|0.9|1.1|1.0|417|Incidence|41939120|All Races|Male|Bones and Joints|2009|0.9|1.1|1.0
0-19|2.9|3.3|3.1|1147|Incidence|37188457|All Races|Male|Brain and Other Nervous System|1999|2.9|3.3|3.1
0-19|3.1|3.5|3.3|1240|Incidence|37431805|All Races|Male|Brain and Other Nervous System|2000|3.1|3.5|3.3
0-19|3.0|3.3|3.2|1238|Incidence|39251872|All Races|Male|Brain and Other Nervous System|2001|3.0|3.3|3.2
0-19|3.3|3.7|3.5|1404|Incidence|40327357|All Races|Male|Brain and Other Nervous System|2002|3.3|3.7|3.5
0-19|3.0|3.3|3.1|1301|Incidence|41753613|All Races|Male|Brain and Other Nervous System|2003|2.9|3.3|3.1
0-19|3.1|3.5|3.3|1374|Incidence|41911213|All Races|Male|Brain and Other Nervous System|2004|3.1|3.5|3.3
0-19|2.9|3.3|3.1|1302|Incidence|42031490|All Races|Male|Brain and Other Nervous System|2005|2.9|3.3|3.1
0-19|3.2|3.3|3.2|6858|Incidence|211925010|All Races|Male|Brain and Other Nervous System|2005-2009|3.2|3.3|3.2
0-19|3.1|3.5|3.3|1396|Incidence|42186878|All Races|Male|Brain and Other Nervous System|2006|3.1|3.5|3.3
0-19|3.1|3.4|3.3|1380|Incidence|42421376|All Races|Male|Brain and Other Nervous System|2007|3.1|3.4|3.3
0-19|3.2|3.5|3.3|1430|Incidence|42588547|All Races|Male|Brain and Other Nervous System|2008|3.2|3.5|3.4
0-19|2.9|3.3|3.1|1307|Incidence|41939120|All Races|Male|Brain and Other Nervous System|2009|2.9|3.3|3.1
0-19|1.2|1.4|1.3|481|Incidence|37188457|All Races|Male|Hodgkin Lymphoma|1999|1.2|1.4|1.3
0-19|1.1|1.4|1.3|471|Incidence|37431805|All Races|Male|Hodgkin Lymphoma|2000|1.1|1.4|1.3
0-19|1.2|1.4|1.3|512|Incidence|39251872|All Races|Male|Hodgkin Lymphoma|2001|1.2|1.4|1.3
0-19|1.1|1.4|1.2|503|Incidence|40327357|All Races|Male|Hodgkin Lymphoma|2002|1.1|1.4|1.2
0-19|1.2|1.4|1.3|557|Incidence|41753613|All Races|Male|Hodgkin Lymphoma|2003|1.2|1.4|1.3
0-19|1.1|1.3|1.2|511|Incidence|41911213|All Races|Male|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.2|1.5|1.4|575|Incidence|42031490|All Races|Male|Hodgkin Lymphoma|2005|1.3|1.5|1.4
0-19|1.3|1.4|1.3|2824|Incidence|211925010|All Races|Male|Hodgkin Lymphoma|2005-2009|1.3|1.4|1.3
0-19|1.2|1.5|1.3|573|Incidence|42186878|All Races|Male|Hodgkin Lymphoma|2006|1.2|1.5|1.4
0-19|1.2|1.4|1.3|567|Incidence|42421376|All Races|Male|Hodgkin Lymphoma|2007|1.2|1.5|1.3
0-19|1.2|1.4|1.3|562|Incidence|42588547|All Races|Male|Hodgkin Lymphoma|2008|1.2|1.4|1.3
0-19|1.2|1.4|1.3|535|Incidence|41939120|All Races|Male|Hodgkin Lymphoma|2009|1.2|1.4|1.3
0-19|0.5|0.7|0.6|226|Incidence|37188457|All Races|Male|Kidney and Renal Pelvis|1999|0.5|0.7|0.6
0-19|0.6|0.8|0.7|248|Incidence|37431805|All Races|Male|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.6|0.7|0.6|253|Incidence|39251872|All Races|Male|Kidney and Renal Pelvis|2001|0.6|0.7|0.6
0-19|0.6|0.8|0.7|270|Incidence|40327357|All Races|Male|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|249|Incidence|41753613|All Races|Male|Kidney and Renal Pelvis|2003|0.5|0.7|0.6
0-19|0.6|0.7|0.6|275|Incidence|41911213|All Races|Male|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.6|271|Incidence|42031490|All Races|Male|Kidney and Renal Pelvis|2005|0.6|0.7|0.6
0-19|0.6|0.7|0.6|1390|Incidence|211925010|All Races|Male|Kidney and Renal Pelvis|2005-2009|0.6|0.7|0.7
0-19|0.6|0.8|0.7|287|Incidence|42186878|All Races|Male|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.5|0.7|0.6|258|Incidence|42421376|All Races|Male|Kidney and Renal Pelvis|2007|0.5|0.7|0.6
0-19|0.6|0.7|0.6|284|Incidence|42588547|All Races|Male|Kidney and Renal Pelvis|2008|0.6|0.7|0.7
0-19|0.6|0.7|0.6|282|Incidence|41939120|All Races|Male|Kidney and Renal Pelvis|2009|0.6|0.8|0.7
0-19|4.3|4.8|4.6|1695|Incidence|37188457|All Races|Male|Leukemia|1999|4.3|4.8|4.6
0-19|4.2|4.7|4.4|1656|Incidence|37431805|All Races|Male|Leukemia|2000|4.2|4.6|4.4
0-19|4.5|4.9|4.7|1841|Incidence|39251872|All Races|Male|Leukemia|2001|4.5|4.9|4.7
0-19|4.4|4.9|4.6|1868|Incidence|40327357|All Races|Male|Leukemia|2002|4.4|4.8|4.6
0-19|4.3|4.7|4.5|1870|Incidence|41753613|All Races|Male|Leukemia|2003|4.3|4.7|4.5
0-19|4.8|5.2|5.0|2101|Incidence|41911213|All Races|Male|Leukemia|2004|4.8|5.2|5.0
0-19|4.4|4.8|4.6|1960|Incidence|42031490|All Races|Male|Leukemia|2005|4.5|4.9|4.7
0-19|4.7|4.8|4.8|10164|Incidence|211925010|All Races|Male|Leukemia|2005-2009|4.7|4.9|4.8
0-19|4.6|5.0|4.8|2042|Incidence|42186878|All Races|Male|Leukemia|2006|4.6|5.1|4.8
0-19|4.6|5.0|4.8|2050|Incidence|42421376|All Races|Male|Leukemia|2007|4.6|5.0|4.8
0-19|4.7|5.1|4.9|2096|Incidence|42588547|All Races|Male|Leukemia|2008|4.7|5.1|4.9
0-19|4.5|4.9|4.7|1985|Incidence|41939120|All Races|Male|Leukemia|2009|4.5|4.9|4.7
0-19|1.3|1.5|1.4|512|Incidence|37188457|All Races|Male|Non-Hodgkin Lymphoma|1999|1.3|1.5|1.4
0-19|1.4|1.6|1.5|560|Incidence|37431805|All Races|Male|Non-Hodgkin Lymphoma|2000|1.4|1.6|1.5
0-19|1.3|1.6|1.4|563|Incidence|39251872|All Races|Male|Non-Hodgkin Lymphoma|2001|1.3|1.6|1.4
0-19|1.3|1.6|1.4|581|Incidence|40327357|All Races|Male|Non-Hodgkin Lymphoma|2002|1.3|1.6|1.4
0-19|1.3|1.5|1.4|586|Incidence|41753613|All Races|Male|Non-Hodgkin Lymphoma|2003|1.3|1.5|1.4
0-19|1.3|1.6|1.4|602|Incidence|41911213|All Races|Male|Non-Hodgkin Lymphoma|2004|1.3|1.6|1.4
0-19|1.4|1.7|1.5|648|Incidence|42031490|All Races|Male|Non-Hodgkin Lymphoma|2005|1.4|1.7|1.5
0-19|1.5|1.6|1.5|3185|Incidence|211925010|All Races|Male|Non-Hodgkin Lymphoma|2005-2009|1.5|1.6|1.5
0-19|1.4|1.6|1.5|629|Incidence|42186878|All Races|Male|Non-Hodgkin Lymphoma|2006|1.4|1.6|1.5
0-19|1.4|1.7|1.5|648|Incidence|42421376|All Races|Male|Non-Hodgkin Lymphoma|2007|1.4|1.6|1.5
0-19|1.4|1.6|1.5|645|Incidence|42588547|All Races|Male|Non-Hodgkin Lymphoma|2008|1.4|1.6|1.5
0-19|1.4|1.6|1.5|612|Incidence|41939120|All Races|Male|Non-Hodgkin Lymphoma|2009|1.3|1.6|1.5
0-19|3.8|4.2|4.0|1491|Incidence|37188457|All Races|Male|Other|1999|3.8|4.2|4.0
0-19|3.8|4.2|4.0|1490|Incidence|37431805|All Races|Male|Other|2000|3.8|4.2|4.0
0-19|4.2|4.6|4.4|1731|Incidence|39251872|All Races|Male|Other|2001|4.2|4.6|4.4
0-19|4.3|4.7|4.5|1812|Incidence|40327357|All Races|Male|Other|2002|4.3|4.7|4.5
0-19|4.1|4.5|4.3|1816|Incidence|41753613|All Races|Male|Other|2003|4.2|4.6|4.3
0-19|4.4|4.8|4.6|1955|Incidence|41911213|All Races|Male|Other|2004|4.5|4.9|4.7
0-19|4.3|4.7|4.5|1915|Incidence|42031490|All Races|Male|Other|2005|4.4|4.8|4.6
0-19|4.4|4.6|4.5|9688|Incidence|211925010|All Races|Male|Other|2005-2009|4.5|4.7|4.6
0-19|4.2|4.5|4.3|1872|Incidence|42186878|All Races|Male|Other|2006|4.2|4.6|4.4
0-19|4.4|4.8|4.6|2003|Incidence|42421376|All Races|Male|Other|2007|4.5|4.9|4.7
0-19|4.3|4.7|4.5|1986|Incidence|42588547|All Races|Male|Other|2008|4.5|4.9|4.7
0-19|4.2|4.6|4.4|1883|Incidence|41939120|All Races|Male|Other|2009|4.3|4.7|4.5
0-19|0.8|1.0|0.9|319|Incidence|37188457|All Races|Male|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|395|Incidence|37431805|All Races|Male|Soft Tissue|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|396|Incidence|39251872|All Races|Male|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.2|1.1|426|Incidence|40327357|All Races|Male|Soft Tissue|2002|1.0|1.2|1.1
0-19|0.9|1.1|1.0|416|Incidence|41753613|All Races|Male|Soft Tissue|2003|0.9|1.1|1.0
0-19|0.9|1.1|1.0|430|Incidence|41911213|All Races|Male|Soft Tissue|2004|0.9|1.1|1.0
0-19|1.0|1.2|1.1|472|Incidence|42031490|All Races|Male|Soft Tissue|2005|1.0|1.2|1.1
0-19|1.0|1.1|1.1|2282|Incidence|211925010|All Races|Male|Soft Tissue|2005-2009|1.0|1.1|1.1
0-19|0.9|1.1|1.0|428|Incidence|42186878|All Races|Male|Soft Tissue|2006|0.9|1.1|1.0
0-19|0.9|1.1|1.0|447|Incidence|42421376|All Races|Male|Soft Tissue|2007|1.0|1.2|1.1
0-19|1.0|1.2|1.1|466|Incidence|42588547|All Races|Male|Soft Tissue|2008|1.0|1.2|1.1
0-19|1.0|1.2|1.1|460|Incidence|41939120|All Races|Male|Soft Tissue|2009|1.0|1.2|1.1
0-19|2.9|3.2|3.0|2195|Incidence|72548146|All Races|Male and Female|Acute Lymphocytic|1999|2.9|3.2|3.0
0-19|3.0|3.3|3.1|2288|Incidence|73017204|All Races|Male and Female|Acute Lymphocytic|2000|3.0|3.3|3.1
0-19|3.1|3.4|3.2|2468|Incidence|76546373|All Races|Male and Female|Acute Lymphocytic|2001|3.1|3.4|3.2
0-19|3.0|3.2|3.1|2440|Incidence|78657753|All Races|Male and Female|Acute Lymphocytic|2002|3.0|3.2|3.1
0-19|2.9|3.1|3.0|2445|Incidence|81485313|All Races|Male and Female|Acute Lymphocytic|2003|2.9|3.1|3.0
0-19|3.1|3.4|3.2|2663|Incidence|81819970|All Races|Male and Female|Acute Lymphocytic|2004|3.1|3.4|3.3
0-19|3.0|3.3|3.1|2582|Incidence|82072745|All Races|Male and Female|Acute Lymphocytic|2005|3.0|3.3|3.1
0-19|3.2|3.3|3.3|13612|Incidence|413937810|All Races|Male and Female|Acute Lymphocytic|2005-2009|3.2|3.3|3.3
0-19|3.1|3.4|3.2|2682|Incidence|82389800|All Races|Male and Female|Acute Lymphocytic|2006|3.1|3.4|3.3
0-19|3.2|3.4|3.3|2759|Incidence|82856970|All Races|Male and Female|Acute Lymphocytic|2007|3.2|3.5|3.3
0-19|3.2|3.5|3.4|2825|Incidence|83197604|All Races|Male and Female|Acute Lymphocytic|2008|3.3|3.5|3.4
0-19|3.1|3.4|3.3|2714|Incidence|81937898|All Races|Male and Female|Acute Lymphocytic|2009|3.2|3.4|3.3
0-19|0.7|0.8|0.7|534|Incidence|72548146|All Races|Male and Female|Acute Myeloid|1999|0.7|0.8|0.7
0-19|0.6|0.7|0.7|475|Incidence|73017204|All Races|Male and Female|Acute Myeloid|2000|0.6|0.7|0.7
0-19|0.6|0.8|0.7|542|Incidence|76546373|All Races|Male and Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.7|0.8|0.7|563|Incidence|78657753|All Races|Male and Female|Acute Myeloid|2002|0.7|0.8|0.7
0-19|0.6|0.7|0.7|557|Incidence|81485313|All Races|Male and Female|Acute Myeloid|2003|0.6|0.7|0.7
0-19|0.7|0.8|0.7|598|Incidence|81819970|All Races|Male and Female|Acute Myeloid|2004|0.7|0.8|0.7
0-19|0.6|0.7|0.7|543|Incidence|82072745|All Races|Male and Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.7|0.7|0.7|2890|Incidence|413937810|All Races|Male and Female|Acute Myeloid|2005-2009|0.7|0.7|0.7
0-19|0.7|0.8|0.7|588|Incidence|82389800|All Races|Male and Female|Acute Myeloid|2006|0.7|0.8|0.7
0-19|0.6|0.7|0.7|578|Incidence|82856970|All Races|Male and Female|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.7|0.8|0.7|620|Incidence|83197604|All Races|Male and Female|Acute Myeloid|2008|0.7|0.8|0.7
0-19|0.6|0.7|0.7|547|Incidence|81937898|All Races|Male and Female|Acute Myeloid|2009|0.6|0.7|0.7
0-19|15.6|16.2|15.9|11494|Incidence|72548146|All Races|Male and Female|All Cancer Sites Combined|1999|15.6|16.1|15.8
0-19|16.0|16.6|16.3|11878|Incidence|73017204|All Races|Male and Female|All Cancer Sites Combined|2000|16.0|16.6|16.3
0-19|16.7|17.3|17.0|12989|Incidence|76546373|All Races|Male and Female|All Cancer Sites Combined|2001|16.7|17.3|17.0
0-19|16.6|17.2|16.9|13303|Incidence|78657753|All Races|Male and Female|All Cancer Sites Combined|2002|16.6|17.2|16.9
0-19|16.3|16.9|16.6|13586|Incidence|81485313|All Races|Male and Female|All Cancer Sites Combined|2003|16.4|17.0|16.7
0-19|17.0|17.5|17.2|14195|Incidence|81819970|All Races|Male and Female|All Cancer Sites Combined|2004|17.1|17.6|17.3
0-19|16.7|17.3|17.0|14088|Incidence|82072745|All Races|Male and Female|All Cancer Sites Combined|2005|16.9|17.5|17.2
0-19|17.0|17.3|17.2|71728|Incidence|413937810|All Races|Male and Female|All Cancer Sites Combined|2005-2009|17.2|17.5|17.3
0-19|16.7|17.3|17.0|14156|Incidence|82389800|All Races|Male and Female|All Cancer Sites Combined|2006|16.9|17.5|17.2
0-19|17.1|17.6|17.3|14526|Incidence|82856970|All Races|Male and Female|All Cancer Sites Combined|2007|17.2|17.8|17.5
0-19|17.2|17.7|17.4|14676|Incidence|83197604|All Races|Male and Female|All Cancer Sites Combined|2008|17.4|17.9|17.6
0-19|16.7|17.2|16.9|14023|Incidence|81937898|All Races|Male and Female|All Cancer Sites Combined|2009|16.8|17.4|17.1
0-19|0.8|1.0|0.9|655|Incidence|72548146|All Races|Male and Female|Bones and Joints|1999|0.8|1.0|0.9
0-19|0.8|0.9|0.9|635|Incidence|73017204|All Races|Male and Female|Bones and Joints|2000|0.8|0.9|0.9
0-19|0.9|1.0|1.0|740|Incidence|76546373|All Races|Male and Female|Bones and Joints|2001|0.9|1.0|1.0
0-19|0.9|1.0|0.9|740|Incidence|78657753|All Races|Male and Female|Bones and Joints|2002|0.9|1.0|0.9
0-19|0.8|1.0|0.9|736|Incidence|81485313|All Races|Male and Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.9|1.0|0.9|764|Incidence|81819970|All Races|Male and Female|Bones and Joints|2004|0.9|1.0|0.9
0-19|0.8|1.0|0.9|742|Incidence|82072745|All Races|Male and Female|Bones and Joints|2005|0.8|1.0|0.9
0-19|0.9|0.9|0.9|3745|Incidence|413937810|All Races|Male and Female|Bones and Joints|2005-2009|0.9|0.9|0.9
0-19|0.9|1.0|1.0|792|Incidence|82389800|All Races|Male and Female|Bones and Joints|2006|0.9|1.0|1.0
0-19|0.8|1.0|0.9|741|Incidence|82856970|All Races|Male and Female|Bones and Joints|2007|0.8|1.0|0.9
0-19|0.8|1.0|0.9|734|Incidence|83197604|All Races|Male and Female|Bones and Joints|2008|0.8|0.9|0.9
0-19|0.8|1.0|0.9|727|Incidence|81937898|All Races|Male and Female|Bones and Joints|2009|0.8|1.0|0.9
0-19|2.8|3.0|2.9|2116|Incidence|72548146|All Races|Male and Female|Brain and Other Nervous System|1999|2.8|3.0|2.9
0-19|2.9|3.2|3.1|2240|Incidence|73017204|All Races|Male and Female|Brain and Other Nervous System|2000|2.9|3.2|3.1
0-19|2.9|3.1|3.0|2296|Incidence|76546373|All Races|Male and Female|Brain and Other Nervous System|2001|2.9|3.1|3.0
0-19|3.0|3.3|3.1|2459|Incidence|78657753|All Races|Male and Female|Brain and Other Nervous System|2002|3.0|3.3|3.1
0-19|2.9|3.1|3.0|2460|Incidence|81485313|All Races|Male and Female|Brain and Other Nervous System|2003|2.9|3.1|3.0
0-19|3.1|3.3|3.2|2608|Incidence|81819970|All Races|Male and Female|Brain and Other Nervous System|2004|3.1|3.3|3.2
0-19|2.9|3.1|3.0|2460|Incidence|82072745|All Races|Male and Female|Brain and Other Nervous System|2005|2.9|3.1|3.0
0-19|3.0|3.1|3.1|12758|Incidence|413937810|All Races|Male and Female|Brain and Other Nervous System|2005-2009|3.0|3.1|3.1
0-19|3.0|3.2|3.1|2555|Incidence|82389800|All Races|Male and Female|Brain and Other Nervous System|2006|3.0|3.2|3.1
0-19|3.0|3.3|3.2|2624|Incidence|82856970|All Races|Male and Female|Brain and Other Nervous System|2007|3.0|3.3|3.2
0-19|3.0|3.3|3.1|2626|Incidence|83197604|All Races|Male and Female|Brain and Other Nervous System|2008|3.0|3.3|3.2
0-19|2.8|3.1|3.0|2426|Incidence|81937898|All Races|Male and Female|Brain and Other Nervous System|2009|2.8|3.1|3.0
0-19|1.1|1.3|1.2|857|Incidence|72548146|All Races|Male and Female|Hodgkin Lymphoma|1999|1.1|1.3|1.2
0-19|1.2|1.3|1.2|900|Incidence|73017204|All Races|Male and Female|Hodgkin Lymphoma|2000|1.2|1.3|1.2
0-19|1.2|1.3|1.3|961|Incidence|76546373|All Races|Male and Female|Hodgkin Lymphoma|2001|1.2|1.3|1.3
0-19|1.2|1.3|1.2|969|Incidence|78657753|All Races|Male and Female|Hodgkin Lymphoma|2002|1.2|1.3|1.2
0-19|1.2|1.3|1.2|1022|Incidence|81485313|All Races|Male and Female|Hodgkin Lymphoma|2003|1.2|1.3|1.3
0-19|1.1|1.3|1.2|985|Incidence|81819970|All Races|Male and Female|Hodgkin Lymphoma|2004|1.1|1.3|1.2
0-19|1.2|1.4|1.3|1066|Incidence|82072745|All Races|Male and Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.2|1.3|1.3|5274|Incidence|413937810|All Races|Male and Female|Hodgkin Lymphoma|2005-2009|1.2|1.3|1.3
0-19|1.2|1.3|1.3|1048|Incidence|82389800|All Races|Male and Female|Hodgkin Lymphoma|2006|1.2|1.4|1.3
0-19|1.1|1.3|1.2|1021|Incidence|82856970|All Races|Male and Female|Hodgkin Lymphoma|2007|1.2|1.3|1.2
0-19|1.2|1.4|1.3|1093|Incidence|83197604|All Races|Male and Female|Hodgkin Lymphoma|2008|1.2|1.4|1.3
0-19|1.2|1.3|1.3|1026|Incidence|81937898|All Races|Male and Female|Hodgkin Lymphoma|2009|1.2|1.3|1.3
0-19|0.6|0.7|0.7|480|Incidence|72548146|All Races|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.7|0.7
0-19|0.6|0.8|0.7|507|Incidence|73017204|All Races|Male and Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.6|0.8|0.7|532|Incidence|76546373|All Races|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.8|0.7
0-19|0.6|0.7|0.7|524|Incidence|78657753|All Races|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.7
0-19|0.6|0.7|0.7|557|Incidence|81485313|All Races|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Incidence|81819970|All Races|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|566|Incidence|82072745|All Races|Male and Female|Kidney and Renal Pelvis|2005|0.6|0.7|0.7
0-19|0.7|0.7|0.7|2948|Incidence|413937810|All Races|Male and Female|Kidney and Renal Pelvis|2005-2009|0.7|0.7|0.7
0-19|0.6|0.7|0.7|571|Incidence|82389800|All Races|Male and Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.6|0.7|0.7|581|Incidence|82856970|All Races|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.8|0.7
0-19|0.7|0.8|0.7|614|Incidence|83197604|All Races|Male and Female|Kidney and Renal Pelvis|2008|0.7|0.8|0.7
0-19|0.7|0.8|0.7|605|Incidence|81937898|All Races|Male and Female|Kidney and Renal Pelvis|2009|0.7|0.8|0.7
0-19|4.0|4.3|4.1|2979|Incidence|72548146|All Races|Male and Female|Leukemia|1999|4.0|4.3|4.1
0-19|4.0|4.3|4.1|2999|Incidence|73017204|All Races|Male and Female|Leukemia|2000|4.0|4.3|4.1
0-19|4.2|4.5|4.4|3321|Incidence|76546373|All Races|Male and Female|Leukemia|2001|4.2|4.5|4.3
0-19|4.1|4.4|4.2|3322|Incidence|78657753|All Races|Male and Female|Leukemia|2002|4.1|4.4|4.2
0-19|3.9|4.2|4.1|3305|Incidence|81485313|All Races|Male and Female|Leukemia|2003|3.9|4.2|4.1
0-19|4.2|4.5|4.4|3587|Incidence|81819970|All Races|Male and Female|Leukemia|2004|4.2|4.5|4.4
0-19|4.1|4.3|4.2|3466|Incidence|82072745|All Races|Male and Female|Leukemia|2005|4.1|4.4|4.2
0-19|4.3|4.4|4.3|18141|Incidence|413937810|All Races|Male and Female|Leukemia|2005-2009|4.3|4.4|4.4
0-19|4.2|4.5|4.4|3619|Incidence|82389800|All Races|Male and Female|Leukemia|2006|4.3|4.5|4.4
0-19|4.2|4.5|4.4|3670|Incidence|82856970|All Races|Male and Female|Leukemia|2007|4.3|4.6|4.4
0-19|4.3|4.6|4.5|3767|Incidence|83197604|All Races|Male and Female|Leukemia|2008|4.4|4.7|4.5
0-19|4.1|4.4|4.3|3547|Incidence|81937898|All Races|Male and Female|Leukemia|2009|4.2|4.5|4.3
0-19|1.0|1.1|1.0|759|Incidence|72548146|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|1.0|1.1|1.0
0-19|1.1|1.2|1.1|837|Incidence|73017204|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|1.1|1.2|1.1
0-19|1.0|1.2|1.1|860|Incidence|76546373|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|1.0|1.2|1.1
0-19|1.0|1.2|1.1|880|Incidence|78657753|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|1.0|1.2|1.1
0-19|1.0|1.2|1.1|880|Incidence|81485313|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|1.0|1.2|1.1
0-19|1.0|1.2|1.1|916|Incidence|81819970|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.2|1.1
0-19|1.1|1.2|1.2|962|Incidence|82072745|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|1.1|1.2|1.2
0-19|1.1|1.2|1.1|4735|Incidence|413937810|All Races|Male and Female|Non-Hodgkin Lymphoma|2005-2009|1.1|1.2|1.1
0-19|1.1|1.2|1.1|932|Incidence|82389800|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|1.1|1.2|1.1
0-19|1.1|1.2|1.2|966|Incidence|82856970|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|1.1|1.2|1.2
0-19|1.1|1.2|1.1|951|Incidence|83197604|All Races|Male and Female|Non-Hodgkin Lymphoma|2008|1.1|1.2|1.1
0-19|1.1|1.2|1.1|919|Incidence|81937898|All Races|Male and Female|Non-Hodgkin Lymphoma|2009|1.1|1.2|1.1
0-19|4.0|4.3|4.2|3015|Incidence|72548146|All Races|Male and Female|Other|1999|4.0|4.3|4.2
0-19|4.0|4.3|4.1|3018|Incidence|73017204|All Races|Male and Female|Other|2000|4.0|4.3|4.1
0-19|4.4|4.7|4.6|3514|Incidence|76546373|All Races|Male and Female|Other|2001|4.4|4.7|4.6
0-19|4.4|4.7|4.6|3604|Incidence|78657753|All Races|Male and Female|Other|2002|4.4|4.7|4.6
0-19|4.5|4.8|4.6|3797|Incidence|81485313|All Races|Male and Female|Other|2003|4.5|4.8|4.7
0-19|4.6|4.9|4.7|3933|Incidence|81819970|All Races|Male and Female|Other|2004|4.7|5.0|4.8
0-19|4.6|4.9|4.8|3966|Incidence|82072745|All Races|Male and Female|Other|2005|4.7|5.0|4.8
0-19|4.6|4.7|4.7|19745|Incidence|413937810|All Races|Male and Female|Other|2005-2009|4.7|4.8|4.8
0-19|4.4|4.7|4.5|3815|Incidence|82389800|All Races|Male and Female|Other|2006|4.5|4.8|4.6
0-19|4.6|4.9|4.7|4020|Incidence|82856970|All Races|Male and Female|Other|2007|4.7|5.0|4.9
0-19|4.5|4.8|4.7|3985|Incidence|83197604|All Races|Male and Female|Other|2008|4.6|4.9|4.8
0-19|4.5|4.8|4.7|3897|Incidence|81937898|All Races|Male and Female|Other|2009|4.6|4.9|4.8
0-19|0.8|0.9|0.9|633|Incidence|72548146|All Races|Male and Female|Soft Tissue|1999|0.8|0.9|0.9
0-19|0.9|1.1|1.0|742|Incidence|73017204|All Races|Male and Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|765|Incidence|76546373|All Races|Male and Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.1|1.0|805|Incidence|78657753|All Races|Male and Female|Soft Tissue|2002|1.0|1.1|1.0
0-19|0.9|1.1|1.0|829|Incidence|81485313|All Races|Male and Female|Soft Tissue|2003|0.9|1.1|1.0
0-19|1.0|1.1|1.0|857|Incidence|81819970|All Races|Male and Female|Soft Tissue|2004|1.0|1.1|1.0
0-19|1.0|1.1|1.0|860|Incidence|82072745|All Races|Male and Female|Soft Tissue|2005|1.0|1.1|1.0
0-19|1.0|1.1|1.0|4382|Incidence|413937810|All Races|Male and Female|Soft Tissue|2005-2009|1.0|1.1|1.1
0-19|0.9|1.1|1.0|824|Incidence|82389800|All Races|Male and Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.1|1.1|903|Incidence|82856970|All Races|Male and Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|1.0|1.1|1.1|906|Incidence|83197604|All Races|Male and Female|Soft Tissue|2008|1.0|1.2|1.1
0-19|1.0|1.1|1.1|876|Incidence|81937898|All Races|Male and Female|Soft Tissue|2009|1.0|1.1|1.1
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Acute Lymphocytic|2005|~|~|~
0-19|1.3|2.3|1.7|51|Incidence|2917463|American Indian/Alaska Native|Female|Acute Lymphocytic|2005-2009|1.3|2.3|1.7
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Acute Lymphocytic|2009|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Acute Myeloid|2005|~|~|~
0-19|0.4|1.1|0.7|20|Incidence|2917463|American Indian/Alaska Native|Female|Acute Myeloid|2005-2009|0.4|1.1|0.7
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Acute Myeloid|2009|~|~|~
0-19|7.2|12.9|9.8|48|Incidence|496850|American Indian/Alaska Native|Female|All Cancer Sites Combined|1999|7.1|12.8|9.7
0-19|5.9|11.1|8.2|42|Incidence|514503|American Indian/Alaska Native|Female|All Cancer Sites Combined|2000|5.9|11.0|8.2
0-19|9.0|14.9|11.7|65|Incidence|554054|American Indian/Alaska Native|Female|All Cancer Sites Combined|2001|9.1|15.0|11.7
0-19|8.0|13.5|10.5|59|Incidence|560058|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002|8.0|13.6|10.5
0-19|6.4|11.4|8.6|49|Incidence|567307|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003|6.4|11.4|8.6
0-19|7.2|12.4|9.6|55|Incidence|569596|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004|7.3|12.6|9.7
0-19|8.4|13.9|10.9|64|Incidence|572960|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005|8.6|14.3|11.2
0-19|8.9|11.2|10.0|297|Incidence|2917463|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005-2009|9.1|11.4|10.2
0-19|8.5|14.1|11.0|65|Incidence|577169|American Indian/Alaska Native|Female|All Cancer Sites Combined|2006|8.7|14.4|11.3
0-19|7.4|12.7|9.8|58|Incidence|583397|American Indian/Alaska Native|Female|All Cancer Sites Combined|2007|7.5|12.9|9.9
0-19|6.8|11.8|9.0|54|Incidence|589357|American Indian/Alaska Native|Female|All Cancer Sites Combined|2008|6.9|12.0|9.2
0-19|6.9|12.0|9.2|54|Incidence|583146|American Indian/Alaska Native|Female|All Cancer Sites Combined|2009|7.0|12.1|9.3
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Bones and Joints|2005|~|~|~
0-19|0.5|1.1|0.7|21|Incidence|2917463|American Indian/Alaska Native|Female|Bones and Joints|2005-2009|0.4|1.1|0.7
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Bones and Joints|2009|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005|~|~|~
0-19|1.0|1.9|1.4|41|Incidence|2917463|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005-2009|1.0|1.9|1.4
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Brain and Other Nervous System|2009|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|2917463|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.4|1.0|0.6|20|Incidence|2917463|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005-2009|0.4|1.1|0.7
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Leukemia|2000|~|~|~
0-19|2.2|5.6|3.6|20|Incidence|554054|American Indian/Alaska Native|Female|Leukemia|2001|2.2|5.6|3.6
0-19|1.6|4.7|2.9|16|Incidence|560058|American Indian/Alaska Native|Female|Leukemia|2002|1.6|4.6|2.9
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Leukemia|2003|~|~|~
0-19|1.6|4.6|2.8|16|Incidence|569596|American Indian/Alaska Native|Female|Leukemia|2004|1.6|4.6|2.8
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Leukemia|2005|~|~|~
0-19|2.1|3.4|2.7|80|Incidence|2917463|American Indian/Alaska Native|Female|Leukemia|2005-2009|2.2|3.4|2.7
0-19|2.0|5.1|3.3|19|Incidence|577169|American Indian/Alaska Native|Female|Leukemia|2006|2.0|5.1|3.3
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Leukemia|2007|~|~|~
0-19|2.0|5.1|3.3|20|Incidence|589357|American Indian/Alaska Native|Female|Leukemia|2008|2.1|5.2|3.4
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Leukemia|2009|~|~|~
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|2917463|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|2.3|6.1|3.9|19|Incidence|496850|American Indian/Alaska Native|Female|Other|1999|2.3|6.0|3.8
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Other|2000|~|~|~
0-19|2.3|5.8|3.8|21|Incidence|554054|American Indian/Alaska Native|Female|Other|2001|2.3|5.8|3.8
0-19|2.0|5.3|3.4|19|Incidence|560058|American Indian/Alaska Native|Female|Other|2002|2.0|5.3|3.4
0-19|1.6|4.5|2.8|16|Incidence|567307|American Indian/Alaska Native|Female|Other|2003|1.6|4.6|2.8
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Other|2004|~|~|~
0-19|2.5|5.9|3.9|23|Incidence|572960|American Indian/Alaska Native|Female|Other|2005|2.5|6.0|4.0
0-19|2.3|3.6|2.9|88|Incidence|2917463|American Indian/Alaska Native|Female|Other|2005-2009|2.4|3.7|3.0
0-19|2.0|5.1|3.3|20|Incidence|577169|American Indian/Alaska Native|Female|Other|2006|2.1|5.4|3.5
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Other|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Other|2008|~|~|~
0-19|1.7|4.6|2.9|17|Incidence|583146|American Indian/Alaska Native|Female|Other|2009|1.7|4.7|2.9
0-19|~|~|~|~|Incidence|496850|American Indian/Alaska Native|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|514503|American Indian/Alaska Native|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|554054|American Indian/Alaska Native|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|560058|American Indian/Alaska Native|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|567307|American Indian/Alaska Native|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|569596|American Indian/Alaska Native|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|572960|American Indian/Alaska Native|Female|Soft Tissue|2005|~|~|~
0-19|0.5|1.1|0.8|23|Incidence|2917463|American Indian/Alaska Native|Female|Soft Tissue|2005-2009|0.5|1.2|0.8
0-19|~|~|~|~|Incidence|577169|American Indian/Alaska Native|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|583397|American Indian/Alaska Native|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Incidence|589357|American Indian/Alaska Native|Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Incidence|583146|American Indian/Alaska Native|Female|Soft Tissue|2009|~|~|~
0-19|2.0|5.4|3.4|17|Incidence|515305|American Indian/Alaska Native|Male|Acute Lymphocytic|1999|1.9|5.3|3.3
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Acute Lymphocytic|2000|~|~|~
0-19|1.7|4.8|3.0|17|Incidence|573609|American Indian/Alaska Native|Male|Acute Lymphocytic|2001|1.7|4.7|3.0
0-19|1.9|4.9|3.1|18|Incidence|578827|American Indian/Alaska Native|Male|Acute Lymphocytic|2002|1.8|4.9|3.1
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Acute Lymphocytic|2003|~|~|~
0-19|2.1|5.2|3.4|20|Incidence|588062|American Indian/Alaska Native|Male|Acute Lymphocytic|2004|2.1|5.3|3.4
0-19|2.0|5.1|3.3|19|Incidence|591083|American Indian/Alaska Native|Male|Acute Lymphocytic|2005|1.9|5.0|3.2
0-19|2.1|3.4|2.7|82|Incidence|3009444|American Indian/Alaska Native|Male|Acute Lymphocytic|2005-2009|2.2|3.4|2.7
0-19|1.5|4.4|2.7|16|Incidence|595112|American Indian/Alaska Native|Male|Acute Lymphocytic|2006|1.5|4.4|2.7
0-19|2.0|4.9|3.2|20|Incidence|602074|American Indian/Alaska Native|Male|Acute Lymphocytic|2007|2.0|5.1|3.3
0-19|1.6|4.5|2.8|17|Incidence|607761|American Indian/Alaska Native|Male|Acute Lymphocytic|2008|1.6|4.5|2.8
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Acute Lymphocytic|2009|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Incidence|3009444|American Indian/Alaska Native|Male|Acute Myeloid|2005-2009|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Acute Myeloid|2009|~|~|~
0-19|6.3|11.6|8.6|44|Incidence|515305|American Indian/Alaska Native|Male|All Cancer Sites Combined|1999|6.2|11.5|8.5
0-19|7.3|12.8|9.8|52|Incidence|533133|American Indian/Alaska Native|Male|All Cancer Sites Combined|2000|7.3|12.8|9.8
0-19|7.9|13.4|10.4|60|Incidence|573609|American Indian/Alaska Native|Male|All Cancer Sites Combined|2001|8.0|13.5|10.5
0-19|9.4|15.2|12.0|70|Incidence|578827|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002|9.4|15.3|12.1
0-19|7.6|12.9|10.0|59|Incidence|585517|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003|7.7|13.0|10.1
0-19|8.8|14.4|11.4|67|Incidence|588062|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004|8.8|14.5|11.4
0-19|10.6|16.7|13.4|79|Incidence|591083|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005|10.6|16.7|13.4
0-19|10.1|12.5|11.2|340|Incidence|3009444|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005-2009|10.1|12.6|11.3
0-19|8.9|14.5|11.4|68|Incidence|595112|American Indian/Alaska Native|Male|All Cancer Sites Combined|2006|8.9|14.5|11.4
0-19|7.8|13.0|10.1|62|Incidence|602074|American Indian/Alaska Native|Male|All Cancer Sites Combined|2007|7.9|13.2|10.3
0-19|7.8|13.0|10.1|62|Incidence|607761|American Indian/Alaska Native|Male|All Cancer Sites Combined|2008|7.8|13.1|10.2
0-19|8.3|13.7|10.7|65|Incidence|601482|American Indian/Alaska Native|Male|All Cancer Sites Combined|2009|8.3|13.8|10.8
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Incidence|3009444|American Indian/Alaska Native|Male|Bones and Joints|2005-2009|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Bones and Joints|2009|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005|~|~|~
0-19|1.5|2.5|1.9|58|Incidence|3009444|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005-2009|1.5|2.5|1.9
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Brain and Other Nervous System|2009|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Incidence|3009444|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.3|0.8|0.5|16|Incidence|3009444|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005-2009|0.3|0.9|0.5
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2009|~|~|~
0-19|2.1|5.7|3.6|18|Incidence|515305|American Indian/Alaska Native|Male|Leukemia|1999|2.1|5.5|3.5
0-19|2.0|5.4|3.4|18|Incidence|533133|American Indian/Alaska Native|Male|Leukemia|2000|2.0|5.3|3.4
0-19|2.4|5.8|3.9|22|Incidence|573609|American Indian/Alaska Native|Male|Leukemia|2001|2.4|5.8|3.8
0-19|2.8|6.4|4.3|25|Incidence|578827|American Indian/Alaska Native|Male|Leukemia|2002|2.8|6.4|4.3
0-19|1.8|4.9|3.1|18|Incidence|585517|American Indian/Alaska Native|Male|Leukemia|2003|1.8|4.9|3.1
0-19|2.6|6.0|4.0|24|Incidence|588062|American Indian/Alaska Native|Male|Leukemia|2004|2.6|6.1|4.1
0-19|3.0|6.7|4.6|27|Incidence|591083|American Indian/Alaska Native|Male|Leukemia|2005|3.0|6.6|4.6
0-19|2.8|4.2|3.5|105|Incidence|3009444|American Indian/Alaska Native|Male|Leukemia|2005-2009|2.9|4.2|3.5
0-19|2.2|5.4|3.5|21|Incidence|595112|American Indian/Alaska Native|Male|Leukemia|2006|2.2|5.4|3.5
0-19|2.1|5.1|3.4|21|Incidence|602074|American Indian/Alaska Native|Male|Leukemia|2007|2.2|5.3|3.5
0-19|2.3|5.5|3.6|22|Incidence|607761|American Indian/Alaska Native|Male|Leukemia|2008|2.3|5.5|3.6
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Leukemia|2009|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.7|1.5|1.1|32|Incidence|3009444|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005-2009|0.7|1.5|1.1
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Other|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Other|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Other|2001|~|~|~
0-19|2.2|5.5|3.6|21|Incidence|578827|American Indian/Alaska Native|Male|Other|2002|2.2|5.5|3.6
0-19|1.7|4.6|2.8|17|Incidence|585517|American Indian/Alaska Native|Male|Other|2003|1.7|4.6|2.9
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Other|2004|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Other|2005|~|~|~
0-19|2.1|3.3|2.6|81|Incidence|3009444|American Indian/Alaska Native|Male|Other|2005-2009|2.1|3.3|2.7
0-19|1.6|4.5|2.8|17|Incidence|595112|American Indian/Alaska Native|Male|Other|2006|1.7|4.6|2.9
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Other|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Other|2008|~|~|~
0-19|1.9|4.9|3.1|19|Incidence|601482|American Indian/Alaska Native|Male|Other|2009|1.9|4.9|3.2
0-19|~|~|~|~|Incidence|515305|American Indian/Alaska Native|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|533133|American Indian/Alaska Native|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|573609|American Indian/Alaska Native|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|578827|American Indian/Alaska Native|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|585517|American Indian/Alaska Native|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|588062|American Indian/Alaska Native|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|591083|American Indian/Alaska Native|Male|Soft Tissue|2005|~|~|~
0-19|0.3|0.9|0.6|18|Incidence|3009444|American Indian/Alaska Native|Male|Soft Tissue|2005-2009|0.4|0.9|0.6
0-19|~|~|~|~|Incidence|595112|American Indian/Alaska Native|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|602074|American Indian/Alaska Native|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Incidence|607761|American Indian/Alaska Native|Male|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Incidence|601482|American Indian/Alaska Native|Male|Soft Tissue|2009|~|~|~
0-19|1.9|4.1|2.8|28|Incidence|1012155|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|1999|1.8|4.0|2.8
0-19|1.5|3.4|2.3|24|Incidence|1047636|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2000|1.5|3.4|2.3
0-19|1.9|4.0|2.8|32|Incidence|1127663|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2001|1.9|4.0|2.8
0-19|1.6|3.6|2.5|28|Incidence|1138885|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002|1.6|3.6|2.5
0-19|1.0|2.6|1.7|19|Incidence|1152824|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003|1.0|2.6|1.6
0-19|1.9|3.9|2.8|32|Incidence|1157658|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004|1.9|3.9|2.8
0-19|1.7|3.7|2.6|30|Incidence|1164043|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005|1.7|3.7|2.6
0-19|1.9|2.6|2.2|133|Incidence|5926907|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005-2009|1.9|2.7|2.2
0-19|1.4|3.2|2.1|25|Incidence|1172281|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2006|1.4|3.1|2.1
0-19|1.5|3.3|2.3|28|Incidence|1185471|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2007|1.6|3.4|2.4
0-19|1.6|3.4|2.4|29|Incidence|1197118|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2008|1.6|3.5|2.4
0-19|1.1|2.7|1.7|21|Incidence|1184628|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2009|1.1|2.7|1.8
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005|~|~|~
0-19|0.4|0.8|0.6|34|Incidence|5926907|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005-2009|0.4|0.8|0.6
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Incidence|1184628|American Indian/Alaska Native|Male and Female|Acute Myeloid|2009|~|~|~
0-19|7.4|11.3|9.2|92|Incidence|1012155|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|1999|7.3|11.1|9.1
0-19|7.3|11.0|9.0|94|Incidence|1047636|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2000|7.3|11.0|9.0
0-19|9.2|13.2|11.0|125|Incidence|1127663|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2001|9.2|13.2|11.1
0-19|9.4|13.4|11.3|129|Incidence|1138885|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002|9.5|13.5|11.3
0-19|7.6|11.2|9.3|108|Incidence|1152824|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003|7.7|11.3|9.4
0-19|8.7|12.5|10.5|122|Incidence|1157658|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004|8.8|12.6|10.5
0-19|10.3|14.3|12.2|143|Incidence|1164043|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005|10.4|14.5|12.3
0-19|9.8|11.5|10.6|637|Incidence|5926907|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005-2009|9.9|11.6|10.7
0-19|9.4|13.3|11.2|133|Incidence|1172281|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2006|9.5|13.4|11.3
0-19|8.3|11.9|10.0|120|Incidence|1185471|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2007|8.4|12.1|10.1
0-19|7.9|11.5|9.6|116|Incidence|1197118|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2008|8.0|11.6|9.7
0-19|8.3|12.0|10.0|119|Incidence|1184628|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2009|8.3|12.0|10.0
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Bones and Joints|2005|~|~|~
0-19|0.4|0.9|0.6|36|Incidence|5926907|American Indian/Alaska Native|Male and Female|Bones and Joints|2005-2009|0.4|0.8|0.6
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Incidence|1184628|American Indian/Alaska Native|Male and Female|Bones and Joints|2009|~|~|~
0-19|0.9|2.6|1.6|16|Incidence|1012155|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|1999|0.9|2.6|1.6
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|1.1|2.7|1.8|20|Incidence|1127663|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2001|1.1|2.7|1.8
0-19|1.1|2.8|1.8|21|Incidence|1138885|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002|1.1|2.8|1.8
0-19|0.8|2.2|1.4|16|Incidence|1152824|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003|0.8|2.3|1.4
0-19|1.4|3.1|2.1|24|Incidence|1157658|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004|1.3|3.1|2.1
0-19|1.6|3.5|2.4|28|Incidence|1164043|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005|1.6|3.5|2.4
0-19|1.4|2.0|1.7|99|Incidence|5926907|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005-2009|1.4|2.0|1.7
0-19|1.0|2.6|1.7|20|Incidence|1172281|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2006|1.0|2.6|1.7
0-19|0.9|2.4|1.5|17|Incidence|1185471|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2007|0.8|2.3|1.4
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2008|~|~|~
0-19|1.0|2.5|1.6|19|Incidence|1184628|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2009|1.0|2.5|1.6
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.3|0.7|0.5|29|Incidence|5926907|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005-2009|0.3|0.7|0.5
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|1184628|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.4|0.8|0.6|36|Incidence|5926907|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005-2009|0.4|0.8|0.6
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Incidence|1184628|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|2.3|4.7|3.3|33|Incidence|1012155|American Indian/Alaska Native|Male and Female|Leukemia|1999|2.2|4.6|3.3
0-19|2.0|4.2|3.0|31|Incidence|1047636|American Indian/Alaska Native|Male and Female|Leukemia|2000|2.0|4.2|3.0
0-19|2.7|5.0|3.7|42|Incidence|1127663|American Indian/Alaska Native|Male and Female|Leukemia|2001|2.7|5.0|3.7
0-19|2.6|4.9|3.6|41|Incidence|1138885|American Indian/Alaska Native|Male and Female|Leukemia|2002|2.6|4.9|3.6
0-19|1.9|3.9|2.8|32|Incidence|1152824|American Indian/Alaska Native|Male and Female|Leukemia|2003|1.9|3.9|2.8
0-19|2.5|4.7|3.4|40|Incidence|1157658|American Indian/Alaska Native|Male and Female|Leukemia|2004|2.5|4.7|3.5
0-19|2.6|4.9|3.6|42|Incidence|1164043|American Indian/Alaska Native|Male and Female|Leukemia|2005|2.6|4.9|3.6
0-19|2.7|3.6|3.1|185|Incidence|5926907|American Indian/Alaska Native|Male and Female|Leukemia|2005-2009|2.7|3.6|3.1
0-19|2.4|4.7|3.4|40|Incidence|1172281|American Indian/Alaska Native|Male and Female|Leukemia|2006|2.4|4.6|3.4
0-19|1.9|3.8|2.7|33|Incidence|1185471|American Indian/Alaska Native|Male and Female|Leukemia|2007|1.9|3.9|2.8
0-19|2.5|4.7|3.5|42|Incidence|1197118|American Indian/Alaska Native|Male and Female|Leukemia|2008|2.5|4.7|3.5
0-19|1.5|3.3|2.3|27|Incidence|1184628|American Indian/Alaska Native|Male and Female|Leukemia|2009|1.5|3.3|2.3
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.5|1.0|0.7|42|Incidence|5926907|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005-2009|0.5|1.0|0.7
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|1184628|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|1.7|3.8|2.6|26|Incidence|1012155|American Indian/Alaska Native|Male and Female|Other|1999|1.7|3.8|2.6
0-19|1.1|2.9|1.8|19|Incidence|1047636|American Indian/Alaska Native|Male and Female|Other|2000|1.1|2.8|1.8
0-19|2.2|4.4|3.2|36|Incidence|1127663|American Indian/Alaska Native|Male and Female|Other|2001|2.2|4.4|3.2
0-19|2.5|4.7|3.5|40|Incidence|1138885|American Indian/Alaska Native|Male and Female|Other|2002|2.5|4.8|3.5
0-19|1.9|4.0|2.8|33|Incidence|1152824|American Indian/Alaska Native|Male and Female|Other|2003|2.0|4.0|2.9
0-19|1.4|3.1|2.1|25|Incidence|1157658|American Indian/Alaska Native|Male and Female|Other|2004|1.4|3.2|2.2
0-19|2.3|4.4|3.2|38|Incidence|1164043|American Indian/Alaska Native|Male and Female|Other|2005|2.3|4.5|3.3
0-19|2.4|3.2|2.8|169|Incidence|5926907|American Indian/Alaska Native|Male and Female|Other|2005-2009|2.4|3.3|2.9
0-19|2.2|4.2|3.1|37|Incidence|1172281|American Indian/Alaska Native|Male and Female|Other|2006|2.2|4.4|3.2
0-19|1.7|3.5|2.5|30|Incidence|1185471|American Indian/Alaska Native|Male and Female|Other|2007|1.7|3.6|2.5
0-19|1.4|3.1|2.2|27|Incidence|1197118|American Indian/Alaska Native|Male and Female|Other|2008|1.5|3.3|2.3
0-19|2.1|4.1|3.0|36|Incidence|1184628|American Indian/Alaska Native|Male and Female|Other|2009|2.1|4.2|3.0
0-19|~|~|~|~|Incidence|1012155|American Indian/Alaska Native|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1047636|American Indian/Alaska Native|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1127663|American Indian/Alaska Native|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|1138885|American Indian/Alaska Native|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|1152824|American Indian/Alaska Native|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|1157658|American Indian/Alaska Native|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Incidence|1164043|American Indian/Alaska Native|Male and Female|Soft Tissue|2005|~|~|~
0-19|0.5|0.9|0.7|41|Incidence|5926907|American Indian/Alaska Native|Male and Female|Soft Tissue|2005-2009|0.5|0.9|0.7
0-19|~|~|~|~|Incidence|1172281|American Indian/Alaska Native|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|1185471|American Indian/Alaska Native|Male and Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Incidence|1197118|American Indian/Alaska Native|Male and Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Incidence|1184628|American Indian/Alaska Native|Male and Female|Soft Tissue|2009|~|~|~
0-19|1.9|3.5|2.6|41|Incidence|1570391|Asian/Pacific Islander|Female|Acute Lymphocytic|1999|1.9|3.5|2.6
0-19|1.4|2.8|2.0|33|Incidence|1618332|Asian/Pacific Islander|Female|Acute Lymphocytic|2000|1.4|2.9|2.0
0-19|2.1|3.7|2.8|48|Incidence|1682415|Asian/Pacific Islander|Female|Acute Lymphocytic|2001|2.1|3.8|2.9
0-19|2.3|3.9|3.0|55|Incidence|1762776|Asian/Pacific Islander|Female|Acute Lymphocytic|2002|2.4|4.1|3.1
0-19|1.8|3.3|2.5|46|Incidence|1822464|Asian/Pacific Islander|Female|Acute Lymphocytic|2003|1.8|3.4|2.5
0-19|1.8|3.3|2.5|49|Incidence|1866675|Asian/Pacific Islander|Female|Acute Lymphocytic|2004|1.9|3.5|2.6
0-19|1.9|3.4|2.6|53|Incidence|1914016|Asian/Pacific Islander|Female|Acute Lymphocytic|2005|2.1|3.6|2.8
0-19|2.2|2.9|2.5|270|Incidence|10067369|Asian/Pacific Islander|Female|Acute Lymphocytic|2005-2009|2.4|3.0|2.7
0-19|1.8|3.2|2.4|49|Incidence|1962226|Asian/Pacific Islander|Female|Acute Lymphocytic|2006|1.8|3.3|2.5
0-19|2.1|3.6|2.8|59|Incidence|2013981|Asian/Pacific Islander|Female|Acute Lymphocytic|2007|2.2|3.8|2.9
0-19|2.0|3.4|2.7|58|Incidence|2064812|Asian/Pacific Islander|Female|Acute Lymphocytic|2008|2.1|3.6|2.8
0-19|1.7|3.0|2.3|51|Incidence|2087702|Asian/Pacific Islander|Female|Acute Lymphocytic|2009|1.8|3.2|2.4
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1762776|Asian/Pacific Islander|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Incidence|1914016|Asian/Pacific Islander|Female|Acute Myeloid|2005|~|~|~
0-19|0.7|1.1|0.9|85|Incidence|10067369|Asian/Pacific Islander|Female|Acute Myeloid|2005-2009|0.7|1.0|0.8
0-19|0.7|1.7|1.1|22|Incidence|1962226|Asian/Pacific Islander|Female|Acute Myeloid|2006|0.7|1.7|1.1
0-19|~|~|~|~|Incidence|2013981|Asian/Pacific Islander|Female|Acute Myeloid|2007|~|~|~
0-19|0.7|1.6|1.1|23|Incidence|2064812|Asian/Pacific Islander|Female|Acute Myeloid|2008|0.7|1.7|1.1
0-19|~|~|~|~|Incidence|2087702|Asian/Pacific Islander|Female|Acute Myeloid|2009|~|~|~
0-19|10.7|14.2|12.3|195|Incidence|1570391|Asian/Pacific Islander|Female|All Cancer Sites Combined|1999|10.7|14.3|12.4
0-19|8.7|11.9|10.2|167|Incidence|1618332|Asian/Pacific Islander|Female|All Cancer Sites Combined|2000|8.8|12.0|10.3
0-19|11.5|15.1|13.2|224|Incidence|1682415|Asian/Pacific Islander|Female|All Cancer Sites Combined|2001|11.6|15.2|13.3
0-19|11.0|14.4|12.7|224|Incidence|1762776|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002|11.1|14.5|12.7
0-19|9.4|12.5|10.9|201|Incidence|1822464|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003|9.6|12.7|11.0
0-19|10.4|13.5|11.9|226|Incidence|1866675|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004|10.6|13.8|12.1
0-19|11.9|15.3|13.5|261|Incidence|1914016|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005|12.0|15.4|13.6
0-19|12.5|13.9|13.2|1338|Incidence|10067369|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005-2009|12.6|14.0|13.3
0-19|11.4|14.6|12.9|255|Incidence|1962226|Asian/Pacific Islander|Female|All Cancer Sites Combined|2006|11.4|14.7|13.0
0-19|11.4|14.5|12.9|263|Incidence|2013981|Asian/Pacific Islander|Female|All Cancer Sites Combined|2007|11.5|14.7|13.1
0-19|11.8|15.0|13.4|279|Incidence|2064812|Asian/Pacific Islander|Female|All Cancer Sites Combined|2008|12.0|15.2|13.5
0-19|12.0|15.2|13.5|280|Incidence|2087702|Asian/Pacific Islander|Female|All Cancer Sites Combined|2009|11.9|15.1|13.4
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Incidence|1762776|Asian/Pacific Islander|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Incidence|1914016|Asian/Pacific Islander|Female|Bones and Joints|2005|~|~|~
0-19|0.5|0.8|0.7|63|Incidence|10067369|Asian/Pacific Islander|Female|Bones and Joints|2005-2009|0.5|0.8|0.6
0-19|~|~|~|~|Incidence|1962226|Asian/Pacific Islander|Female|Bones and Joints|2006|~|~|~
0-19|0.6|1.5|0.9|18|Incidence|2013981|Asian/Pacific Islander|Female|Bones and Joints|2007|0.5|1.4|0.9
0-19|0.5|1.4|0.9|17|Incidence|2064812|Asian/Pacific Islander|Female|Bones and Joints|2008|0.5|1.3|0.8
0-19|~|~|~|~|Incidence|2087702|Asian/Pacific Islander|Female|Bones and Joints|2009|~|~|~
0-19|1.2|2.7|1.9|29|Incidence|1570391|Asian/Pacific Islander|Female|Brain and Other Nervous System|1999|1.2|2.7|1.8
0-19|1.3|2.7|1.9|31|Incidence|1618332|Asian/Pacific Islander|Female|Brain and Other Nervous System|2000|1.3|2.7|1.9
0-19|1.9|3.6|2.7|45|Incidence|1682415|Asian/Pacific Islander|Female|Brain and Other Nervous System|2001|2.0|3.6|2.7
0-19|1.2|2.6|1.8|32|Incidence|1762776|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002|1.2|2.6|1.8
0-19|1.4|2.7|1.9|36|Incidence|1822464|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003|1.4|2.7|2.0
0-19|1.6|3.0|2.2|43|Incidence|1866675|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004|1.7|3.1|2.3
0-19|1.8|3.2|2.4|47|Incidence|1914016|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005|1.8|3.3|2.5
0-19|1.8|2.4|2.1|214|Incidence|10067369|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005-2009|1.9|2.4|2.1
0-19|1.4|2.7|2.0|40|Incidence|1962226|Asian/Pacific Islander|Female|Brain and Other Nervous System|2006|1.5|2.8|2.0
0-19|1.3|2.6|1.9|38|Incidence|2013981|Asian/Pacific Islander|Female|Brain and Other Nervous System|2007|1.3|2.6|1.9
0-19|1.4|2.6|2.0|41|Incidence|2064812|Asian/Pacific Islander|Female|Brain and Other Nervous System|2008|1.4|2.7|2.0
0-19|1.7|3.0|2.3|48|Incidence|2087702|Asian/Pacific Islander|Female|Brain and Other Nervous System|2009|1.7|3.0|2.3
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|0.5|1.5|0.9|16|Incidence|1762776|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002|0.5|1.5|0.9
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Incidence|1914016|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.6|1.0|0.8|76|Incidence|10067369|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005-2009|0.6|0.9|0.8
0-19|0.6|1.6|1.0|19|Incidence|1962226|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2006|0.6|1.5|1.0
0-19|~|~|~|~|Incidence|2013981|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Incidence|2064812|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|0.6|1.6|1.0|20|Incidence|2087702|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2009|0.6|1.5|1.0
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1762776|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1914016|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.2|0.5|0.3|38|Incidence|10067369|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005-2009|0.3|0.5|0.4
0-19|~|~|~|~|Incidence|1962226|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|2013981|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|2064812|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Incidence|2087702|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|2.7|4.7|3.6|57|Incidence|1570391|Asian/Pacific Islander|Female|Leukemia|1999|2.7|4.7|3.6
0-19|1.7|3.3|2.4|40|Incidence|1618332|Asian/Pacific Islander|Female|Leukemia|2000|1.8|3.4|2.5
0-19|2.9|4.9|3.8|65|Incidence|1682415|Asian/Pacific Islander|Female|Leukemia|2001|3.0|4.9|3.9
0-19|3.1|4.9|3.9|71|Incidence|1762776|Asian/Pacific Islander|Female|Leukemia|2002|3.1|5.1|4.0
0-19|2.5|4.2|3.3|62|Incidence|1822464|Asian/Pacific Islander|Female|Leukemia|2003|2.6|4.4|3.4
0-19|2.8|4.5|3.6|70|Incidence|1866675|Asian/Pacific Islander|Female|Leukemia|2004|2.9|4.7|3.7
0-19|2.9|4.6|3.7|74|Incidence|1914016|Asian/Pacific Islander|Female|Leukemia|2005|3.0|4.9|3.9
0-19|3.3|4.1|3.7|385|Incidence|10067369|Asian/Pacific Islander|Female|Leukemia|2005-2009|3.5|4.2|3.8
0-19|2.9|4.6|3.7|74|Incidence|1962226|Asian/Pacific Islander|Female|Leukemia|2006|3.0|4.7|3.8
0-19|3.0|4.7|3.8|78|Incidence|2013981|Asian/Pacific Islander|Female|Leukemia|2007|3.1|4.8|3.9
0-19|3.2|4.9|4.0|86|Incidence|2064812|Asian/Pacific Islander|Female|Leukemia|2008|3.3|5.1|4.2
0-19|2.6|4.3|3.4|73|Incidence|2087702|Asian/Pacific Islander|Female|Leukemia|2009|2.7|4.4|3.5
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|0.6|1.6|1.0|17|Incidence|1762776|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002|0.6|1.5|1.0
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|0.6|1.6|1.1|20|Incidence|1914016|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005|0.6|1.6|1.0
0-19|0.7|1.0|0.8|81|Incidence|10067369|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005-2009|0.6|1.0|0.8
0-19|0.5|1.4|0.9|16|Incidence|1962226|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2006|0.5|1.3|0.8
0-19|0.5|1.3|0.8|16|Incidence|2013981|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2007|0.5|1.3|0.8
0-19|~|~|~|~|Incidence|2064812|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Incidence|2087702|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|3.0|5.0|3.9|62|Incidence|1570391|Asian/Pacific Islander|Female|Other|1999|3.0|5.1|3.9
0-19|2.5|4.4|3.4|55|Incidence|1618332|Asian/Pacific Islander|Female|Other|2000|2.6|4.4|3.4
0-19|2.9|4.8|3.7|64|Incidence|1682415|Asian/Pacific Islander|Female|Other|2001|2.9|4.9|3.8
0-19|2.5|4.2|3.3|57|Incidence|1762776|Asian/Pacific Islander|Female|Other|2002|2.4|4.2|3.2
0-19|2.5|4.2|3.3|61|Incidence|1822464|Asian/Pacific Islander|Female|Other|2003|2.6|4.3|3.3
0-19|2.6|4.3|3.3|63|Incidence|1866675|Asian/Pacific Islander|Female|Other|2004|2.6|4.3|3.4
0-19|3.1|5.0|4.0|76|Incidence|1914016|Asian/Pacific Islander|Female|Other|2005|3.1|5.0|4.0
0-19|3.7|4.6|4.1|413|Incidence|10067369|Asian/Pacific Islander|Female|Other|2005-2009|3.7|4.5|4.1
0-19|3.3|5.1|4.1|81|Incidence|1962226|Asian/Pacific Islander|Female|Other|2006|3.3|5.1|4.1
0-19|3.1|4.9|3.9|81|Incidence|2013981|Asian/Pacific Islander|Female|Other|2007|3.2|5.0|4.0
0-19|3.3|5.2|4.2|86|Incidence|2064812|Asian/Pacific Islander|Female|Other|2008|3.3|5.1|4.2
0-19|3.6|5.5|4.4|89|Incidence|2087702|Asian/Pacific Islander|Female|Other|2009|3.4|5.2|4.3
0-19|~|~|~|~|Incidence|1570391|Asian/Pacific Islander|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1618332|Asian/Pacific Islander|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1682415|Asian/Pacific Islander|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Incidence|1762776|Asian/Pacific Islander|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Incidence|1822464|Asian/Pacific Islander|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Incidence|1866675|Asian/Pacific Islander|Female|Soft Tissue|2004|~|~|~
0-19|0.5|1.4|0.8|16|Incidence|1914016|Asian/Pacific Islander|Female|Soft Tissue|2005|0.5|1.4|0.8
0-19|0.5|0.8|0.7|68|Incidence|10067369|Asian/Pacific Islander|Female|Soft Tissue|2005-2009|0.5|0.9|0.7
0-19|~|~|~|~|Incidence|1962226|Asian/Pacific Islander|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|2013981|Asian/Pacific Islander|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Incidence|2064812|Asian/Pacific Islander|Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Incidence|2087702|Asian/Pacific Islander|Female|Soft Tissue|2009|~|~|~
0-19|2.0|3.7|2.8|46|Incidence|1639643|Asian/Pacific Islander|Male|Acute Lymphocytic|1999|2.1|3.7|2.8
0-19|1.9|3.6|2.7|45|Incidence|1686323|Asian/Pacific Islander|Male|Acute Lymphocytic|2000|1.9|3.6|2.7
0-19|2.4|4.1|3.1|55|Incidence|1754020|Asian/Pacific Islander|Male|Acute Lymphocytic|2001|2.4|4.1|3.1
0-19|2.6|4.3|3.3|62|Incidence|1837465|Asian/Pacific Islander|Male|Acute Lymphocytic|2002|2.6|4.3|3.4
0-19|2.5|4.1|3.2|62|Incidence|1898564|Asian/Pacific Islander|Male|Acute Lymphocytic|2003|2.5|4.2|3.3
0-19|2.3|3.9|3.0|60|Incidence|1943682|Asian/Pacific Islander|Male|Acute Lymphocytic|2004|2.4|4.0|3.1
0-19|2.7|4.3|3.4|72|Incidence|1991945|Asian/Pacific Islander|Male|Acute Lymphocytic|2005|2.8|4.6|3.6
0-19|3.0|3.7|3.3|362|Incidence|10466929|Asian/Pacific Islander|Male|Acute Lymphocytic|2005-2009|3.1|3.8|3.5
0-19|2.2|3.8|2.9|62|Incidence|2040932|Asian/Pacific Islander|Male|Acute Lymphocytic|2006|2.3|3.9|3.0
0-19|2.5|4.1|3.2|71|Incidence|2094159|Asian/Pacific Islander|Male|Acute Lymphocytic|2007|2.6|4.3|3.4
0-19|2.8|4.5|3.6|81|Incidence|2146576|Asian/Pacific Islander|Male|Acute Lymphocytic|2008|3.0|4.7|3.8
0-19|2.6|4.2|3.4|75|Incidence|2168060|Asian/Pacific Islander|Male|Acute Lymphocytic|2009|2.7|4.3|3.5
0-19|0.6|1.6|1.0|16|Incidence|1639643|Asian/Pacific Islander|Male|Acute Myeloid|1999|0.6|1.6|1.0
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Incidence|1754020|Asian/Pacific Islander|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Incidence|1837465|Asian/Pacific Islander|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Incidence|1898564|Asian/Pacific Islander|Male|Acute Myeloid|2003|~|~|~
0-19|0.6|1.6|1.0|20|Incidence|1943682|Asian/Pacific Islander|Male|Acute Myeloid|2004|0.6|1.6|1.0
0-19|0.5|1.3|0.8|16|Incidence|1991945|Asian/Pacific Islander|Male|Acute Myeloid|2005|0.5|1.3|0.8
0-19|0.6|0.9|0.8|80|Incidence|10466929|Asian/Pacific Islander|Male|Acute Myeloid|2005-2009|0.6|1.0|0.8
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Acute Myeloid|2006|~|~|~
0-19|0.5|1.4|0.9|19|Incidence|2094159|Asian/Pacific Islander|Male|Acute Myeloid|2007|0.5|1.4|0.9
0-19|0.5|1.3|0.8|17|Incidence|2146576|Asian/Pacific Islander|Male|Acute Myeloid|2008|0.5|1.3|0.8
0-19|~|~|~|~|Incidence|2168060|Asian/Pacific Islander|Male|Acute Myeloid|2009|~|~|~
0-19|10.7|14.2|12.4|204|Incidence|1639643|Asian/Pacific Islander|Male|All Cancer Sites Combined|1999|10.8|14.3|12.4
0-19|11.6|15.1|13.3|225|Incidence|1686323|Asian/Pacific Islander|Male|All Cancer Sites Combined|2000|11.7|15.2|13.3
0-19|13.0|16.6|14.7|259|Incidence|1754020|Asian/Pacific Islander|Male|All Cancer Sites Combined|2001|13.0|16.7|14.8
0-19|12.4|15.8|14.0|260|Incidence|1837465|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002|12.5|16.0|14.1
0-19|12.0|15.4|13.6|260|Incidence|1898564|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003|12.1|15.5|13.7
0-19|12.1|15.4|13.7|269|Incidence|1943682|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004|12.2|15.6|13.8
0-19|13.4|16.9|15.1|304|Incidence|1991945|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005|13.6|17.1|15.3
0-19|13.9|15.3|14.6|1548|Incidence|10466929|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005-2009|14.1|15.5|14.8
0-19|11.5|14.7|13.0|271|Incidence|2040932|Asian/Pacific Islander|Male|All Cancer Sites Combined|2006|11.7|15.0|13.3
0-19|12.8|16.1|14.4|308|Incidence|2094159|Asian/Pacific Islander|Male|All Cancer Sites Combined|2007|13.1|16.4|14.7
0-19|13.6|17.0|15.2|329|Incidence|2146576|Asian/Pacific Islander|Male|All Cancer Sites Combined|2008|13.7|17.1|15.3
0-19|13.7|17.0|15.3|334|Incidence|2168060|Asian/Pacific Islander|Male|All Cancer Sites Combined|2009|13.8|17.1|15.4
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Bones and Joints|2000|~|~|~
0-19|0.6|1.6|1.0|18|Incidence|1754020|Asian/Pacific Islander|Male|Bones and Joints|2001|0.6|1.6|1.0
0-19|0.5|1.5|0.9|17|Incidence|1837465|Asian/Pacific Islander|Male|Bones and Joints|2002|0.5|1.5|0.9
0-19|0.5|1.4|0.9|16|Incidence|1898564|Asian/Pacific Islander|Male|Bones and Joints|2003|0.5|1.4|0.8
0-19|~|~|~|~|Incidence|1943682|Asian/Pacific Islander|Male|Bones and Joints|2004|~|~|~
0-19|0.6|1.6|1.0|19|Incidence|1991945|Asian/Pacific Islander|Male|Bones and Joints|2005|0.6|1.5|1.0
0-19|0.6|1.0|0.8|79|Incidence|10466929|Asian/Pacific Islander|Male|Bones and Joints|2005-2009|0.6|0.9|0.8
0-19|0.5|1.3|0.8|16|Incidence|2040932|Asian/Pacific Islander|Male|Bones and Joints|2006|0.4|1.3|0.8
0-19|~|~|~|~|Incidence|2094159|Asian/Pacific Islander|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Incidence|2146576|Asian/Pacific Islander|Male|Bones and Joints|2008|~|~|~
0-19|0.7|1.7|1.1|23|Incidence|2168060|Asian/Pacific Islander|Male|Bones and Joints|2009|0.7|1.6|1.1
0-19|1.3|2.7|1.9|31|Incidence|1639643|Asian/Pacific Islander|Male|Brain and Other Nervous System|1999|1.3|2.7|1.9
0-19|1.3|2.8|2.0|33|Incidence|1686323|Asian/Pacific Islander|Male|Brain and Other Nervous System|2000|1.3|2.7|2.0
0-19|1.6|3.1|2.3|40|Incidence|1754020|Asian/Pacific Islander|Male|Brain and Other Nervous System|2001|1.6|3.1|2.3
0-19|1.4|2.7|2.0|36|Incidence|1837465|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002|1.4|2.7|2.0
0-19|1.7|3.1|2.3|44|Incidence|1898564|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003|1.7|3.1|2.3
0-19|1.2|2.5|1.8|35|Incidence|1943682|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004|1.3|2.5|1.8
0-19|1.6|3.0|2.2|44|Incidence|1991945|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005|1.6|3.0|2.2
0-19|2.1|2.7|2.4|250|Incidence|10466929|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005-2009|2.1|2.7|2.4
0-19|1.6|2.9|2.1|45|Incidence|2040932|Asian/Pacific Islander|Male|Brain and Other Nervous System|2006|1.6|3.0|2.2
0-19|1.9|3.3|2.5|54|Incidence|2094159|Asian/Pacific Islander|Male|Brain and Other Nervous System|2007|1.9|3.4|2.6
0-19|2.0|3.5|2.7|58|Incidence|2146576|Asian/Pacific Islander|Male|Brain and Other Nervous System|2008|2.1|3.5|2.7
0-19|1.6|2.9|2.2|48|Incidence|2168060|Asian/Pacific Islander|Male|Brain and Other Nervous System|2009|1.6|2.9|2.2
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Incidence|1754020|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|0.5|1.4|0.9|16|Incidence|1837465|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002|0.5|1.4|0.9
0-19|0.8|1.9|1.2|23|Incidence|1898564|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003|0.8|1.8|1.2
0-19|0.5|1.4|0.9|17|Incidence|1943682|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004|0.5|1.4|0.9
0-19|0.7|1.7|1.1|21|Incidence|1991945|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005|0.7|1.6|1.1
0-19|0.7|1.0|0.8|83|Incidence|10466929|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005-2009|0.6|1.0|0.8
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|0.5|1.4|0.9|17|Incidence|2094159|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2007|0.5|1.3|0.8
0-19|0.4|1.3|0.8|16|Incidence|2146576|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2008|0.4|1.2|0.7
0-19|~|~|~|~|Incidence|2168060|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|1754020|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|1837465|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Incidence|1898564|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Incidence|1943682|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|1991945|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.2|0.5|0.3|39|Incidence|10466929|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005-2009|0.3|0.5|0.4
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Incidence|2094159|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Incidence|2146576|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Incidence|2168060|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2009|~|~|~
0-19|3.3|5.4|4.3|70|Incidence|1639643|Asian/Pacific Islander|Male|Leukemia|1999|3.3|5.4|4.3
0-19|3.0|4.9|3.8|65|Incidence|1686323|Asian/Pacific Islander|Male|Leukemia|2000|3.0|4.9|3.9
0-19|3.7|5.7|4.6|81|Incidence|1754020|Asian/Pacific Islander|Male|Leukemia|2001|3.7|5.7|4.6
0-19|3.8|5.8|4.7|87|Incidence|1837465|Asian/Pacific Islander|Male|Leukemia|2002|3.8|5.8|4.7
0-19|3.5|5.5|4.4|86|Incidence|1898564|Asian/Pacific Islander|Male|Leukemia|2003|3.6|5.6|4.5
0-19|3.6|5.6|4.5|90|Incidence|1943682|Asian/Pacific Islander|Male|Leukemia|2004|3.7|5.7|4.6
0-19|3.7|5.6|4.6|96|Incidence|1991945|Asian/Pacific Islander|Male|Leukemia|2005|3.9|5.9|4.8
0-19|4.0|4.8|4.4|482|Incidence|10466929|Asian/Pacific Islander|Male|Leukemia|2005-2009|4.2|5.0|4.6
0-19|3.2|5.0|4.1|86|Incidence|2040932|Asian/Pacific Islander|Male|Leukemia|2006|3.4|5.2|4.2
0-19|3.6|5.4|4.4|96|Incidence|2094159|Asian/Pacific Islander|Male|Leukemia|2007|3.7|5.6|4.6
0-19|3.9|5.8|4.8|107|Incidence|2146576|Asian/Pacific Islander|Male|Leukemia|2008|4.1|6.0|5.0
0-19|3.5|5.2|4.3|96|Incidence|2168060|Asian/Pacific Islander|Male|Leukemia|2009|3.6|5.4|4.4
0-19|0.6|1.6|1.0|16|Incidence|1639643|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|1999|0.6|1.6|1.0
0-19|1.0|2.3|1.6|27|Incidence|1686323|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2000|1.1|2.3|1.6
0-19|0.8|1.9|1.3|22|Incidence|1754020|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2001|0.8|1.9|1.3
0-19|0.7|1.7|1.1|20|Incidence|1837465|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002|0.7|1.7|1.1
0-19|0.9|2.0|1.4|26|Incidence|1898564|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003|0.9|2.0|1.4
0-19|0.6|1.6|1.0|19|Incidence|1943682|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004|0.6|1.5|1.0
0-19|1.0|2.2|1.6|30|Incidence|1991945|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005|1.0|2.2|1.5
0-19|1.1|1.6|1.3|134|Incidence|10466929|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005-2009|1.1|1.5|1.3
0-19|0.7|1.6|1.1|21|Incidence|2040932|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2006|0.6|1.6|1.0
0-19|0.6|1.6|1.0|21|Incidence|2094159|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2007|0.6|1.5|1.0
0-19|0.8|1.7|1.2|25|Incidence|2146576|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2008|0.8|1.7|1.2
0-19|1.2|2.4|1.8|37|Incidence|2168060|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2009|1.2|2.4|1.7
0-19|2.2|4.0|3.0|50|Incidence|1639643|Asian/Pacific Islander|Male|Other|1999|2.3|4.0|3.0
0-19|2.5|4.3|3.3|56|Incidence|1686323|Asian/Pacific Islander|Male|Other|2000|2.5|4.3|3.3
0-19|2.7|4.5|3.5|63|Incidence|1754020|Asian/Pacific Islander|Male|Other|2001|2.8|4.6|3.6
0-19|2.4|4.0|3.1|59|Incidence|1837465|Asian/Pacific Islander|Male|Other|2002|2.4|4.1|3.2
0-19|1.8|3.2|2.4|47|Incidence|1898564|Asian/Pacific Islander|Male|Other|2003|1.8|3.3|2.5
0-19|2.7|4.3|3.4|68|Incidence|1943682|Asian/Pacific Islander|Male|Other|2004|2.7|4.4|3.5
0-19|2.6|4.2|3.3|68|Incidence|1991945|Asian/Pacific Islander|Male|Other|2005|2.7|4.3|3.4
0-19|3.4|4.1|3.7|398|Incidence|10466929|Asian/Pacific Islander|Male|Other|2005-2009|3.4|4.2|3.8
0-19|2.5|4.2|3.3|68|Incidence|2040932|Asian/Pacific Islander|Male|Other|2006|2.6|4.2|3.3
0-19|3.2|4.9|4.0|87|Incidence|2094159|Asian/Pacific Islander|Male|Other|2007|3.3|5.1|4.2
0-19|3.2|4.9|4.0|86|Incidence|2146576|Asian/Pacific Islander|Male|Other|2008|3.2|4.9|4.0
0-19|3.3|5.0|4.1|89|Incidence|2168060|Asian/Pacific Islander|Male|Other|2009|3.3|5.1|4.1
0-19|~|~|~|~|Incidence|1639643|Asian/Pacific Islander|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Incidence|1686323|Asian/Pacific Islander|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Incidence|1754020|Asian/Pacific Islander|Male|Soft Tissue|2001|~|~|~
0-19|0.7|1.8|1.2|22|Incidence|1837465|Asian/Pacific Islander|Male|Soft Tissue|2002|0.8|1.8|1.2
0-19|~|~|~|~|Incidence|1898564|Asian/Pacific Islander|Male|Soft Tissue|2003|~|~|~
0-19|0.5|1.4|0.9|18|Incidence|1943682|Asian/Pacific Islander|Male|Soft Tissue|2004|0.5|1.5|0.9
0-19|0.7|1.6|1.1|22|Incidence|1991945|Asian/Pacific Islander|Male|Soft Tissue|2005|0.7|1.7|1.1
0-19|0.6|1.0|0.8|83|Incidence|10466929|Asian/Pacific Islander|Male|Soft Tissue|2005-2009|0.6|1.0|0.8
0-19|~|~|~|~|Incidence|2040932|Asian/Pacific Islander|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Incidence|2094159|Asian/Pacific Islander|Male|Soft Tissue|2007|~|~|~
0-19|0.5|1.4|0.9|19|Incidence|2146576|Asian/Pacific Islander|Male|Soft Tissue|2008|0.5|1.4|0.9
0-19|0.5|1.3|0.8|19|Incidence|2168060|Asian/Pacific Islander|Male|Soft Tissue|2009|0.5|1.4|0.9
0-19|2.2|3.3|2.7|87|Incidence|3210034|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|1999|2.2|3.3|2.7
0-19|1.8|2.9|2.3|78|Incidence|3304655|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2000|1.9|2.9|2.4
0-19|2.4|3.6|3.0|103|Incidence|3436435|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2001|2.4|3.6|3.0
0-19|2.6|3.8|3.2|117|Incidence|3600241|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002|2.7|3.9|3.2
0-19|2.3|3.4|2.8|108|Incidence|3721028|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003|2.4|3.5|2.9
0-19|2.3|3.3|2.8|109|Incidence|3810357|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004|2.3|3.5|2.9
0-19|2.5|3.6|3.0|125|Incidence|3905961|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005|2.7|3.8|3.2
0-19|2.7|3.2|2.9|632|Incidence|20534298|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005-2009|2.8|3.3|3.1
0-19|2.2|3.2|2.7|111|Incidence|4003158|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2006|2.3|3.3|2.8
0-19|2.5|3.6|3.0|130|Incidence|4108140|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2007|2.6|3.8|3.2
0-19|2.6|3.7|3.1|139|Incidence|4211388|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2008|2.8|3.9|3.3
0-19|2.4|3.4|2.8|126|Incidence|4255762|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2009|2.5|3.5|3.0
0-19|0.5|1.2|0.8|26|Incidence|3210034|Asian/Pacific Islander|Male and Female|Acute Myeloid|1999|0.5|1.2|0.8
0-19|0.3|0.8|0.5|16|Incidence|3304655|Asian/Pacific Islander|Male and Female|Acute Myeloid|2000|0.3|0.8|0.5
0-19|0.5|1.1|0.8|26|Incidence|3436435|Asian/Pacific Islander|Male and Female|Acute Myeloid|2001|0.5|1.1|0.8
0-19|0.4|0.9|0.6|22|Incidence|3600241|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002|0.4|0.9|0.6
0-19|0.4|1.0|0.6|25|Incidence|3721028|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003|0.4|1.0|0.7
0-19|0.6|1.2|0.9|34|Incidence|3810357|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004|0.6|1.2|0.9
0-19|0.5|1.1|0.8|29|Incidence|3905961|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005|0.5|1.1|0.7
0-19|0.7|0.9|0.8|165|Incidence|20534298|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005-2009|0.7|0.9|0.8
0-19|0.6|1.3|0.9|37|Incidence|4003158|Asian/Pacific Islander|Male and Female|Acute Myeloid|2006|0.7|1.3|0.9
0-19|0.5|1.1|0.8|32|Incidence|4108140|Asian/Pacific Islander|Male and Female|Acute Myeloid|2007|0.5|1.1|0.8
0-19|0.7|1.3|0.9|40|Incidence|4211388|Asian/Pacific Islander|Male and Female|Acute Myeloid|2008|0.7|1.3|0.9
0-19|0.4|0.9|0.6|27|Incidence|4255762|Asian/Pacific Islander|Male and Female|Acute Myeloid|2009|0.4|0.9|0.6
0-19|11.2|13.6|12.4|399|Incidence|3210034|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|1999|11.2|13.7|12.4
0-19|10.6|13.0|11.8|392|Incidence|3304655|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2000|10.7|13.1|11.9
0-19|12.8|15.3|14.0|483|Incidence|3436435|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2001|12.8|15.4|14.1
0-19|12.2|14.6|13.4|484|Incidence|3600241|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002|12.3|14.7|13.4
0-19|11.2|13.4|12.3|461|Incidence|3721028|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003|11.3|13.6|12.4
0-19|11.7|14.0|12.8|495|Incidence|3810357|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004|11.9|14.2|13.0
0-19|13.1|15.5|14.3|565|Incidence|3905961|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005|13.3|15.7|14.5
0-19|13.4|14.4|13.9|2886|Incidence|20534298|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005-2009|13.5|14.6|14.1
0-19|11.9|14.1|13.0|526|Incidence|4003158|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2006|12.0|14.3|13.1
0-19|12.5|14.8|13.6|571|Incidence|4108140|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2007|12.8|15.1|13.9
0-19|13.2|15.5|14.3|608|Incidence|4211388|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2008|13.3|15.6|14.4
0-19|13.3|15.6|14.4|614|Incidence|4255762|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2009|13.3|15.6|14.4
0-19|0.3|0.9|0.6|18|Incidence|3210034|Asian/Pacific Islander|Male and Female|Bones and Joints|1999|0.3|0.9|0.6
0-19|0.4|1.0|0.7|22|Incidence|3304655|Asian/Pacific Islander|Male and Female|Bones and Joints|2000|0.4|1.0|0.7
0-19|0.6|1.3|0.9|31|Incidence|3436435|Asian/Pacific Islander|Male and Female|Bones and Joints|2001|0.6|1.3|0.9
0-19|0.5|1.1|0.7|26|Incidence|3600241|Asian/Pacific Islander|Male and Female|Bones and Joints|2002|0.5|1.1|0.7
0-19|0.4|1.0|0.7|24|Incidence|3721028|Asian/Pacific Islander|Male and Female|Bones and Joints|2003|0.4|1.0|0.6
0-19|0.4|1.0|0.7|25|Incidence|3810357|Asian/Pacific Islander|Male and Female|Bones and Joints|2004|0.4|1.0|0.7
0-19|0.5|1.1|0.7|27|Incidence|3905961|Asian/Pacific Islander|Male and Female|Bones and Joints|2005|0.5|1.0|0.7
0-19|0.6|0.9|0.7|142|Incidence|20534298|Asian/Pacific Islander|Male and Female|Bones and Joints|2005-2009|0.6|0.8|0.7
0-19|0.4|0.9|0.6|23|Incidence|4003158|Asian/Pacific Islander|Male and Female|Bones and Joints|2006|0.4|0.9|0.6
0-19|0.5|1.0|0.7|28|Incidence|4108140|Asian/Pacific Islander|Male and Female|Bones and Joints|2007|0.5|1.0|0.7
0-19|0.5|1.0|0.7|28|Incidence|4211388|Asian/Pacific Islander|Male and Female|Bones and Joints|2008|0.4|1.0|0.7
0-19|0.6|1.2|0.9|36|Incidence|4255762|Asian/Pacific Islander|Male and Female|Bones and Joints|2009|0.6|1.2|0.8
0-19|1.4|2.4|1.9|60|Incidence|3210034|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|1999|1.4|2.4|1.9
0-19|1.5|2.5|1.9|64|Incidence|3304655|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2000|1.5|2.5|1.9
0-19|2.0|3.1|2.5|85|Incidence|3436435|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2001|2.0|3.1|2.5
0-19|1.5|2.4|1.9|68|Incidence|3600241|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002|1.5|2.4|1.9
0-19|1.7|2.7|2.1|80|Incidence|3721028|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003|1.7|2.7|2.1
0-19|1.6|2.5|2.0|78|Incidence|3810357|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004|1.6|2.6|2.0
0-19|1.9|2.8|2.3|91|Incidence|3905961|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005|1.9|2.9|2.3
0-19|2.0|2.4|2.2|464|Incidence|20534298|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005-2009|2.1|2.5|2.3
0-19|1.6|2.6|2.1|85|Incidence|4003158|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2006|1.7|2.6|2.1
0-19|1.8|2.7|2.2|92|Incidence|4108140|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2007|1.8|2.7|2.2
0-19|1.9|2.8|2.3|99|Incidence|4211388|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2008|1.9|2.9|2.4
0-19|1.8|2.7|2.2|96|Incidence|4255762|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2009|1.8|2.8|2.3
0-19|0.3|0.8|0.5|16|Incidence|3210034|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|1999|0.3|0.8|0.5
0-19|0.3|0.9|0.6|19|Incidence|3304655|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2000|0.3|0.9|0.6
0-19|0.5|1.2|0.8|27|Incidence|3436435|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2001|0.5|1.1|0.8
0-19|0.6|1.3|0.9|32|Incidence|3600241|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002|0.6|1.3|0.9
0-19|0.5|1.1|0.8|28|Incidence|3721028|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003|0.5|1.1|0.8
0-19|0.4|0.9|0.6|23|Incidence|3810357|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004|0.4|0.9|0.6
0-19|0.7|1.3|1.0|36|Incidence|3905961|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005|0.6|1.3|0.9
0-19|0.7|1.0|0.8|159|Incidence|20534298|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005-2009|0.7|0.9|0.8
0-19|0.6|1.2|0.9|34|Incidence|4003158|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2006|0.6|1.2|0.8
0-19|0.4|1.0|0.7|26|Incidence|4108140|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2007|0.4|0.9|0.6
0-19|0.5|1.0|0.7|29|Incidence|4211388|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2008|0.5|1.0|0.7
0-19|0.6|1.2|0.8|34|Incidence|4255762|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2009|0.6|1.1|0.8
0-19|~|~|~|~|Incidence|3210034|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Incidence|3304655|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Incidence|3436435|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Incidence|3600241|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|0.3|0.8|0.5|19|Incidence|3721028|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003|0.3|0.8|0.5
0-19|~|~|~|~|Incidence|3810357|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Incidence|3905961|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.3|0.4|0.3|77|Incidence|20534298|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005-2009|0.3|0.5|0.4
0-19|~|~|~|~|Incidence|4003158|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|0.2|0.6|0.4|18|Incidence|4108140|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2007|0.3|0.7|0.4
0-19|0.2|0.7|0.4|19|Incidence|4211388|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2008|0.3|0.7|0.5
0-19|0.2|0.6|0.4|18|Incidence|4255762|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2009|0.3|0.7|0.4
0-19|3.3|4.7|3.9|127|Incidence|3210034|Asian/Pacific Islander|Male and Female|Leukemia|1999|3.3|4.7|4.0
0-19|2.6|3.8|3.2|105|Incidence|3304655|Asian/Pacific Islander|Male and Female|Leukemia|2000|2.6|3.8|3.2
0-19|3.6|5.0|4.2|146|Incidence|3436435|Asian/Pacific Islander|Male and Female|Leukemia|2001|3.6|5.0|4.2
0-19|3.7|5.1|4.3|158|Incidence|3600241|Asian/Pacific Islander|Male and Female|Leukemia|2002|3.7|5.1|4.4
0-19|3.3|4.6|3.9|148|Incidence|3721028|Asian/Pacific Islander|Male and Female|Leukemia|2003|3.4|4.7|4.0
0-19|3.5|4.8|4.1|160|Incidence|3810357|Asian/Pacific Islander|Male and Female|Leukemia|2004|3.6|4.9|4.2
0-19|3.5|4.8|4.2|170|Incidence|3905961|Asian/Pacific Islander|Male and Female|Leukemia|2005|3.7|5.1|4.4
0-19|3.8|4.4|4.1|867|Incidence|20534298|Asian/Pacific Islander|Male and Female|Leukemia|2005-2009|3.9|4.5|4.2
0-19|3.3|4.5|3.9|160|Incidence|4003158|Asian/Pacific Islander|Male and Female|Leukemia|2006|3.4|4.7|4.0
0-19|3.5|4.8|4.1|174|Incidence|4108140|Asian/Pacific Islander|Male and Female|Leukemia|2007|3.6|4.9|4.2
0-19|3.8|5.1|4.4|193|Incidence|4211388|Asian/Pacific Islander|Male and Female|Leukemia|2008|4.0|5.3|4.6
0-19|3.3|4.5|3.8|169|Incidence|4255762|Asian/Pacific Islander|Male and Female|Leukemia|2009|3.4|4.6|4.0
0-19|0.6|1.3|0.9|28|Incidence|3210034|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|1999|0.6|1.3|0.9
0-19|0.9|1.7|1.3|42|Incidence|3304655|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2000|0.9|1.7|1.3
0-19|0.7|1.4|1.0|35|Incidence|3436435|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2001|0.7|1.4|1.0
0-19|0.7|1.4|1.0|37|Incidence|3600241|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002|0.7|1.4|1.0
0-19|0.7|1.4|1.0|37|Incidence|3721028|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003|0.7|1.4|1.0
0-19|0.6|1.2|0.9|33|Incidence|3810357|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004|0.6|1.2|0.9
0-19|1.0|1.7|1.3|50|Incidence|3905961|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.7|1.3
0-19|0.9|1.2|1.1|215|Incidence|20534298|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005-2009|0.9|1.2|1.0
0-19|0.7|1.3|1.0|37|Incidence|4003158|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2006|0.7|1.3|0.9
0-19|0.6|1.3|0.9|37|Incidence|4108140|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2007|0.6|1.2|0.9
0-19|0.7|1.3|1.0|40|Incidence|4211388|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2008|0.7|1.3|0.9
0-19|0.9|1.6|1.2|51|Incidence|4255762|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2009|0.9|1.6|1.2
0-19|2.8|4.1|3.4|112|Incidence|3210034|Asian/Pacific Islander|Male and Female|Other|1999|2.9|4.2|3.5
0-19|2.7|4.0|3.3|111|Incidence|3304655|Asian/Pacific Islander|Male and Female|Other|2000|2.8|4.0|3.4
0-19|3.0|4.3|3.6|127|Incidence|3436435|Asian/Pacific Islander|Male and Female|Other|2001|3.1|4.4|3.7
0-19|2.6|3.8|3.2|116|Incidence|3600241|Asian/Pacific Islander|Male and Female|Other|2002|2.7|3.9|3.2
0-19|2.3|3.4|2.8|108|Incidence|3721028|Asian/Pacific Islander|Male and Female|Other|2003|2.4|3.5|2.9
0-19|2.8|4.0|3.4|131|Incidence|3810357|Asian/Pacific Islander|Male and Female|Other|2004|2.9|4.1|3.4
0-19|3.1|4.3|3.7|144|Incidence|3905961|Asian/Pacific Islander|Male and Female|Other|2005|3.1|4.3|3.7
0-19|3.7|4.2|3.9|811|Incidence|20534298|Asian/Pacific Islander|Male and Female|Other|2005-2009|3.7|4.2|3.9
0-19|3.1|4.3|3.7|149|Incidence|4003158|Asian/Pacific Islander|Male and Female|Other|2006|3.1|4.4|3.7
0-19|3.4|4.6|4.0|168|Incidence|4108140|Asian/Pacific Islander|Male and Female|Other|2007|3.5|4.8|4.1
0-19|3.5|4.7|4.1|172|Incidence|4211388|Asian/Pacific Islander|Male and Female|Other|2008|3.5|4.7|4.1
0-19|3.7|4.9|4.3|178|Incidence|4255762|Asian/Pacific Islander|Male and Female|Other|2009|3.6|4.8|4.2
0-19|0.5|1.1|0.8|25|Incidence|3210034|Asian/Pacific Islander|Male and Female|Soft Tissue|1999|0.5|1.1|0.8
0-19|0.3|0.8|0.5|18|Incidence|3304655|Asian/Pacific Islander|Male and Female|Soft Tissue|2000|0.3|0.9|0.5
0-19|0.3|0.9|0.6|20|Incidence|3436435|Asian/Pacific Islander|Male and Female|Soft Tissue|2001|0.4|0.9|0.6
0-19|0.7|1.4|1.0|37|Incidence|3600241|Asian/Pacific Islander|Male and Female|Soft Tissue|2002|0.7|1.4|1.0
0-19|0.3|0.7|0.5|17|Incidence|3721028|Asian/Pacific Islander|Male and Female|Soft Tissue|2003|0.3|0.7|0.5
0-19|0.5|1.1|0.8|30|Incidence|3810357|Asian/Pacific Islander|Male and Female|Soft Tissue|2004|0.5|1.1|0.8
0-19|0.7|1.3|1.0|38|Incidence|3905961|Asian/Pacific Islander|Male and Female|Soft Tissue|2005|0.7|1.3|1.0
0-19|0.6|0.8|0.7|151|Incidence|20534298|Asian/Pacific Islander|Male and Female|Soft Tissue|2005-2009|0.6|0.9|0.7
0-19|0.4|0.9|0.6|25|Incidence|4003158|Asian/Pacific Islander|Male and Female|Soft Tissue|2006|0.4|0.9|0.6
0-19|0.4|1.0|0.7|28|Incidence|4108140|Asian/Pacific Islander|Male and Female|Soft Tissue|2007|0.5|1.0|0.7
0-19|0.4|1.0|0.7|28|Incidence|4211388|Asian/Pacific Islander|Male and Female|Soft Tissue|2008|0.4|1.0|0.7
0-19|0.5|1.0|0.7|32|Incidence|4255762|Asian/Pacific Islander|Male and Female|Soft Tissue|2009|0.5|1.1|0.8
0-19|1.1|1.7|1.4|74|Incidence|5402131|Black|Female|Acute Lymphocytic|1999|1.1|1.7|1.4
0-19|1.2|1.8|1.5|80|Incidence|5446152|Black|Female|Acute Lymphocytic|2000|1.2|1.8|1.5
0-19|1.3|2.0|1.6|96|Incidence|5847078|Black|Female|Acute Lymphocytic|2001|1.3|2.0|1.6
0-19|1.0|1.6|1.3|77|Incidence|6055801|Black|Female|Acute Lymphocytic|2002|1.0|1.6|1.3
0-19|1.1|1.6|1.3|86|Incidence|6482277|Black|Female|Acute Lymphocytic|2003|1.1|1.6|1.3
0-19|1.1|1.7|1.4|91|Incidence|6505891|Black|Female|Acute Lymphocytic|2004|1.1|1.7|1.4
0-19|1.1|1.7|1.4|89|Incidence|6530380|Black|Female|Acute Lymphocytic|2005|1.1|1.7|1.4
0-19|1.3|1.6|1.5|478|Incidence|32987293|Black|Female|Acute Lymphocytic|2005-2009|1.3|1.6|1.4
0-19|1.2|1.8|1.4|94|Incidence|6560240|Black|Female|Acute Lymphocytic|2006|1.2|1.8|1.4
0-19|1.2|1.8|1.5|97|Incidence|6604633|Black|Female|Acute Lymphocytic|2007|1.2|1.8|1.5
0-19|1.2|1.8|1.5|96|Incidence|6638744|Black|Female|Acute Lymphocytic|2008|1.2|1.8|1.4
0-19|1.3|1.9|1.5|101|Incidence|6581190|Black|Female|Acute Lymphocytic|2009|1.3|1.9|1.5
0-19|0.4|0.9|0.6|34|Incidence|5402131|Black|Female|Acute Myeloid|1999|0.4|0.9|0.6
0-19|0.3|0.7|0.5|27|Incidence|5446152|Black|Female|Acute Myeloid|2000|0.3|0.7|0.5
0-19|0.3|0.7|0.5|30|Incidence|5847078|Black|Female|Acute Myeloid|2001|0.3|0.7|0.5
0-19|0.5|0.9|0.7|40|Incidence|6055801|Black|Female|Acute Myeloid|2002|0.5|0.9|0.7
0-19|0.5|0.9|0.7|43|Incidence|6482277|Black|Female|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.4|0.8|0.6|36|Incidence|6505891|Black|Female|Acute Myeloid|2004|0.4|0.8|0.6
0-19|0.4|0.8|0.5|36|Incidence|6530380|Black|Female|Acute Myeloid|2005|0.4|0.8|0.6
0-19|0.6|0.8|0.7|225|Incidence|32987293|Black|Female|Acute Myeloid|2005-2009|0.6|0.8|0.7
0-19|0.6|1.1|0.8|54|Incidence|6560240|Black|Female|Acute Myeloid|2006|0.6|1.1|0.8
0-19|0.4|0.8|0.6|38|Incidence|6604633|Black|Female|Acute Myeloid|2007|0.4|0.8|0.6
0-19|0.7|1.1|0.9|60|Incidence|6638744|Black|Female|Acute Myeloid|2008|0.7|1.2|0.9
0-19|0.4|0.7|0.5|36|Incidence|6581190|Black|Female|Acute Myeloid|2009|0.4|0.8|0.5
0-19|10.5|12.3|11.4|608|Incidence|5402131|Black|Female|All Cancer Sites Combined|1999|10.4|12.2|11.3
0-19|9.8|11.6|10.7|575|Incidence|5446152|Black|Female|All Cancer Sites Combined|2000|9.7|11.5|10.6
0-19|10.6|12.3|11.4|666|Incidence|5847078|Black|Female|All Cancer Sites Combined|2001|10.5|12.3|11.4
0-19|10.5|12.2|11.3|686|Incidence|6055801|Black|Female|All Cancer Sites Combined|2002|10.5|12.2|11.3
0-19|11.8|13.6|12.7|822|Incidence|6482277|Black|Female|All Cancer Sites Combined|2003|11.8|13.6|12.7
0-19|11.8|13.6|12.7|826|Incidence|6505891|Black|Female|All Cancer Sites Combined|2004|11.8|13.6|12.7
0-19|11.6|13.3|12.5|818|Incidence|6530380|Black|Female|All Cancer Sites Combined|2005|11.7|13.4|12.5
0-19|12.2|12.9|12.5|4176|Incidence|32987293|Black|Female|All Cancer Sites Combined|2005-2009|12.3|13.0|12.7
0-19|11.4|13.1|12.2|810|Incidence|6560240|Black|Female|All Cancer Sites Combined|2006|11.5|13.2|12.3
0-19|11.8|13.5|12.6|842|Incidence|6604633|Black|Female|All Cancer Sites Combined|2007|11.9|13.6|12.7
0-19|12.0|13.8|12.9|864|Incidence|6638744|Black|Female|All Cancer Sites Combined|2008|12.2|13.9|13.0
0-19|11.7|13.4|12.5|835|Incidence|6581190|Black|Female|All Cancer Sites Combined|2009|11.8|13.6|12.7
0-19|0.5|1.0|0.7|38|Incidence|5402131|Black|Female|Bones and Joints|1999|0.5|1.0|0.7
0-19|0.3|0.7|0.5|27|Incidence|5446152|Black|Female|Bones and Joints|2000|0.3|0.7|0.5
0-19|0.5|0.9|0.7|39|Incidence|5847078|Black|Female|Bones and Joints|2001|0.5|0.9|0.7
0-19|0.4|0.8|0.6|37|Incidence|6055801|Black|Female|Bones and Joints|2002|0.4|0.8|0.6
0-19|0.5|0.9|0.7|45|Incidence|6482277|Black|Female|Bones and Joints|2003|0.5|0.9|0.7
0-19|0.7|1.2|0.9|60|Incidence|6505891|Black|Female|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.5|0.9|0.7|44|Incidence|6530380|Black|Female|Bones and Joints|2005|0.5|0.9|0.7
0-19|0.6|0.7|0.6|213|Incidence|32987293|Black|Female|Bones and Joints|2005-2009|0.6|0.7|0.6
0-19|0.5|0.9|0.7|47|Incidence|6560240|Black|Female|Bones and Joints|2006|0.5|1.0|0.7
0-19|0.4|0.8|0.6|41|Incidence|6604633|Black|Female|Bones and Joints|2007|0.4|0.8|0.6
0-19|0.4|0.8|0.5|36|Incidence|6638744|Black|Female|Bones and Joints|2008|0.4|0.8|0.5
0-19|0.5|0.9|0.7|45|Incidence|6581190|Black|Female|Bones and Joints|2009|0.5|0.9|0.7
0-19|1.5|2.2|1.8|101|Incidence|5402131|Black|Female|Brain and Other Nervous System|1999|1.5|2.3|1.9
0-19|1.6|2.4|2.0|109|Incidence|5446152|Black|Female|Brain and Other Nervous System|2000|1.6|2.4|2.0
0-19|1.7|2.4|2.0|119|Incidence|5847078|Black|Female|Brain and Other Nervous System|2001|1.7|2.4|2.0
0-19|1.7|2.4|2.0|121|Incidence|6055801|Black|Female|Brain and Other Nervous System|2002|1.7|2.4|2.0
0-19|1.8|2.6|2.2|142|Incidence|6482277|Black|Female|Brain and Other Nervous System|2003|1.8|2.6|2.2
0-19|2.0|2.8|2.4|156|Incidence|6505891|Black|Female|Brain and Other Nervous System|2004|2.0|2.8|2.4
0-19|2.0|2.7|2.3|151|Incidence|6530380|Black|Female|Brain and Other Nervous System|2005|2.0|2.7|2.3
0-19|2.2|2.5|2.4|774|Incidence|32987293|Black|Female|Brain and Other Nervous System|2005-2009|2.2|2.5|2.3
0-19|2.0|2.7|2.3|153|Incidence|6560240|Black|Female|Brain and Other Nervous System|2006|2.0|2.7|2.3
0-19|2.0|2.7|2.3|151|Incidence|6604633|Black|Female|Brain and Other Nervous System|2007|1.9|2.7|2.3
0-19|2.2|3.0|2.6|173|Incidence|6638744|Black|Female|Brain and Other Nervous System|2008|2.2|3.0|2.6
0-19|1.8|2.6|2.2|144|Incidence|6581190|Black|Female|Brain and Other Nervous System|2009|1.8|2.6|2.2
0-19|0.4|0.9|0.6|33|Incidence|5402131|Black|Female|Hodgkin Lymphoma|1999|0.4|0.9|0.6
0-19|0.6|1.1|0.8|42|Incidence|5446152|Black|Female|Hodgkin Lymphoma|2000|0.6|1.0|0.8
0-19|0.5|1.0|0.7|41|Incidence|5847078|Black|Female|Hodgkin Lymphoma|2001|0.5|1.0|0.7
0-19|0.7|1.2|0.9|56|Incidence|6055801|Black|Female|Hodgkin Lymphoma|2002|0.7|1.2|0.9
0-19|0.8|1.3|1.0|63|Incidence|6482277|Black|Female|Hodgkin Lymphoma|2003|0.7|1.2|1.0
0-19|0.7|1.1|0.9|57|Incidence|6505891|Black|Female|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.8|1.3|1.0|69|Incidence|6530380|Black|Female|Hodgkin Lymphoma|2005|0.8|1.3|1.1
0-19|0.9|1.1|1.0|322|Incidence|32987293|Black|Female|Hodgkin Lymphoma|2005-2009|0.9|1.1|1.0
0-19|0.6|1.0|0.8|52|Incidence|6560240|Black|Female|Hodgkin Lymphoma|2006|0.6|1.0|0.8
0-19|0.6|1.0|0.8|54|Incidence|6604633|Black|Female|Hodgkin Lymphoma|2007|0.6|1.1|0.8
0-19|0.9|1.4|1.1|77|Incidence|6638744|Black|Female|Hodgkin Lymphoma|2008|0.9|1.4|1.2
0-19|0.8|1.3|1.0|69|Incidence|6581190|Black|Female|Hodgkin Lymphoma|2009|0.8|1.3|1.0
0-19|0.7|1.2|0.9|50|Incidence|5402131|Black|Female|Kidney and Renal Pelvis|1999|0.7|1.2|0.9
0-19|0.8|1.4|1.0|57|Incidence|5446152|Black|Female|Kidney and Renal Pelvis|2000|0.8|1.4|1.0
0-19|0.5|1.0|0.7|42|Incidence|5847078|Black|Female|Kidney and Renal Pelvis|2001|0.5|1.0|0.7
0-19|0.6|1.1|0.9|52|Incidence|6055801|Black|Female|Kidney and Renal Pelvis|2002|0.6|1.1|0.9
0-19|0.5|1.0|0.7|46|Incidence|6482277|Black|Female|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.5|0.9|0.7|43|Incidence|6505891|Black|Female|Kidney and Renal Pelvis|2004|0.5|0.9|0.7
0-19|0.7|1.2|0.9|61|Incidence|6530380|Black|Female|Kidney and Renal Pelvis|2005|0.7|1.2|0.9
0-19|0.8|1.0|0.9|294|Incidence|32987293|Black|Female|Kidney and Renal Pelvis|2005-2009|0.8|1.0|0.9
0-19|0.6|1.0|0.8|50|Incidence|6560240|Black|Female|Kidney and Renal Pelvis|2006|0.6|1.0|0.8
0-19|0.7|1.1|0.9|58|Incidence|6604633|Black|Female|Kidney and Renal Pelvis|2007|0.7|1.1|0.9
0-19|0.7|1.2|0.9|61|Incidence|6638744|Black|Female|Kidney and Renal Pelvis|2008|0.7|1.2|0.9
0-19|0.7|1.2|1.0|64|Incidence|6581190|Black|Female|Kidney and Renal Pelvis|2009|0.7|1.2|1.0
0-19|2.0|2.9|2.4|130|Incidence|5402131|Black|Female|Leukemia|1999|2.0|2.9|2.4
0-19|1.7|2.5|2.1|114|Incidence|5446152|Black|Female|Leukemia|2000|1.7|2.5|2.1
0-19|2.0|2.9|2.4|142|Incidence|5847078|Black|Female|Leukemia|2001|2.0|2.9|2.4
0-19|1.9|2.7|2.3|139|Incidence|6055801|Black|Female|Leukemia|2002|1.9|2.7|2.3
0-19|1.9|2.6|2.2|144|Incidence|6482277|Black|Female|Leukemia|2003|1.9|2.6|2.2
0-19|2.0|2.8|2.4|153|Incidence|6505891|Black|Female|Leukemia|2004|2.0|2.8|2.4
0-19|1.8|2.6|2.2|142|Incidence|6530380|Black|Female|Leukemia|2005|1.8|2.6|2.2
0-19|2.2|2.6|2.4|794|Incidence|32987293|Black|Female|Leukemia|2005-2009|2.2|2.6|2.4
0-19|2.2|3.0|2.6|168|Incidence|6560240|Black|Female|Leukemia|2006|2.2|3.0|2.6
0-19|2.1|2.8|2.4|162|Incidence|6604633|Black|Female|Leukemia|2007|2.1|2.9|2.5
0-19|2.2|3.0|2.6|171|Incidence|6638744|Black|Female|Leukemia|2008|2.2|3.0|2.6
0-19|1.9|2.6|2.3|149|Incidence|6581190|Black|Female|Leukemia|2009|1.9|2.7|2.3
0-19|0.5|0.9|0.7|35|Incidence|5402131|Black|Female|Non-Hodgkin Lymphoma|1999|0.5|0.9|0.6
0-19|0.4|0.9|0.6|34|Incidence|5446152|Black|Female|Non-Hodgkin Lymphoma|2000|0.4|0.9|0.6
0-19|0.6|1.1|0.8|46|Incidence|5847078|Black|Female|Non-Hodgkin Lymphoma|2001|0.6|1.0|0.8
0-19|0.6|1.1|0.8|50|Incidence|6055801|Black|Female|Non-Hodgkin Lymphoma|2002|0.6|1.1|0.8
0-19|0.5|0.9|0.7|45|Incidence|6482277|Black|Female|Non-Hodgkin Lymphoma|2003|0.5|0.9|0.7
0-19|0.7|1.1|0.9|57|Incidence|6505891|Black|Female|Non-Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.6|1.1|0.8|55|Incidence|6530380|Black|Female|Non-Hodgkin Lymphoma|2005|0.6|1.1|0.8
0-19|0.7|0.9|0.8|258|Incidence|32987293|Black|Female|Non-Hodgkin Lymphoma|2005-2009|0.7|0.9|0.8
0-19|0.6|1.1|0.8|55|Incidence|6560240|Black|Female|Non-Hodgkin Lymphoma|2006|0.6|1.1|0.8
0-19|0.6|1.0|0.8|50|Incidence|6604633|Black|Female|Non-Hodgkin Lymphoma|2007|0.6|1.0|0.8
0-19|0.7|1.2|0.9|61|Incidence|6638744|Black|Female|Non-Hodgkin Lymphoma|2008|0.7|1.2|0.9
0-19|0.4|0.8|0.6|37|Incidence|6581190|Black|Female|Non-Hodgkin Lymphoma|2009|0.4|0.8|0.6
0-19|3.0|4.0|3.5|183|Incidence|5402131|Black|Female|Other|1999|2.9|3.9|3.4
0-19|2.2|3.1|2.6|141|Incidence|5446152|Black|Female|Other|2000|2.2|3.1|2.6
0-19|2.9|3.8|3.3|192|Incidence|5847078|Black|Female|Other|2001|2.8|3.8|3.3
0-19|2.5|3.4|2.9|177|Incidence|6055801|Black|Female|Other|2002|2.5|3.4|2.9
0-19|3.8|4.8|4.3|278|Incidence|6482277|Black|Female|Other|2003|3.8|4.8|4.3
0-19|2.9|3.9|3.4|220|Incidence|6505891|Black|Female|Other|2004|2.9|3.9|3.4
0-19|3.3|4.2|3.7|245|Incidence|6530380|Black|Female|Other|2005|3.3|4.3|3.8
0-19|3.4|3.8|3.6|1218|Incidence|32987293|Black|Female|Other|2005-2009|3.5|3.9|3.7
0-19|3.0|3.9|3.4|227|Incidence|6560240|Black|Female|Other|2006|3.0|3.9|3.5
0-19|3.3|4.2|3.7|253|Incidence|6604633|Black|Female|Other|2007|3.4|4.3|3.8
0-19|2.9|3.8|3.3|224|Incidence|6638744|Black|Female|Other|2008|2.9|3.8|3.4
0-19|3.5|4.4|3.9|267|Incidence|6581190|Black|Female|Other|2009|3.6|4.6|4.1
0-19|0.5|1.0|0.7|38|Incidence|5402131|Black|Female|Soft Tissue|1999|0.5|1.0|0.7
0-19|0.7|1.2|0.9|51|Incidence|5446152|Black|Female|Soft Tissue|2000|0.7|1.2|0.9
0-19|0.6|1.0|0.8|45|Incidence|5847078|Black|Female|Soft Tissue|2001|0.6|1.0|0.8
0-19|0.7|1.2|0.9|54|Incidence|6055801|Black|Female|Soft Tissue|2002|0.7|1.2|0.9
0-19|0.7|1.2|0.9|59|Incidence|6482277|Black|Female|Soft Tissue|2003|0.7|1.2|0.9
0-19|1.0|1.5|1.2|80|Incidence|6505891|Black|Female|Soft Tissue|2004|1.0|1.5|1.2
0-19|0.6|1.0|0.8|51|Incidence|6530380|Black|Female|Soft Tissue|2005|0.6|1.0|0.8
0-19|0.8|1.0|0.9|303|Incidence|32987293|Black|Female|Soft Tissue|2005-2009|0.8|1.0|0.9
0-19|0.7|1.1|0.9|58|Incidence|6560240|Black|Female|Soft Tissue|2006|0.7|1.1|0.9
0-19|0.9|1.4|1.1|73|Incidence|6604633|Black|Female|Soft Tissue|2007|0.9|1.4|1.1
0-19|0.7|1.2|0.9|61|Incidence|6638744|Black|Female|Soft Tissue|2008|0.7|1.2|0.9
0-19|0.7|1.2|0.9|60|Incidence|6581190|Black|Female|Soft Tissue|2009|0.7|1.2|0.9
0-19|1.5|2.2|1.8|102|Incidence|5567502|Black|Male|Acute Lymphocytic|1999|1.5|2.2|1.8
0-19|1.2|1.8|1.5|83|Incidence|5620506|Black|Male|Acute Lymphocytic|2000|1.2|1.8|1.5
0-19|1.3|1.9|1.6|95|Incidence|6043483|Black|Male|Acute Lymphocytic|2001|1.3|1.9|1.6
0-19|1.4|2.1|1.7|109|Incidence|6261104|Black|Male|Acute Lymphocytic|2002|1.4|2.1|1.7
0-19|1.4|2.0|1.7|114|Incidence|6690871|Black|Male|Acute Lymphocytic|2003|1.4|2.0|1.7
0-19|1.7|2.4|2.0|135|Incidence|6713091|Black|Male|Acute Lymphocytic|2004|1.7|2.4|2.0
0-19|1.8|2.5|2.2|144|Incidence|6738111|Black|Male|Acute Lymphocytic|2005|1.8|2.5|2.1
0-19|1.9|2.2|2.1|712|Incidence|34051259|Black|Male|Acute Lymphocytic|2005-2009|1.9|2.3|2.1
0-19|1.8|2.5|2.1|141|Incidence|6769408|Black|Male|Acute Lymphocytic|2006|1.8|2.5|2.1
0-19|2.0|2.7|2.3|158|Incidence|6818048|Black|Male|Acute Lymphocytic|2007|2.0|2.7|2.3
0-19|1.5|2.2|1.8|125|Incidence|6853996|Black|Male|Acute Lymphocytic|2008|1.5|2.2|1.8
0-19|1.7|2.4|2.1|140|Incidence|6796473|Black|Male|Acute Lymphocytic|2009|1.7|2.4|2.1
0-19|0.6|1.1|0.8|43|Incidence|5567502|Black|Male|Acute Myeloid|1999|0.6|1.0|0.8
0-19|0.5|0.9|0.7|37|Incidence|5620506|Black|Male|Acute Myeloid|2000|0.5|0.9|0.7
0-19|0.3|0.7|0.5|31|Incidence|6043483|Black|Male|Acute Myeloid|2001|0.3|0.7|0.5
0-19|0.4|0.9|0.6|39|Incidence|6261104|Black|Male|Acute Myeloid|2002|0.4|0.9|0.6
0-19|0.6|1.1|0.8|55|Incidence|6690871|Black|Male|Acute Myeloid|2003|0.6|1.1|0.8
0-19|0.6|1.0|0.8|51|Incidence|6713091|Black|Male|Acute Myeloid|2004|0.6|1.0|0.8
0-19|0.5|0.9|0.7|44|Incidence|6738111|Black|Male|Acute Myeloid|2005|0.5|0.9|0.7
0-19|0.5|0.7|0.6|203|Incidence|34051259|Black|Male|Acute Myeloid|2005-2009|0.5|0.7|0.6
0-19|0.5|0.9|0.7|48|Incidence|6769408|Black|Male|Acute Myeloid|2006|0.5|0.9|0.7
0-19|0.3|0.6|0.5|31|Incidence|6818048|Black|Male|Acute Myeloid|2007|0.3|0.6|0.5
0-19|0.5|0.9|0.7|46|Incidence|6853996|Black|Male|Acute Myeloid|2008|0.5|0.9|0.7
0-19|0.3|0.7|0.5|33|Incidence|6796473|Black|Male|Acute Myeloid|2009|0.3|0.7|0.5
0-19|11.2|13.0|12.1|666|Incidence|5567502|Black|Male|All Cancer Sites Combined|1999|11.1|12.9|12.0
0-19|11.2|13.1|12.1|679|Incidence|5620506|Black|Male|All Cancer Sites Combined|2000|11.2|13.0|12.1
0-19|11.1|12.9|11.9|718|Incidence|6043483|Black|Male|All Cancer Sites Combined|2001|11.0|12.8|11.9
0-19|11.2|13.0|12.1|753|Incidence|6261104|Black|Male|All Cancer Sites Combined|2002|11.2|12.9|12.0
0-19|12.1|13.9|13.0|869|Incidence|6690871|Black|Male|All Cancer Sites Combined|2003|12.1|13.9|13.0
0-19|12.5|14.3|13.4|902|Incidence|6713091|Black|Male|All Cancer Sites Combined|2004|12.6|14.3|13.4
0-19|12.8|14.6|13.7|925|Incidence|6738111|Black|Male|All Cancer Sites Combined|2005|12.9|14.6|13.7
0-19|13.2|13.9|13.5|4652|Incidence|34051259|Black|Male|All Cancer Sites Combined|2005-2009|13.3|14.1|13.7
0-19|12.6|14.3|13.4|916|Incidence|6769408|Black|Male|All Cancer Sites Combined|2006|12.7|14.4|13.5
0-19|12.3|14.0|13.1|904|Incidence|6818048|Black|Male|All Cancer Sites Combined|2007|12.4|14.2|13.3
0-19|13.7|15.5|14.5|1010|Incidence|6853996|Black|Male|All Cancer Sites Combined|2008|13.8|15.7|14.7
0-19|12.1|13.8|12.9|885|Incidence|6796473|Black|Male|All Cancer Sites Combined|2009|12.2|13.9|13.0
0-19|0.7|1.2|0.9|49|Incidence|5567502|Black|Male|Bones and Joints|1999|0.7|1.2|0.9
0-19|0.5|1.0|0.7|40|Incidence|5620506|Black|Male|Bones and Joints|2000|0.5|1.0|0.7
0-19|0.5|0.9|0.7|39|Incidence|6043483|Black|Male|Bones and Joints|2001|0.5|0.9|0.6
0-19|0.6|1.1|0.8|51|Incidence|6261104|Black|Male|Bones and Joints|2002|0.6|1.1|0.8
0-19|0.6|1.0|0.7|50|Incidence|6690871|Black|Male|Bones and Joints|2003|0.6|1.0|0.7
0-19|0.7|1.2|0.9|63|Incidence|6713091|Black|Male|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.7|1.2|0.9|63|Incidence|6738111|Black|Male|Bones and Joints|2005|0.7|1.2|0.9
0-19|0.7|0.9|0.8|272|Incidence|34051259|Black|Male|Bones and Joints|2005-2009|0.7|0.9|0.8
0-19|0.6|1.1|0.8|57|Incidence|6769408|Black|Male|Bones and Joints|2006|0.6|1.1|0.8
0-19|0.5|0.9|0.7|48|Incidence|6818048|Black|Male|Bones and Joints|2007|0.5|0.9|0.7
0-19|0.6|1.1|0.8|57|Incidence|6853996|Black|Male|Bones and Joints|2008|0.6|1.1|0.8
0-19|0.5|0.9|0.7|47|Incidence|6796473|Black|Male|Bones and Joints|2009|0.5|0.9|0.7
0-19|1.9|2.7|2.2|125|Incidence|5567502|Black|Male|Brain and Other Nervous System|1999|1.9|2.7|2.2
0-19|2.1|2.9|2.5|140|Incidence|5620506|Black|Male|Brain and Other Nervous System|2000|2.1|2.9|2.5
0-19|1.7|2.5|2.1|125|Incidence|6043483|Black|Male|Brain and Other Nervous System|2001|1.7|2.5|2.1
0-19|2.0|2.8|2.4|148|Incidence|6261104|Black|Male|Brain and Other Nervous System|2002|2.0|2.8|2.4
0-19|1.9|2.6|2.2|149|Incidence|6690871|Black|Male|Brain and Other Nervous System|2003|1.9|2.6|2.2
0-19|2.1|2.9|2.5|165|Incidence|6713091|Black|Male|Brain and Other Nervous System|2004|2.1|2.9|2.5
0-19|1.9|2.7|2.3|151|Incidence|6738111|Black|Male|Brain and Other Nervous System|2005|1.9|2.6|2.2
0-19|2.2|2.5|2.3|796|Incidence|34051259|Black|Male|Brain and Other Nervous System|2005-2009|2.2|2.5|2.3
0-19|1.9|2.6|2.2|148|Incidence|6769408|Black|Male|Brain and Other Nervous System|2006|1.8|2.6|2.2
0-19|1.8|2.5|2.1|142|Incidence|6818048|Black|Male|Brain and Other Nervous System|2007|1.8|2.5|2.1
0-19|2.4|3.2|2.8|191|Incidence|6853996|Black|Male|Brain and Other Nervous System|2008|2.4|3.2|2.8
0-19|2.0|2.8|2.4|162|Incidence|6796473|Black|Male|Brain and Other Nervous System|2009|2.0|2.8|2.4
0-19|0.8|1.4|1.1|57|Incidence|5567502|Black|Male|Hodgkin Lymphoma|1999|0.8|1.3|1.0
0-19|0.9|1.5|1.1|62|Incidence|5620506|Black|Male|Hodgkin Lymphoma|2000|0.8|1.4|1.1
0-19|0.8|1.3|1.0|59|Incidence|6043483|Black|Male|Hodgkin Lymphoma|2001|0.7|1.3|1.0
0-19|0.7|1.2|0.9|56|Incidence|6261104|Black|Male|Hodgkin Lymphoma|2002|0.7|1.2|0.9
0-19|0.7|1.2|0.9|62|Incidence|6690871|Black|Male|Hodgkin Lymphoma|2003|0.7|1.2|0.9
0-19|0.8|1.3|1.0|68|Incidence|6713091|Black|Male|Hodgkin Lymphoma|2004|0.8|1.3|1.0
0-19|1.0|1.5|1.2|85|Incidence|6738111|Black|Male|Hodgkin Lymphoma|2005|1.0|1.6|1.3
0-19|1.0|1.3|1.1|392|Incidence|34051259|Black|Male|Hodgkin Lymphoma|2005-2009|1.0|1.3|1.2
0-19|0.8|1.3|1.1|72|Incidence|6769408|Black|Male|Hodgkin Lymphoma|2006|0.8|1.3|1.1
0-19|0.8|1.3|1.0|72|Incidence|6818048|Black|Male|Hodgkin Lymphoma|2007|0.8|1.3|1.1
0-19|1.0|1.5|1.2|84|Incidence|6853996|Black|Male|Hodgkin Lymphoma|2008|1.0|1.5|1.2
0-19|0.9|1.4|1.1|78|Incidence|6796473|Black|Male|Hodgkin Lymphoma|2009|0.9|1.4|1.1
0-19|0.5|0.9|0.7|37|Incidence|5567502|Black|Male|Kidney and Renal Pelvis|1999|0.5|0.9|0.7
0-19|0.6|1.1|0.9|48|Incidence|5620506|Black|Male|Kidney and Renal Pelvis|2000|0.6|1.1|0.9
0-19|0.5|1.0|0.7|45|Incidence|6043483|Black|Male|Kidney and Renal Pelvis|2001|0.5|1.0|0.7
0-19|0.5|1.0|0.7|45|Incidence|6261104|Black|Male|Kidney and Renal Pelvis|2002|0.5|1.0|0.7
0-19|0.5|1.0|0.7|48|Incidence|6690871|Black|Male|Kidney and Renal Pelvis|2003|0.5|1.0|0.7
0-19|0.7|1.1|0.9|59|Incidence|6713091|Black|Male|Kidney and Renal Pelvis|2004|0.7|1.1|0.9
0-19|0.6|1.0|0.8|53|Incidence|6738111|Black|Male|Kidney and Renal Pelvis|2005|0.6|1.0|0.8
0-19|0.7|0.9|0.8|282|Incidence|34051259|Black|Male|Kidney and Renal Pelvis|2005-2009|0.7|0.9|0.8
0-19|0.7|1.2|0.9|61|Incidence|6769408|Black|Male|Kidney and Renal Pelvis|2006|0.7|1.2|0.9
0-19|0.6|1.0|0.8|53|Incidence|6818048|Black|Male|Kidney and Renal Pelvis|2007|0.6|1.0|0.8
0-19|0.6|1.0|0.8|57|Incidence|6853996|Black|Male|Kidney and Renal Pelvis|2008|0.6|1.1|0.8
0-19|0.6|1.0|0.8|57|Incidence|6796473|Black|Male|Kidney and Renal Pelvis|2009|0.6|1.1|0.8
0-19|2.5|3.4|2.9|161|Incidence|5567502|Black|Male|Leukemia|1999|2.5|3.4|2.9
0-19|2.0|2.8|2.4|133|Incidence|5620506|Black|Male|Leukemia|2000|2.0|2.8|2.4
0-19|2.0|2.8|2.4|143|Incidence|6043483|Black|Male|Leukemia|2001|2.0|2.8|2.4
0-19|2.3|3.1|2.7|167|Incidence|6261104|Black|Male|Leukemia|2002|2.3|3.1|2.7
0-19|2.6|3.5|3.1|204|Incidence|6690871|Black|Male|Leukemia|2003|2.6|3.5|3.0
0-19|2.8|3.6|3.2|213|Incidence|6713091|Black|Male|Leukemia|2004|2.8|3.6|3.2
0-19|2.7|3.6|3.1|209|Incidence|6738111|Black|Male|Leukemia|2005|2.7|3.6|3.1
0-19|2.8|3.2|3.0|1020|Incidence|34051259|Black|Male|Leukemia|2005-2009|2.8|3.2|3.0
0-19|2.7|3.5|3.1|208|Incidence|6769408|Black|Male|Leukemia|2006|2.7|3.5|3.1
0-19|2.7|3.6|3.1|213|Incidence|6818048|Black|Male|Leukemia|2007|2.7|3.6|3.1
0-19|2.4|3.2|2.8|193|Incidence|6853996|Black|Male|Leukemia|2008|2.4|3.2|2.8
0-19|2.4|3.2|2.8|192|Incidence|6796473|Black|Male|Leukemia|2009|2.4|3.3|2.8
0-19|1.0|1.6|1.2|68|Incidence|5567502|Black|Male|Non-Hodgkin Lymphoma|1999|0.9|1.5|1.2
0-19|0.8|1.4|1.1|61|Incidence|5620506|Black|Male|Non-Hodgkin Lymphoma|2000|0.8|1.4|1.1
0-19|1.0|1.5|1.2|73|Incidence|6043483|Black|Male|Non-Hodgkin Lymphoma|2001|0.9|1.5|1.2
0-19|0.9|1.4|1.1|69|Incidence|6261104|Black|Male|Non-Hodgkin Lymphoma|2002|0.9|1.4|1.1
0-19|1.0|1.6|1.3|85|Incidence|6690871|Black|Male|Non-Hodgkin Lymphoma|2003|1.0|1.6|1.3
0-19|1.2|1.9|1.5|103|Incidence|6713091|Black|Male|Non-Hodgkin Lymphoma|2004|1.3|1.9|1.5
0-19|1.2|1.8|1.5|103|Incidence|6738111|Black|Male|Non-Hodgkin Lymphoma|2005|1.2|1.9|1.5
0-19|1.3|1.6|1.5|498|Incidence|34051259|Black|Male|Non-Hodgkin Lymphoma|2005-2009|1.3|1.6|1.5
0-19|1.2|1.8|1.5|101|Incidence|6769408|Black|Male|Non-Hodgkin Lymphoma|2006|1.2|1.8|1.5
0-19|1.2|1.7|1.4|97|Incidence|6818048|Black|Male|Non-Hodgkin Lymphoma|2007|1.2|1.7|1.4
0-19|1.3|1.9|1.6|108|Incidence|6853996|Black|Male|Non-Hodgkin Lymphoma|2008|1.3|1.9|1.6
0-19|1.0|1.6|1.3|88|Incidence|6796473|Black|Male|Non-Hodgkin Lymphoma|2009|1.0|1.6|1.3
0-19|2.0|2.8|2.4|129|Incidence|5567502|Black|Male|Other|1999|1.9|2.8|2.3
0-19|2.2|3.1|2.6|145|Incidence|5620506|Black|Male|Other|2000|2.2|3.0|2.6
0-19|2.4|3.3|2.8|170|Incidence|6043483|Black|Male|Other|2001|2.4|3.3|2.8
0-19|2.4|3.3|2.8|175|Incidence|6261104|Black|Male|Other|2002|2.4|3.2|2.8
0-19|2.8|3.7|3.2|213|Incidence|6690871|Black|Male|Other|2003|2.8|3.6|3.2
0-19|2.2|3.0|2.6|175|Incidence|6713091|Black|Male|Other|2004|2.2|3.0|2.6
0-19|2.6|3.4|3.0|201|Incidence|6738111|Black|Male|Other|2005|2.6|3.4|3.0
0-19|2.9|3.2|3.0|1058|Incidence|34051259|Black|Male|Other|2005-2009|2.9|3.3|3.1
0-19|2.6|3.4|3.0|206|Incidence|6769408|Black|Male|Other|2006|2.6|3.5|3.0
0-19|2.6|3.4|3.0|210|Incidence|6818048|Black|Male|Other|2007|2.7|3.5|3.1
0-19|3.1|4.0|3.5|250|Incidence|6853996|Black|Male|Other|2008|3.2|4.1|3.6
0-19|2.3|3.1|2.7|190|Incidence|6796473|Black|Male|Other|2009|2.4|3.2|2.8
0-19|0.5|1.0|0.7|40|Incidence|5567502|Black|Male|Soft Tissue|1999|0.5|1.0|0.7
0-19|0.7|1.2|0.9|50|Incidence|5620506|Black|Male|Soft Tissue|2000|0.7|1.2|0.9
0-19|0.8|1.4|1.1|64|Incidence|6043483|Black|Male|Soft Tissue|2001|0.8|1.4|1.1
0-19|0.5|0.9|0.7|42|Incidence|6261104|Black|Male|Soft Tissue|2002|0.5|0.9|0.7
0-19|0.7|1.1|0.9|58|Incidence|6690871|Black|Male|Soft Tissue|2003|0.7|1.1|0.9
0-19|0.6|1.1|0.8|56|Incidence|6713091|Black|Male|Soft Tissue|2004|0.6|1.1|0.8
0-19|0.7|1.1|0.9|60|Incidence|6738111|Black|Male|Soft Tissue|2005|0.7|1.1|0.9
0-19|0.9|1.1|1.0|334|Incidence|34051259|Black|Male|Soft Tissue|2005-2009|0.9|1.1|1.0
0-19|0.7|1.2|0.9|63|Incidence|6769408|Black|Male|Soft Tissue|2006|0.7|1.2|0.9
0-19|0.8|1.3|1.0|69|Incidence|6818048|Black|Male|Soft Tissue|2007|0.8|1.3|1.0
0-19|0.8|1.3|1.0|70|Incidence|6853996|Black|Male|Soft Tissue|2008|0.8|1.3|1.0
0-19|0.8|1.3|1.0|71|Incidence|6796473|Black|Male|Soft Tissue|2009|0.8|1.3|1.0
0-19|1.4|1.8|1.6|176|Incidence|10969633|Black|Male and Female|Acute Lymphocytic|1999|1.4|1.9|1.6
0-19|1.2|1.7|1.5|163|Incidence|11066658|Black|Male and Female|Acute Lymphocytic|2000|1.3|1.7|1.5
0-19|1.4|1.9|1.6|191|Incidence|11890561|Black|Male and Female|Acute Lymphocytic|2001|1.4|1.9|1.6
0-19|1.3|1.7|1.5|186|Incidence|12316905|Black|Male and Female|Acute Lymphocytic|2002|1.3|1.7|1.5
0-19|1.3|1.7|1.5|200|Incidence|13173148|Black|Male and Female|Acute Lymphocytic|2003|1.3|1.7|1.5
0-19|1.5|2.0|1.7|226|Incidence|13218982|Black|Male and Female|Acute Lymphocytic|2004|1.5|1.9|1.7
0-19|1.5|2.0|1.8|233|Incidence|13268491|Black|Male and Female|Acute Lymphocytic|2005|1.5|2.0|1.8
0-19|1.7|1.9|1.8|1190|Incidence|67038552|Black|Male and Female|Acute Lymphocytic|2005-2009|1.7|1.9|1.8
0-19|1.5|2.0|1.8|235|Incidence|13329648|Black|Male and Female|Acute Lymphocytic|2006|1.5|2.0|1.8
0-19|1.7|2.2|1.9|255|Incidence|13422681|Black|Male and Female|Acute Lymphocytic|2007|1.7|2.1|1.9
0-19|1.4|1.9|1.6|221|Incidence|13492740|Black|Male and Female|Acute Lymphocytic|2008|1.4|1.9|1.6
0-19|1.6|2.0|1.8|241|Incidence|13377663|Black|Male and Female|Acute Lymphocytic|2009|1.6|2.0|1.8
0-19|0.6|0.9|0.7|77|Incidence|10969633|Black|Male and Female|Acute Myeloid|1999|0.6|0.9|0.7
0-19|0.5|0.7|0.6|64|Incidence|11066658|Black|Male and Female|Acute Myeloid|2000|0.4|0.7|0.6
0-19|0.4|0.7|0.5|61|Incidence|11890561|Black|Male and Female|Acute Myeloid|2001|0.4|0.7|0.5
0-19|0.5|0.8|0.6|79|Incidence|12316905|Black|Male and Female|Acute Myeloid|2002|0.5|0.8|0.6
0-19|0.6|0.9|0.7|98|Incidence|13173148|Black|Male and Female|Acute Myeloid|2003|0.6|0.9|0.7
0-19|0.5|0.8|0.7|87|Incidence|13218982|Black|Male and Female|Acute Myeloid|2004|0.5|0.8|0.7
0-19|0.5|0.7|0.6|80|Incidence|13268491|Black|Male and Female|Acute Myeloid|2005|0.5|0.8|0.6
0-19|0.6|0.7|0.6|428|Incidence|67038552|Black|Male and Female|Acute Myeloid|2005-2009|0.6|0.7|0.6
0-19|0.6|0.9|0.8|102|Incidence|13329648|Black|Male and Female|Acute Myeloid|2006|0.6|0.9|0.8
0-19|0.4|0.6|0.5|69|Incidence|13422681|Black|Male and Female|Acute Myeloid|2007|0.4|0.7|0.5
0-19|0.6|0.9|0.8|106|Incidence|13492740|Black|Male and Female|Acute Myeloid|2008|0.6|1.0|0.8
0-19|0.4|0.6|0.5|69|Incidence|13377663|Black|Male and Female|Acute Myeloid|2009|0.4|0.7|0.5
0-19|11.1|12.4|11.7|1274|Incidence|10969633|Black|Male and Female|All Cancer Sites Combined|1999|11.0|12.3|11.6
0-19|10.8|12.1|11.4|1254|Incidence|11066658|Black|Male and Female|All Cancer Sites Combined|2000|10.7|12.0|11.3
0-19|11.1|12.3|11.7|1384|Incidence|11890561|Black|Male and Female|All Cancer Sites Combined|2001|11.0|12.3|11.6
0-19|11.1|12.3|11.7|1439|Incidence|12316905|Black|Male and Female|All Cancer Sites Combined|2002|11.1|12.3|11.7
0-19|12.2|13.5|12.9|1691|Incidence|13173148|Black|Male and Female|All Cancer Sites Combined|2003|12.2|13.5|12.8
0-19|12.4|13.7|13.1|1728|Incidence|13218982|Black|Male and Female|All Cancer Sites Combined|2004|12.5|13.7|13.1
0-19|12.5|13.7|13.1|1743|Incidence|13268491|Black|Male and Female|All Cancer Sites Combined|2005|12.5|13.8|13.1
0-19|12.8|13.3|13.0|8828|Incidence|67038552|Black|Male and Female|All Cancer Sites Combined|2005-2009|12.9|13.4|13.2
0-19|12.2|13.5|12.8|1726|Incidence|13329648|Black|Male and Female|All Cancer Sites Combined|2006|12.3|13.6|12.9
0-19|12.3|13.5|12.9|1746|Incidence|13422681|Black|Male and Female|All Cancer Sites Combined|2007|12.4|13.6|13.0
0-19|13.1|14.4|13.7|1874|Incidence|13492740|Black|Male and Female|All Cancer Sites Combined|2008|13.3|14.5|13.9
0-19|12.1|13.3|12.7|1720|Incidence|13377663|Black|Male and Female|All Cancer Sites Combined|2009|12.3|13.5|12.9
0-19|0.6|1.0|0.8|87|Incidence|10969633|Black|Male and Female|Bones and Joints|1999|0.6|1.0|0.8
0-19|0.5|0.8|0.6|67|Incidence|11066658|Black|Male and Female|Bones and Joints|2000|0.5|0.8|0.6
0-19|0.5|0.8|0.7|78|Incidence|11890561|Black|Male and Female|Bones and Joints|2001|0.5|0.8|0.7
0-19|0.6|0.9|0.7|88|Incidence|12316905|Black|Male and Female|Bones and Joints|2002|0.6|0.9|0.7
0-19|0.6|0.9|0.7|95|Incidence|13173148|Black|Male and Female|Bones and Joints|2003|0.6|0.9|0.7
0-19|0.8|1.1|0.9|123|Incidence|13218982|Black|Male and Female|Bones and Joints|2004|0.8|1.1|0.9
0-19|0.7|1.0|0.8|107|Incidence|13268491|Black|Male and Female|Bones and Joints|2005|0.7|1.0|0.8
0-19|0.7|0.8|0.7|485|Incidence|67038552|Black|Male and Female|Bones and Joints|2005-2009|0.7|0.8|0.7
0-19|0.6|0.9|0.8|104|Incidence|13329648|Black|Male and Female|Bones and Joints|2006|0.6|0.9|0.8
0-19|0.5|0.8|0.7|89|Incidence|13422681|Black|Male and Female|Bones and Joints|2007|0.5|0.8|0.7
0-19|0.6|0.8|0.7|93|Incidence|13492740|Black|Male and Female|Bones and Joints|2008|0.6|0.8|0.7
0-19|0.6|0.9|0.7|92|Incidence|13377663|Black|Male and Female|Bones and Joints|2009|0.6|0.8|0.7
0-19|1.8|2.3|2.0|226|Incidence|10969633|Black|Male and Female|Brain and Other Nervous System|1999|1.8|2.3|2.1
0-19|2.0|2.5|2.2|249|Incidence|11066658|Black|Male and Female|Brain and Other Nervous System|2000|2.0|2.5|2.3
0-19|1.8|2.3|2.1|244|Incidence|11890561|Black|Male and Female|Brain and Other Nervous System|2001|1.8|2.3|2.1
0-19|1.9|2.5|2.2|269|Incidence|12316905|Black|Male and Female|Brain and Other Nervous System|2002|1.9|2.5|2.2
0-19|2.0|2.5|2.2|291|Incidence|13173148|Black|Male and Female|Brain and Other Nervous System|2003|2.0|2.5|2.2
0-19|2.2|2.7|2.4|321|Incidence|13218982|Black|Male and Female|Brain and Other Nervous System|2004|2.2|2.7|2.4
0-19|2.0|2.6|2.3|302|Incidence|13268491|Black|Male and Female|Brain and Other Nervous System|2005|2.0|2.5|2.3
0-19|2.2|2.5|2.3|1570|Incidence|67038552|Black|Male and Female|Brain and Other Nervous System|2005-2009|2.2|2.5|2.3
0-19|2.0|2.5|2.3|301|Incidence|13329648|Black|Male and Female|Brain and Other Nervous System|2006|2.0|2.5|2.3
0-19|2.0|2.5|2.2|293|Incidence|13422681|Black|Male and Female|Brain and Other Nervous System|2007|1.9|2.4|2.2
0-19|2.4|3.0|2.7|364|Incidence|13492740|Black|Male and Female|Brain and Other Nervous System|2008|2.4|3.0|2.7
0-19|2.0|2.6|2.3|306|Incidence|13377663|Black|Male and Female|Brain and Other Nervous System|2009|2.0|2.6|2.3
0-19|0.7|1.0|0.8|90|Incidence|10969633|Black|Male and Female|Hodgkin Lymphoma|1999|0.7|1.0|0.8
0-19|0.8|1.2|1.0|104|Incidence|11066658|Black|Male and Female|Hodgkin Lymphoma|2000|0.8|1.1|0.9
0-19|0.7|1.0|0.9|100|Incidence|11890561|Black|Male and Female|Hodgkin Lymphoma|2001|0.7|1.0|0.8
0-19|0.8|1.1|0.9|112|Incidence|12316905|Black|Male and Female|Hodgkin Lymphoma|2002|0.7|1.1|0.9
0-19|0.8|1.1|1.0|125|Incidence|13173148|Black|Male and Female|Hodgkin Lymphoma|2003|0.8|1.1|0.9
0-19|0.8|1.1|0.9|125|Incidence|13218982|Black|Male and Female|Hodgkin Lymphoma|2004|0.8|1.1|0.9
0-19|1.0|1.3|1.1|154|Incidence|13268491|Black|Male and Female|Hodgkin Lymphoma|2005|1.0|1.4|1.2
0-19|1.0|1.1|1.0|714|Incidence|67038552|Black|Male and Female|Hodgkin Lymphoma|2005-2009|1.0|1.1|1.1
0-19|0.8|1.1|0.9|124|Incidence|13329648|Black|Male and Female|Hodgkin Lymphoma|2006|0.8|1.1|0.9
0-19|0.8|1.1|0.9|126|Incidence|13422681|Black|Male and Female|Hodgkin Lymphoma|2007|0.8|1.1|0.9
0-19|1.0|1.4|1.2|161|Incidence|13492740|Black|Male and Female|Hodgkin Lymphoma|2008|1.0|1.4|1.2
0-19|0.9|1.3|1.1|147|Incidence|13377663|Black|Male and Female|Hodgkin Lymphoma|2009|0.9|1.3|1.1
0-19|0.6|1.0|0.8|87|Incidence|10969633|Black|Male and Female|Kidney and Renal Pelvis|1999|0.6|1.0|0.8
0-19|0.8|1.1|0.9|105|Incidence|11066658|Black|Male and Female|Kidney and Renal Pelvis|2000|0.8|1.1|0.9
0-19|0.6|0.9|0.7|87|Incidence|11890561|Black|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.9|0.7
0-19|0.6|1.0|0.8|97|Incidence|12316905|Black|Male and Female|Kidney and Renal Pelvis|2002|0.6|1.0|0.8
0-19|0.6|0.9|0.7|94|Incidence|13173148|Black|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.9|0.7
0-19|0.6|0.9|0.8|102|Incidence|13218982|Black|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.9|0.8
0-19|0.7|1.0|0.9|114|Incidence|13268491|Black|Male and Female|Kidney and Renal Pelvis|2005|0.7|1.0|0.9
0-19|0.8|0.9|0.9|576|Incidence|67038552|Black|Male and Female|Kidney and Renal Pelvis|2005-2009|0.8|0.9|0.9
0-19|0.7|1.0|0.8|111|Incidence|13329648|Black|Male and Female|Kidney and Renal Pelvis|2006|0.7|1.0|0.8
0-19|0.7|1.0|0.8|111|Incidence|13422681|Black|Male and Female|Kidney and Renal Pelvis|2007|0.7|1.0|0.8
0-19|0.7|1.0|0.9|118|Incidence|13492740|Black|Male and Female|Kidney and Renal Pelvis|2008|0.7|1.0|0.9
0-19|0.7|1.1|0.9|121|Incidence|13377663|Black|Male and Female|Kidney and Renal Pelvis|2009|0.8|1.1|0.9
0-19|2.4|3.0|2.7|291|Incidence|10969633|Black|Male and Female|Leukemia|1999|2.4|3.0|2.7
0-19|2.0|2.5|2.2|247|Incidence|11066658|Black|Male and Female|Leukemia|2000|2.0|2.5|2.2
0-19|2.1|2.7|2.4|285|Incidence|11890561|Black|Male and Female|Leukemia|2001|2.1|2.7|2.4
0-19|2.2|2.8|2.5|306|Incidence|12316905|Black|Male and Female|Leukemia|2002|2.2|2.8|2.5
0-19|2.4|2.9|2.6|348|Incidence|13173148|Black|Male and Female|Leukemia|2003|2.4|2.9|2.6
0-19|2.5|3.1|2.8|366|Incidence|13218982|Black|Male and Female|Leukemia|2004|2.5|3.1|2.8
0-19|2.4|2.9|2.6|351|Incidence|13268491|Black|Male and Female|Leukemia|2005|2.4|2.9|2.6
0-19|2.6|2.8|2.7|1814|Incidence|67038552|Black|Male and Female|Leukemia|2005-2009|2.6|2.8|2.7
0-19|2.5|3.1|2.8|376|Incidence|13329648|Black|Male and Female|Leukemia|2006|2.5|3.1|2.8
0-19|2.5|3.1|2.8|375|Incidence|13422681|Black|Male and Female|Leukemia|2007|2.5|3.1|2.8
0-19|2.4|3.0|2.7|364|Incidence|13492740|Black|Male and Female|Leukemia|2008|2.4|3.0|2.7
0-19|2.3|2.8|2.5|341|Incidence|13377663|Black|Male and Female|Leukemia|2009|2.3|2.8|2.5
0-19|0.8|1.2|1.0|103|Incidence|10969633|Black|Male and Female|Non-Hodgkin Lymphoma|1999|0.8|1.1|0.9
0-19|0.7|1.1|0.9|95|Incidence|11066658|Black|Male and Female|Non-Hodgkin Lymphoma|2000|0.7|1.0|0.9
0-19|0.8|1.2|1.0|119|Incidence|11890561|Black|Male and Female|Non-Hodgkin Lymphoma|2001|0.8|1.2|1.0
0-19|0.8|1.2|1.0|119|Incidence|12316905|Black|Male and Female|Non-Hodgkin Lymphoma|2002|0.8|1.2|1.0
0-19|0.8|1.2|1.0|130|Incidence|13173148|Black|Male and Female|Non-Hodgkin Lymphoma|2003|0.8|1.2|1.0
0-19|1.0|1.4|1.2|160|Incidence|13218982|Black|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.4|1.2
0-19|1.0|1.4|1.2|158|Incidence|13268491|Black|Male and Female|Non-Hodgkin Lymphoma|2005|1.0|1.4|1.2
0-19|1.0|1.2|1.1|756|Incidence|67038552|Black|Male and Female|Non-Hodgkin Lymphoma|2005-2009|1.0|1.2|1.1
0-19|1.0|1.3|1.2|156|Incidence|13329648|Black|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.4|1.2
0-19|0.9|1.3|1.1|147|Incidence|13422681|Black|Male and Female|Non-Hodgkin Lymphoma|2007|0.9|1.3|1.1
0-19|1.1|1.4|1.2|169|Incidence|13492740|Black|Male and Female|Non-Hodgkin Lymphoma|2008|1.1|1.5|1.3
0-19|0.8|1.1|0.9|125|Incidence|13377663|Black|Male and Female|Non-Hodgkin Lymphoma|2009|0.8|1.1|0.9
0-19|2.6|3.3|2.9|312|Incidence|10969633|Black|Male and Female|Other|1999|2.5|3.2|2.8
0-19|2.3|2.9|2.6|286|Incidence|11066658|Black|Male and Female|Other|2000|2.3|2.9|2.6
0-19|2.8|3.4|3.1|362|Incidence|11890561|Black|Male and Female|Other|2001|2.7|3.4|3.0
0-19|2.6|3.2|2.9|352|Incidence|12316905|Black|Male and Female|Other|2002|2.6|3.2|2.9
0-19|3.4|4.1|3.7|491|Incidence|13173148|Black|Male and Female|Other|2003|3.4|4.1|3.7
0-19|2.7|3.3|3.0|395|Incidence|13218982|Black|Male and Female|Other|2004|2.7|3.3|3.0
0-19|3.0|3.7|3.3|446|Incidence|13268491|Black|Male and Female|Other|2005|3.1|3.7|3.4
0-19|3.2|3.5|3.3|2276|Incidence|67038552|Black|Male and Female|Other|2005-2009|3.3|3.5|3.4
0-19|2.9|3.5|3.2|433|Incidence|13329648|Black|Male and Female|Other|2006|2.9|3.6|3.2
0-19|3.1|3.7|3.4|463|Incidence|13422681|Black|Male and Female|Other|2007|3.1|3.8|3.4
0-19|3.1|3.7|3.4|474|Incidence|13492740|Black|Male and Female|Other|2008|3.2|3.8|3.5
0-19|3.0|3.6|3.3|457|Incidence|13377663|Black|Male and Female|Other|2009|3.1|3.7|3.4
0-19|0.6|0.9|0.7|78|Incidence|10969633|Black|Male and Female|Soft Tissue|1999|0.6|0.9|0.7
0-19|0.8|1.1|0.9|101|Incidence|11066658|Black|Male and Female|Soft Tissue|2000|0.7|1.1|0.9
0-19|0.8|1.1|0.9|109|Incidence|11890561|Black|Male and Female|Soft Tissue|2001|0.8|1.1|0.9
0-19|0.6|0.9|0.8|96|Incidence|12316905|Black|Male and Female|Soft Tissue|2002|0.6|1.0|0.8
0-19|0.7|1.1|0.9|117|Incidence|13173148|Black|Male and Female|Soft Tissue|2003|0.7|1.1|0.9
0-19|0.9|1.2|1.0|136|Incidence|13218982|Black|Male and Female|Soft Tissue|2004|0.9|1.2|1.0
0-19|0.7|1.0|0.8|111|Incidence|13268491|Black|Male and Female|Soft Tissue|2005|0.7|1.0|0.8
0-19|0.9|1.0|0.9|637|Incidence|67038552|Black|Male and Female|Soft Tissue|2005-2009|0.9|1.0|1.0
0-19|0.7|1.1|0.9|121|Incidence|13329648|Black|Male and Female|Soft Tissue|2006|0.8|1.1|0.9
0-19|0.9|1.2|1.0|142|Incidence|13422681|Black|Male and Female|Soft Tissue|2007|0.9|1.2|1.1
0-19|0.8|1.1|1.0|131|Incidence|13492740|Black|Male and Female|Soft Tissue|2008|0.8|1.2|1.0
0-19|0.8|1.2|1.0|131|Incidence|13377663|Black|Male and Female|Soft Tissue|2009|0.8|1.2|1.0
0-19|2.8|3.7|3.2|210|Incidence|6236914|Hispanic|Female|Acute Lymphocytic|1999|2.9|3.9|3.4
0-19|3.5|4.5|4.0|269|Incidence|6504956|Hispanic|Female|Acute Lymphocytic|2000|3.7|4.7|4.1
0-19|3.1|4.0|3.6|255|Incidence|6813556|Hispanic|Female|Acute Lymphocytic|2001|3.3|4.2|3.7
0-19|3.3|4.2|3.7|278|Incidence|7093421|Hispanic|Female|Acute Lymphocytic|2002|3.5|4.4|3.9
0-19|3.0|3.9|3.4|268|Incidence|7365360|Hispanic|Female|Acute Lymphocytic|2003|3.2|4.1|3.6
0-19|3.0|3.8|3.4|271|Incidence|7606752|Hispanic|Female|Acute Lymphocytic|2004|3.2|4.0|3.6
0-19|2.9|3.7|3.3|278|Incidence|7859967|Hispanic|Female|Acute Lymphocytic|2005|3.1|4.0|3.5
0-19|3.5|3.9|3.7|1659|Incidence|42053234|Hispanic|Female|Acute Lymphocytic|2005-2009|3.8|4.1|3.9
0-19|3.2|4.0|3.6|309|Incidence|8132294|Hispanic|Female|Acute Lymphocytic|2006|3.4|4.2|3.8
0-19|3.2|4.0|3.5|312|Incidence|8418953|Hispanic|Female|Acute Lymphocytic|2007|3.3|4.1|3.7
0-19|3.9|4.7|4.3|393|Incidence|8692766|Hispanic|Female|Acute Lymphocytic|2008|4.1|5.0|4.5
0-19|3.4|4.2|3.8|364|Incidence|8886372|Hispanic|Female|Acute Lymphocytic|2009|3.7|4.5|4.1
0-19|0.5|0.9|0.7|42|Incidence|6236914|Hispanic|Female|Acute Myeloid|1999|0.5|0.9|0.7
0-19|0.6|1.1|0.8|52|Incidence|6504956|Hispanic|Female|Acute Myeloid|2000|0.6|1.0|0.8
0-19|0.5|0.9|0.7|46|Incidence|6813556|Hispanic|Female|Acute Myeloid|2001|0.5|0.9|0.7
0-19|0.5|1.0|0.7|50|Incidence|7093421|Hispanic|Female|Acute Myeloid|2002|0.5|0.9|0.7
0-19|0.5|0.9|0.7|50|Incidence|7365360|Hispanic|Female|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.6|1.0|0.8|60|Incidence|7606752|Hispanic|Female|Acute Myeloid|2004|0.6|1.0|0.8
0-19|0.6|0.9|0.7|58|Incidence|7859967|Hispanic|Female|Acute Myeloid|2005|0.6|1.0|0.7
0-19|0.7|0.9|0.8|340|Incidence|42053234|Hispanic|Female|Acute Myeloid|2005-2009|0.7|0.9|0.8
0-19|0.5|0.9|0.7|57|Incidence|8132294|Hispanic|Female|Acute Myeloid|2006|0.5|0.9|0.7
0-19|0.7|1.2|0.9|78|Incidence|8418953|Hispanic|Female|Acute Myeloid|2007|0.7|1.2|0.9
0-19|0.6|0.9|0.7|68|Incidence|8692766|Hispanic|Female|Acute Myeloid|2008|0.6|1.0|0.8
0-19|0.7|1.1|0.8|77|Incidence|8886372|Hispanic|Female|Acute Myeloid|2009|0.7|1.1|0.9
0-19|13.0|14.9|13.9|876|Incidence|6236914|Hispanic|Female|All Cancer Sites Combined|1999|13.1|15.0|14.0
0-19|14.5|16.5|15.5|1009|Incidence|6504956|Hispanic|Female|All Cancer Sites Combined|2000|14.6|16.5|15.5
0-19|14.1|15.9|15.0|1037|Incidence|6813556|Hispanic|Female|All Cancer Sites Combined|2001|14.3|16.2|15.2
0-19|14.1|16.0|15.0|1075|Incidence|7093421|Hispanic|Female|All Cancer Sites Combined|2002|14.3|16.1|15.2
0-19|14.5|16.3|15.4|1155|Incidence|7365360|Hispanic|Female|All Cancer Sites Combined|2003|14.8|16.6|15.7
0-19|15.6|17.4|16.5|1264|Incidence|7606752|Hispanic|Female|All Cancer Sites Combined|2004|15.7|17.6|16.6
0-19|14.5|16.3|15.4|1211|Incidence|7859967|Hispanic|Female|All Cancer Sites Combined|2005|14.6|16.3|15.4
0-19|15.6|16.3|15.9|6732|Incidence|42053234|Hispanic|Female|All Cancer Sites Combined|2005-2009|15.6|16.4|16.0
0-19|14.9|16.6|15.8|1280|Incidence|8132294|Hispanic|Female|All Cancer Sites Combined|2006|14.9|16.6|15.7
0-19|15.0|16.7|15.9|1345|Incidence|8418953|Hispanic|Female|All Cancer Sites Combined|2007|15.1|16.9|16.0
0-19|15.4|17.1|16.2|1426|Incidence|8692766|Hispanic|Female|All Cancer Sites Combined|2008|15.6|17.3|16.4
0-19|15.6|17.3|16.4|1459|Incidence|8886372|Hispanic|Female|All Cancer Sites Combined|2009|15.6|17.3|16.4
0-19|0.7|1.2|0.9|53|Incidence|6236914|Hispanic|Female|Bones and Joints|1999|0.6|1.1|0.8
0-19|0.7|1.2|0.9|55|Incidence|6504956|Hispanic|Female|Bones and Joints|2000|0.6|1.1|0.8
0-19|0.5|1.0|0.7|47|Incidence|6813556|Hispanic|Female|Bones and Joints|2001|0.5|0.9|0.7
0-19|0.6|1.0|0.8|51|Incidence|7093421|Hispanic|Female|Bones and Joints|2002|0.5|0.9|0.7
0-19|0.7|1.1|0.9|60|Incidence|7365360|Hispanic|Female|Bones and Joints|2003|0.6|1.0|0.8
0-19|0.8|1.3|1.0|70|Incidence|7606752|Hispanic|Female|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.6|1.1|0.8|61|Incidence|7859967|Hispanic|Female|Bones and Joints|2005|0.6|1.0|0.8
0-19|0.7|0.9|0.8|308|Incidence|42053234|Hispanic|Female|Bones and Joints|2005-2009|0.7|0.8|0.7
0-19|0.7|1.1|0.9|68|Incidence|8132294|Hispanic|Female|Bones and Joints|2006|0.6|1.1|0.8
0-19|0.5|0.8|0.6|49|Incidence|8418953|Hispanic|Female|Bones and Joints|2007|0.4|0.8|0.6
0-19|0.6|1.0|0.8|65|Incidence|8692766|Hispanic|Female|Bones and Joints|2008|0.6|1.0|0.7
0-19|0.6|1.0|0.8|65|Incidence|8886372|Hispanic|Female|Bones and Joints|2009|0.6|0.9|0.7
0-19|1.9|2.6|2.2|144|Incidence|6236914|Hispanic|Female|Brain and Other Nervous System|1999|1.9|2.7|2.3
0-19|2.0|2.8|2.4|158|Incidence|6504956|Hispanic|Female|Brain and Other Nervous System|2000|2.1|2.8|2.4
0-19|2.0|2.7|2.4|166|Incidence|6813556|Hispanic|Female|Brain and Other Nervous System|2001|2.1|2.8|2.4
0-19|1.9|2.6|2.3|168|Incidence|7093421|Hispanic|Female|Brain and Other Nervous System|2002|2.0|2.8|2.4
0-19|2.2|2.9|2.5|193|Incidence|7365360|Hispanic|Female|Brain and Other Nervous System|2003|2.3|3.0|2.6
0-19|2.7|3.5|3.1|241|Incidence|7606752|Hispanic|Female|Brain and Other Nervous System|2004|2.8|3.6|3.2
0-19|2.0|2.6|2.3|184|Incidence|7859967|Hispanic|Female|Brain and Other Nervous System|2005|2.0|2.7|2.3
0-19|2.2|2.5|2.4|1031|Incidence|42053234|Hispanic|Female|Brain and Other Nervous System|2005-2009|2.3|2.6|2.5
0-19|2.0|2.7|2.4|196|Incidence|8132294|Hispanic|Female|Brain and Other Nervous System|2006|2.1|2.8|2.4
0-19|2.4|3.1|2.7|235|Incidence|8418953|Hispanic|Female|Brain and Other Nervous System|2007|2.4|3.2|2.8
0-19|2.0|2.6|2.3|207|Incidence|8692766|Hispanic|Female|Brain and Other Nervous System|2008|2.1|2.7|2.4
0-19|2.0|2.6|2.3|206|Incidence|8886372|Hispanic|Female|Brain and Other Nervous System|2009|2.0|2.7|2.3
0-19|0.6|1.0|0.8|44|Incidence|6236914|Hispanic|Female|Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.6|1.1|0.8|49|Incidence|6504956|Hispanic|Female|Hodgkin Lymphoma|2000|0.6|1.0|0.8
0-19|0.7|1.2|1.0|60|Incidence|6813556|Hispanic|Female|Hodgkin Lymphoma|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|50|Incidence|7093421|Hispanic|Female|Hodgkin Lymphoma|2002|0.5|0.9|0.7
0-19|0.7|1.1|0.9|57|Incidence|7365360|Hispanic|Female|Hodgkin Lymphoma|2003|0.6|1.0|0.8
0-19|0.8|1.3|1.0|68|Incidence|7606752|Hispanic|Female|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.8|1.3|1.0|70|Incidence|7859967|Hispanic|Female|Hodgkin Lymphoma|2005|0.7|1.1|0.9
0-19|0.9|1.1|1.0|364|Incidence|42053234|Hispanic|Female|Hodgkin Lymphoma|2005-2009|0.8|1.0|0.9
0-19|0.8|1.3|1.1|77|Incidence|8132294|Hispanic|Female|Hodgkin Lymphoma|2006|0.7|1.2|0.9
0-19|0.7|1.1|0.9|64|Incidence|8418953|Hispanic|Female|Hodgkin Lymphoma|2007|0.6|1.0|0.8
0-19|0.8|1.2|1.0|77|Incidence|8692766|Hispanic|Female|Hodgkin Lymphoma|2008|0.7|1.1|0.9
0-19|0.7|1.2|1.0|75|Incidence|8886372|Hispanic|Female|Hodgkin Lymphoma|2009|0.7|1.1|0.8
0-19|0.5|0.9|0.7|45|Incidence|6236914|Hispanic|Female|Kidney and Renal Pelvis|1999|0.5|1.0|0.7
0-19|0.3|0.6|0.4|29|Incidence|6504956|Hispanic|Female|Kidney and Renal Pelvis|2000|0.3|0.6|0.4
0-19|0.4|0.8|0.6|45|Incidence|6813556|Hispanic|Female|Kidney and Renal Pelvis|2001|0.5|0.9|0.7
0-19|0.4|0.7|0.5|43|Incidence|7093421|Hispanic|Female|Kidney and Renal Pelvis|2002|0.4|0.8|0.6
0-19|0.5|0.8|0.6|52|Incidence|7365360|Hispanic|Female|Kidney and Renal Pelvis|2003|0.5|0.9|0.7
0-19|0.4|0.8|0.6|52|Incidence|7606752|Hispanic|Female|Kidney and Renal Pelvis|2004|0.5|0.9|0.7
0-19|0.3|0.6|0.4|37|Incidence|7859967|Hispanic|Female|Kidney and Renal Pelvis|2005|0.3|0.6|0.5
0-19|0.5|0.6|0.6|278|Incidence|42053234|Hispanic|Female|Kidney and Renal Pelvis|2005-2009|0.6|0.7|0.7
0-19|0.4|0.7|0.6|52|Incidence|8132294|Hispanic|Female|Kidney and Renal Pelvis|2006|0.5|0.8|0.6
0-19|0.5|0.9|0.7|67|Incidence|8418953|Hispanic|Female|Kidney and Renal Pelvis|2007|0.6|1.0|0.8
0-19|0.4|0.7|0.5|56|Incidence|8692766|Hispanic|Female|Kidney and Renal Pelvis|2008|0.5|0.8|0.6
0-19|0.5|0.8|0.7|66|Incidence|8886372|Hispanic|Female|Kidney and Renal Pelvis|2009|0.6|0.9|0.7
0-19|3.8|4.8|4.2|275|Incidence|6236914|Hispanic|Female|Leukemia|1999|3.9|5.0|4.4
0-19|4.7|5.8|5.2|349|Incidence|6504956|Hispanic|Female|Leukemia|2000|4.8|6.0|5.4
0-19|4.2|5.2|4.7|334|Incidence|6813556|Hispanic|Female|Leukemia|2001|4.4|5.5|4.9
0-19|4.5|5.5|5.0|369|Incidence|7093421|Hispanic|Female|Leukemia|2002|4.7|5.8|5.2
0-19|4.1|5.1|4.6|355|Incidence|7365360|Hispanic|Female|Leukemia|2003|4.3|5.3|4.8
0-19|4.1|5.0|4.5|360|Incidence|7606752|Hispanic|Female|Leukemia|2004|4.3|5.2|4.7
0-19|4.0|5.0|4.5|370|Incidence|7859967|Hispanic|Female|Leukemia|2005|4.2|5.2|4.7
0-19|4.7|5.1|4.9|2169|Incidence|42053234|Hispanic|Female|Leukemia|2005-2009|4.9|5.4|5.2
0-19|4.3|5.2|4.7|400|Incidence|8132294|Hispanic|Female|Leukemia|2006|4.4|5.4|4.9
0-19|4.5|5.4|4.9|429|Incidence|8418953|Hispanic|Female|Leukemia|2007|4.6|5.6|5.1
0-19|4.9|5.9|5.4|489|Incidence|8692766|Hispanic|Female|Leukemia|2008|5.1|6.1|5.6
0-19|4.6|5.5|5.0|476|Incidence|8886372|Hispanic|Female|Leukemia|2009|4.9|5.9|5.4
0-19|0.5|1.0|0.7|43|Incidence|6236914|Hispanic|Female|Non-Hodgkin Lymphoma|1999|0.5|0.9|0.7
0-19|0.5|1.0|0.7|46|Incidence|6504956|Hispanic|Female|Non-Hodgkin Lymphoma|2000|0.5|0.9|0.7
0-19|0.5|0.9|0.7|43|Incidence|6813556|Hispanic|Female|Non-Hodgkin Lymphoma|2001|0.5|0.9|0.6
0-19|0.6|1.1|0.8|55|Incidence|7093421|Hispanic|Female|Non-Hodgkin Lymphoma|2002|0.6|1.0|0.8
0-19|0.4|0.8|0.6|44|Incidence|7365360|Hispanic|Female|Non-Hodgkin Lymphoma|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|50|Incidence|7606752|Hispanic|Female|Non-Hodgkin Lymphoma|2004|0.5|0.9|0.7
0-19|0.6|1.1|0.8|62|Incidence|7859967|Hispanic|Female|Non-Hodgkin Lymphoma|2005|0.6|1.0|0.8
0-19|0.7|0.8|0.8|300|Incidence|42053234|Hispanic|Female|Non-Hodgkin Lymphoma|2005-2009|0.6|0.8|0.7
0-19|0.6|1.0|0.8|58|Incidence|8132294|Hispanic|Female|Non-Hodgkin Lymphoma|2006|0.5|0.9|0.7
0-19|0.6|0.9|0.7|58|Incidence|8418953|Hispanic|Female|Non-Hodgkin Lymphoma|2007|0.5|0.9|0.7
0-19|0.5|0.9|0.7|58|Incidence|8692766|Hispanic|Female|Non-Hodgkin Lymphoma|2008|0.5|0.9|0.7
0-19|0.6|1.0|0.8|64|Incidence|8886372|Hispanic|Female|Non-Hodgkin Lymphoma|2009|0.6|0.9|0.7
0-19|3.2|4.2|3.7|225|Incidence|6236914|Hispanic|Female|Other|1999|3.2|4.1|3.6
0-19|3.7|4.8|4.2|268|Incidence|6504956|Hispanic|Female|Other|2000|3.6|4.6|4.1
0-19|3.6|4.6|4.1|280|Incidence|6813556|Hispanic|Female|Other|2001|3.6|4.6|4.1
0-19|3.5|4.5|4.0|277|Incidence|7093421|Hispanic|Female|Other|2002|3.5|4.4|3.9
0-19|3.7|4.7|4.2|303|Incidence|7365360|Hispanic|Female|Other|2003|3.7|4.6|4.1
0-19|4.1|5.1|4.6|351|Incidence|7606752|Hispanic|Female|Other|2004|4.1|5.1|4.6
0-19|4.0|5.0|4.5|344|Incidence|7859967|Hispanic|Female|Other|2005|3.9|4.9|4.4
0-19|4.4|4.8|4.6|1878|Incidence|42053234|Hispanic|Female|Other|2005-2009|4.3|4.7|4.5
0-19|3.9|4.9|4.4|346|Incidence|8132294|Hispanic|Female|Other|2006|3.8|4.7|4.3
0-19|3.9|4.9|4.4|361|Incidence|8418953|Hispanic|Female|Other|2007|3.9|4.8|4.3
0-19|4.2|5.1|4.6|393|Incidence|8692766|Hispanic|Female|Other|2008|4.1|5.0|4.5
0-19|4.6|5.6|5.1|432|Incidence|8886372|Hispanic|Female|Other|2009|4.4|5.3|4.9
0-19|0.5|1.0|0.7|47|Incidence|6236914|Hispanic|Female|Soft Tissue|1999|0.6|1.0|0.8
0-19|0.6|1.1|0.9|55|Incidence|6504956|Hispanic|Female|Soft Tissue|2000|0.6|1.1|0.8
0-19|0.7|1.1|0.9|62|Incidence|6813556|Hispanic|Female|Soft Tissue|2001|0.7|1.2|0.9
0-19|0.7|1.1|0.9|62|Incidence|7093421|Hispanic|Female|Soft Tissue|2002|0.7|1.1|0.9
0-19|1.0|1.5|1.2|91|Incidence|7365360|Hispanic|Female|Soft Tissue|2003|1.0|1.5|1.2
0-19|0.7|1.2|0.9|72|Incidence|7606752|Hispanic|Female|Soft Tissue|2004|0.7|1.2|0.9
0-19|0.8|1.3|1.1|83|Incidence|7859967|Hispanic|Female|Soft Tissue|2005|0.8|1.3|1.1
0-19|0.9|1.1|1.0|404|Incidence|42053234|Hispanic|Female|Soft Tissue|2005-2009|0.9|1.1|1.0
0-19|0.8|1.3|1.0|83|Incidence|8132294|Hispanic|Female|Soft Tissue|2006|0.8|1.3|1.0
0-19|0.7|1.2|0.9|82|Incidence|8418953|Hispanic|Female|Soft Tissue|2007|0.8|1.2|1.0
0-19|0.7|1.1|0.9|81|Incidence|8692766|Hispanic|Female|Soft Tissue|2008|0.7|1.2|0.9
0-19|0.7|1.1|0.8|75|Incidence|8886372|Hispanic|Female|Soft Tissue|2009|0.7|1.1|0.8
0-19|3.9|4.9|4.3|297|Incidence|6635632|Hispanic|Male|Acute Lymphocytic|1999|4.0|5.0|4.5
0-19|4.0|5.0|4.4|316|Incidence|6919053|Hispanic|Male|Acute Lymphocytic|2000|4.1|5.1|4.6
0-19|3.9|4.9|4.4|323|Incidence|7240643|Hispanic|Male|Acute Lymphocytic|2001|4.0|5.0|4.5
0-19|4.2|5.2|4.7|363|Incidence|7518483|Hispanic|Male|Acute Lymphocytic|2002|4.3|5.4|4.8
0-19|3.6|4.4|4.0|321|Incidence|7785714|Hispanic|Male|Acute Lymphocytic|2003|3.7|4.6|4.1
0-19|4.1|5.0|4.6|383|Incidence|8024129|Hispanic|Male|Acute Lymphocytic|2004|4.3|5.3|4.8
0-19|4.1|5.0|4.5|389|Incidence|8283812|Hispanic|Male|Acute Lymphocytic|2005|4.2|5.2|4.7
0-19|4.6|5.0|4.8|2219|Incidence|44270660|Hispanic|Male|Acute Lymphocytic|2005-2009|4.8|5.2|5.0
0-19|4.4|5.3|4.8|424|Incidence|8563877|Hispanic|Male|Acute Lymphocytic|2006|4.5|5.4|5.0
0-19|4.7|5.6|5.1|470|Incidence|8863218|Hispanic|Male|Acute Lymphocytic|2007|4.8|5.8|5.3
0-19|4.3|5.2|4.7|453|Incidence|9146469|Hispanic|Male|Acute Lymphocytic|2008|4.5|5.4|5.0
0-19|4.5|5.4|4.9|480|Incidence|9347691|Hispanic|Male|Acute Lymphocytic|2009|4.7|5.6|5.1
0-19|0.8|1.3|1.0|66|Incidence|6635632|Hispanic|Male|Acute Myeloid|1999|0.8|1.3|1.0
0-19|0.5|0.9|0.7|47|Incidence|6919053|Hispanic|Male|Acute Myeloid|2000|0.5|0.9|0.7
0-19|0.7|1.1|0.8|63|Incidence|7240643|Hispanic|Male|Acute Myeloid|2001|0.7|1.1|0.9
0-19|0.6|1.0|0.8|59|Incidence|7518483|Hispanic|Male|Acute Myeloid|2002|0.6|1.0|0.8
0-19|0.5|0.9|0.7|56|Incidence|7785714|Hispanic|Male|Acute Myeloid|2003|0.5|0.9|0.7
0-19|0.8|1.3|1.0|81|Incidence|8024129|Hispanic|Male|Acute Myeloid|2004|0.8|1.3|1.0
0-19|0.7|1.1|0.8|71|Incidence|8283812|Hispanic|Male|Acute Myeloid|2005|0.7|1.1|0.9
0-19|0.7|0.9|0.8|346|Incidence|44270660|Hispanic|Male|Acute Myeloid|2005-2009|0.7|0.9|0.8
0-19|0.6|1.0|0.8|65|Incidence|8563877|Hispanic|Male|Acute Myeloid|2006|0.6|1.0|0.8
0-19|0.6|0.9|0.7|67|Incidence|8863218|Hispanic|Male|Acute Myeloid|2007|0.6|1.0|0.8
0-19|0.6|1.0|0.8|74|Incidence|9146469|Hispanic|Male|Acute Myeloid|2008|0.6|1.0|0.8
0-19|0.6|0.9|0.7|69|Incidence|9347691|Hispanic|Male|Acute Myeloid|2009|0.6|0.9|0.7
0-19|16.3|18.3|17.3|1163|Incidence|6635632|Hispanic|Male|All Cancer Sites Combined|1999|16.5|18.6|17.5
0-19|15.4|17.3|16.4|1140|Incidence|6919053|Hispanic|Male|All Cancer Sites Combined|2000|15.5|17.5|16.5
0-19|17.2|19.2|18.2|1330|Incidence|7240643|Hispanic|Male|All Cancer Sites Combined|2001|17.4|19.4|18.4
0-19|17.6|19.6|18.6|1403|Incidence|7518483|Hispanic|Male|All Cancer Sites Combined|2002|17.7|19.7|18.7
0-19|15.5|17.4|16.4|1288|Incidence|7785714|Hispanic|Male|All Cancer Sites Combined|2003|15.7|17.5|16.5
0-19|16.8|18.7|17.7|1443|Incidence|8024129|Hispanic|Male|All Cancer Sites Combined|2004|17.1|18.9|18.0
0-19|16.7|18.5|17.6|1472|Incidence|8283812|Hispanic|Male|All Cancer Sites Combined|2005|16.9|18.7|17.8
0-19|17.7|18.5|18.1|8054|Incidence|44270660|Hispanic|Male|All Cancer Sites Combined|2005-2009|17.8|18.6|18.2
0-19|17.6|19.5|18.5|1586|Incidence|8563877|Hispanic|Male|All Cancer Sites Combined|2006|17.6|19.5|18.5
0-19|17.4|19.2|18.2|1633|Incidence|8863218|Hispanic|Male|All Cancer Sites Combined|2007|17.5|19.3|18.4
0-19|17.0|18.8|17.9|1647|Incidence|9146469|Hispanic|Male|All Cancer Sites Combined|2008|17.1|18.9|18.0
0-19|17.3|19.0|18.2|1701|Incidence|9347691|Hispanic|Male|All Cancer Sites Combined|2009|17.3|19.1|18.2
0-19|0.5|1.0|0.7|46|Incidence|6635632|Hispanic|Male|Bones and Joints|1999|0.5|0.9|0.7
0-19|0.7|1.2|0.9|60|Incidence|6919053|Hispanic|Male|Bones and Joints|2000|0.7|1.1|0.9
0-19|0.9|1.4|1.2|79|Incidence|7240643|Hispanic|Male|Bones and Joints|2001|0.9|1.4|1.1
0-19|0.9|1.5|1.2|83|Incidence|7518483|Hispanic|Male|Bones and Joints|2002|0.9|1.4|1.1
0-19|0.7|1.2|1.0|69|Incidence|7785714|Hispanic|Male|Bones and Joints|2003|0.7|1.1|0.9
0-19|0.8|1.2|1.0|74|Incidence|8024129|Hispanic|Male|Bones and Joints|2004|0.7|1.2|0.9
0-19|0.8|1.2|1.0|76|Incidence|8283812|Hispanic|Male|Bones and Joints|2005|0.7|1.1|0.9
0-19|1.0|1.2|1.1|457|Incidence|44270660|Hispanic|Male|Bones and Joints|2005-2009|0.9|1.1|1.0
0-19|1.0|1.5|1.2|97|Incidence|8563877|Hispanic|Male|Bones and Joints|2006|0.9|1.4|1.1
0-19|0.8|1.3|1.1|86|Incidence|8863218|Hispanic|Male|Bones and Joints|2007|0.8|1.2|1.0
0-19|0.9|1.4|1.1|93|Incidence|9146469|Hispanic|Male|Bones and Joints|2008|0.8|1.2|1.0
0-19|1.0|1.5|1.2|103|Incidence|9347691|Hispanic|Male|Bones and Joints|2009|0.9|1.3|1.1
0-19|2.7|3.6|3.1|207|Incidence|6635632|Hispanic|Male|Brain and Other Nervous System|1999|2.7|3.6|3.1
0-19|2.4|3.1|2.7|191|Incidence|6919053|Hispanic|Male|Brain and Other Nervous System|2000|2.4|3.2|2.8
0-19|2.6|3.4|3.0|221|Incidence|7240643|Hispanic|Male|Brain and Other Nervous System|2001|2.7|3.5|3.1
0-19|2.5|3.3|2.9|221|Incidence|7518483|Hispanic|Male|Brain and Other Nervous System|2002|2.6|3.4|2.9
0-19|2.3|3.0|2.7|211|Incidence|7785714|Hispanic|Male|Brain and Other Nervous System|2003|2.4|3.1|2.7
0-19|2.2|2.9|2.5|211|Incidence|8024129|Hispanic|Male|Brain and Other Nervous System|2004|2.3|3.0|2.6
0-19|2.5|3.2|2.8|241|Incidence|8283812|Hispanic|Male|Brain and Other Nervous System|2005|2.6|3.3|2.9
0-19|2.5|2.8|2.7|1215|Incidence|44270660|Hispanic|Male|Brain and Other Nervous System|2005-2009|2.6|2.9|2.7
0-19|2.6|3.4|3.0|259|Incidence|8563877|Hispanic|Male|Brain and Other Nervous System|2006|2.7|3.4|3.0
0-19|2.3|3.0|2.6|239|Incidence|8863218|Hispanic|Male|Brain and Other Nervous System|2007|2.4|3.1|2.7
0-19|2.1|2.7|2.4|230|Incidence|9146469|Hispanic|Male|Brain and Other Nervous System|2008|2.2|2.9|2.5
0-19|2.2|2.9|2.5|244|Incidence|9347691|Hispanic|Male|Brain and Other Nervous System|2009|2.3|3.0|2.6
0-19|0.9|1.5|1.2|74|Incidence|6635632|Hispanic|Male|Hodgkin Lymphoma|1999|0.9|1.4|1.1
0-19|0.9|1.4|1.1|73|Incidence|6919053|Hispanic|Male|Hodgkin Lymphoma|2000|0.8|1.3|1.1
0-19|1.1|1.7|1.4|96|Incidence|7240643|Hispanic|Male|Hodgkin Lymphoma|2001|1.1|1.6|1.3
0-19|0.9|1.4|1.1|80|Incidence|7518483|Hispanic|Male|Hodgkin Lymphoma|2002|0.8|1.3|1.1
0-19|1.2|1.8|1.5|109|Incidence|7785714|Hispanic|Male|Hodgkin Lymphoma|2003|1.1|1.7|1.4
0-19|0.8|1.2|1.0|72|Incidence|8024129|Hispanic|Male|Hodgkin Lymphoma|2004|0.7|1.1|0.9
0-19|0.9|1.4|1.2|89|Incidence|8283812|Hispanic|Male|Hodgkin Lymphoma|2005|0.9|1.3|1.1
0-19|1.1|1.3|1.2|486|Incidence|44270660|Hispanic|Male|Hodgkin Lymphoma|2005-2009|1.0|1.2|1.1
0-19|1.0|1.6|1.3|101|Incidence|8563877|Hispanic|Male|Hodgkin Lymphoma|2006|1.0|1.4|1.2
0-19|1.0|1.5|1.2|99|Incidence|8863218|Hispanic|Male|Hodgkin Lymphoma|2007|0.9|1.4|1.1
0-19|0.9|1.4|1.1|94|Incidence|9146469|Hispanic|Male|Hodgkin Lymphoma|2008|0.8|1.3|1.0
0-19|1.0|1.4|1.2|100|Incidence|9347691|Hispanic|Male|Hodgkin Lymphoma|2009|0.9|1.3|1.1
0-19|0.4|0.7|0.5|38|Incidence|6635632|Hispanic|Male|Kidney and Renal Pelvis|1999|0.4|0.8|0.6
0-19|0.3|0.7|0.5|35|Incidence|6919053|Hispanic|Male|Kidney and Renal Pelvis|2000|0.4|0.7|0.5
0-19|0.4|0.7|0.5|42|Incidence|7240643|Hispanic|Male|Kidney and Renal Pelvis|2001|0.4|0.8|0.6
0-19|0.4|0.7|0.5|44|Incidence|7518483|Hispanic|Male|Kidney and Renal Pelvis|2002|0.4|0.8|0.6
0-19|0.4|0.7|0.5|44|Incidence|7785714|Hispanic|Male|Kidney and Renal Pelvis|2003|0.4|0.8|0.6
0-19|0.3|0.6|0.4|40|Incidence|8024129|Hispanic|Male|Kidney and Renal Pelvis|2004|0.4|0.7|0.5
0-19|0.3|0.6|0.5|43|Incidence|8283812|Hispanic|Male|Kidney and Renal Pelvis|2005|0.4|0.7|0.5
0-19|0.4|0.5|0.5|236|Incidence|44270660|Hispanic|Male|Kidney and Renal Pelvis|2005-2009|0.5|0.6|0.5
0-19|0.3|0.6|0.4|40|Incidence|8563877|Hispanic|Male|Kidney and Renal Pelvis|2006|0.3|0.6|0.5
0-19|0.4|0.7|0.5|51|Incidence|8863218|Hispanic|Male|Kidney and Renal Pelvis|2007|0.4|0.8|0.6
0-19|0.3|0.5|0.4|42|Incidence|9146469|Hispanic|Male|Kidney and Renal Pelvis|2008|0.3|0.6|0.5
0-19|0.4|0.7|0.6|60|Incidence|9347691|Hispanic|Male|Kidney and Renal Pelvis|2009|0.5|0.8|0.6
0-19|5.3|6.4|5.8|396|Incidence|6635632|Hispanic|Male|Leukemia|1999|5.4|6.6|6.0
0-19|5.0|6.1|5.6|392|Incidence|6919053|Hispanic|Male|Leukemia|2000|5.1|6.3|5.7
0-19|5.3|6.4|5.8|429|Incidence|7240643|Hispanic|Male|Leukemia|2001|5.4|6.5|5.9
0-19|5.4|6.5|5.9|460|Incidence|7518483|Hispanic|Male|Leukemia|2002|5.6|6.7|6.1
0-19|4.5|5.5|5.0|403|Incidence|7785714|Hispanic|Male|Leukemia|2003|4.7|5.7|5.2
0-19|5.5|6.6|6.0|502|Incidence|8024129|Hispanic|Male|Leukemia|2004|5.7|6.8|6.3
0-19|5.3|6.4|5.9|501|Incidence|8283812|Hispanic|Male|Leukemia|2005|5.5|6.6|6.0
0-19|5.8|6.3|6.1|2778|Incidence|44270660|Hispanic|Male|Leukemia|2005-2009|6.0|6.5|6.3
0-19|5.5|6.6|6.1|532|Incidence|8563877|Hispanic|Male|Leukemia|2006|5.7|6.8|6.2
0-19|5.8|6.9|6.4|582|Incidence|8863218|Hispanic|Male|Leukemia|2007|6.0|7.1|6.6
0-19|5.5|6.5|6.0|571|Incidence|9146469|Hispanic|Male|Leukemia|2008|5.7|6.8|6.2
0-19|5.6|6.6|6.1|589|Incidence|9347691|Hispanic|Male|Leukemia|2009|5.8|6.8|6.3
0-19|0.9|1.5|1.2|77|Incidence|6635632|Hispanic|Male|Non-Hodgkin Lymphoma|1999|0.9|1.5|1.2
0-19|1.0|1.6|1.3|88|Incidence|6919053|Hispanic|Male|Non-Hodgkin Lymphoma|2000|1.0|1.6|1.3
0-19|1.0|1.5|1.2|86|Incidence|7240643|Hispanic|Male|Non-Hodgkin Lymphoma|2001|1.0|1.5|1.2
0-19|1.4|2.0|1.6|120|Incidence|7518483|Hispanic|Male|Non-Hodgkin Lymphoma|2002|1.3|1.9|1.6
0-19|0.8|1.3|1.1|80|Incidence|7785714|Hispanic|Male|Non-Hodgkin Lymphoma|2003|0.8|1.3|1.0
0-19|1.2|1.8|1.5|117|Incidence|8024129|Hispanic|Male|Non-Hodgkin Lymphoma|2004|1.2|1.7|1.5
0-19|1.0|1.6|1.3|100|Incidence|8283812|Hispanic|Male|Non-Hodgkin Lymphoma|2005|1.0|1.5|1.2
0-19|1.1|1.3|1.2|501|Incidence|44270660|Hispanic|Male|Non-Hodgkin Lymphoma|2005-2009|1.0|1.2|1.1
0-19|1.0|1.5|1.2|98|Incidence|8563877|Hispanic|Male|Non-Hodgkin Lymphoma|2006|0.9|1.4|1.1
0-19|0.9|1.4|1.2|98|Incidence|8863218|Hispanic|Male|Non-Hodgkin Lymphoma|2007|0.9|1.3|1.1
0-19|1.1|1.6|1.3|113|Incidence|9146469|Hispanic|Male|Non-Hodgkin Lymphoma|2008|1.0|1.5|1.2
0-19|0.8|1.2|1.0|90|Incidence|9347691|Hispanic|Male|Non-Hodgkin Lymphoma|2009|0.8|1.2|1.0
0-19|3.4|4.4|3.9|265|Incidence|6635632|Hispanic|Male|Other|1999|3.5|4.5|4.0
0-19|2.9|3.7|3.3|229|Incidence|6919053|Hispanic|Male|Other|2000|2.9|3.8|3.3
0-19|3.8|4.7|4.2|311|Incidence|7240643|Hispanic|Male|Other|2001|3.8|4.8|4.3
0-19|3.7|4.6|4.2|314|Incidence|7518483|Hispanic|Male|Other|2002|3.7|4.7|4.2
0-19|3.4|4.3|3.9|305|Incidence|7785714|Hispanic|Male|Other|2003|3.5|4.4|3.9
0-19|3.8|4.7|4.2|343|Incidence|8024129|Hispanic|Male|Other|2004|3.8|4.8|4.3
0-19|3.8|4.7|4.2|353|Incidence|8283812|Hispanic|Male|Other|2005|3.8|4.7|4.3
0-19|4.2|4.6|4.4|1970|Incidence|44270660|Hispanic|Male|Other|2005-2009|4.3|4.7|4.4
0-19|4.0|4.9|4.4|377|Incidence|8563877|Hispanic|Male|Other|2006|4.0|4.9|4.4
0-19|4.0|4.8|4.4|394|Incidence|8863218|Hispanic|Male|Other|2007|4.0|4.9|4.4
0-19|4.1|5.0|4.5|415|Incidence|9146469|Hispanic|Male|Other|2008|4.1|5.0|4.5
0-19|4.2|5.1|4.6|428|Incidence|9347691|Hispanic|Male|Other|2009|4.2|5.0|4.6
0-19|0.7|1.1|0.9|60|Incidence|6635632|Hispanic|Male|Soft Tissue|1999|0.7|1.2|0.9
0-19|0.8|1.3|1.0|72|Incidence|6919053|Hispanic|Male|Soft Tissue|2000|0.8|1.3|1.0
0-19|0.7|1.2|0.9|66|Incidence|7240643|Hispanic|Male|Soft Tissue|2001|0.7|1.2|0.9
0-19|0.8|1.3|1.1|81|Incidence|7518483|Hispanic|Male|Soft Tissue|2002|0.9|1.3|1.1
0-19|0.6|1.1|0.8|67|Incidence|7785714|Hispanic|Male|Soft Tissue|2003|0.7|1.1|0.9
0-19|0.8|1.3|1.0|84|Incidence|8024129|Hispanic|Male|Soft Tissue|2004|0.8|1.3|1.0
0-19|0.6|1.0|0.8|69|Incidence|8283812|Hispanic|Male|Soft Tissue|2005|0.6|1.1|0.8
0-19|0.8|1.0|0.9|411|Incidence|44270660|Hispanic|Male|Soft Tissue|2005-2009|0.8|1.0|0.9
0-19|0.8|1.2|1.0|82|Incidence|8563877|Hispanic|Male|Soft Tissue|2006|0.8|1.2|1.0
0-19|0.7|1.2|0.9|84|Incidence|8863218|Hispanic|Male|Soft Tissue|2007|0.8|1.2|0.9
0-19|0.8|1.2|1.0|89|Incidence|9146469|Hispanic|Male|Soft Tissue|2008|0.8|1.2|1.0
0-19|0.7|1.1|0.9|87|Incidence|9347691|Hispanic|Male|Soft Tissue|2009|0.7|1.1|0.9
0-19|3.5|4.1|3.8|507|Incidence|12872546|Hispanic|Male and Female|Acute Lymphocytic|1999|3.6|4.3|3.9
0-19|3.9|4.6|4.2|585|Incidence|13424009|Hispanic|Male and Female|Acute Lymphocytic|2000|4.0|4.7|4.4
0-19|3.7|4.3|4.0|578|Incidence|14054199|Hispanic|Male and Female|Acute Lymphocytic|2001|3.8|4.5|4.1
0-19|3.9|4.6|4.2|641|Incidence|14611904|Hispanic|Male and Female|Acute Lymphocytic|2002|4.1|4.7|4.4
0-19|3.4|4.0|3.7|589|Incidence|15151074|Hispanic|Male and Female|Acute Lymphocytic|2003|3.6|4.2|3.9
0-19|3.7|4.3|4.0|654|Incidence|15630881|Hispanic|Male and Female|Acute Lymphocytic|2004|3.9|4.5|4.2
0-19|3.7|4.3|3.9|667|Incidence|16143779|Hispanic|Male and Female|Acute Lymphocytic|2005|3.8|4.5|4.1
0-19|4.2|4.4|4.3|3878|Incidence|86323894|Hispanic|Male and Female|Acute Lymphocytic|2005-2009|4.4|4.6|4.5
0-19|3.9|4.5|4.2|733|Incidence|16696171|Hispanic|Male and Female|Acute Lymphocytic|2006|4.1|4.7|4.4
0-19|4.0|4.7|4.3|782|Incidence|17282171|Hispanic|Male and Female|Acute Lymphocytic|2007|4.2|4.9|4.5
0-19|4.2|4.8|4.5|846|Incidence|17839235|Hispanic|Male and Female|Acute Lymphocytic|2008|4.4|5.1|4.7
0-19|4.1|4.7|4.4|844|Incidence|18234063|Hispanic|Male and Female|Acute Lymphocytic|2009|4.3|5.0|4.6
0-19|0.7|1.0|0.8|108|Incidence|12872546|Hispanic|Male and Female|Acute Myeloid|1999|0.7|1.0|0.8
0-19|0.6|0.9|0.7|99|Incidence|13424009|Hispanic|Male and Female|Acute Myeloid|2000|0.6|0.9|0.7
0-19|0.6|0.9|0.8|109|Incidence|14054199|Hispanic|Male and Female|Acute Myeloid|2001|0.6|0.9|0.8
0-19|0.6|0.9|0.8|109|Incidence|14611904|Hispanic|Male and Female|Acute Myeloid|2002|0.6|0.9|0.7
0-19|0.6|0.8|0.7|106|Incidence|15151074|Hispanic|Male and Female|Acute Myeloid|2003|0.6|0.8|0.7
0-19|0.8|1.1|0.9|141|Incidence|15630881|Hispanic|Male and Female|Acute Myeloid|2004|0.8|1.1|0.9
0-19|0.7|0.9|0.8|129|Incidence|16143779|Hispanic|Male and Female|Acute Myeloid|2005|0.7|0.9|0.8
0-19|0.7|0.8|0.8|686|Incidence|86323894|Hispanic|Male and Female|Acute Myeloid|2005-2009|0.7|0.9|0.8
0-19|0.6|0.9|0.7|122|Incidence|16696171|Hispanic|Male and Female|Acute Myeloid|2006|0.6|0.9|0.7
0-19|0.7|1.0|0.8|145|Incidence|17282171|Hispanic|Male and Female|Acute Myeloid|2007|0.7|1.0|0.8
0-19|0.6|0.9|0.8|142|Incidence|17839235|Hispanic|Male and Female|Acute Myeloid|2008|0.7|0.9|0.8
0-19|0.7|0.9|0.8|146|Incidence|18234063|Hispanic|Male and Female|Acute Myeloid|2009|0.7|0.9|0.8
0-19|15.0|16.4|15.7|2039|Incidence|12872546|Hispanic|Male and Female|All Cancer Sites Combined|1999|15.2|16.5|15.8
0-19|15.3|16.6|15.9|2149|Incidence|13424009|Hispanic|Male and Female|All Cancer Sites Combined|2000|15.3|16.7|16.0
0-19|16.0|17.4|16.7|2367|Incidence|14054199|Hispanic|Male and Female|All Cancer Sites Combined|2001|16.2|17.5|16.8
0-19|16.2|17.5|16.8|2478|Incidence|14611904|Hispanic|Male and Female|All Cancer Sites Combined|2002|16.3|17.6|17.0
0-19|15.3|16.6|15.9|2443|Incidence|15151074|Hispanic|Male and Female|All Cancer Sites Combined|2003|15.5|16.8|16.1
0-19|16.5|17.8|17.1|2707|Incidence|15630881|Hispanic|Male and Female|All Cancer Sites Combined|2004|16.7|18.0|17.3
0-19|15.9|17.1|16.5|2683|Incidence|16143779|Hispanic|Male and Female|All Cancer Sites Combined|2005|16.0|17.3|16.6
0-19|16.8|17.3|17.0|14786|Incidence|86323894|Hispanic|Male and Female|All Cancer Sites Combined|2005-2009|16.9|17.4|17.1
0-19|16.6|17.8|17.2|2866|Incidence|16696171|Hispanic|Male and Female|All Cancer Sites Combined|2006|16.5|17.8|17.2
0-19|16.5|17.7|17.1|2978|Incidence|17282171|Hispanic|Male and Female|All Cancer Sites Combined|2007|16.6|17.9|17.2
0-19|16.5|17.7|17.1|3073|Incidence|17839235|Hispanic|Male and Female|All Cancer Sites Combined|2008|16.6|17.8|17.2
0-19|16.7|17.9|17.3|3160|Incidence|18234063|Hispanic|Male and Female|All Cancer Sites Combined|2009|16.7|17.9|17.3
0-19|0.7|1.0|0.8|99|Incidence|12872546|Hispanic|Male and Female|Bones and Joints|1999|0.6|0.9|0.8
0-19|0.7|1.1|0.9|115|Incidence|13424009|Hispanic|Male and Female|Bones and Joints|2000|0.7|1.0|0.9
0-19|0.8|1.1|1.0|126|Incidence|14054199|Hispanic|Male and Female|Bones and Joints|2001|0.7|1.1|0.9
0-19|0.8|1.2|1.0|134|Incidence|14611904|Hispanic|Male and Female|Bones and Joints|2002|0.8|1.1|0.9
0-19|0.8|1.1|0.9|129|Incidence|15151074|Hispanic|Male and Female|Bones and Joints|2003|0.7|1.0|0.9
0-19|0.8|1.2|1.0|144|Incidence|15630881|Hispanic|Male and Female|Bones and Joints|2004|0.8|1.1|0.9
0-19|0.8|1.1|0.9|137|Incidence|16143779|Hispanic|Male and Female|Bones and Joints|2005|0.7|1.0|0.8
0-19|0.9|1.0|1.0|765|Incidence|86323894|Hispanic|Male and Female|Bones and Joints|2005-2009|0.8|1.0|0.9
0-19|0.9|1.2|1.1|165|Incidence|16696171|Hispanic|Male and Female|Bones and Joints|2006|0.8|1.2|1.0
0-19|0.7|1.0|0.9|135|Incidence|17282171|Hispanic|Male and Female|Bones and Joints|2007|0.7|0.9|0.8
0-19|0.8|1.1|1.0|158|Incidence|17839235|Hispanic|Male and Female|Bones and Joints|2008|0.8|1.0|0.9
0-19|0.9|1.2|1.0|168|Incidence|18234063|Hispanic|Male and Female|Bones and Joints|2009|0.8|1.1|0.9
0-19|2.4|3.0|2.7|351|Incidence|12872546|Hispanic|Male and Female|Brain and Other Nervous System|1999|2.4|3.0|2.7
0-19|2.3|2.8|2.6|349|Incidence|13424009|Hispanic|Male and Female|Brain and Other Nervous System|2000|2.3|2.9|2.6
0-19|2.4|3.0|2.7|387|Incidence|14054199|Hispanic|Male and Female|Brain and Other Nervous System|2001|2.5|3.0|2.8
0-19|2.3|2.9|2.6|389|Incidence|14611904|Hispanic|Male and Female|Brain and Other Nervous System|2002|2.4|2.9|2.7
0-19|2.3|2.9|2.6|404|Incidence|15151074|Hispanic|Male and Female|Brain and Other Nervous System|2003|2.4|2.9|2.7
0-19|2.6|3.1|2.8|452|Incidence|15630881|Hispanic|Male and Female|Brain and Other Nervous System|2004|2.6|3.2|2.9
0-19|2.3|2.8|2.6|425|Incidence|16143779|Hispanic|Male and Female|Brain and Other Nervous System|2005|2.4|2.9|2.6
0-19|2.4|2.6|2.5|2246|Incidence|86323894|Hispanic|Male and Female|Brain and Other Nervous System|2005-2009|2.5|2.7|2.6
0-19|2.4|2.9|2.7|455|Incidence|16696171|Hispanic|Male and Female|Brain and Other Nervous System|2006|2.5|3.0|2.7
0-19|2.4|2.9|2.7|474|Incidence|17282171|Hispanic|Male and Female|Brain and Other Nervous System|2007|2.5|3.0|2.7
0-19|2.1|2.6|2.3|437|Incidence|17839235|Hispanic|Male and Female|Brain and Other Nervous System|2008|2.2|2.7|2.4
0-19|2.2|2.6|2.4|450|Incidence|18234063|Hispanic|Male and Female|Brain and Other Nervous System|2009|2.2|2.7|2.5
0-19|0.8|1.2|1.0|118|Incidence|12872546|Hispanic|Male and Female|Hodgkin Lymphoma|1999|0.8|1.1|0.9
0-19|0.8|1.1|1.0|122|Incidence|13424009|Hispanic|Male and Female|Hodgkin Lymphoma|2000|0.8|1.1|0.9
0-19|1.0|1.4|1.2|156|Incidence|14054199|Hispanic|Male and Female|Hodgkin Lymphoma|2001|0.9|1.3|1.1
0-19|0.8|1.2|1.0|130|Incidence|14611904|Hispanic|Male and Female|Hodgkin Lymphoma|2002|0.7|1.1|0.9
0-19|1.0|1.4|1.2|166|Incidence|15151074|Hispanic|Male and Female|Hodgkin Lymphoma|2003|0.9|1.3|1.1
0-19|0.8|1.2|1.0|140|Incidence|15630881|Hispanic|Male and Female|Hodgkin Lymphoma|2004|0.8|1.1|0.9
0-19|0.9|1.3|1.1|159|Incidence|16143779|Hispanic|Male and Female|Hodgkin Lymphoma|2005|0.8|1.2|1.0
0-19|1.0|1.2|1.1|850|Incidence|86323894|Hispanic|Male and Female|Hodgkin Lymphoma|2005-2009|0.9|1.1|1.0
0-19|1.0|1.4|1.2|178|Incidence|16696171|Hispanic|Male and Female|Hodgkin Lymphoma|2006|0.9|1.2|1.1
0-19|0.9|1.2|1.0|163|Incidence|17282171|Hispanic|Male and Female|Hodgkin Lymphoma|2007|0.8|1.1|0.9
0-19|0.9|1.2|1.1|171|Incidence|17839235|Hispanic|Male and Female|Hodgkin Lymphoma|2008|0.8|1.1|1.0
0-19|0.9|1.2|1.1|175|Incidence|18234063|Hispanic|Male and Female|Hodgkin Lymphoma|2009|0.8|1.1|1.0
0-19|0.5|0.7|0.6|83|Incidence|12872546|Hispanic|Male and Female|Kidney and Renal Pelvis|1999|0.5|0.8|0.6
0-19|0.3|0.6|0.4|64|Incidence|13424009|Hispanic|Male and Female|Kidney and Renal Pelvis|2000|0.4|0.6|0.5
0-19|0.5|0.7|0.6|87|Incidence|14054199|Hispanic|Male and Female|Kidney and Renal Pelvis|2001|0.5|0.8|0.6
0-19|0.4|0.7|0.5|87|Incidence|14611904|Hispanic|Male and Female|Kidney and Renal Pelvis|2002|0.5|0.7|0.6
0-19|0.5|0.7|0.6|96|Incidence|15151074|Hispanic|Male and Female|Kidney and Renal Pelvis|2003|0.5|0.8|0.6
0-19|0.4|0.6|0.5|92|Incidence|15630881|Hispanic|Male and Female|Kidney and Renal Pelvis|2004|0.5|0.7|0.6
0-19|0.3|0.6|0.4|80|Incidence|16143779|Hispanic|Male and Female|Kidney and Renal Pelvis|2005|0.4|0.6|0.5
0-19|0.5|0.6|0.5|514|Incidence|86323894|Hispanic|Male and Female|Kidney and Renal Pelvis|2005-2009|0.5|0.6|0.6
0-19|0.4|0.6|0.5|92|Incidence|16696171|Hispanic|Male and Female|Kidney and Renal Pelvis|2006|0.4|0.7|0.6
0-19|0.5|0.7|0.6|118|Incidence|17282171|Hispanic|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.8|0.7
0-19|0.4|0.6|0.5|98|Incidence|17839235|Hispanic|Male and Female|Kidney and Renal Pelvis|2008|0.4|0.7|0.5
0-19|0.5|0.7|0.6|126|Incidence|18234063|Hispanic|Male and Female|Kidney and Renal Pelvis|2009|0.6|0.8|0.7
0-19|4.7|5.5|5.1|671|Incidence|12872546|Hispanic|Male and Female|Leukemia|1999|4.8|5.6|5.2
0-19|5.0|5.8|5.4|741|Incidence|13424009|Hispanic|Male and Female|Leukemia|2000|5.1|5.9|5.5
0-19|4.9|5.7|5.3|763|Incidence|14054199|Hispanic|Male and Female|Leukemia|2001|5.1|5.8|5.4
0-19|5.1|5.9|5.5|829|Incidence|14611904|Hispanic|Male and Female|Leukemia|2002|5.3|6.1|5.7
0-19|4.5|5.2|4.8|758|Incidence|15151074|Hispanic|Male and Female|Leukemia|2003|4.7|5.4|5.0
0-19|4.9|5.7|5.3|862|Incidence|15630881|Hispanic|Male and Female|Leukemia|2004|5.2|5.9|5.5
0-19|4.8|5.5|5.2|871|Incidence|16143779|Hispanic|Male and Female|Leukemia|2005|5.0|5.8|5.4
0-19|5.4|5.7|5.5|4947|Incidence|86323894|Hispanic|Male and Female|Leukemia|2005-2009|5.6|5.9|5.7
0-19|5.1|5.8|5.4|932|Incidence|16696171|Hispanic|Male and Female|Leukemia|2006|5.2|6.0|5.6
0-19|5.3|6.0|5.7|1011|Incidence|17282171|Hispanic|Male and Female|Leukemia|2007|5.5|6.2|5.8
0-19|5.4|6.1|5.7|1060|Incidence|17839235|Hispanic|Male and Female|Leukemia|2008|5.6|6.3|5.9
0-19|5.3|5.9|5.6|1065|Incidence|18234063|Hispanic|Male and Female|Leukemia|2009|5.5|6.2|5.8
0-19|0.8|1.1|1.0|120|Incidence|12872546|Hispanic|Male and Female|Non-Hodgkin Lymphoma|1999|0.8|1.1|0.9
0-19|0.9|1.2|1.0|134|Incidence|13424009|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2000|0.8|1.2|1.0
0-19|0.8|1.1|0.9|129|Incidence|14054199|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2001|0.8|1.1|0.9
0-19|1.1|1.4|1.2|175|Incidence|14611904|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002|1.0|1.4|1.2
0-19|0.7|1.0|0.8|124|Incidence|15151074|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003|0.7|1.0|0.8
0-19|0.9|1.3|1.1|167|Incidence|15630881|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004|0.9|1.2|1.1
0-19|0.9|1.2|1.1|162|Incidence|16143779|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005|0.9|1.2|1.0
0-19|0.9|1.1|1.0|801|Incidence|86323894|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005-2009|0.9|1.0|0.9
0-19|0.8|1.2|1.0|156|Incidence|16696171|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2006|0.8|1.1|0.9
0-19|0.8|1.1|1.0|156|Incidence|17282171|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2007|0.8|1.1|0.9
0-19|0.9|1.2|1.0|171|Incidence|17839235|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2008|0.8|1.1|1.0
0-19|0.8|1.0|0.9|154|Incidence|18234063|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2009|0.7|1.0|0.8
0-19|3.5|4.1|3.8|490|Incidence|12872546|Hispanic|Male and Female|Other|1999|3.5|4.2|3.8
0-19|3.4|4.1|3.7|497|Incidence|13424009|Hispanic|Male and Female|Other|2000|3.4|4.0|3.7
0-19|3.8|4.5|4.2|591|Incidence|14054199|Hispanic|Male and Female|Other|2001|3.9|4.6|4.2
0-19|3.7|4.4|4.1|591|Incidence|14611904|Hispanic|Male and Female|Other|2002|3.7|4.4|4.0
0-19|3.7|4.4|4.0|608|Incidence|15151074|Hispanic|Male and Female|Other|2003|3.7|4.3|4.0
0-19|4.1|4.7|4.4|694|Incidence|15630881|Hispanic|Male and Female|Other|2004|4.1|4.8|4.4
0-19|4.0|4.7|4.3|697|Incidence|16143779|Hispanic|Male and Female|Other|2005|4.0|4.7|4.3
0-19|4.4|4.7|4.5|3848|Incidence|86323894|Hispanic|Male and Female|Other|2005-2009|4.3|4.6|4.5
0-19|4.1|4.7|4.4|723|Incidence|16696171|Hispanic|Male and Female|Other|2006|4.0|4.7|4.3
0-19|4.1|4.7|4.4|755|Incidence|17282171|Hispanic|Male and Female|Other|2007|4.1|4.7|4.4
0-19|4.3|4.9|4.6|808|Incidence|17839235|Hispanic|Male and Female|Other|2008|4.2|4.9|4.5
0-19|4.5|5.2|4.9|860|Incidence|18234063|Hispanic|Male and Female|Other|2009|4.4|5.0|4.7
0-19|0.7|1.0|0.8|107|Incidence|12872546|Hispanic|Male and Female|Soft Tissue|1999|0.7|1.0|0.8
0-19|0.8|1.1|1.0|127|Incidence|13424009|Hispanic|Male and Female|Soft Tissue|2000|0.8|1.1|0.9
0-19|0.8|1.1|0.9|128|Incidence|14054199|Hispanic|Male and Female|Soft Tissue|2001|0.8|1.1|0.9
0-19|0.8|1.1|1.0|143|Incidence|14611904|Hispanic|Male and Female|Soft Tissue|2002|0.8|1.2|1.0
0-19|0.9|1.2|1.0|158|Incidence|15151074|Hispanic|Male and Female|Soft Tissue|2003|0.9|1.2|1.0
0-19|0.8|1.2|1.0|156|Incidence|15630881|Hispanic|Male and Female|Soft Tissue|2004|0.8|1.2|1.0
0-19|0.8|1.1|0.9|152|Incidence|16143779|Hispanic|Male and Female|Soft Tissue|2005|0.8|1.1|0.9
0-19|0.9|1.0|0.9|815|Incidence|86323894|Hispanic|Male and Female|Soft Tissue|2005-2009|0.9|1.0|0.9
0-19|0.8|1.1|1.0|165|Incidence|16696171|Hispanic|Male and Female|Soft Tissue|2006|0.8|1.2|1.0
0-19|0.8|1.1|0.9|166|Incidence|17282171|Hispanic|Male and Female|Soft Tissue|2007|0.8|1.1|1.0
0-19|0.8|1.1|0.9|170|Incidence|17839235|Hispanic|Male and Female|Soft Tissue|2008|0.8|1.1|1.0
0-19|0.7|1.0|0.9|162|Incidence|18234063|Hispanic|Male and Female|Soft Tissue|2009|0.8|1.0|0.9
0-19|2.7|3.1|2.9|804|Incidence|27890317|White|Female|Acute Lymphocytic|1999|2.7|3.1|2.9
0-19|2.9|3.3|3.1|865|Incidence|28006412|White|Female|Acute Lymphocytic|2000|2.9|3.3|3.1
0-19|2.9|3.4|3.1|912|Incidence|29210954|White|Female|Acute Lymphocytic|2001|2.9|3.3|3.1
0-19|2.8|3.2|3.0|884|Incidence|29951761|White|Female|Acute Lymphocytic|2002|2.8|3.2|3.0
0-19|2.7|3.1|2.9|894|Incidence|30859652|White|Female|Acute Lymphocytic|2003|2.7|3.1|2.9
0-19|2.8|3.2|3.0|925|Incidence|30966595|White|Female|Acute Lymphocytic|2004|2.8|3.2|3.0
0-19|2.8|3.1|3.0|921|Incidence|31023899|White|Female|Acute Lymphocytic|2005|2.8|3.2|3.0
0-19|3.0|3.2|3.1|4896|Incidence|156040675|White|Female|Acute Lymphocytic|2005-2009|3.1|3.2|3.1
0-19|2.9|3.3|3.1|959|Incidence|31103287|White|Female|Acute Lymphocytic|2006|2.9|3.3|3.1
0-19|3.0|3.4|3.2|995|Incidence|31233583|White|Female|Acute Lymphocytic|2007|3.0|3.4|3.2
0-19|3.1|3.5|3.3|1045|Incidence|31316144|White|Female|Acute Lymphocytic|2008|3.1|3.5|3.3
0-19|2.9|3.3|3.1|953|Incidence|30746740|White|Female|Acute Lymphocytic|2009|2.9|3.3|3.1
0-19|0.6|0.8|0.7|184|Incidence|27890317|White|Female|Acute Myeloid|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|188|Incidence|28006412|White|Female|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.6|0.8|0.7|202|Incidence|29210954|White|Female|Acute Myeloid|2001|0.6|0.8|0.7
0-19|0.6|0.8|0.7|200|Incidence|29951761|White|Female|Acute Myeloid|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|185|Incidence|30859652|White|Female|Acute Myeloid|2003|0.5|0.7|0.6
0-19|0.5|0.7|0.6|190|Incidence|30966595|White|Female|Acute Myeloid|2004|0.5|0.7|0.6
0-19|0.6|0.7|0.7|204|Incidence|31023899|White|Female|Acute Myeloid|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.7|1051|Incidence|156040675|White|Female|Acute Myeloid|2005-2009|0.6|0.7|0.7
0-19|0.6|0.7|0.6|202|Incidence|31103287|White|Female|Acute Myeloid|2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|217|Incidence|31233583|White|Female|Acute Myeloid|2007|0.6|0.8|0.7
0-19|0.5|0.7|0.6|197|Incidence|31316144|White|Female|Acute Myeloid|2008|0.5|0.7|0.6
0-19|0.6|0.8|0.7|223|Incidence|30746740|White|Female|Acute Myeloid|2009|0.6|0.8|0.7
0-19|15.0|15.9|15.4|4301|Incidence|27890317|White|Female|All Cancer Sites Combined|1999|15.0|15.9|15.4
0-19|15.9|16.8|16.3|4570|Incidence|28006412|White|Female|All Cancer Sites Combined|2000|15.8|16.8|16.3
0-19|16.5|17.4|16.9|4955|Incidence|29210954|White|Female|All Cancer Sites Combined|2001|16.5|17.4|17.0
0-19|15.9|16.8|16.3|4893|Incidence|29951761|White|Female|All Cancer Sites Combined|2002|15.9|16.8|16.3
0-19|16.3|17.2|16.7|5190|Incidence|30859652|White|Female|All Cancer Sites Combined|2003|16.4|17.3|16.8
0-19|16.5|17.4|17.0|5290|Incidence|30966595|White|Female|All Cancer Sites Combined|2004|16.6|17.5|17.1
0-19|16.3|17.2|16.7|5230|Incidence|31023899|White|Female|All Cancer Sites Combined|2005|16.4|17.3|16.9
0-19|16.6|17.0|16.8|26446|Incidence|156040675|White|Female|All Cancer Sites Combined|2005-2009|16.7|17.2|16.9
0-19|16.0|16.9|16.5|5179|Incidence|31103287|White|Female|All Cancer Sites Combined|2006|16.2|17.1|16.7
0-19|16.6|17.5|17.1|5385|Incidence|31233583|White|Female|All Cancer Sites Combined|2007|16.8|17.7|17.2
0-19|16.6|17.6|17.1|5413|Incidence|31316144|White|Female|All Cancer Sites Combined|2008|16.8|17.8|17.3
0-19|16.1|17.0|16.5|5135|Incidence|30746740|White|Female|All Cancer Sites Combined|2009|16.2|17.2|16.7
0-19|0.7|0.9|0.8|222|Incidence|27890317|White|Female|Bones and Joints|1999|0.7|0.9|0.8
0-19|0.7|1.0|0.8|238|Incidence|28006412|White|Female|Bones and Joints|2000|0.7|1.0|0.8
0-19|0.7|1.0|0.8|249|Incidence|29210954|White|Female|Bones and Joints|2001|0.7|1.0|0.9
0-19|0.7|0.9|0.8|245|Incidence|29951761|White|Female|Bones and Joints|2002|0.7|0.9|0.8
0-19|0.8|1.0|0.9|279|Incidence|30859652|White|Female|Bones and Joints|2003|0.8|1.0|0.9
0-19|0.8|1.0|0.9|276|Incidence|30966595|White|Female|Bones and Joints|2004|0.8|1.0|0.9
0-19|0.7|0.9|0.8|259|Incidence|31023899|White|Female|Bones and Joints|2005|0.7|0.9|0.8
0-19|0.8|0.9|0.8|1253|Incidence|156040675|White|Female|Bones and Joints|2005-2009|0.8|0.8|0.8
0-19|0.7|0.9|0.8|260|Incidence|31103287|White|Female|Bones and Joints|2006|0.7|0.9|0.8
0-19|0.7|0.9|0.8|238|Incidence|31233583|White|Female|Bones and Joints|2007|0.7|0.9|0.8
0-19|0.7|0.9|0.8|254|Incidence|31316144|White|Female|Bones and Joints|2008|0.7|0.9|0.8
0-19|0.7|0.9|0.8|239|Incidence|30746740|White|Female|Bones and Joints|2009|0.7|0.9|0.8
0-19|2.7|3.1|2.9|819|Incidence|27890317|White|Female|Brain and Other Nervous System|1999|2.7|3.1|2.9
0-19|2.8|3.2|3.0|837|Incidence|28006412|White|Female|Brain and Other Nervous System|2000|2.8|3.2|3.0
0-19|2.8|3.2|3.0|864|Incidence|29210954|White|Female|Brain and Other Nervous System|2001|2.8|3.2|3.0
0-19|2.7|3.1|2.9|870|Incidence|29951761|White|Female|Brain and Other Nervous System|2002|2.7|3.1|2.9
0-19|2.9|3.3|3.1|949|Incidence|30859652|White|Female|Brain and Other Nervous System|2003|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1004|Incidence|30966595|White|Female|Brain and Other Nervous System|2004|3.0|3.4|3.2
0-19|2.8|3.2|3.0|918|Incidence|31023899|White|Female|Brain and Other Nervous System|2005|2.8|3.2|3.0
0-19|2.9|3.1|3.0|4702|Incidence|156040675|White|Female|Brain and Other Nervous System|2005-2009|2.9|3.1|3.0
0-19|2.8|3.2|3.0|932|Incidence|31103287|White|Female|Brain and Other Nervous System|2006|2.8|3.2|3.0
0-19|3.0|3.4|3.2|1010|Incidence|31233583|White|Female|Brain and Other Nervous System|2007|3.0|3.4|3.2
0-19|2.8|3.2|3.0|949|Incidence|31316144|White|Female|Brain and Other Nervous System|2008|2.8|3.2|3.0
0-19|2.6|3.0|2.8|873|Incidence|30746740|White|Female|Brain and Other Nervous System|2009|2.7|3.0|2.8
0-19|1.1|1.3|1.2|331|Incidence|27890317|White|Female|Hodgkin Lymphoma|1999|1.1|1.3|1.2
0-19|1.2|1.5|1.3|371|Incidence|28006412|White|Female|Hodgkin Lymphoma|2000|1.2|1.5|1.3
0-19|1.2|1.5|1.3|389|Incidence|29210954|White|Female|Hodgkin Lymphoma|2001|1.2|1.5|1.3
0-19|1.2|1.4|1.3|387|Incidence|29951761|White|Female|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.1|1.4|1.2|386|Incidence|30859652|White|Female|Hodgkin Lymphoma|2003|1.1|1.4|1.3
0-19|1.1|1.4|1.3|396|Incidence|30966595|White|Female|Hodgkin Lymphoma|2004|1.2|1.4|1.3
0-19|1.1|1.4|1.3|397|Incidence|31023899|White|Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.2|1.3|1.3|1996|Incidence|156040675|White|Female|Hodgkin Lymphoma|2005-2009|1.2|1.3|1.3
0-19|1.1|1.4|1.3|395|Incidence|31103287|White|Female|Hodgkin Lymphoma|2006|1.1|1.4|1.3
0-19|1.1|1.3|1.2|380|Incidence|31233583|White|Female|Hodgkin Lymphoma|2007|1.1|1.3|1.2
0-19|1.2|1.5|1.4|428|Incidence|31316144|White|Female|Hodgkin Lymphoma|2008|1.2|1.5|1.4
0-19|1.1|1.4|1.3|389|Incidence|30746740|White|Female|Hodgkin Lymphoma|2009|1.1|1.4|1.3
0-19|0.6|0.8|0.7|192|Incidence|27890317|White|Female|Kidney and Renal Pelvis|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|194|Incidence|28006412|White|Female|Kidney and Renal Pelvis|2000|0.6|0.8|0.7
0-19|0.7|0.9|0.8|224|Incidence|29210954|White|Female|Kidney and Renal Pelvis|2001|0.7|0.9|0.8
0-19|0.5|0.7|0.6|182|Incidence|29951761|White|Female|Kidney and Renal Pelvis|2002|0.5|0.7|0.6
0-19|0.7|0.9|0.8|243|Incidence|30859652|White|Female|Kidney and Renal Pelvis|2003|0.7|0.9|0.8
0-19|0.6|0.8|0.7|209|Incidence|30966595|White|Female|Kidney and Renal Pelvis|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|223|Incidence|31023899|White|Female|Kidney and Renal Pelvis|2005|0.6|0.8|0.7
0-19|0.7|0.8|0.7|1158|Incidence|156040675|White|Female|Kidney and Renal Pelvis|2005-2009|0.7|0.8|0.7
0-19|0.6|0.8|0.7|220|Incidence|31103287|White|Female|Kidney and Renal Pelvis|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|243|Incidence|31233583|White|Female|Kidney and Renal Pelvis|2007|0.7|0.9|0.8
0-19|0.7|0.9|0.8|242|Incidence|31316144|White|Female|Kidney and Renal Pelvis|2008|0.7|0.9|0.8
0-19|0.6|0.8|0.7|228|Incidence|30746740|White|Female|Kidney and Renal Pelvis|2009|0.6|0.8|0.7
0-19|3.6|4.1|3.8|1064|Incidence|27890317|White|Female|Leukemia|1999|3.6|4.1|3.8
0-19|3.9|4.4|4.1|1151|Incidence|28006412|White|Female|Leukemia|2000|3.9|4.4|4.1
0-19|4.0|4.5|4.2|1233|Incidence|29210954|White|Female|Leukemia|2001|4.0|4.5|4.2
0-19|3.8|4.3|4.0|1204|Incidence|29951761|White|Female|Leukemia|2002|3.8|4.3|4.0
0-19|3.6|4.1|3.8|1188|Incidence|30859652|White|Female|Leukemia|2003|3.6|4.1|3.8
0-19|3.7|4.2|3.9|1221|Incidence|30966595|White|Female|Leukemia|2004|3.7|4.2|3.9
0-19|3.8|4.2|4.0|1242|Incidence|31023899|White|Female|Leukemia|2005|3.8|4.2|4.0
0-19|4.0|4.2|4.1|6510|Incidence|156040675|White|Female|Leukemia|2005-2009|4.1|4.3|4.2
0-19|3.9|4.3|4.1|1285|Incidence|31103287|White|Female|Leukemia|2006|3.9|4.4|4.1
0-19|4.0|4.4|4.2|1324|Incidence|31233583|White|Female|Leukemia|2007|4.0|4.5|4.2
0-19|4.0|4.5|4.3|1347|Incidence|31316144|White|Female|Leukemia|2008|4.1|4.5|4.3
0-19|3.9|4.3|4.1|1275|Incidence|30746740|White|Female|Leukemia|2009|3.9|4.4|4.1
0-19|0.6|0.8|0.7|193|Incidence|27890317|White|Female|Non-Hodgkin Lymphoma|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|221|Incidence|28006412|White|Female|Non-Hodgkin Lymphoma|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|231|Incidence|29210954|White|Female|Non-Hodgkin Lymphoma|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|228|Incidence|29951761|White|Female|Non-Hodgkin Lymphoma|2002|0.7|0.9|0.8
0-19|0.7|0.9|0.8|233|Incidence|30859652|White|Female|Non-Hodgkin Lymphoma|2003|0.7|0.9|0.8
0-19|0.7|0.9|0.8|236|Incidence|30966595|White|Female|Non-Hodgkin Lymphoma|2004|0.7|0.9|0.8
0-19|0.7|0.9|0.8|234|Incidence|31023899|White|Female|Non-Hodgkin Lymphoma|2005|0.7|0.9|0.8
0-19|0.7|0.8|0.7|1159|Incidence|156040675|White|Female|Non-Hodgkin Lymphoma|2005-2009|0.7|0.8|0.7
0-19|0.6|0.8|0.7|225|Incidence|31103287|White|Female|Non-Hodgkin Lymphoma|2006|0.6|0.8|0.7
0-19|0.7|0.9|0.8|243|Incidence|31233583|White|Female|Non-Hodgkin Lymphoma|2007|0.7|0.9|0.8
0-19|0.6|0.8|0.7|220|Incidence|31316144|White|Female|Non-Hodgkin Lymphoma|2008|0.6|0.8|0.7
0-19|0.7|0.9|0.8|236|Incidence|30746740|White|Female|Non-Hodgkin Lymphoma|2009|0.7|0.9|0.8
0-19|4.2|4.7|4.4|1224|Incidence|27890317|White|Female|Other|1999|4.1|4.6|4.4
0-19|4.3|4.8|4.6|1282|Incidence|28006412|White|Female|Other|2000|4.3|4.8|4.6
0-19|4.7|5.2|5.0|1457|Incidence|29210954|White|Female|Other|2001|4.7|5.3|5.0
0-19|4.7|5.2|4.9|1479|Incidence|29951761|White|Female|Other|2002|4.7|5.2|4.9
0-19|4.8|5.3|5.1|1574|Incidence|30859652|White|Female|Other|2003|4.9|5.4|5.1
0-19|4.9|5.4|5.2|1626|Incidence|30966595|White|Female|Other|2004|5.0|5.5|5.3
0-19|5.0|5.5|5.2|1646|Incidence|31023899|White|Female|Other|2005|5.1|5.6|5.3
0-19|4.9|5.2|5.0|8010|Incidence|156040675|White|Female|Other|2005-2009|5.0|5.2|5.1
0-19|4.7|5.2|4.9|1555|Incidence|31103287|White|Female|Other|2006|4.8|5.3|5.0
0-19|4.8|5.3|5.0|1594|Incidence|31233583|White|Female|Other|2007|4.9|5.4|5.1
0-19|4.8|5.3|5.1|1614|Incidence|31316144|White|Female|Other|2008|4.9|5.4|5.2
0-19|4.8|5.3|5.0|1570|Incidence|30746740|White|Female|Other|2009|4.9|5.4|5.1
0-19|0.8|1.0|0.9|256|Incidence|27890317|White|Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|276|Incidence|28006412|White|Female|Soft Tissue|2000|0.9|1.1|1.0
0-19|0.9|1.2|1.0|308|Incidence|29210954|White|Female|Soft Tissue|2001|0.9|1.2|1.1
0-19|0.9|1.1|1.0|298|Incidence|29951761|White|Female|Soft Tissue|2002|0.9|1.1|1.0
0-19|1.0|1.2|1.1|338|Incidence|30859652|White|Female|Soft Tissue|2003|1.0|1.2|1.1
0-19|0.9|1.1|1.0|322|Incidence|30966595|White|Female|Soft Tissue|2004|0.9|1.2|1.0
0-19|0.9|1.1|1.0|311|Incidence|31023899|White|Female|Soft Tissue|2005|0.9|1.1|1.0
0-19|1.0|1.1|1.0|1658|Incidence|156040675|White|Female|Soft Tissue|2005-2009|1.0|1.1|1.1
0-19|0.9|1.1|1.0|307|Incidence|31103287|White|Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|353|Incidence|31233583|White|Female|Soft Tissue|2007|1.0|1.3|1.1
0-19|1.0|1.3|1.1|359|Incidence|31316144|White|Female|Soft Tissue|2008|1.0|1.3|1.1
0-19|0.9|1.2|1.0|325|Incidence|30746740|White|Female|Soft Tissue|2009|0.9|1.2|1.1
0-19|3.4|3.9|3.7|1077|Incidence|29466007|White|Male|Acute Lymphocytic|1999|3.4|3.9|3.7
0-19|3.6|4.0|3.8|1117|Incidence|29591843|White|Male|Acute Lymphocytic|2000|3.6|4.0|3.8
0-19|3.7|4.1|3.9|1196|Incidence|30880760|White|Male|Acute Lymphocytic|2001|3.7|4.1|3.9
0-19|3.6|4.0|3.8|1186|Incidence|31649961|White|Male|Acute Lymphocytic|2002|3.5|4.0|3.7
0-19|3.4|3.8|3.6|1180|Incidence|32578661|White|Male|Acute Lymphocytic|2003|3.4|3.8|3.6
0-19|3.8|4.3|4.0|1325|Incidence|32666378|White|Male|Acute Lymphocytic|2004|3.8|4.3|4.1
0-19|3.5|4.0|3.7|1228|Incidence|32710351|White|Male|Acute Lymphocytic|2005|3.5|4.0|3.8
0-19|3.8|4.0|3.9|6422|Incidence|164397378|White|Male|Acute Lymphocytic|2005-2009|3.8|4.0|3.9
0-19|3.7|4.2|3.9|1301|Incidence|32781426|White|Male|Acute Lymphocytic|2006|3.8|4.2|4.0
0-19|3.7|4.1|3.9|1286|Incidence|32907095|White|Male|Acute Lymphocytic|2007|3.7|4.1|3.9
0-19|3.7|4.1|3.9|1302|Incidence|32980214|White|Male|Acute Lymphocytic|2008|3.7|4.2|3.9
0-19|3.7|4.1|3.9|1285|Incidence|32373105|White|Male|Acute Lymphocytic|2009|3.8|4.2|4.0
0-19|0.7|0.9|0.8|228|Incidence|29466007|White|Male|Acute Myeloid|1999|0.7|0.9|0.8
0-19|0.6|0.8|0.7|198|Incidence|29591843|White|Male|Acute Myeloid|2000|0.6|0.8|0.7
0-19|0.7|0.9|0.8|240|Incidence|30880760|White|Male|Acute Myeloid|2001|0.7|0.9|0.8
0-19|0.7|0.9|0.8|243|Incidence|31649961|White|Male|Acute Myeloid|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|232|Incidence|32578661|White|Male|Acute Myeloid|2003|0.6|0.8|0.7
0-19|0.8|1.0|0.9|281|Incidence|32666378|White|Male|Acute Myeloid|2004|0.8|1.0|0.9
0-19|0.6|0.7|0.6|213|Incidence|32710351|White|Male|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.7|0.7|0.7|1157|Incidence|164397378|White|Male|Acute Myeloid|2005-2009|0.7|0.7|0.7
0-19|0.6|0.8|0.7|228|Incidence|32781426|White|Male|Acute Myeloid|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|245|Incidence|32907095|White|Male|Acute Myeloid|2007|0.7|0.8|0.7
0-19|0.7|0.9|0.8|252|Incidence|32980214|White|Male|Acute Myeloid|2008|0.7|0.9|0.8
0-19|0.6|0.8|0.7|216|Incidence|32373105|White|Male|Acute Myeloid|2009|0.6|0.8|0.7
0-19|17.3|18.3|17.8|5235|Incidence|29466007|White|Male|All Cancer Sites Combined|1999|17.3|18.3|17.8
0-19|17.6|18.6|18.1|5353|Incidence|29591843|White|Male|All Cancer Sites Combined|2000|17.6|18.6|18.1
0-19|18.3|19.3|18.8|5809|Incidence|30880760|White|Male|All Cancer Sites Combined|2001|18.3|19.3|18.8
0-19|18.7|19.7|19.2|6085|Incidence|31649961|White|Male|All Cancer Sites Combined|2002|18.7|19.7|19.2
0-19|17.5|18.4|17.9|5869|Incidence|32578661|White|Male|All Cancer Sites Combined|2003|17.6|18.5|18.0
0-19|18.6|19.5|19.0|6260|Incidence|32666378|White|Male|All Cancer Sites Combined|2004|18.7|19.6|19.2
0-19|18.0|18.9|18.4|6088|Incidence|32710351|White|Male|All Cancer Sites Combined|2005|18.1|19.1|18.6
0-19|18.5|18.9|18.7|31047|Incidence|164397378|White|Male|All Cancer Sites Combined|2005-2009|18.7|19.1|18.9
0-19|18.5|19.4|19.0|6275|Incidence|32781426|White|Male|All Cancer Sites Combined|2006|18.7|19.6|19.1
0-19|18.6|19.5|19.0|6329|Incidence|32907095|White|Male|All Cancer Sites Combined|2007|18.8|19.7|19.2
0-19|18.3|19.2|18.8|6261|Incidence|32980214|White|Male|All Cancer Sites Combined|2008|18.5|19.5|19.0
0-19|17.8|18.7|18.3|5975|Incidence|32373105|White|Male|All Cancer Sites Combined|2009|18.0|18.9|18.5
0-19|0.9|1.2|1.1|313|Incidence|29466007|White|Male|Bones and Joints|1999|0.9|1.2|1.1
0-19|0.9|1.1|1.0|290|Incidence|29591843|White|Male|Bones and Joints|2000|0.9|1.1|1.0
0-19|1.1|1.3|1.2|366|Incidence|30880760|White|Male|Bones and Joints|2001|1.1|1.3|1.2
0-19|1.0|1.3|1.1|366|Incidence|31649961|White|Male|Bones and Joints|2002|1.0|1.3|1.2
0-19|0.9|1.1|1.0|317|Incidence|32578661|White|Male|Bones and Joints|2003|0.9|1.1|1.0
0-19|0.9|1.1|1.0|318|Incidence|32666378|White|Male|Bones and Joints|2004|0.9|1.1|1.0
0-19|0.9|1.1|1.0|326|Incidence|32710351|White|Male|Bones and Joints|2005|0.9|1.1|1.0
0-19|1.0|1.1|1.1|1739|Incidence|164397378|White|Male|Bones and Joints|2005-2009|1.0|1.1|1.1
0-19|1.0|1.3|1.1|376|Incidence|32781426|White|Male|Bones and Joints|2006|1.0|1.3|1.1
0-19|1.0|1.2|1.1|367|Incidence|32907095|White|Male|Bones and Joints|2007|1.0|1.2|1.1
0-19|0.9|1.1|1.0|328|Incidence|32980214|White|Male|Bones and Joints|2008|0.9|1.1|1.0
0-19|0.9|1.2|1.0|337|Incidence|32373105|White|Male|Bones and Joints|2009|0.9|1.2|1.0
0-19|3.1|3.5|3.3|965|Incidence|29466007|White|Male|Brain and Other Nervous System|1999|3.1|3.5|3.3
0-19|3.3|3.7|3.5|1042|Incidence|29591843|White|Male|Brain and Other Nervous System|2000|3.3|3.7|3.5
0-19|3.2|3.6|3.4|1044|Incidence|30880760|White|Male|Brain and Other Nervous System|2001|3.2|3.6|3.4
0-19|3.5|4.0|3.8|1184|Incidence|31649961|White|Male|Brain and Other Nervous System|2002|3.5|4.0|3.7
0-19|3.1|3.5|3.3|1080|Incidence|32578661|White|Male|Brain and Other Nervous System|2003|3.1|3.5|3.3
0-19|3.3|3.7|3.5|1127|Incidence|32666378|White|Male|Brain and Other Nervous System|2004|3.3|3.7|3.5
0-19|3.1|3.5|3.3|1071|Incidence|32710351|White|Male|Brain and Other Nervous System|2005|3.1|3.5|3.3
0-19|3.3|3.5|3.4|5601|Incidence|164397378|White|Male|Brain and Other Nervous System|2005-2009|3.3|3.5|3.4
0-19|3.4|3.8|3.6|1167|Incidence|32781426|White|Male|Brain and Other Nervous System|2006|3.4|3.8|3.6
0-19|3.3|3.7|3.5|1141|Incidence|32907095|White|Male|Brain and Other Nervous System|2007|3.3|3.7|3.5
0-19|3.2|3.6|3.4|1135|Incidence|32980214|White|Male|Brain and Other Nervous System|2008|3.2|3.6|3.4
0-19|3.0|3.4|3.2|1049|Incidence|32373105|White|Male|Brain and Other Nervous System|2009|3.0|3.4|3.2
0-19|1.2|1.5|1.4|406|Incidence|29466007|White|Male|Hodgkin Lymphoma|1999|1.2|1.5|1.4
0-19|1.2|1.5|1.3|392|Incidence|29591843|White|Male|Hodgkin Lymphoma|2000|1.2|1.5|1.3
0-19|1.3|1.5|1.4|431|Incidence|30880760|White|Male|Hodgkin Lymphoma|2001|1.3|1.5|1.4
0-19|1.2|1.4|1.3|417|Incidence|31649961|White|Male|Hodgkin Lymphoma|2002|1.2|1.5|1.3
0-19|1.3|1.5|1.4|459|Incidence|32578661|White|Male|Hodgkin Lymphoma|2003|1.3|1.5|1.4
0-19|1.1|1.4|1.3|414|Incidence|32666378|White|Male|Hodgkin Lymphoma|2004|1.1|1.4|1.3
0-19|1.2|1.5|1.4|452|Incidence|32710351|White|Male|Hodgkin Lymphoma|2005|1.3|1.5|1.4
0-19|1.3|1.4|1.4|2286|Incidence|164397378|White|Male|Hodgkin Lymphoma|2005-2009|1.3|1.4|1.4
0-19|1.3|1.6|1.4|475|Incidence|32781426|White|Male|Hodgkin Lymphoma|2006|1.3|1.6|1.4
0-19|1.3|1.5|1.4|471|Incidence|32907095|White|Male|Hodgkin Lymphoma|2007|1.3|1.6|1.4
0-19|1.2|1.5|1.4|450|Incidence|32980214|White|Male|Hodgkin Lymphoma|2008|1.2|1.5|1.4
0-19|1.2|1.4|1.3|427|Incidence|32373105|White|Male|Hodgkin Lymphoma|2009|1.2|1.5|1.3
0-19|0.5|0.7|0.6|178|Incidence|29466007|White|Male|Kidney and Renal Pelvis|1999|0.5|0.7|0.6
0-19|0.5|0.7|0.6|185|Incidence|29591843|White|Male|Kidney and Renal Pelvis|2000|0.5|0.7|0.6
0-19|0.5|0.7|0.6|192|Incidence|30880760|White|Male|Kidney and Renal Pelvis|2001|0.5|0.7|0.6
0-19|0.6|0.8|0.7|215|Incidence|31649961|White|Male|Kidney and Renal Pelvis|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|187|Incidence|32578661|White|Male|Kidney and Renal Pelvis|2003|0.5|0.7|0.6
0-19|0.5|0.7|0.6|203|Incidence|32666378|White|Male|Kidney and Renal Pelvis|2004|0.5|0.7|0.6
0-19|0.5|0.7|0.6|207|Incidence|32710351|White|Male|Kidney and Renal Pelvis|2005|0.5|0.7|0.6
0-19|0.6|0.6|0.6|1013|Incidence|164397378|White|Male|Kidney and Renal Pelvis|2005-2009|0.6|0.7|0.6
0-19|0.5|0.7|0.6|206|Incidence|32781426|White|Male|Kidney and Renal Pelvis|2006|0.5|0.7|0.6
0-19|0.5|0.6|0.5|183|Incidence|32907095|White|Male|Kidney and Renal Pelvis|2007|0.5|0.6|0.6
0-19|0.5|0.7|0.6|209|Incidence|32980214|White|Male|Kidney and Renal Pelvis|2008|0.6|0.7|0.6
0-19|0.5|0.7|0.6|202|Incidence|32373105|White|Male|Kidney and Renal Pelvis|2009|0.5|0.7|0.6
0-19|4.6|5.1|4.8|1424|Incidence|29466007|White|Male|Leukemia|1999|4.6|5.1|4.8
0-19|4.6|5.1|4.8|1417|Incidence|29591843|White|Male|Leukemia|2000|4.5|5.0|4.8
0-19|4.9|5.4|5.1|1568|Incidence|30880760|White|Male|Leukemia|2001|4.8|5.3|5.1
0-19|4.7|5.2|4.9|1561|Incidence|31649961|White|Male|Leukemia|2002|4.7|5.2|4.9
0-19|4.5|4.9|4.7|1533|Incidence|32578661|White|Male|Leukemia|2003|4.5|4.9|4.7
0-19|5.1|5.6|5.3|1744|Incidence|32666378|White|Male|Leukemia|2004|5.1|5.6|5.3
0-19|4.6|5.1|4.8|1595|Incidence|32710351|White|Male|Leukemia|2005|4.6|5.1|4.9
0-19|4.9|5.1|5.0|8321|Incidence|164397378|White|Male|Leukemia|2005-2009|5.0|5.2|5.1
0-19|4.9|5.4|5.1|1689|Incidence|32781426|White|Male|Leukemia|2006|4.9|5.4|5.2
0-19|4.8|5.3|5.0|1675|Incidence|32907095|White|Male|Leukemia|2007|4.8|5.3|5.1
0-19|4.9|5.4|5.1|1708|Incidence|32980214|White|Male|Leukemia|2008|4.9|5.4|5.2
0-19|4.7|5.2|5.0|1629|Incidence|32373105|White|Male|Leukemia|2009|4.8|5.3|5.0
0-19|1.3|1.6|1.4|418|Incidence|29466007|White|Male|Non-Hodgkin Lymphoma|1999|1.3|1.6|1.4
0-19|1.4|1.7|1.5|452|Incidence|29591843|White|Male|Non-Hodgkin Lymphoma|2000|1.4|1.7|1.5
0-19|1.3|1.6|1.5|457|Incidence|30880760|White|Male|Non-Hodgkin Lymphoma|2001|1.3|1.6|1.5
0-19|1.4|1.7|1.5|484|Incidence|31649961|White|Male|Non-Hodgkin Lymphoma|2002|1.4|1.7|1.5
0-19|1.3|1.6|1.4|464|Incidence|32578661|White|Male|Non-Hodgkin Lymphoma|2003|1.3|1.6|1.4
0-19|1.3|1.5|1.4|462|Incidence|32666378|White|Male|Non-Hodgkin Lymphoma|2004|1.3|1.5|1.4
0-19|1.4|1.6|1.5|488|Incidence|32710351|White|Male|Non-Hodgkin Lymphoma|2005|1.4|1.6|1.5
0-19|1.4|1.5|1.5|2438|Incidence|164397378|White|Male|Non-Hodgkin Lymphoma|2005-2009|1.4|1.5|1.5
0-19|1.4|1.6|1.5|489|Incidence|32781426|White|Male|Non-Hodgkin Lymphoma|2006|1.4|1.6|1.5
0-19|1.4|1.7|1.6|510|Incidence|32907095|White|Male|Non-Hodgkin Lymphoma|2007|1.4|1.7|1.5
0-19|1.4|1.6|1.5|492|Incidence|32980214|White|Male|Non-Hodgkin Lymphoma|2008|1.4|1.6|1.5
0-19|1.3|1.6|1.4|458|Incidence|32373105|White|Male|Non-Hodgkin Lymphoma|2009|1.3|1.6|1.4
0-19|4.1|4.6|4.3|1272|Incidence|29466007|White|Male|Other|1999|4.1|4.6|4.3
0-19|4.0|4.4|4.2|1247|Incidence|29591843|White|Male|Other|2000|4.0|4.5|4.2
0-19|4.4|4.9|4.6|1443|Incidence|30880760|White|Male|Other|2001|4.4|4.9|4.7
0-19|4.5|5.0|4.7|1512|Incidence|31649961|White|Male|Other|2002|4.5|5.0|4.8
0-19|4.3|4.8|4.5|1492|Incidence|32578661|White|Male|Other|2003|4.4|4.8|4.6
0-19|4.7|5.2|5.0|1650|Incidence|32666378|White|Male|Other|2004|4.8|5.3|5.1
0-19|4.5|5.0|4.7|1572|Incidence|32710351|White|Male|Other|2005|4.6|5.0|4.8
0-19|4.6|4.8|4.7|7849|Incidence|164397378|White|Male|Other|2005-2009|4.7|4.9|4.8
0-19|4.3|4.8|4.6|1531|Incidence|32781426|White|Male|Other|2006|4.4|4.9|4.7
0-19|4.6|5.1|4.8|1628|Incidence|32907095|White|Male|Other|2007|4.7|5.2|4.9
0-19|4.4|4.9|4.7|1575|Incidence|32980214|White|Male|Other|2008|4.5|5.0|4.8
0-19|4.4|4.8|4.6|1518|Incidence|32373105|White|Male|Other|2009|4.5|4.9|4.7
0-19|0.8|1.0|0.9|259|Incidence|29466007|White|Male|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.2|1.1|328|Incidence|29591843|White|Male|Soft Tissue|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|308|Incidence|30880760|White|Male|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.2|1.1|346|Incidence|31649961|White|Male|Soft Tissue|2002|1.0|1.2|1.1
0-19|0.9|1.1|1.0|337|Incidence|32578661|White|Male|Soft Tissue|2003|0.9|1.2|1.0
0-19|0.9|1.2|1.0|342|Incidence|32666378|White|Male|Soft Tissue|2004|0.9|1.2|1.0
0-19|1.0|1.3|1.1|377|Incidence|32710351|White|Male|Soft Tissue|2005|1.0|1.3|1.2
0-19|1.0|1.1|1.1|1800|Incidence|164397378|White|Male|Soft Tissue|2005-2009|1.0|1.1|1.1
0-19|0.9|1.1|1.0|342|Incidence|32781426|White|Male|Soft Tissue|2006|0.9|1.2|1.0
0-19|1.0|1.2|1.1|354|Incidence|32907095|White|Male|Soft Tissue|2007|1.0|1.2|1.1
0-19|1.0|1.2|1.1|364|Incidence|32980214|White|Male|Soft Tissue|2008|1.0|1.2|1.1
0-19|1.0|1.2|1.1|355|Incidence|32373105|White|Male|Soft Tissue|2009|1.0|1.2|1.1
0-19|3.1|3.4|3.3|1881|Incidence|57356324|White|Male and Female|Acute Lymphocytic|1999|3.1|3.4|3.3
0-19|3.3|3.6|3.5|1982|Incidence|57598255|White|Male and Female|Acute Lymphocytic|2000|3.3|3.6|3.4
0-19|3.4|3.7|3.5|2108|Incidence|60091714|White|Male and Female|Acute Lymphocytic|2001|3.4|3.7|3.5
0-19|3.2|3.5|3.4|2070|Incidence|61601722|White|Male and Female|Acute Lymphocytic|2002|3.2|3.5|3.4
0-19|3.1|3.4|3.3|2074|Incidence|63438313|White|Male and Female|Acute Lymphocytic|2003|3.1|3.4|3.3
0-19|3.4|3.7|3.5|2250|Incidence|63632973|White|Male and Female|Acute Lymphocytic|2004|3.4|3.7|3.5
0-19|3.2|3.5|3.4|2149|Incidence|63734250|White|Male and Female|Acute Lymphocytic|2005|3.2|3.5|3.4
0-19|3.4|3.6|3.5|11318|Incidence|320438053|White|Male and Female|Acute Lymphocytic|2005-2009|3.5|3.6|3.5
0-19|3.4|3.7|3.5|2260|Incidence|63884713|White|Male and Female|Acute Lymphocytic|2006|3.4|3.7|3.5
0-19|3.4|3.7|3.5|2281|Incidence|64140678|White|Male and Female|Acute Lymphocytic|2007|3.4|3.7|3.6
0-19|3.5|3.8|3.6|2347|Incidence|64296358|White|Male and Female|Acute Lymphocytic|2008|3.5|3.8|3.7
0-19|3.4|3.6|3.5|2238|Incidence|63119845|White|Male and Female|Acute Lymphocytic|2009|3.4|3.7|3.5
0-19|0.7|0.8|0.7|412|Incidence|57356324|White|Male and Female|Acute Myeloid|1999|0.7|0.8|0.7
0-19|0.6|0.7|0.7|386|Incidence|57598255|White|Male and Female|Acute Myeloid|2000|0.6|0.7|0.7
0-19|0.7|0.8|0.7|442|Incidence|60091714|White|Male and Female|Acute Myeloid|2001|0.7|0.8|0.7
0-19|0.7|0.8|0.7|443|Incidence|61601722|White|Male and Female|Acute Myeloid|2002|0.7|0.8|0.7
0-19|0.6|0.7|0.7|417|Incidence|63438313|White|Male and Female|Acute Myeloid|2003|0.6|0.7|0.7
0-19|0.7|0.8|0.7|471|Incidence|63632973|White|Male and Female|Acute Myeloid|2004|0.7|0.8|0.7
0-19|0.6|0.7|0.6|417|Incidence|63734250|White|Male and Female|Acute Myeloid|2005|0.6|0.7|0.7
0-19|0.7|0.7|0.7|2208|Incidence|320438053|White|Male and Female|Acute Myeloid|2005-2009|0.7|0.7|0.7
0-19|0.6|0.7|0.7|430|Incidence|63884713|White|Male and Female|Acute Myeloid|2006|0.6|0.7|0.7
0-19|0.6|0.8|0.7|462|Incidence|64140678|White|Male and Female|Acute Myeloid|2007|0.7|0.8|0.7
0-19|0.6|0.8|0.7|449|Incidence|64296358|White|Male and Female|Acute Myeloid|2008|0.6|0.8|0.7
0-19|0.6|0.8|0.7|439|Incidence|63119845|White|Male and Female|Acute Myeloid|2009|0.6|0.8|0.7
0-19|16.3|17.0|16.6|9536|Incidence|57356324|White|Male and Female|All Cancer Sites Combined|1999|16.3|17.0|16.6
0-19|16.9|17.6|17.2|9923|Incidence|57598255|White|Male and Female|All Cancer Sites Combined|2000|16.9|17.6|17.2
0-19|17.6|18.2|17.9|10764|Incidence|60091714|White|Male and Female|All Cancer Sites Combined|2001|17.6|18.3|17.9
0-19|17.5|18.1|17.8|10978|Incidence|61601722|White|Male and Female|All Cancer Sites Combined|2002|17.5|18.2|17.8
0-19|17.0|17.7|17.4|11059|Incidence|63438313|White|Male and Female|All Cancer Sites Combined|2003|17.1|17.8|17.4
0-19|17.7|18.4|18.0|11550|Incidence|63632973|White|Male and Female|All Cancer Sites Combined|2004|17.8|18.5|18.2
0-19|17.3|17.9|17.6|11318|Incidence|63734250|White|Male and Female|All Cancer Sites Combined|2005|17.4|18.1|17.8
0-19|17.6|17.9|17.8|57493|Incidence|320438053|White|Male and Female|All Cancer Sites Combined|2005-2009|17.8|18.1|17.9
0-19|17.4|18.1|17.8|11454|Incidence|63884713|White|Male and Female|All Cancer Sites Combined|2006|17.6|18.3|17.9
0-19|17.7|18.4|18.1|11714|Incidence|64140678|White|Male and Female|All Cancer Sites Combined|2007|17.9|18.6|18.3
0-19|17.6|18.3|18.0|11674|Incidence|64296358|White|Male and Female|All Cancer Sites Combined|2008|17.8|18.5|18.2
0-19|17.1|17.8|17.4|11110|Incidence|63119845|White|Male and Female|All Cancer Sites Combined|2009|17.3|17.9|17.6
0-19|0.9|1.0|0.9|535|Incidence|57356324|White|Male and Female|Bones and Joints|1999|0.9|1.0|0.9
0-19|0.8|1.0|0.9|528|Incidence|57598255|White|Male and Female|Bones and Joints|2000|0.8|1.0|0.9
0-19|0.9|1.1|1.0|615|Incidence|60091714|White|Male and Female|Bones and Joints|2001|0.9|1.1|1.0
0-19|0.9|1.1|1.0|611|Incidence|61601722|White|Male and Female|Bones and Joints|2002|0.9|1.1|1.0
0-19|0.9|1.0|0.9|596|Incidence|63438313|White|Male and Female|Bones and Joints|2003|0.9|1.0|0.9
0-19|0.9|1.0|0.9|594|Incidence|63632973|White|Male and Female|Bones and Joints|2004|0.9|1.0|0.9
0-19|0.8|1.0|0.9|585|Incidence|63734250|White|Male and Female|Bones and Joints|2005|0.8|1.0|0.9
0-19|0.9|1.0|0.9|2992|Incidence|320438053|White|Male and Female|Bones and Joints|2005-2009|0.9|1.0|0.9
0-19|0.9|1.1|1.0|636|Incidence|63884713|White|Male and Female|Bones and Joints|2006|0.9|1.1|1.0
0-19|0.9|1.0|0.9|605|Incidence|64140678|White|Male and Female|Bones and Joints|2007|0.9|1.0|0.9
0-19|0.8|1.0|0.9|582|Incidence|64296358|White|Male and Female|Bones and Joints|2008|0.8|1.0|0.9
0-19|0.8|1.0|0.9|576|Incidence|63119845|White|Male and Female|Bones and Joints|2009|0.8|1.0|0.9
0-19|3.0|3.3|3.1|1784|Incidence|57356324|White|Male and Female|Brain and Other Nervous System|1999|3.0|3.3|3.1
0-19|3.1|3.4|3.3|1879|Incidence|57598255|White|Male and Female|Brain and Other Nervous System|2000|3.1|3.4|3.3
0-19|3.0|3.3|3.2|1908|Incidence|60091714|White|Male and Female|Brain and Other Nervous System|2001|3.0|3.3|3.2
0-19|3.2|3.5|3.3|2054|Incidence|61601722|White|Male and Female|Brain and Other Nervous System|2002|3.2|3.5|3.3
0-19|3.1|3.3|3.2|2029|Incidence|63438313|White|Male and Female|Brain and Other Nervous System|2003|3.1|3.3|3.2
0-19|3.2|3.5|3.3|2131|Incidence|63632973|White|Male and Female|Brain and Other Nervous System|2004|3.2|3.5|3.3
0-19|3.0|3.3|3.1|1989|Incidence|63734250|White|Male and Female|Brain and Other Nervous System|2005|3.0|3.3|3.1
0-19|3.1|3.3|3.2|10303|Incidence|320438053|White|Male and Female|Brain and Other Nervous System|2005-2009|3.2|3.3|3.2
0-19|3.1|3.4|3.3|2099|Incidence|63884713|White|Male and Female|Brain and Other Nervous System|2006|3.1|3.4|3.3
0-19|3.2|3.5|3.4|2151|Incidence|64140678|White|Male and Female|Brain and Other Nervous System|2007|3.2|3.5|3.4
0-19|3.1|3.4|3.2|2084|Incidence|64296358|White|Male and Female|Brain and Other Nervous System|2008|3.1|3.4|3.2
0-19|2.9|3.2|3.0|1922|Incidence|63119845|White|Male and Female|Brain and Other Nervous System|2009|2.9|3.2|3.0
0-19|1.2|1.4|1.3|737|Incidence|57356324|White|Male and Female|Hodgkin Lymphoma|1999|1.2|1.4|1.3
0-19|1.2|1.4|1.3|763|Incidence|57598255|White|Male and Female|Hodgkin Lymphoma|2000|1.2|1.4|1.3
0-19|1.3|1.5|1.4|820|Incidence|60091714|White|Male and Female|Hodgkin Lymphoma|2001|1.3|1.5|1.4
0-19|1.2|1.4|1.3|804|Incidence|61601722|White|Male and Female|Hodgkin Lymphoma|2002|1.2|1.4|1.3
0-19|1.2|1.4|1.3|845|Incidence|63438313|White|Male and Female|Hodgkin Lymphoma|2003|1.2|1.4|1.3
0-19|1.2|1.3|1.3|810|Incidence|63632973|White|Male and Female|Hodgkin Lymphoma|2004|1.2|1.4|1.3
0-19|1.2|1.4|1.3|849|Incidence|63734250|White|Male and Female|Hodgkin Lymphoma|2005|1.2|1.4|1.3
0-19|1.3|1.4|1.3|4282|Incidence|320438053|White|Male and Female|Hodgkin Lymphoma|2005-2009|1.3|1.4|1.3
0-19|1.3|1.4|1.3|870|Incidence|63884713|White|Male and Female|Hodgkin Lymphoma|2006|1.3|1.5|1.4
0-19|1.2|1.4|1.3|851|Incidence|64140678|White|Male and Female|Hodgkin Lymphoma|2007|1.2|1.4|1.3
0-19|1.3|1.4|1.4|878|Incidence|64296358|White|Male and Female|Hodgkin Lymphoma|2008|1.3|1.5|1.4
0-19|1.2|1.4|1.3|816|Incidence|63119845|White|Male and Female|Hodgkin Lymphoma|2009|1.2|1.4|1.3
0-19|0.6|0.7|0.6|370|Incidence|57356324|White|Male and Female|Kidney and Renal Pelvis|1999|0.6|0.7|0.6
0-19|0.6|0.7|0.7|379|Incidence|57598255|White|Male and Female|Kidney and Renal Pelvis|2000|0.6|0.7|0.7
0-19|0.6|0.8|0.7|416|Incidence|60091714|White|Male and Female|Kidney and Renal Pelvis|2001|0.6|0.8|0.7
0-19|0.6|0.7|0.6|397|Incidence|61601722|White|Male and Female|Kidney and Renal Pelvis|2002|0.6|0.7|0.6
0-19|0.6|0.7|0.7|430|Incidence|63438313|White|Male and Female|Kidney and Renal Pelvis|2003|0.6|0.7|0.7
0-19|0.6|0.7|0.6|412|Incidence|63632973|White|Male and Female|Kidney and Renal Pelvis|2004|0.6|0.7|0.6
0-19|0.6|0.7|0.7|430|Incidence|63734250|White|Male and Female|Kidney and Renal Pelvis|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.7|2171|Incidence|320438053|White|Male and Female|Kidney and Renal Pelvis|2005-2009|0.6|0.7|0.7
0-19|0.6|0.7|0.7|426|Incidence|63884713|White|Male and Female|Kidney and Renal Pelvis|2006|0.6|0.7|0.7
0-19|0.6|0.7|0.7|426|Incidence|64140678|White|Male and Female|Kidney and Renal Pelvis|2007|0.6|0.7|0.7
0-19|0.6|0.7|0.7|451|Incidence|64296358|White|Male and Female|Kidney and Renal Pelvis|2008|0.6|0.8|0.7
0-19|0.6|0.7|0.7|430|Incidence|63119845|White|Male and Female|Kidney and Renal Pelvis|2009|0.6|0.7|0.7
0-19|4.2|4.5|4.3|2488|Incidence|57356324|White|Male and Female|Leukemia|1999|4.2|4.5|4.3
0-19|4.3|4.7|4.5|2568|Incidence|57598255|White|Male and Female|Leukemia|2000|4.3|4.6|4.5
0-19|4.5|4.9|4.7|2801|Incidence|60091714|White|Male and Female|Leukemia|2001|4.5|4.8|4.7
0-19|4.3|4.7|4.5|2765|Incidence|61601722|White|Male and Female|Leukemia|2002|4.3|4.7|4.5
0-19|4.1|4.5|4.3|2721|Incidence|63438313|White|Male and Female|Leukemia|2003|4.1|4.5|4.3
0-19|4.5|4.8|4.6|2965|Incidence|63632973|White|Male and Female|Leukemia|2004|4.5|4.8|4.7
0-19|4.3|4.6|4.4|2837|Incidence|63734250|White|Male and Female|Leukemia|2005|4.3|4.6|4.5
0-19|4.5|4.7|4.6|14831|Incidence|320438053|White|Male and Female|Leukemia|2005-2009|4.6|4.7|4.6
0-19|4.5|4.8|4.6|2974|Incidence|63884713|White|Male and Female|Leukemia|2006|4.5|4.8|4.7
0-19|4.5|4.8|4.6|2999|Incidence|64140678|White|Male and Female|Leukemia|2007|4.5|4.8|4.7
0-19|4.5|4.9|4.7|3055|Incidence|64296358|White|Male and Female|Leukemia|2008|4.6|4.9|4.8
0-19|4.4|4.7|4.5|2904|Incidence|63119845|White|Male and Female|Leukemia|2009|4.4|4.8|4.6
0-19|1.0|1.2|1.1|611|Incidence|57356324|White|Male and Female|Non-Hodgkin Lymphoma|1999|1.0|1.2|1.1
0-19|1.1|1.3|1.2|673|Incidence|57598255|White|Male and Female|Non-Hodgkin Lymphoma|2000|1.1|1.3|1.2
0-19|1.1|1.2|1.1|688|Incidence|60091714|White|Male and Female|Non-Hodgkin Lymphoma|2001|1.1|1.2|1.1
0-19|1.1|1.2|1.2|712|Incidence|61601722|White|Male and Female|Non-Hodgkin Lymphoma|2002|1.1|1.2|1.2
0-19|1.0|1.2|1.1|697|Incidence|63438313|White|Male and Female|Non-Hodgkin Lymphoma|2003|1.0|1.2|1.1
0-19|1.0|1.2|1.1|698|Incidence|63632973|White|Male and Female|Non-Hodgkin Lymphoma|2004|1.0|1.2|1.1
0-19|1.0|1.2|1.1|722|Incidence|63734250|White|Male and Female|Non-Hodgkin Lymphoma|2005|1.1|1.2|1.1
0-19|1.1|1.2|1.1|3597|Incidence|320438053|White|Male and Female|Non-Hodgkin Lymphoma|2005-2009|1.1|1.2|1.1
0-19|1.0|1.2|1.1|714|Incidence|63884713|White|Male and Female|Non-Hodgkin Lymphoma|2006|1.0|1.2|1.1
0-19|1.1|1.3|1.2|753|Incidence|64140678|White|Male and Female|Non-Hodgkin Lymphoma|2007|1.1|1.3|1.2
0-19|1.0|1.2|1.1|712|Incidence|64296358|White|Male and Female|Non-Hodgkin Lymphoma|2008|1.0|1.2|1.1
0-19|1.0|1.2|1.1|694|Incidence|63119845|White|Male and Female|Non-Hodgkin Lymphoma|2009|1.0|1.2|1.1
0-19|4.2|4.5|4.4|2496|Incidence|57356324|White|Male and Female|Other|1999|4.2|4.5|4.4
0-19|4.2|4.6|4.4|2529|Incidence|57598255|White|Male and Female|Other|2000|4.2|4.6|4.4
0-19|4.6|5.0|4.8|2900|Incidence|60091714|White|Male and Female|Other|2001|4.7|5.0|4.8
0-19|4.7|5.0|4.8|2991|Incidence|61601722|White|Male and Female|Other|2002|4.7|5.0|4.9
0-19|4.6|5.0|4.8|3066|Incidence|63438313|White|Male and Female|Other|2003|4.7|5.0|4.8
0-19|4.9|5.3|5.1|3276|Incidence|63632973|White|Male and Female|Other|2004|5.0|5.3|5.1
0-19|4.8|5.1|5.0|3218|Incidence|63734250|White|Male and Female|Other|2005|4.9|5.2|5.0
0-19|4.8|4.9|4.9|15859|Incidence|320438053|White|Male and Female|Other|2005-2009|4.9|5.0|4.9
0-19|4.6|4.9|4.7|3086|Incidence|63884713|White|Male and Female|Other|2006|4.7|5.0|4.8
0-19|4.7|5.1|4.9|3222|Incidence|64140678|White|Male and Female|Other|2007|4.9|5.2|5.0
0-19|4.7|5.0|4.9|3189|Incidence|64296358|White|Male and Female|Other|2008|4.8|5.1|5.0
0-19|4.6|5.0|4.8|3088|Incidence|63119845|White|Male and Female|Other|2009|4.7|5.1|4.9
0-19|0.8|1.0|0.9|515|Incidence|57356324|White|Male and Female|Soft Tissue|1999|0.8|1.0|0.9
0-19|1.0|1.1|1.0|604|Incidence|57598255|White|Male and Female|Soft Tissue|2000|1.0|1.1|1.0
0-19|0.9|1.1|1.0|616|Incidence|60091714|White|Male and Female|Soft Tissue|2001|0.9|1.1|1.0
0-19|1.0|1.1|1.0|644|Incidence|61601722|White|Male and Female|Soft Tissue|2002|1.0|1.1|1.0
0-19|1.0|1.1|1.1|675|Incidence|63438313|White|Male and Female|Soft Tissue|2003|1.0|1.1|1.1
0-19|1.0|1.1|1.0|664|Incidence|63632973|White|Male and Female|Soft Tissue|2004|1.0|1.1|1.0
0-19|1.0|1.2|1.1|688|Incidence|63734250|White|Male and Female|Soft Tissue|2005|1.0|1.2|1.1
0-19|1.0|1.1|1.1|3458|Incidence|320438053|White|Male and Female|Soft Tissue|2005-2009|1.0|1.1|1.1
0-19|0.9|1.1|1.0|649|Incidence|63884713|White|Male and Female|Soft Tissue|2006|0.9|1.1|1.0
0-19|1.0|1.2|1.1|707|Incidence|64140678|White|Male and Female|Soft Tissue|2007|1.0|1.2|1.1
0-19|1.0|1.2|1.1|723|Incidence|64296358|White|Male and Female|Soft Tissue|2008|1.0|1.2|1.1
0-19|1.0|1.1|1.1|680|Incidence|63119845|White|Male and Female|Soft Tissue|2009|1.0|1.2|1.1
0-19|0.2|0.3|0.3|109|Mortality|39015588|All Races|Female|Acute Lymphocytic|1999|0.2|0.3|0.3
0-19|0.3|0.4|0.3|126|Mortality|39272685|All Races|Female|Acute Lymphocytic|2000|0.3|0.4|0.3
0-19|0.3|0.4|0.3|120|Mortality|39436460|All Races|Female|Acute Lymphocytic|2001|0.3|0.4|0.3
0-19|0.3|0.4|0.3|135|Mortality|39582689|All Races|Female|Acute Lymphocytic|2002|0.3|0.4|0.3
0-19|0.3|0.4|0.3|122|Mortality|39731700|All Races|Female|Acute Lymphocytic|2003|0.3|0.4|0.3
0-19|0.2|0.4|0.3|118|Mortality|39908757|All Races|Female|Acute Lymphocytic|2004|0.2|0.4|0.3
0-19|0.2|0.3|0.2|91|Mortality|40041255|All Races|Female|Acute Lymphocytic|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.3|516|Mortality|202012800|All Races|Female|Acute Lymphocytic|2005-2009|0.2|0.3|0.3
0-19|0.2|0.3|0.3|108|Mortality|40202922|All Races|Female|Acute Lymphocytic|2006|0.2|0.3|0.3
0-19|0.2|0.4|0.3|118|Mortality|40435594|All Races|Female|Acute Lymphocytic|2007|0.2|0.3|0.3
0-19|0.2|0.3|0.3|107|Mortality|40609057|All Races|Female|Acute Lymphocytic|2008|0.2|0.3|0.3
0-19|0.2|0.3|0.2|92|Mortality|40723972|All Races|Female|Acute Lymphocytic|2009|0.2|0.3|0.2
0-19|0.2|0.3|0.3|106|Mortality|39015588|All Races|Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|95|Mortality|39272685|All Races|Female|Acute Myeloid|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.3|113|Mortality|39436460|All Races|Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|100|Mortality|39582689|All Races|Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.2|94|Mortality|39731700|All Races|Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|96|Mortality|39908757|All Races|Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|101|Mortality|40041255|All Races|Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.2|0.2|458|Mortality|202012800|All Races|Female|Acute Myeloid|2005-2009|0.2|0.2|0.2
0-19|0.2|0.3|0.2|90|Mortality|40202922|All Races|Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|89|Mortality|40435594|All Races|Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|100|Mortality|40609057|All Races|Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|0.1|0.2|0.2|78|Mortality|40723972|All Races|Female|Acute Myeloid|2009|0.2|0.2|0.2
0-19|2.4|2.7|2.5|977|Mortality|39015588|All Races|Female|All Cancer Sites Combined|1999|2.3|2.7|2.5
0-19|2.3|2.6|2.5|973|Mortality|39272685|All Races|Female|All Cancer Sites Combined|2000|2.3|2.6|2.5
0-19|2.3|2.7|2.5|986|Mortality|39436460|All Races|Female|All Cancer Sites Combined|2001|2.3|2.7|2.5
0-19|2.3|2.7|2.5|989|Mortality|39582689|All Races|Female|All Cancer Sites Combined|2002|2.3|2.7|2.5
0-19|2.2|2.5|2.4|943|Mortality|39731700|All Races|Female|All Cancer Sites Combined|2003|2.2|2.5|2.4
0-19|2.3|2.6|2.4|967|Mortality|39908757|All Races|Female|All Cancer Sites Combined|2004|2.3|2.6|2.4
0-19|2.2|2.5|2.3|922|Mortality|40041255|All Races|Female|All Cancer Sites Combined|2005|2.2|2.5|2.3
0-19|2.2|2.3|2.2|4519|Mortality|202012800|All Races|Female|All Cancer Sites Combined|2005-2009|2.2|2.3|2.2
0-19|2.0|2.3|2.2|866|Mortality|40202922|All Races|Female|All Cancer Sites Combined|2006|2.0|2.3|2.2
0-19|2.2|2.5|2.3|944|Mortality|40435594|All Races|Female|All Cancer Sites Combined|2007|2.2|2.5|2.3
0-19|2.1|2.4|2.2|909|Mortality|40609057|All Races|Female|All Cancer Sites Combined|2008|2.1|2.4|2.2
0-19|2.0|2.3|2.2|878|Mortality|40723972|All Races|Female|All Cancer Sites Combined|2009|2.0|2.3|2.2
0-19|0.2|0.3|0.2|92|Mortality|39015588|All Races|Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.2|0.2|76|Mortality|39272685|All Races|Female|Bones and Joints|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|75|Mortality|39436460|All Races|Female|Bones and Joints|2001|0.1|0.2|0.2
0-19|0.2|0.3|0.2|83|Mortality|39582689|All Races|Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.1|0.2|0.2|64|Mortality|39731700|All Races|Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|71|Mortality|39908757|All Races|Female|Bones and Joints|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|91|Mortality|40041255|All Races|Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.2|0.2|0.2|415|Mortality|202012800|All Races|Female|Bones and Joints|2005-2009|0.2|0.2|0.2
0-19|0.1|0.2|0.2|75|Mortality|40202922|All Races|Female|Bones and Joints|2006|0.1|0.2|0.2
0-19|0.2|0.2|0.2|80|Mortality|40435594|All Races|Female|Bones and Joints|2007|0.2|0.2|0.2
0-19|0.2|0.3|0.2|83|Mortality|40609057|All Races|Female|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|86|Mortality|40723972|All Races|Female|Bones and Joints|2009|0.2|0.3|0.2
0-19|0.6|0.7|0.7|259|Mortality|39015588|All Races|Female|Brain and Other Nervous System|1999|0.6|0.7|0.7
0-19|0.5|0.7|0.6|238|Mortality|39272685|All Races|Female|Brain and Other Nervous System|2000|0.5|0.7|0.6
0-19|0.6|0.7|0.6|252|Mortality|39436460|All Races|Female|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.5|0.7|0.6|244|Mortality|39582689|All Races|Female|Brain and Other Nervous System|2002|0.5|0.7|0.6
0-19|0.6|0.8|0.7|269|Mortality|39731700|All Races|Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.6|254|Mortality|39908757|All Races|Female|Brain and Other Nervous System|2004|0.6|0.7|0.6
0-19|0.5|0.7|0.6|246|Mortality|40041255|All Races|Female|Brain and Other Nervous System|2005|0.5|0.7|0.6
0-19|0.6|0.6|0.6|1228|Mortality|202012800|All Races|Female|Brain and Other Nervous System|2005-2009|0.6|0.6|0.6
0-19|0.5|0.7|0.6|237|Mortality|40202922|All Races|Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|0.6|0.7|0.7|261|Mortality|40435594|All Races|Female|Brain and Other Nervous System|2007|0.6|0.7|0.6
0-19|0.5|0.7|0.6|243|Mortality|40609057|All Races|Female|Brain and Other Nervous System|2008|0.5|0.7|0.6
0-19|0.5|0.7|0.6|241|Mortality|40723972|All Races|Female|Brain and Other Nervous System|2009|0.5|0.7|0.6
0-19|0.0|0.1|0.0|17|Mortality|39015588|All Races|Female|Hodgkin Lymphoma|1999|0.0|0.1|0.0
0-19|0.0|0.1|0.0|19|Mortality|39272685|All Races|Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|39436460|All Races|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|39582689|All Races|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|39731700|All Races|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|39908757|All Races|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|40041255|All Races|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.0|0.0|44|Mortality|202012800|All Races|Female|Hodgkin Lymphoma|2005-2009|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|40202922|All Races|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|40435594|All Races|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|40609057|All Races|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|40723972|All Races|Female|Hodgkin Lymphoma|2009|~|~|~
0-19|0.1|0.1|0.1|30|Mortality|39015588|All Races|Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|39272685|All Races|Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.1|0.1|0.1|39|Mortality|39436460|All Races|Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|39582689|All Races|Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|34|Mortality|39731700|All Races|Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|39908757|All Races|Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|40041255|All Races|Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.1|0.1|0.1|138|Mortality|202012800|All Races|Female|Kidney and Renal Pelvis|2005-2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|25|Mortality|40202922|All Races|Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|40435594|All Races|Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|29|Mortality|40609057|All Races|Female|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|40723972|All Races|Female|Kidney and Renal Pelvis|2009|0.0|0.1|0.1
0-19|0.7|0.8|0.8|293|Mortality|39015588|All Races|Female|Leukemia|1999|0.7|0.8|0.8
0-19|0.7|0.9|0.8|302|Mortality|39272685|All Races|Female|Leukemia|2000|0.7|0.9|0.8
0-19|0.7|0.9|0.8|318|Mortality|39436460|All Races|Female|Leukemia|2001|0.7|0.9|0.8
0-19|0.7|0.8|0.7|296|Mortality|39582689|All Races|Female|Leukemia|2002|0.7|0.8|0.7
0-19|0.6|0.8|0.7|284|Mortality|39731700|All Races|Female|Leukemia|2003|0.6|0.8|0.7
0-19|0.6|0.8|0.7|278|Mortality|39908757|All Races|Female|Leukemia|2004|0.6|0.8|0.7
0-19|0.6|0.7|0.6|258|Mortality|40041255|All Races|Female|Leukemia|2005|0.6|0.7|0.6
0-19|0.6|0.7|0.6|1308|Mortality|202012800|All Races|Female|Leukemia|2005-2009|0.6|0.7|0.6
0-19|0.6|0.7|0.6|259|Mortality|40202922|All Races|Female|Leukemia|2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|278|Mortality|40435594|All Races|Female|Leukemia|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|282|Mortality|40609057|All Races|Female|Leukemia|2008|0.6|0.8|0.7
0-19|0.5|0.6|0.6|231|Mortality|40723972|All Races|Female|Leukemia|2009|0.5|0.6|0.6
0-19|0.1|0.1|0.1|37|Mortality|39015588|All Races|Female|Non-Hodgkin Lymphoma|1999|0.1|0.1|0.1
0-19|0.1|0.1|0.1|36|Mortality|39272685|All Races|Female|Non-Hodgkin Lymphoma|2000|0.1|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|39436460|All Races|Female|Non-Hodgkin Lymphoma|2001|0.0|0.1|0.1
0-19|0.1|0.1|0.1|40|Mortality|39582689|All Races|Female|Non-Hodgkin Lymphoma|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|38|Mortality|39731700|All Races|Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|39908757|All Races|Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|24|Mortality|40041255|All Races|Female|Non-Hodgkin Lymphoma|2005|0.0|0.1|0.1
0-19|0.1|0.1|0.1|126|Mortality|202012800|All Races|Female|Non-Hodgkin Lymphoma|2005-2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|19|Mortality|40202922|All Races|Female|Non-Hodgkin Lymphoma|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|28|Mortality|40435594|All Races|Female|Non-Hodgkin Lymphoma|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|40609057|All Races|Female|Non-Hodgkin Lymphoma|2008|0.0|0.1|0.1
0-19|0.1|0.1|0.1|33|Mortality|40723972|All Races|Female|Non-Hodgkin Lymphoma|2009|0.1|0.1|0.1
0-19|0.4|0.6|0.5|189|Mortality|39015588|All Races|Female|Other|1999|0.4|0.6|0.5
0-19|0.5|0.6|0.5|207|Mortality|39272685|All Races|Female|Other|2000|0.5|0.6|0.5
0-19|0.4|0.6|0.5|202|Mortality|39436460|All Races|Female|Other|2001|0.4|0.6|0.5
0-19|0.5|0.6|0.5|215|Mortality|39582689|All Races|Female|Other|2002|0.5|0.6|0.5
0-19|0.4|0.5|0.5|182|Mortality|39731700|All Races|Female|Other|2003|0.4|0.5|0.5
0-19|0.4|0.6|0.5|205|Mortality|39908757|All Races|Female|Other|2004|0.4|0.6|0.5
0-19|0.4|0.5|0.4|177|Mortality|40041255|All Races|Female|Other|2005|0.4|0.5|0.4
0-19|0.4|0.5|0.4|895|Mortality|202012800|All Races|Female|Other|2005-2009|0.4|0.5|0.4
0-19|0.4|0.5|0.5|188|Mortality|40202922|All Races|Female|Other|2006|0.4|0.5|0.5
0-19|0.4|0.5|0.5|189|Mortality|40435594|All Races|Female|Other|2007|0.4|0.5|0.5
0-19|0.4|0.5|0.4|170|Mortality|40609057|All Races|Female|Other|2008|0.4|0.5|0.4
0-19|0.4|0.5|0.4|171|Mortality|40723972|All Races|Female|Other|2009|0.4|0.5|0.4
0-19|0.1|0.2|0.2|60|Mortality|39015588|All Races|Female|Soft Tissue|1999|0.1|0.2|0.2
0-19|0.1|0.2|0.2|69|Mortality|39272685|All Races|Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.2|0.2|60|Mortality|39436460|All Races|Female|Soft Tissue|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|71|Mortality|39582689|All Races|Female|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|62|Mortality|39731700|All Races|Female|Soft Tissue|2003|0.1|0.2|0.2
0-19|0.2|0.3|0.2|81|Mortality|39908757|All Races|Female|Soft Tissue|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|87|Mortality|40041255|All Races|Female|Soft Tissue|2005|0.2|0.3|0.2
0-19|0.2|0.2|0.2|365|Mortality|202012800|All Races|Female|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.1|0.2|0.1|56|Mortality|40202922|All Races|Female|Soft Tissue|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.2|68|Mortality|40435594|All Races|Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.1|0.2|0.2|73|Mortality|40609057|All Races|Female|Soft Tissue|2008|0.1|0.2|0.2
0-19|0.2|0.2|0.2|81|Mortality|40723972|All Races|Female|Soft Tissue|2009|0.2|0.2|0.2
0-19|0.4|0.5|0.4|176|Mortality|41024382|All Races|Male|Acute Lymphocytic|1999|0.4|0.5|0.4
0-19|0.4|0.6|0.5|206|Mortality|41303405|All Races|Male|Acute Lymphocytic|2000|0.4|0.6|0.5
0-19|0.4|0.5|0.5|193|Mortality|41499718|All Races|Male|Acute Lymphocytic|2001|0.4|0.5|0.5
0-19|0.4|0.5|0.5|188|Mortality|41637877|All Races|Male|Acute Lymphocytic|2002|0.4|0.5|0.5
0-19|0.4|0.6|0.5|206|Mortality|41753613|All Races|Male|Acute Lymphocytic|2003|0.4|0.6|0.5
0-19|0.4|0.5|0.4|177|Mortality|41911213|All Races|Male|Acute Lymphocytic|2004|0.4|0.5|0.4
0-19|0.4|0.5|0.4|176|Mortality|42031490|All Races|Male|Acute Lymphocytic|2005|0.4|0.5|0.4
0-19|0.4|0.4|0.4|804|Mortality|211925010|All Races|Male|Acute Lymphocytic|2005-2009|0.4|0.4|0.4
0-19|0.3|0.4|0.4|158|Mortality|42186878|All Races|Male|Acute Lymphocytic|2006|0.3|0.4|0.4
0-19|0.4|0.5|0.4|176|Mortality|42421376|All Races|Male|Acute Lymphocytic|2007|0.4|0.5|0.4
0-19|0.3|0.4|0.3|146|Mortality|42588547|All Races|Male|Acute Lymphocytic|2008|0.3|0.4|0.3
0-19|0.3|0.4|0.3|148|Mortality|42696719|All Races|Male|Acute Lymphocytic|2009|0.3|0.4|0.3
0-19|0.2|0.3|0.2|101|Mortality|41024382|All Races|Male|Acute Myeloid|1999|0.2|0.3|0.2
0-19|0.3|0.4|0.3|127|Mortality|41303405|All Races|Male|Acute Myeloid|2000|0.3|0.4|0.3
0-19|0.2|0.3|0.3|114|Mortality|41499718|All Races|Male|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|109|Mortality|41637877|All Races|Male|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|113|Mortality|41753613|All Races|Male|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|115|Mortality|41911213|All Races|Male|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|111|Mortality|42031490|All Races|Male|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|509|Mortality|211925010|All Races|Male|Acute Myeloid|2005-2009|0.2|0.3|0.2
0-19|0.2|0.3|0.2|105|Mortality|42186878|All Races|Male|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|106|Mortality|42421376|All Races|Male|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.2|0.2|83|Mortality|42588547|All Races|Male|Acute Myeloid|2008|0.2|0.2|0.2
0-19|0.2|0.3|0.2|104|Mortality|42696719|All Races|Male|Acute Myeloid|2009|0.2|0.3|0.2
0-19|2.9|3.3|3.1|1266|Mortality|41024382|All Races|Male|All Cancer Sites Combined|1999|2.9|3.3|3.1
0-19|3.0|3.3|3.1|1298|Mortality|41303405|All Races|Male|All Cancer Sites Combined|2000|3.0|3.3|3.1
0-19|2.8|3.2|3.0|1240|Mortality|41499718|All Races|Male|All Cancer Sites Combined|2001|2.8|3.2|3.0
0-19|2.9|3.3|3.1|1282|Mortality|41637877|All Races|Male|All Cancer Sites Combined|2002|2.9|3.3|3.1
0-19|2.9|3.3|3.1|1290|Mortality|41753613|All Races|Male|All Cancer Sites Combined|2003|2.9|3.3|3.1
0-19|2.8|3.2|3.0|1256|Mortality|41911213|All Races|Male|All Cancer Sites Combined|2004|2.8|3.2|3.0
0-19|2.8|3.2|3.0|1261|Mortality|42031490|All Races|Male|All Cancer Sites Combined|2005|2.8|3.2|3.0
0-19|2.6|2.8|2.7|5770|Mortality|211925010|All Races|Male|All Cancer Sites Combined|2005-2009|2.7|2.8|2.7
0-19|2.6|2.9|2.8|1169|Mortality|42186878|All Races|Male|All Cancer Sites Combined|2006|2.6|2.9|2.8
0-19|2.5|2.8|2.6|1124|Mortality|42421376|All Races|Male|All Cancer Sites Combined|2007|2.5|2.8|2.6
0-19|2.5|2.8|2.6|1130|Mortality|42588547|All Races|Male|All Cancer Sites Combined|2008|2.5|2.8|2.7
0-19|2.4|2.7|2.5|1086|Mortality|42696719|All Races|Male|All Cancer Sites Combined|2009|2.4|2.7|2.5
0-19|0.2|0.3|0.3|117|Mortality|41024382|All Races|Male|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|105|Mortality|41303405|All Races|Male|Bones and Joints|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|114|Mortality|41499718|All Races|Male|Bones and Joints|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.2|96|Mortality|41637877|All Races|Male|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.3|122|Mortality|41753613|All Races|Male|Bones and Joints|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|118|Mortality|41911213|All Races|Male|Bones and Joints|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|121|Mortality|42031490|All Races|Male|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|504|Mortality|211925010|All Races|Male|Bones and Joints|2005-2009|0.2|0.3|0.2
0-19|0.2|0.3|0.2|99|Mortality|42186878|All Races|Male|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|92|Mortality|42421376|All Races|Male|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|99|Mortality|42588547|All Races|Male|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|93|Mortality|42696719|All Races|Male|Bones and Joints|2009|0.2|0.3|0.2
0-19|0.6|0.8|0.7|287|Mortality|41024382|All Races|Male|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.7|0.8|0.7|307|Mortality|41303405|All Races|Male|Brain and Other Nervous System|2000|0.7|0.8|0.7
0-19|0.6|0.7|0.6|268|Mortality|41499718|All Races|Male|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.7|0.9|0.8|327|Mortality|41637877|All Races|Male|Brain and Other Nervous System|2002|0.7|0.9|0.8
0-19|0.7|0.8|0.7|308|Mortality|41753613|All Races|Male|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.8|0.7|301|Mortality|41911213|All Races|Male|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|298|Mortality|42031490|All Races|Male|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.7|1416|Mortality|211925010|All Races|Male|Brain and Other Nervous System|2005-2009|0.6|0.7|0.7
0-19|0.6|0.8|0.7|287|Mortality|42186878|All Races|Male|Brain and Other Nervous System|2006|0.6|0.8|0.7
0-19|0.5|0.7|0.6|260|Mortality|42421376|All Races|Male|Brain and Other Nervous System|2007|0.5|0.7|0.6
0-19|0.6|0.8|0.7|290|Mortality|42588547|All Races|Male|Brain and Other Nervous System|2008|0.6|0.8|0.7
0-19|0.6|0.7|0.7|281|Mortality|42696719|All Races|Male|Brain and Other Nervous System|2009|0.6|0.7|0.7
0-19|0.0|0.1|0.1|24|Mortality|41024382|All Races|Male|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|41303405|All Races|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|0.0|0.1|0.0|18|Mortality|41499718|All Races|Male|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|20|Mortality|41637877|All Races|Male|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|41753613|All Races|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|41911213|All Races|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|42031490|All Races|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.0|0.0|56|Mortality|211925010|All Races|Male|Hodgkin Lymphoma|2005-2009|0.0|0.0|0.0
0-19|0.0|0.1|0.0|16|Mortality|42186878|All Races|Male|Hodgkin Lymphoma|2006|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|42421376|All Races|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|42588547|All Races|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|42696719|All Races|Male|Hodgkin Lymphoma|2009|~|~|~
0-19|0.1|0.1|0.1|32|Mortality|41024382|All Races|Male|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|28|Mortality|41303405|All Races|Male|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.0|0.1|0.1|27|Mortality|41499718|All Races|Male|Kidney and Renal Pelvis|2001|0.0|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|41637877|All Races|Male|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|41753613|All Races|Male|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.0|0.1|0.1|26|Mortality|41911213|All Races|Male|Kidney and Renal Pelvis|2004|0.0|0.1|0.1
0-19|0.1|0.1|0.1|31|Mortality|42031490|All Races|Male|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.1|122|Mortality|211925010|All Races|Male|Kidney and Renal Pelvis|2005-2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|29|Mortality|42186878|All Races|Male|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|20|Mortality|42421376|All Races|Male|Kidney and Renal Pelvis|2007|0.0|0.1|0.0
0-19|0.0|0.1|0.1|23|Mortality|42588547|All Races|Male|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|19|Mortality|42696719|All Races|Male|Kidney and Renal Pelvis|2009|0.0|0.1|0.0
0-19|0.8|1.0|0.9|379|Mortality|41024382|All Races|Male|Leukemia|1999|0.8|1.0|0.9
0-19|0.9|1.1|1.0|430|Mortality|41303405|All Races|Male|Leukemia|2000|0.9|1.1|1.0
0-19|0.9|1.1|1.0|410|Mortality|41499718|All Races|Male|Leukemia|2001|0.9|1.1|1.0
0-19|0.8|1.0|0.9|382|Mortality|41637877|All Races|Male|Leukemia|2002|0.8|1.0|0.9
0-19|0.9|1.1|1.0|404|Mortality|41753613|All Races|Male|Leukemia|2003|0.9|1.1|1.0
0-19|0.8|1.0|0.9|387|Mortality|41911213|All Races|Male|Leukemia|2004|0.8|1.0|0.9
0-19|0.8|1.0|0.9|382|Mortality|42031490|All Races|Male|Leukemia|2005|0.8|1.0|0.9
0-19|0.8|0.9|0.8|1752|Mortality|211925010|All Races|Male|Leukemia|2005-2009|0.8|0.9|0.8
0-19|0.8|0.9|0.8|359|Mortality|42186878|All Races|Male|Leukemia|2006|0.8|0.9|0.9
0-19|0.8|1.0|0.9|365|Mortality|42421376|All Races|Male|Leukemia|2007|0.8|1.0|0.9
0-19|0.7|0.8|0.7|316|Mortality|42588547|All Races|Male|Leukemia|2008|0.7|0.8|0.7
0-19|0.7|0.9|0.8|330|Mortality|42696719|All Races|Male|Leukemia|2009|0.7|0.9|0.8
0-19|0.1|0.2|0.2|69|Mortality|41024382|All Races|Male|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.2
0-19|0.2|0.2|0.2|79|Mortality|41303405|All Races|Male|Non-Hodgkin Lymphoma|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|74|Mortality|41499718|All Races|Male|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|78|Mortality|41637877|All Races|Male|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|65|Mortality|41753613|All Races|Male|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|67|Mortality|41911213|All Races|Male|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|78|Mortality|42031490|All Races|Male|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.2
0-19|0.1|0.2|0.2|320|Mortality|211925010|All Races|Male|Non-Hodgkin Lymphoma|2005-2009|0.1|0.2|0.2
0-19|0.1|0.2|0.2|70|Mortality|42186878|All Races|Male|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.1|59|Mortality|42421376|All Races|Male|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.1|0.2|0.2|71|Mortality|42588547|All Races|Male|Non-Hodgkin Lymphoma|2008|0.1|0.2|0.2
0-19|0.1|0.1|0.1|42|Mortality|42696719|All Races|Male|Non-Hodgkin Lymphoma|2009|0.1|0.1|0.1
0-19|0.6|0.7|0.6|266|Mortality|41024382|All Races|Male|Other|1999|0.6|0.7|0.6
0-19|0.6|0.7|0.6|264|Mortality|41303405|All Races|Male|Other|2000|0.6|0.7|0.6
0-19|0.5|0.7|0.6|242|Mortality|41499718|All Races|Male|Other|2001|0.5|0.7|0.6
0-19|0.6|0.7|0.7|275|Mortality|41637877|All Races|Male|Other|2002|0.6|0.7|0.7
0-19|0.6|0.7|0.6|265|Mortality|41753613|All Races|Male|Other|2003|0.6|0.7|0.6
0-19|0.6|0.7|0.6|263|Mortality|41911213|All Races|Male|Other|2004|0.6|0.7|0.6
0-19|0.5|0.7|0.6|261|Mortality|42031490|All Races|Male|Other|2005|0.5|0.7|0.6
0-19|0.5|0.6|0.6|1198|Mortality|211925010|All Races|Male|Other|2005-2009|0.5|0.6|0.6
0-19|0.5|0.6|0.5|225|Mortality|42186878|All Races|Male|Other|2006|0.5|0.6|0.5
0-19|0.5|0.7|0.6|250|Mortality|42421376|All Races|Male|Other|2007|0.5|0.7|0.6
0-19|0.5|0.6|0.5|237|Mortality|42588547|All Races|Male|Other|2008|0.5|0.6|0.6
0-19|0.5|0.6|0.5|225|Mortality|42696719|All Races|Male|Other|2009|0.5|0.6|0.5
0-19|0.2|0.3|0.2|92|Mortality|41024382|All Races|Male|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.2|0.2|75|Mortality|41303405|All Races|Male|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.2|0.3|0.2|87|Mortality|41499718|All Races|Male|Soft Tissue|2001|0.2|0.3|0.2
0-19|0.2|0.2|0.2|82|Mortality|41637877|All Races|Male|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|84|Mortality|41753613|All Races|Male|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|83|Mortality|41911213|All Races|Male|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.1|0.2|0.2|76|Mortality|42031490|All Races|Male|Soft Tissue|2005|0.1|0.2|0.2
0-19|0.2|0.2|0.2|402|Mortality|211925010|All Races|Male|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.2|0.2|0.2|84|Mortality|42186878|All Races|Male|Soft Tissue|2006|0.2|0.2|0.2
0-19|0.1|0.2|0.2|72|Mortality|42421376|All Races|Male|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.3|0.2|87|Mortality|42588547|All Races|Male|Soft Tissue|2008|0.2|0.3|0.2
0-19|0.2|0.2|0.2|83|Mortality|42696719|All Races|Male|Soft Tissue|2009|0.2|0.2|0.2
0-19|0.3|0.4|0.4|285|Mortality|80039970|All Races|Male and Female|Acute Lymphocytic|1999|0.3|0.4|0.4
0-19|0.4|0.5|0.4|332|Mortality|80576090|All Races|Male and Female|Acute Lymphocytic|2000|0.4|0.5|0.4
0-19|0.3|0.4|0.4|313|Mortality|80936178|All Races|Male and Female|Acute Lymphocytic|2001|0.3|0.4|0.4
0-19|0.4|0.4|0.4|323|Mortality|81220566|All Races|Male and Female|Acute Lymphocytic|2002|0.4|0.4|0.4
0-19|0.4|0.4|0.4|328|Mortality|81485313|All Races|Male and Female|Acute Lymphocytic|2003|0.4|0.4|0.4
0-19|0.3|0.4|0.4|295|Mortality|81819970|All Races|Male and Female|Acute Lymphocytic|2004|0.3|0.4|0.4
0-19|0.3|0.4|0.3|267|Mortality|82072745|All Races|Male and Female|Acute Lymphocytic|2005|0.3|0.4|0.3
0-19|0.3|0.3|0.3|1320|Mortality|413937810|All Races|Male and Female|Acute Lymphocytic|2005-2009|0.3|0.3|0.3
0-19|0.3|0.4|0.3|266|Mortality|82389800|All Races|Male and Female|Acute Lymphocytic|2006|0.3|0.4|0.3
0-19|0.3|0.4|0.4|294|Mortality|82856970|All Races|Male and Female|Acute Lymphocytic|2007|0.3|0.4|0.4
0-19|0.3|0.3|0.3|253|Mortality|83197604|All Races|Male and Female|Acute Lymphocytic|2008|0.3|0.3|0.3
0-19|0.3|0.3|0.3|240|Mortality|83420691|All Races|Male and Female|Acute Lymphocytic|2009|0.3|0.3|0.3
0-19|0.2|0.3|0.3|207|Mortality|80039970|All Races|Male and Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|222|Mortality|80576090|All Races|Male and Female|Acute Myeloid|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|227|Mortality|80936178|All Races|Male and Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|209|Mortality|81220566|All Races|Male and Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|207|Mortality|81485313|All Races|Male and Female|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|211|Mortality|81819970|All Races|Male and Female|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.3|212|Mortality|82072745|All Races|Male and Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.2|0.2|967|Mortality|413937810|All Races|Male and Female|Acute Myeloid|2005-2009|0.2|0.2|0.2
0-19|0.2|0.3|0.2|195|Mortality|82389800|All Races|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|195|Mortality|82856970|All Races|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|183|Mortality|83197604|All Races|Male and Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|0.2|0.2|0.2|182|Mortality|83420691|All Races|Male and Female|Acute Myeloid|2009|0.2|0.3|0.2
0-19|2.7|2.9|2.8|2243|Mortality|80039970|All Races|Male and Female|All Cancer Sites Combined|1999|2.7|2.9|2.8
0-19|2.7|2.9|2.8|2271|Mortality|80576090|All Races|Male and Female|All Cancer Sites Combined|2000|2.7|2.9|2.8
0-19|2.6|2.9|2.8|2226|Mortality|80936178|All Races|Male and Female|All Cancer Sites Combined|2001|2.6|2.9|2.8
0-19|2.7|2.9|2.8|2271|Mortality|81220566|All Races|Male and Female|All Cancer Sites Combined|2002|2.7|2.9|2.8
0-19|2.6|2.9|2.7|2233|Mortality|81485313|All Races|Male and Female|All Cancer Sites Combined|2003|2.6|2.9|2.7
0-19|2.6|2.8|2.7|2223|Mortality|81819970|All Races|Male and Female|All Cancer Sites Combined|2004|2.6|2.8|2.7
0-19|2.5|2.8|2.7|2183|Mortality|82072745|All Races|Male and Female|All Cancer Sites Combined|2005|2.5|2.8|2.7
0-19|2.4|2.5|2.5|10289|Mortality|413937810|All Races|Male and Female|All Cancer Sites Combined|2005-2009|2.4|2.5|2.5
0-19|2.4|2.6|2.5|2035|Mortality|82389800|All Races|Male and Female|All Cancer Sites Combined|2006|2.4|2.6|2.5
0-19|2.4|2.6|2.5|2068|Mortality|82856970|All Races|Male and Female|All Cancer Sites Combined|2007|2.4|2.6|2.5
0-19|2.3|2.6|2.4|2039|Mortality|83197604|All Races|Male and Female|All Cancer Sites Combined|2008|2.3|2.6|2.5
0-19|2.2|2.5|2.4|1964|Mortality|83420691|All Races|Male and Female|All Cancer Sites Combined|2009|2.3|2.5|2.4
0-19|0.2|0.3|0.3|209|Mortality|80039970|All Races|Male and Female|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|181|Mortality|80576090|All Races|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|189|Mortality|80936178|All Races|Male and Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|179|Mortality|81220566|All Races|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|186|Mortality|81485313|All Races|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|189|Mortality|81819970|All Races|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|212|Mortality|82072745|All Races|Male and Female|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.2|0.2|919|Mortality|413937810|All Races|Male and Female|Bones and Joints|2005-2009|0.2|0.2|0.2
0-19|0.2|0.2|0.2|174|Mortality|82389800|All Races|Male and Female|Bones and Joints|2006|0.2|0.2|0.2
0-19|0.2|0.2|0.2|172|Mortality|82856970|All Races|Male and Female|Bones and Joints|2007|0.2|0.2|0.2
0-19|0.2|0.3|0.2|182|Mortality|83197604|All Races|Male and Female|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|179|Mortality|83420691|All Races|Male and Female|Bones and Joints|2009|0.2|0.2|0.2
0-19|0.6|0.7|0.7|546|Mortality|80039970|All Races|Male and Female|Brain and Other Nervous System|1999|0.6|0.7|0.7
0-19|0.6|0.7|0.7|545|Mortality|80576090|All Races|Male and Female|Brain and Other Nervous System|2000|0.6|0.7|0.7
0-19|0.6|0.7|0.6|520|Mortality|80936178|All Races|Male and Female|Brain and Other Nervous System|2001|0.6|0.7|0.6
0-19|0.6|0.8|0.7|571|Mortality|81220566|All Races|Male and Female|Brain and Other Nervous System|2002|0.6|0.8|0.7
0-19|0.7|0.8|0.7|577|Mortality|81485313|All Races|Male and Female|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.7|0.7|555|Mortality|81819970|All Races|Male and Female|Brain and Other Nervous System|2004|0.6|0.7|0.7
0-19|0.6|0.7|0.7|544|Mortality|82072745|All Races|Male and Female|Brain and Other Nervous System|2005|0.6|0.7|0.7
0-19|0.6|0.7|0.6|2644|Mortality|413937810|All Races|Male and Female|Brain and Other Nervous System|2005-2009|0.6|0.7|0.6
0-19|0.6|0.7|0.6|524|Mortality|82389800|All Races|Male and Female|Brain and Other Nervous System|2006|0.6|0.7|0.6
0-19|0.6|0.7|0.6|521|Mortality|82856970|All Races|Male and Female|Brain and Other Nervous System|2007|0.6|0.7|0.6
0-19|0.6|0.7|0.6|533|Mortality|83197604|All Races|Male and Female|Brain and Other Nervous System|2008|0.6|0.7|0.6
0-19|0.6|0.7|0.6|522|Mortality|83420691|All Races|Male and Female|Brain and Other Nervous System|2009|0.6|0.7|0.6
0-19|0.0|0.1|0.1|41|Mortality|80039970|All Races|Male and Female|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.0|29|Mortality|80576090|All Races|Male and Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|0.0|0.1|0.0|31|Mortality|80936178|All Races|Male and Female|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|33|Mortality|81220566|All Races|Male and Female|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|21|Mortality|81485313|All Races|Male and Female|Hodgkin Lymphoma|2003|0.0|0.0|0.0
0-19|0.0|0.0|0.0|23|Mortality|81819970|All Races|Male and Female|Hodgkin Lymphoma|2004|0.0|0.0|0.0
0-19|0.0|0.0|0.0|22|Mortality|82072745|All Races|Male and Female|Hodgkin Lymphoma|2005|0.0|0.0|0.0
0-19|0.0|0.0|0.0|100|Mortality|413937810|All Races|Male and Female|Hodgkin Lymphoma|2005-2009|0.0|0.0|0.0
0-19|0.0|0.0|0.0|23|Mortality|82389800|All Races|Male and Female|Hodgkin Lymphoma|2006|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|82856970|All Races|Male and Female|Hodgkin Lymphoma|2007|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|83197604|All Races|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|0.0|0.0|0.0|22|Mortality|83420691|All Races|Male and Female|Hodgkin Lymphoma|2009|0.0|0.0|0.0
0-19|0.1|0.1|0.1|62|Mortality|80039970|All Races|Male and Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.1|0.1|0.1|54|Mortality|80576090|All Races|Male and Female|Kidney and Renal Pelvis|2000|0.1|0.1|0.1
0-19|0.1|0.1|0.1|66|Mortality|80936178|All Races|Male and Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.0|0.1|0.1|49|Mortality|81220566|All Races|Male and Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|65|Mortality|81485313|All Races|Male and Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|59|Mortality|81819970|All Races|Male and Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|62|Mortality|82072745|All Races|Male and Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.1|0.1|0.1|260|Mortality|413937810|All Races|Male and Female|Kidney and Renal Pelvis|2005-2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|54|Mortality|82389800|All Races|Male and Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|47|Mortality|82856970|All Races|Male and Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|52|Mortality|83197604|All Races|Male and Female|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.1|45|Mortality|83420691|All Races|Male and Female|Kidney and Renal Pelvis|2009|0.0|0.1|0.1
0-19|0.8|0.9|0.8|672|Mortality|80039970|All Races|Male and Female|Leukemia|1999|0.8|0.9|0.8
0-19|0.8|1.0|0.9|732|Mortality|80576090|All Races|Male and Female|Leukemia|2000|0.8|1.0|0.9
0-19|0.8|1.0|0.9|728|Mortality|80936178|All Races|Male and Female|Leukemia|2001|0.8|1.0|0.9
0-19|0.8|0.9|0.8|678|Mortality|81220566|All Races|Male and Female|Leukemia|2002|0.8|0.9|0.8
0-19|0.8|0.9|0.8|688|Mortality|81485313|All Races|Male and Female|Leukemia|2003|0.8|0.9|0.8
0-19|0.8|0.9|0.8|665|Mortality|81819970|All Races|Male and Female|Leukemia|2004|0.8|0.9|0.8
0-19|0.7|0.8|0.8|640|Mortality|82072745|All Races|Male and Female|Leukemia|2005|0.7|0.8|0.8
0-19|0.7|0.8|0.7|3060|Mortality|413937810|All Races|Male and Female|Leukemia|2005-2009|0.7|0.8|0.7
0-19|0.7|0.8|0.7|618|Mortality|82389800|All Races|Male and Female|Leukemia|2006|0.7|0.8|0.8
0-19|0.7|0.8|0.8|643|Mortality|82856970|All Races|Male and Female|Leukemia|2007|0.7|0.8|0.8
0-19|0.7|0.8|0.7|598|Mortality|83197604|All Races|Male and Female|Leukemia|2008|0.7|0.8|0.7
0-19|0.6|0.7|0.7|561|Mortality|83420691|All Races|Male and Female|Leukemia|2009|0.6|0.7|0.7
0-19|0.1|0.2|0.1|106|Mortality|80039970|All Races|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.1|115|Mortality|80576090|All Races|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.1|101|Mortality|80936178|All Races|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|0.1|0.2|0.1|118|Mortality|81220566|All Races|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.1
0-19|0.1|0.2|0.1|103|Mortality|81485313|All Races|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.1|0.1|100|Mortality|81819970|All Races|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.1|0.2|0.1|102|Mortality|82072745|All Races|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.1|0.1|446|Mortality|413937810|All Races|Male and Female|Non-Hodgkin Lymphoma|2005-2009|0.1|0.1|0.1
0-19|0.1|0.1|0.1|89|Mortality|82389800|All Races|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|87|Mortality|82856970|All Races|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|93|Mortality|83197604|All Races|Male and Female|Non-Hodgkin Lymphoma|2008|0.1|0.1|0.1
0-19|0.1|0.1|0.1|75|Mortality|83420691|All Races|Male and Female|Non-Hodgkin Lymphoma|2009|0.1|0.1|0.1
0-19|0.5|0.6|0.6|455|Mortality|80039970|All Races|Male and Female|Other|1999|0.5|0.6|0.6
0-19|0.5|0.6|0.6|471|Mortality|80576090|All Races|Male and Female|Other|2000|0.5|0.6|0.6
0-19|0.5|0.6|0.5|444|Mortality|80936178|All Races|Male and Female|Other|2001|0.5|0.6|0.5
0-19|0.6|0.7|0.6|490|Mortality|81220566|All Races|Male and Female|Other|2002|0.6|0.7|0.6
0-19|0.5|0.6|0.5|447|Mortality|81485313|All Races|Male and Female|Other|2003|0.5|0.6|0.5
0-19|0.5|0.6|0.6|468|Mortality|81819970|All Races|Male and Female|Other|2004|0.5|0.6|0.6
0-19|0.5|0.6|0.5|438|Mortality|82072745|All Races|Male and Female|Other|2005|0.5|0.6|0.5
0-19|0.5|0.5|0.5|2093|Mortality|413937810|All Races|Male and Female|Other|2005-2009|0.5|0.5|0.5
0-19|0.5|0.5|0.5|413|Mortality|82389800|All Races|Male and Female|Other|2006|0.5|0.6|0.5
0-19|0.5|0.6|0.5|439|Mortality|82856970|All Races|Male and Female|Other|2007|0.5|0.6|0.5
0-19|0.4|0.5|0.5|407|Mortality|83197604|All Races|Male and Female|Other|2008|0.4|0.5|0.5
0-19|0.4|0.5|0.5|396|Mortality|83420691|All Races|Male and Female|Other|2009|0.4|0.5|0.5
0-19|0.2|0.2|0.2|152|Mortality|80039970|All Races|Male and Female|Soft Tissue|1999|0.2|0.2|0.2
0-19|0.2|0.2|0.2|144|Mortality|80576090|All Races|Male and Female|Soft Tissue|2000|0.2|0.2|0.2
0-19|0.2|0.2|0.2|147|Mortality|80936178|All Races|Male and Female|Soft Tissue|2001|0.2|0.2|0.2
0-19|0.2|0.2|0.2|153|Mortality|81220566|All Races|Male and Female|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|146|Mortality|81485313|All Races|Male and Female|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|164|Mortality|81819970|All Races|Male and Female|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|163|Mortality|82072745|All Races|Male and Female|Soft Tissue|2005|0.2|0.2|0.2
0-19|0.2|0.2|0.2|767|Mortality|413937810|All Races|Male and Female|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.1|0.2|0.2|140|Mortality|82389800|All Races|Male and Female|Soft Tissue|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.2|140|Mortality|82856970|All Races|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.2|0.2|160|Mortality|83197604|All Races|Male and Female|Soft Tissue|2008|0.2|0.2|0.2
0-19|0.2|0.2|0.2|164|Mortality|83420691|All Races|Male and Female|Soft Tissue|2009|0.2|0.2|0.2
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Acute Lymphocytic|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Acute Lymphocytic|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Acute Myeloid|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Acute Myeloid|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|All Cancer Sites Combined|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|All Cancer Sites Combined|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|All Cancer Sites Combined|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|All Cancer Sites Combined|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|All Cancer Sites Combined|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|All Cancer Sites Combined|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005|~|~|~
0-19|1.1|2.0|1.5|44|Mortality|2917463|American Indian/Alaska Native|Female|All Cancer Sites Combined|2005-2009|1.1|2.0|1.5
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|All Cancer Sites Combined|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|All Cancer Sites Combined|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|All Cancer Sites Combined|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|All Cancer Sites Combined|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Bones and Joints|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Bones and Joints|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Brain and Other Nervous System|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Brain and Other Nervous System|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Leukemia|2005|~|~|~
0-19|0.4|1.0|0.7|19|Mortality|2917463|American Indian/Alaska Native|Female|Leukemia|2005-2009|0.4|1.0|0.7
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Leukemia|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Other|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Other|2009|~|~|~
0-19|~|~|~|~|Mortality|539705|American Indian/Alaska Native|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|559367|American Indian/Alaska Native|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|562543|American Indian/Alaska Native|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|565248|American Indian/Alaska Native|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|567307|American Indian/Alaska Native|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|569596|American Indian/Alaska Native|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|572960|American Indian/Alaska Native|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|2917463|American Indian/Alaska Native|Female|Soft Tissue|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|577169|American Indian/Alaska Native|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|583397|American Indian/Alaska Native|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|589357|American Indian/Alaska Native|Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|594580|American Indian/Alaska Native|Female|Soft Tissue|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Acute Lymphocytic|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Acute Lymphocytic|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Acute Myeloid|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Acute Myeloid|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|All Cancer Sites Combined|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|All Cancer Sites Combined|2000|~|~|~
0-19|1.6|4.4|2.7|16|Mortality|582379|American Indian/Alaska Native|Male|All Cancer Sites Combined|2001|1.6|4.5|2.7
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|All Cancer Sites Combined|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|All Cancer Sites Combined|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|All Cancer Sites Combined|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005|~|~|~
0-19|1.4|2.4|1.8|55|Mortality|3009444|American Indian/Alaska Native|Male|All Cancer Sites Combined|2005-2009|1.4|2.4|1.8
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|All Cancer Sites Combined|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|All Cancer Sites Combined|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|All Cancer Sites Combined|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|All Cancer Sites Combined|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Bones and Joints|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Bones and Joints|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Brain and Other Nervous System|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Brain and Other Nervous System|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Kidney and Renal Pelvis|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Leukemia|2005|~|~|~
0-19|0.4|1.0|0.6|19|Mortality|3009444|American Indian/Alaska Native|Male|Leukemia|2005-2009|0.4|1.0|0.6
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Leukemia|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Other|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Other|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Other|2009|~|~|~
0-19|~|~|~|~|Mortality|559553|American Indian/Alaska Native|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|579537|American Indian/Alaska Native|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|582379|American Indian/Alaska Native|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|584302|American Indian/Alaska Native|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|585517|American Indian/Alaska Native|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|588062|American Indian/Alaska Native|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|591083|American Indian/Alaska Native|Male|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|3009444|American Indian/Alaska Native|Male|Soft Tissue|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|595112|American Indian/Alaska Native|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|602074|American Indian/Alaska Native|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|607761|American Indian/Alaska Native|Male|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|613414|American Indian/Alaska Native|Male|Soft Tissue|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005|~|~|~
0-19|0.2|0.5|0.3|18|Mortality|5926907|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2005-2009|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Acute Lymphocytic|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005|~|~|~
0-19|~|~|~|~|Mortality|5926907|American Indian/Alaska Native|Male and Female|Acute Myeloid|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Acute Myeloid|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|1999|~|~|~
0-19|1.0|2.6|1.7|19|Mortality|1138904|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2000|1.0|2.6|1.7
0-19|1.2|2.9|1.9|22|Mortality|1144922|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2001|1.2|2.9|1.9
0-19|1.4|3.2|2.2|25|Mortality|1149550|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2002|1.4|3.2|2.2
0-19|1.3|3.1|2.1|24|Mortality|1152824|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2003|1.3|3.1|2.1
0-19|0.9|2.5|1.6|18|Mortality|1157658|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2004|0.9|2.5|1.6
0-19|0.9|2.4|1.5|18|Mortality|1164043|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005|0.9|2.4|1.5
0-19|1.3|2.0|1.7|99|Mortality|5926907|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2005-2009|1.4|2.0|1.7
0-19|1.0|2.5|1.6|19|Mortality|1172281|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2006|1.0|2.5|1.6
0-19|1.0|2.5|1.6|19|Mortality|1185471|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2007|1.0|2.5|1.6
0-19|0.9|2.4|1.6|19|Mortality|1197118|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2008|1.0|2.5|1.6
0-19|1.3|3.0|2.0|24|Mortality|1207994|American Indian/Alaska Native|Male and Female|All Cancer Sites Combined|2009|1.3|3.0|2.0
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|5926907|American Indian/Alaska Native|Male and Female|Bones and Joints|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Bones and Joints|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005|~|~|~
0-19|0.3|0.6|0.4|25|Mortality|5926907|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2005-2009|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Brain and Other Nervous System|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|5926907|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|5926907|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Leukemia|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Leukemia|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Leukemia|2005|~|~|~
0-19|0.4|0.9|0.6|38|Mortality|5926907|American Indian/Alaska Native|Male and Female|Leukemia|2005-2009|0.5|0.9|0.6
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Leukemia|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|5926907|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Other|2005|~|~|~
0-19|0.2|0.5|0.3|19|Mortality|5926907|American Indian/Alaska Native|Male and Female|Other|2005-2009|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Other|2009|~|~|~
0-19|~|~|~|~|Mortality|1099258|American Indian/Alaska Native|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1138904|American Indian/Alaska Native|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1144922|American Indian/Alaska Native|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1149550|American Indian/Alaska Native|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1152824|American Indian/Alaska Native|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1157658|American Indian/Alaska Native|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1164043|American Indian/Alaska Native|Male and Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|5926907|American Indian/Alaska Native|Male and Female|Soft Tissue|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1172281|American Indian/Alaska Native|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|1185471|American Indian/Alaska Native|Male and Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|1197118|American Indian/Alaska Native|Male and Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|1207994|American Indian/Alaska Native|Male and Female|Soft Tissue|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Acute Lymphocytic|2005|~|~|~
0-19|~|~|~|~|Mortality|10067369|Asian/Pacific Islander|Female|Acute Lymphocytic|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Acute Lymphocytic|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Acute Myeloid|2005|~|~|~
0-19|0.2|0.4|0.3|29|Mortality|10067369|Asian/Pacific Islander|Female|Acute Myeloid|2005-2009|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Acute Myeloid|2009|~|~|~
0-19|1.7|3.3|2.4|39|Mortality|1642417|Asian/Pacific Islander|Female|All Cancer Sites Combined|1999|1.7|3.2|2.4
0-19|1.6|3.1|2.3|39|Mortality|1696351|Asian/Pacific Islander|Female|All Cancer Sites Combined|2000|1.6|3.1|2.3
0-19|1.5|2.9|2.1|37|Mortality|1737759|Asian/Pacific Islander|Female|All Cancer Sites Combined|2001|1.5|2.9|2.1
0-19|1.5|2.9|2.1|38|Mortality|1778779|Asian/Pacific Islander|Female|All Cancer Sites Combined|2002|1.5|2.9|2.1
0-19|1.3|2.7|1.9|35|Mortality|1822464|Asian/Pacific Islander|Female|All Cancer Sites Combined|2003|1.3|2.7|1.9
0-19|1.3|2.6|1.8|34|Mortality|1866675|Asian/Pacific Islander|Female|All Cancer Sites Combined|2004|1.3|2.5|1.8
0-19|1.2|2.4|1.7|32|Mortality|1914016|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005|1.1|2.4|1.7
0-19|1.5|2.0|1.7|169|Mortality|10067369|Asian/Pacific Islander|Female|All Cancer Sites Combined|2005-2009|1.4|2.0|1.7
0-19|1.5|2.9|2.1|41|Mortality|1962226|Asian/Pacific Islander|Female|All Cancer Sites Combined|2006|1.5|2.8|2.1
0-19|1.3|2.6|1.9|38|Mortality|2013981|Asian/Pacific Islander|Female|All Cancer Sites Combined|2007|1.3|2.6|1.9
0-19|0.7|1.7|1.1|23|Mortality|2064812|Asian/Pacific Islander|Female|All Cancer Sites Combined|2008|0.7|1.7|1.1
0-19|1.2|2.4|1.7|35|Mortality|2112334|Asian/Pacific Islander|Female|All Cancer Sites Combined|2009|1.2|2.3|1.7
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Bones and Joints|2005|~|~|~
0-19|~|~|~|~|Mortality|10067369|Asian/Pacific Islander|Female|Bones and Joints|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Bones and Joints|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005|~|~|~
0-19|0.3|0.6|0.4|44|Mortality|10067369|Asian/Pacific Islander|Female|Brain and Other Nervous System|2005-2009|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Brain and Other Nervous System|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Brain and Other Nervous System|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Brain and Other Nervous System|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|10067369|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|10067369|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Leukemia|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Leukemia|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Leukemia|2001|~|~|~
0-19|0.6|1.6|1.0|18|Mortality|1778779|Asian/Pacific Islander|Female|Leukemia|2002|0.6|1.6|1.0
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Leukemia|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Leukemia|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Leukemia|2005|~|~|~
0-19|0.4|0.7|0.5|50|Mortality|10067369|Asian/Pacific Islander|Female|Leukemia|2005-2009|0.4|0.7|0.5
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Leukemia|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Leukemia|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Leukemia|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Leukemia|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|10067369|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Other|2005|~|~|~
0-19|0.3|0.6|0.4|42|Mortality|10067369|Asian/Pacific Islander|Female|Other|2005-2009|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Other|2009|~|~|~
0-19|~|~|~|~|Mortality|1642417|Asian/Pacific Islander|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1696351|Asian/Pacific Islander|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1737759|Asian/Pacific Islander|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1778779|Asian/Pacific Islander|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1822464|Asian/Pacific Islander|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1866675|Asian/Pacific Islander|Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1914016|Asian/Pacific Islander|Female|Soft Tissue|2005|~|~|~
0-19|~|~|~|~|Mortality|10067369|Asian/Pacific Islander|Female|Soft Tissue|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|1962226|Asian/Pacific Islander|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|2013981|Asian/Pacific Islander|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|2064812|Asian/Pacific Islander|Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|2112334|Asian/Pacific Islander|Female|Soft Tissue|2009|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Acute Lymphocytic|2005|~|~|~
0-19|0.3|0.5|0.4|37|Mortality|10466929|Asian/Pacific Islander|Male|Acute Lymphocytic|2005-2009|0.2|0.5|0.4
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Acute Lymphocytic|2009|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Acute Myeloid|2005|~|~|~
0-19|0.1|0.3|0.2|20|Mortality|10466929|Asian/Pacific Islander|Male|Acute Myeloid|2005-2009|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Acute Myeloid|2009|~|~|~
0-19|2.3|4.0|3.1|53|Mortality|1714818|Asian/Pacific Islander|Male|All Cancer Sites Combined|1999|2.3|4.0|3.1
0-19|1.9|3.5|2.7|47|Mortality|1767231|Asian/Pacific Islander|Male|All Cancer Sites Combined|2000|2.0|3.5|2.7
0-19|2.1|3.7|2.8|50|Mortality|1811188|Asian/Pacific Islander|Male|All Cancer Sites Combined|2001|2.0|3.6|2.8
0-19|2.1|3.7|2.9|53|Mortality|1853321|Asian/Pacific Islander|Male|All Cancer Sites Combined|2002|2.1|3.7|2.9
0-19|1.8|3.3|2.4|46|Mortality|1898564|Asian/Pacific Islander|Male|All Cancer Sites Combined|2003|1.8|3.2|2.4
0-19|2.1|3.7|2.8|55|Mortality|1943682|Asian/Pacific Islander|Male|All Cancer Sites Combined|2004|2.1|3.7|2.8
0-19|1.9|3.4|2.5|50|Mortality|1991945|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005|1.9|3.3|2.5
0-19|2.2|2.8|2.5|258|Mortality|10466929|Asian/Pacific Islander|Male|All Cancer Sites Combined|2005-2009|2.2|2.8|2.5
0-19|1.8|3.2|2.4|48|Mortality|2040932|Asian/Pacific Islander|Male|All Cancer Sites Combined|2006|1.7|3.1|2.4
0-19|1.7|3.1|2.3|49|Mortality|2094159|Asian/Pacific Islander|Male|All Cancer Sites Combined|2007|1.7|3.1|2.3
0-19|1.8|3.2|2.4|51|Mortality|2146576|Asian/Pacific Islander|Male|All Cancer Sites Combined|2008|1.8|3.1|2.4
0-19|2.1|3.6|2.8|60|Mortality|2193317|Asian/Pacific Islander|Male|All Cancer Sites Combined|2009|2.1|3.5|2.7
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Bones and Joints|2005|~|~|~
0-19|0.1|0.3|0.2|20|Mortality|10466929|Asian/Pacific Islander|Male|Bones and Joints|2005-2009|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Bones and Joints|2009|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Brain and Other Nervous System|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Brain and Other Nervous System|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Brain and Other Nervous System|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Brain and Other Nervous System|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Brain and Other Nervous System|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Brain and Other Nervous System|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005|~|~|~
0-19|0.5|0.8|0.6|63|Mortality|10466929|Asian/Pacific Islander|Male|Brain and Other Nervous System|2005-2009|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Brain and Other Nervous System|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Brain and Other Nervous System|2007|~|~|~
0-19|0.4|1.2|0.8|16|Mortality|2146576|Asian/Pacific Islander|Male|Brain and Other Nervous System|2008|0.4|1.2|0.7
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Brain and Other Nervous System|2009|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|10466929|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|10466929|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.5|1.5|0.9|16|Mortality|1714818|Asian/Pacific Islander|Male|Leukemia|1999|0.5|1.5|0.9
0-19|0.8|1.9|1.3|22|Mortality|1767231|Asian/Pacific Islander|Male|Leukemia|2000|0.8|1.9|1.2
0-19|0.6|1.7|1.1|19|Mortality|1811188|Asian/Pacific Islander|Male|Leukemia|2001|0.6|1.6|1.0
0-19|0.5|1.5|0.9|17|Mortality|1853321|Asian/Pacific Islander|Male|Leukemia|2002|0.5|1.5|0.9
0-19|0.5|1.4|0.8|16|Mortality|1898564|Asian/Pacific Islander|Male|Leukemia|2003|0.5|1.4|0.8
0-19|0.5|1.4|0.9|18|Mortality|1943682|Asian/Pacific Islander|Male|Leukemia|2004|0.5|1.5|0.9
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Leukemia|2005|~|~|~
0-19|0.6|1.0|0.8|79|Mortality|10466929|Asian/Pacific Islander|Male|Leukemia|2005-2009|0.6|0.9|0.8
0-19|0.5|1.3|0.8|17|Mortality|2040932|Asian/Pacific Islander|Male|Leukemia|2006|0.5|1.3|0.8
0-19|0.5|1.4|0.9|18|Mortality|2094159|Asian/Pacific Islander|Male|Leukemia|2007|0.5|1.4|0.9
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Leukemia|2008|~|~|~
0-19|0.6|1.5|1.0|21|Mortality|2193317|Asian/Pacific Islander|Male|Leukemia|2009|0.6|1.5|1.0
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|10466929|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Other|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Other|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Other|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Other|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Other|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Other|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Other|2005|~|~|~
0-19|0.5|0.8|0.6|62|Mortality|10466929|Asian/Pacific Islander|Male|Other|2005-2009|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Other|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Other|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Other|2008|~|~|~
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Other|2009|~|~|~
0-19|~|~|~|~|Mortality|1714818|Asian/Pacific Islander|Male|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|1767231|Asian/Pacific Islander|Male|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|1811188|Asian/Pacific Islander|Male|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|1853321|Asian/Pacific Islander|Male|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|1898564|Asian/Pacific Islander|Male|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|1943682|Asian/Pacific Islander|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|1991945|Asian/Pacific Islander|Male|Soft Tissue|2005|~|~|~
0-19|0.1|0.3|0.2|16|Mortality|10466929|Asian/Pacific Islander|Male|Soft Tissue|2005-2009|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|2040932|Asian/Pacific Islander|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|2094159|Asian/Pacific Islander|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|2146576|Asian/Pacific Islander|Male|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|2193317|Asian/Pacific Islander|Male|Soft Tissue|2009|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2003|~|~|~
0-19|0.2|0.7|0.4|16|Mortality|3810357|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2004|0.2|0.7|0.4
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005|~|~|~
0-19|0.2|0.3|0.2|45|Mortality|20534298|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2005-2009|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|4305651|Asian/Pacific Islander|Male and Female|Acute Lymphocytic|2009|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Acute Myeloid|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Acute Myeloid|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Acute Myeloid|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Acute Myeloid|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Acute Myeloid|2004|~|~|~
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005|~|~|~
0-19|0.2|0.3|0.2|49|Mortality|20534298|Asian/Pacific Islander|Male and Female|Acute Myeloid|2005-2009|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Acute Myeloid|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Acute Myeloid|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|4305651|Asian/Pacific Islander|Male and Female|Acute Myeloid|2009|~|~|~
0-19|2.2|3.4|2.7|92|Mortality|3357235|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|1999|2.2|3.4|2.7
0-19|2.0|3.1|2.5|86|Mortality|3463582|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2000|2.0|3.1|2.5
0-19|2.0|3.0|2.5|87|Mortality|3548947|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2001|2.0|3.0|2.5
0-19|2.0|3.1|2.5|91|Mortality|3632100|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2002|2.0|3.1|2.5
0-19|1.7|2.7|2.2|81|Mortality|3721028|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2003|1.7|2.7|2.2
0-19|1.9|2.9|2.3|89|Mortality|3810357|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2004|1.9|2.9|2.3
0-19|1.7|2.6|2.1|82|Mortality|3905961|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005|1.7|2.6|2.1
0-19|1.9|2.3|2.1|427|Mortality|20534298|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2005-2009|1.9|2.3|2.1
0-19|1.8|2.8|2.2|89|Mortality|4003158|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2006|1.8|2.7|2.2
0-19|1.7|2.6|2.1|87|Mortality|4108140|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2007|1.7|2.6|2.1
0-19|1.4|2.3|1.8|74|Mortality|4211388|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2008|1.4|2.2|1.8
0-19|1.8|2.8|2.3|95|Mortality|4305651|Asian/Pacific Islander|Male and Female|All Cancer Sites Combined|2009|1.8|2.7|2.2
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Bones and Joints|2005|~|~|~
0-19|0.1|0.2|0.2|31|Mortality|20534298|Asian/Pacific Islander|Male and Female|Bones and Joints|2005-2009|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|4305651|Asian/Pacific Islander|Male and Female|Bones and Joints|2009|~|~|~
0-19|0.3|0.9|0.6|19|Mortality|3357235|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|1999|0.3|0.9|0.6
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2000|~|~|~
0-19|0.4|0.9|0.6|21|Mortality|3548947|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2001|0.4|0.9|0.6
0-19|0.3|0.8|0.5|20|Mortality|3632100|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2002|0.3|0.9|0.6
0-19|0.3|0.7|0.5|17|Mortality|3721028|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2003|0.3|0.7|0.5
0-19|0.5|1.0|0.7|26|Mortality|3810357|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2004|0.4|1.0|0.7
0-19|0.3|0.8|0.5|20|Mortality|3905961|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005|0.3|0.8|0.5
0-19|0.4|0.6|0.5|107|Mortality|20534298|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2005-2009|0.4|0.6|0.5
0-19|0.4|0.9|0.6|22|Mortality|4003158|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2006|0.3|0.8|0.5
0-19|0.2|0.7|0.4|17|Mortality|4108140|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2007|0.2|0.7|0.4
0-19|0.4|0.9|0.6|24|Mortality|4211388|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2008|0.4|0.8|0.6
0-19|0.4|0.9|0.6|24|Mortality|4305651|Asian/Pacific Islander|Male and Female|Brain and Other Nervous System|2009|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|20534298|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|4305651|Asian/Pacific Islander|Male and Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|~|~|~|~|Mortality|20534298|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|4305651|Asian/Pacific Islander|Male and Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.6|1.3|0.9|30|Mortality|3357235|Asian/Pacific Islander|Male and Female|Leukemia|1999|0.6|1.3|0.9
0-19|0.6|1.2|0.9|30|Mortality|3463582|Asian/Pacific Islander|Male and Female|Leukemia|2000|0.6|1.2|0.9
0-19|0.6|1.2|0.9|31|Mortality|3548947|Asian/Pacific Islander|Male and Female|Leukemia|2001|0.6|1.2|0.9
0-19|0.7|1.4|1.0|35|Mortality|3632100|Asian/Pacific Islander|Male and Female|Leukemia|2002|0.7|1.3|1.0
0-19|0.5|1.1|0.8|29|Mortality|3721028|Asian/Pacific Islander|Male and Female|Leukemia|2003|0.5|1.1|0.8
0-19|0.5|1.1|0.8|30|Mortality|3810357|Asian/Pacific Islander|Male and Female|Leukemia|2004|0.5|1.1|0.8
0-19|0.4|1.0|0.6|25|Mortality|3905961|Asian/Pacific Islander|Male and Female|Leukemia|2005|0.4|0.9|0.6
0-19|0.5|0.8|0.6|129|Mortality|20534298|Asian/Pacific Islander|Male and Female|Leukemia|2005-2009|0.5|0.7|0.6
0-19|0.4|0.9|0.6|25|Mortality|4003158|Asian/Pacific Islander|Male and Female|Leukemia|2006|0.4|0.9|0.6
0-19|0.5|1.1|0.8|32|Mortality|4108140|Asian/Pacific Islander|Male and Female|Leukemia|2007|0.5|1.1|0.8
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Leukemia|2008|~|~|~
0-19|0.5|1.1|0.8|32|Mortality|4305651|Asian/Pacific Islander|Male and Female|Leukemia|2009|0.5|1.0|0.7
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.1|0.1|0.1|18|Mortality|20534298|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2005-2009|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|4305651|Asian/Pacific Islander|Male and Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|0.4|0.9|0.6|20|Mortality|3357235|Asian/Pacific Islander|Male and Female|Other|1999|0.4|0.9|0.6
0-19|0.4|1.0|0.7|23|Mortality|3463582|Asian/Pacific Islander|Male and Female|Other|2000|0.4|1.0|0.7
0-19|0.5|1.1|0.7|26|Mortality|3548947|Asian/Pacific Islander|Male and Female|Other|2001|0.5|1.1|0.7
0-19|0.3|0.8|0.5|20|Mortality|3632100|Asian/Pacific Islander|Male and Female|Other|2002|0.3|0.9|0.6
0-19|0.3|0.8|0.5|19|Mortality|3721028|Asian/Pacific Islander|Male and Female|Other|2003|0.3|0.8|0.5
0-19|0.3|0.8|0.5|19|Mortality|3810357|Asian/Pacific Islander|Male and Female|Other|2004|0.3|0.8|0.5
0-19|0.3|0.7|0.5|18|Mortality|3905961|Asian/Pacific Islander|Male and Female|Other|2005|0.3|0.7|0.5
0-19|0.4|0.6|0.5|104|Mortality|20534298|Asian/Pacific Islander|Male and Female|Other|2005-2009|0.4|0.6|0.5
0-19|0.4|1.0|0.7|27|Mortality|4003158|Asian/Pacific Islander|Male and Female|Other|2006|0.4|1.0|0.7
0-19|0.3|0.8|0.5|21|Mortality|4108140|Asian/Pacific Islander|Male and Female|Other|2007|0.3|0.8|0.5
0-19|0.3|0.7|0.5|19|Mortality|4211388|Asian/Pacific Islander|Male and Female|Other|2008|0.3|0.7|0.5
0-19|0.3|0.7|0.4|19|Mortality|4305651|Asian/Pacific Islander|Male and Female|Other|2009|0.3|0.7|0.4
0-19|~|~|~|~|Mortality|3357235|Asian/Pacific Islander|Male and Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|3463582|Asian/Pacific Islander|Male and Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|3548947|Asian/Pacific Islander|Male and Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|3632100|Asian/Pacific Islander|Male and Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|3721028|Asian/Pacific Islander|Male and Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|3810357|Asian/Pacific Islander|Male and Female|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|3905961|Asian/Pacific Islander|Male and Female|Soft Tissue|2005|~|~|~
0-19|0.1|0.2|0.1|25|Mortality|20534298|Asian/Pacific Islander|Male and Female|Soft Tissue|2005-2009|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|4003158|Asian/Pacific Islander|Male and Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|4108140|Asian/Pacific Islander|Male and Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|4211388|Asian/Pacific Islander|Male and Female|Soft Tissue|2008|~|~|~
0-19|~|~|~|~|Mortality|4305651|Asian/Pacific Islander|Male and Female|Soft Tissue|2009|~|~|~
0-19|~|~|~|~|Mortality|6375857|Black|Female|Acute Lymphocytic|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Acute Lymphocytic|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6446788|Black|Female|Acute Lymphocytic|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6465179|Black|Female|Acute Lymphocytic|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Acute Lymphocytic|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Acute Lymphocytic|2004|~|~|~
0-19|~|~|~|~|Mortality|6530380|Black|Female|Acute Lymphocytic|2005|~|~|~
0-19|0.1|0.2|0.1|41|Mortality|32987293|Black|Female|Acute Lymphocytic|2005-2009|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|6560240|Black|Female|Acute Lymphocytic|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Acute Lymphocytic|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Acute Lymphocytic|2008|~|~|~
0-19|~|~|~|~|Mortality|6653296|Black|Female|Acute Lymphocytic|2009|~|~|~
0-19|0.1|0.4|0.3|16|Mortality|6375857|Black|Female|Acute Myeloid|1999|0.1|0.4|0.3
0-19|~|~|~|~|Mortality|6424150|Black|Female|Acute Myeloid|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Acute Myeloid|2001|~|~|~
0-19|0.2|0.5|0.3|19|Mortality|6465179|Black|Female|Acute Myeloid|2002|0.2|0.5|0.3
0-19|0.2|0.5|0.3|19|Mortality|6482277|Black|Female|Acute Myeloid|2003|0.2|0.5|0.3
0-19|0.2|0.5|0.4|24|Mortality|6505891|Black|Female|Acute Myeloid|2004|0.2|0.5|0.4
0-19|~|~|~|~|Mortality|6530380|Black|Female|Acute Myeloid|2005|~|~|~
0-19|0.2|0.3|0.3|93|Mortality|32987293|Black|Female|Acute Myeloid|2005-2009|0.2|0.3|0.3
0-19|0.2|0.4|0.3|19|Mortality|6560240|Black|Female|Acute Myeloid|2006|0.2|0.5|0.3
0-19|0.2|0.5|0.3|19|Mortality|6604633|Black|Female|Acute Myeloid|2007|0.2|0.4|0.3
0-19|0.2|0.5|0.3|22|Mortality|6638744|Black|Female|Acute Myeloid|2008|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|6653296|Black|Female|Acute Myeloid|2009|0.2|0.4|0.3
0-19|2.3|3.1|2.7|170|Mortality|6375857|Black|Female|All Cancer Sites Combined|1999|2.3|3.1|2.7
0-19|2.1|2.9|2.5|160|Mortality|6424150|Black|Female|All Cancer Sites Combined|2000|2.1|2.9|2.5
0-19|1.8|2.6|2.2|140|Mortality|6446788|Black|Female|All Cancer Sites Combined|2001|1.8|2.6|2.2
0-19|2.2|3.0|2.5|163|Mortality|6465179|Black|Female|All Cancer Sites Combined|2002|2.1|2.9|2.5
0-19|1.9|2.6|2.2|143|Mortality|6482277|Black|Female|All Cancer Sites Combined|2003|1.9|2.6|2.2
0-19|2.3|3.1|2.7|176|Mortality|6505891|Black|Female|All Cancer Sites Combined|2004|2.3|3.1|2.7
0-19|1.9|2.6|2.2|145|Mortality|6530380|Black|Female|All Cancer Sites Combined|2005|1.9|2.6|2.2
0-19|2.1|2.4|2.2|740|Mortality|32987293|Black|Female|All Cancer Sites Combined|2005-2009|2.1|2.4|2.2
0-19|1.8|2.5|2.1|139|Mortality|6560240|Black|Female|All Cancer Sites Combined|2006|1.8|2.5|2.1
0-19|1.9|2.6|2.2|146|Mortality|6604633|Black|Female|All Cancer Sites Combined|2007|1.9|2.6|2.2
0-19|1.9|2.7|2.3|150|Mortality|6638744|Black|Female|All Cancer Sites Combined|2008|1.9|2.7|2.3
0-19|2.0|2.8|2.4|160|Mortality|6653296|Black|Female|All Cancer Sites Combined|2009|2.0|2.8|2.4
0-19|~|~|~|~|Mortality|6375857|Black|Female|Bones and Joints|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Bones and Joints|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Bones and Joints|2004|~|~|~
0-19|~|~|~|~|Mortality|6530380|Black|Female|Bones and Joints|2005|~|~|~
0-19|0.1|0.2|0.2|53|Mortality|32987293|Black|Female|Bones and Joints|2005-2009|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6560240|Black|Female|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|6653296|Black|Female|Bones and Joints|2009|~|~|~
0-19|0.5|1.0|0.7|46|Mortality|6375857|Black|Female|Brain and Other Nervous System|1999|0.5|1.0|0.7
0-19|0.4|0.8|0.6|37|Mortality|6424150|Black|Female|Brain and Other Nervous System|2000|0.4|0.8|0.6
0-19|0.4|0.7|0.5|33|Mortality|6446788|Black|Female|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.5|0.9|0.7|42|Mortality|6465179|Black|Female|Brain and Other Nervous System|2002|0.5|0.9|0.6
0-19|0.4|0.8|0.6|39|Mortality|6482277|Black|Female|Brain and Other Nervous System|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|44|Mortality|6505891|Black|Female|Brain and Other Nervous System|2004|0.5|0.9|0.7
0-19|0.4|0.8|0.6|36|Mortality|6530380|Black|Female|Brain and Other Nervous System|2005|0.4|0.8|0.6
0-19|0.5|0.7|0.6|194|Mortality|32987293|Black|Female|Brain and Other Nervous System|2005-2009|0.5|0.7|0.6
0-19|0.5|0.9|0.7|45|Mortality|6560240|Black|Female|Brain and Other Nervous System|2006|0.5|0.9|0.7
0-19|0.4|0.8|0.6|39|Mortality|6604633|Black|Female|Brain and Other Nervous System|2007|0.4|0.8|0.6
0-19|0.4|0.8|0.6|37|Mortality|6638744|Black|Female|Brain and Other Nervous System|2008|0.4|0.8|0.6
0-19|0.4|0.8|0.6|37|Mortality|6653296|Black|Female|Brain and Other Nervous System|2009|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|6375857|Black|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6530380|Black|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|32987293|Black|Female|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|6560240|Black|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|6653296|Black|Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|6375857|Black|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|6530380|Black|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.1|0.1|0.1|29|Mortality|32987293|Black|Female|Kidney and Renal Pelvis|2005-2009|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|6560240|Black|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|6653296|Black|Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.4|0.8|0.6|39|Mortality|6375857|Black|Female|Leukemia|1999|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6424150|Black|Female|Leukemia|2000|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6446788|Black|Female|Leukemia|2001|0.4|0.8|0.6
0-19|0.4|0.8|0.6|39|Mortality|6465179|Black|Female|Leukemia|2002|0.4|0.8|0.6
0-19|0.4|0.8|0.6|38|Mortality|6482277|Black|Female|Leukemia|2003|0.4|0.8|0.6
0-19|0.5|0.9|0.7|43|Mortality|6505891|Black|Female|Leukemia|2004|0.5|0.9|0.7
0-19|0.4|0.8|0.6|40|Mortality|6530380|Black|Female|Leukemia|2005|0.4|0.8|0.6
0-19|0.5|0.7|0.6|193|Mortality|32987293|Black|Female|Leukemia|2005-2009|0.5|0.7|0.6
0-19|0.4|0.7|0.5|35|Mortality|6560240|Black|Female|Leukemia|2006|0.4|0.7|0.5
0-19|0.4|0.8|0.6|40|Mortality|6604633|Black|Female|Leukemia|2007|0.4|0.8|0.6
0-19|0.5|0.9|0.7|45|Mortality|6638744|Black|Female|Leukemia|2008|0.5|0.9|0.7
0-19|0.3|0.7|0.5|33|Mortality|6653296|Black|Female|Leukemia|2009|0.3|0.7|0.5
0-19|~|~|~|~|Mortality|6375857|Black|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6505891|Black|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6530380|Black|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.1|0.1|21|Mortality|32987293|Black|Female|Non-Hodgkin Lymphoma|2005-2009|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|6560240|Black|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6638744|Black|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|6653296|Black|Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|0.4|0.7|0.5|33|Mortality|6375857|Black|Female|Other|1999|0.4|0.7|0.5
0-19|0.5|0.9|0.7|42|Mortality|6424150|Black|Female|Other|2000|0.5|0.9|0.7
0-19|0.3|0.7|0.5|32|Mortality|6446788|Black|Female|Other|2001|0.3|0.7|0.5
0-19|0.5|1.0|0.7|47|Mortality|6465179|Black|Female|Other|2002|0.5|1.0|0.7
0-19|0.3|0.7|0.5|32|Mortality|6482277|Black|Female|Other|2003|0.3|0.7|0.5
0-19|0.5|0.9|0.6|41|Mortality|6505891|Black|Female|Other|2004|0.5|0.9|0.6
0-19|0.4|0.8|0.6|40|Mortality|6530380|Black|Female|Other|2005|0.4|0.8|0.6
0-19|0.5|0.6|0.5|177|Mortality|32987293|Black|Female|Other|2005-2009|0.5|0.6|0.5
0-19|0.3|0.6|0.4|28|Mortality|6560240|Black|Female|Other|2006|0.3|0.6|0.4
0-19|0.4|0.8|0.5|36|Mortality|6604633|Black|Female|Other|2007|0.4|0.8|0.5
0-19|0.3|0.7|0.5|30|Mortality|6638744|Black|Female|Other|2008|0.3|0.6|0.5
0-19|0.5|0.9|0.6|43|Mortality|6653296|Black|Female|Other|2009|0.5|0.9|0.6
0-19|~|~|~|~|Mortality|6375857|Black|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|6424150|Black|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|6446788|Black|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|6465179|Black|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|6482277|Black|Female|Soft Tissue|2003|~|~|~
0-19|0.2|0.5|0.3|20|Mortality|6505891|Black|Female|Soft Tissue|2004|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6530380|Black|Female|Soft Tissue|2005|~|~|~
0-19|0.1|0.2|0.2|62|Mortality|32987293|Black|Female|Soft Tissue|2005-2009|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6560240|Black|Female|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|6604633|Black|Female|Soft Tissue|2007|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6638744|Black|Female|Soft Tissue|2008|0.1|0.4|0.2
0-19|0.1|0.4|0.3|17|Mortality|6653296|Black|Female|Soft Tissue|2009|0.1|0.4|0.3
0-19|0.3|0.6|0.4|26|Mortality|6562662|Black|Male|Acute Lymphocytic|1999|0.3|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6621172|Black|Male|Acute Lymphocytic|2000|0.2|0.5|0.3
0-19|0.3|0.6|0.4|29|Mortality|6657073|Black|Male|Acute Lymphocytic|2001|0.3|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6678156|Black|Male|Acute Lymphocytic|2002|0.2|0.5|0.3
0-19|0.1|0.4|0.2|16|Mortality|6690871|Black|Male|Acute Lymphocytic|2003|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6713091|Black|Male|Acute Lymphocytic|2004|~|~|~
0-19|0.2|0.5|0.3|22|Mortality|6738111|Black|Male|Acute Lymphocytic|2005|0.2|0.5|0.3
0-19|0.2|0.4|0.3|103|Mortality|34051259|Black|Male|Acute Lymphocytic|2005-2009|0.2|0.4|0.3
0-19|0.2|0.4|0.3|19|Mortality|6769408|Black|Male|Acute Lymphocytic|2006|0.2|0.4|0.3
0-19|0.2|0.5|0.4|24|Mortality|6818048|Black|Male|Acute Lymphocytic|2007|0.2|0.5|0.4
0-19|0.2|0.5|0.4|25|Mortality|6853996|Black|Male|Acute Lymphocytic|2008|0.2|0.5|0.4
0-19|~|~|~|~|Mortality|6871696|Black|Male|Acute Lymphocytic|2009|~|~|~
0-19|0.2|0.5|0.3|20|Mortality|6562662|Black|Male|Acute Myeloid|1999|0.2|0.5|0.3
0-19|0.3|0.6|0.4|25|Mortality|6621172|Black|Male|Acute Myeloid|2000|0.2|0.6|0.4
0-19|0.2|0.5|0.3|20|Mortality|6657073|Black|Male|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|6678156|Black|Male|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.5|0.3|22|Mortality|6690871|Black|Male|Acute Myeloid|2003|0.2|0.5|0.3
0-19|0.2|0.5|0.4|24|Mortality|6713091|Black|Male|Acute Myeloid|2004|0.2|0.5|0.4
0-19|0.2|0.5|0.3|22|Mortality|6738111|Black|Male|Acute Myeloid|2005|0.2|0.5|0.3
0-19|0.2|0.3|0.3|89|Mortality|34051259|Black|Male|Acute Myeloid|2005-2009|0.2|0.3|0.3
0-19|0.1|0.4|0.2|17|Mortality|6769408|Black|Male|Acute Myeloid|2006|0.1|0.4|0.3
0-19|0.2|0.5|0.3|21|Mortality|6818048|Black|Male|Acute Myeloid|2007|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6853996|Black|Male|Acute Myeloid|2008|~|~|~
0-19|~|~|~|~|Mortality|6871696|Black|Male|Acute Myeloid|2009|~|~|~
0-19|2.8|3.7|3.3|212|Mortality|6562662|Black|Male|All Cancer Sites Combined|1999|2.8|3.7|3.2
0-19|2.7|3.6|3.2|207|Mortality|6621172|Black|Male|All Cancer Sites Combined|2000|2.7|3.6|3.1
0-19|2.7|3.5|3.1|203|Mortality|6657073|Black|Male|All Cancer Sites Combined|2001|2.6|3.5|3.0
0-19|2.7|3.6|3.2|210|Mortality|6678156|Black|Male|All Cancer Sites Combined|2002|2.7|3.6|3.1
0-19|2.4|3.2|2.8|188|Mortality|6690871|Black|Male|All Cancer Sites Combined|2003|2.4|3.2|2.8
0-19|2.5|3.3|2.9|192|Mortality|6713091|Black|Male|All Cancer Sites Combined|2004|2.5|3.3|2.9
0-19|2.6|3.5|3.0|204|Mortality|6738111|Black|Male|All Cancer Sites Combined|2005|2.6|3.5|3.0
0-19|2.5|2.8|2.7|907|Mortality|34051259|Black|Male|All Cancer Sites Combined|2005-2009|2.5|2.8|2.7
0-19|2.4|3.2|2.8|187|Mortality|6769408|Black|Male|All Cancer Sites Combined|2006|2.4|3.2|2.8
0-19|2.1|2.8|2.4|167|Mortality|6818048|Black|Male|All Cancer Sites Combined|2007|2.1|2.9|2.4
0-19|2.3|3.1|2.7|186|Mortality|6853996|Black|Male|All Cancer Sites Combined|2008|2.3|3.1|2.7
0-19|2.0|2.7|2.3|163|Mortality|6871696|Black|Male|All Cancer Sites Combined|2009|2.0|2.8|2.4
0-19|0.1|0.4|0.3|16|Mortality|6562662|Black|Male|Bones and Joints|1999|0.1|0.4|0.2
0-19|0.2|0.5|0.3|21|Mortality|6621172|Black|Male|Bones and Joints|2000|0.2|0.5|0.3
0-19|~|~|~|~|Mortality|6657073|Black|Male|Bones and Joints|2001|~|~|~
0-19|~|~|~|~|Mortality|6678156|Black|Male|Bones and Joints|2002|~|~|~
0-19|~|~|~|~|Mortality|6690871|Black|Male|Bones and Joints|2003|~|~|~
0-19|0.2|0.5|0.3|22|Mortality|6713091|Black|Male|Bones and Joints|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|6738111|Black|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|72|Mortality|34051259|Black|Male|Bones and Joints|2005-2009|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|6769408|Black|Male|Bones and Joints|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Bones and Joints|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Bones and Joints|2008|~|~|~
0-19|~|~|~|~|Mortality|6871696|Black|Male|Bones and Joints|2009|~|~|~
0-19|0.5|0.9|0.7|47|Mortality|6562662|Black|Male|Brain and Other Nervous System|1999|0.5|1.0|0.7
0-19|0.6|1.0|0.8|51|Mortality|6621172|Black|Male|Brain and Other Nervous System|2000|0.6|1.0|0.8
0-19|0.4|0.7|0.5|34|Mortality|6657073|Black|Male|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.7|1.1|0.9|58|Mortality|6678156|Black|Male|Brain and Other Nervous System|2002|0.7|1.1|0.9
0-19|0.5|0.9|0.7|45|Mortality|6690871|Black|Male|Brain and Other Nervous System|2003|0.5|0.9|0.7
0-19|0.4|0.8|0.6|41|Mortality|6713091|Black|Male|Brain and Other Nervous System|2004|0.4|0.8|0.6
0-19|0.5|0.9|0.7|44|Mortality|6738111|Black|Male|Brain and Other Nervous System|2005|0.5|0.9|0.7
0-19|0.5|0.6|0.5|180|Mortality|34051259|Black|Male|Brain and Other Nervous System|2005-2009|0.5|0.6|0.5
0-19|0.4|0.8|0.6|37|Mortality|6769408|Black|Male|Brain and Other Nervous System|2006|0.4|0.8|0.5
0-19|0.2|0.5|0.3|22|Mortality|6818048|Black|Male|Brain and Other Nervous System|2007|0.2|0.5|0.3
0-19|0.4|0.7|0.5|37|Mortality|6853996|Black|Male|Brain and Other Nervous System|2008|0.4|0.7|0.5
0-19|0.4|0.8|0.6|40|Mortality|6871696|Black|Male|Brain and Other Nervous System|2009|0.4|0.8|0.6
0-19|~|~|~|~|Mortality|6562662|Black|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6621172|Black|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6657073|Black|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|6678156|Black|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6690871|Black|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6713091|Black|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6738111|Black|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|34051259|Black|Male|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|6769408|Black|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|6871696|Black|Male|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|6562662|Black|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6621172|Black|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6657073|Black|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|6678156|Black|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|6690871|Black|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|6713091|Black|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|6738111|Black|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.1|0.1|0.1|35|Mortality|34051259|Black|Male|Kidney and Renal Pelvis|2005-2009|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|6769408|Black|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|6871696|Black|Male|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.8|1.3|1.0|65|Mortality|6562662|Black|Male|Leukemia|1999|0.8|1.3|1.0
0-19|0.7|1.2|1.0|62|Mortality|6621172|Black|Male|Leukemia|2000|0.7|1.2|0.9
0-19|0.8|1.3|1.0|67|Mortality|6657073|Black|Male|Leukemia|2001|0.8|1.3|1.0
0-19|0.6|1.0|0.8|52|Mortality|6678156|Black|Male|Leukemia|2002|0.6|1.0|0.8
0-19|0.5|0.9|0.7|47|Mortality|6690871|Black|Male|Leukemia|2003|0.5|0.9|0.7
0-19|0.6|1.1|0.8|54|Mortality|6713091|Black|Male|Leukemia|2004|0.6|1.0|0.8
0-19|0.7|1.1|0.9|60|Mortality|6738111|Black|Male|Leukemia|2005|0.7|1.1|0.9
0-19|0.7|0.8|0.7|256|Mortality|34051259|Black|Male|Leukemia|2005-2009|0.7|0.8|0.8
0-19|0.6|1.1|0.8|55|Mortality|6769408|Black|Male|Leukemia|2006|0.6|1.1|0.8
0-19|0.6|1.0|0.8|53|Mortality|6818048|Black|Male|Leukemia|2007|0.6|1.0|0.8
0-19|0.6|1.1|0.8|57|Mortality|6853996|Black|Male|Leukemia|2008|0.6|1.1|0.8
0-19|0.3|0.6|0.4|31|Mortality|6871696|Black|Male|Leukemia|2009|0.3|0.6|0.5
0-19|~|~|~|~|Mortality|6562662|Black|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6621172|Black|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|6657073|Black|Male|Non-Hodgkin Lymphoma|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|6678156|Black|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|6690871|Black|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|6713091|Black|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|6738111|Black|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.1|0.2|0.2|62|Mortality|34051259|Black|Male|Non-Hodgkin Lymphoma|2005-2009|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|6769408|Black|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|6871696|Black|Male|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|0.5|0.9|0.7|46|Mortality|6562662|Black|Male|Other|1999|0.5|0.9|0.7
0-19|0.5|0.9|0.7|46|Mortality|6621172|Black|Male|Other|2000|0.5|0.9|0.7
0-19|0.4|0.8|0.6|41|Mortality|6657073|Black|Male|Other|2001|0.4|0.8|0.6
0-19|0.5|0.9|0.7|47|Mortality|6678156|Black|Male|Other|2002|0.5|0.9|0.7
0-19|0.6|1.0|0.8|52|Mortality|6690871|Black|Male|Other|2003|0.6|1.0|0.8
0-19|0.5|0.9|0.7|44|Mortality|6713091|Black|Male|Other|2004|0.5|0.9|0.7
0-19|0.5|0.9|0.6|43|Mortality|6738111|Black|Male|Other|2005|0.5|0.9|0.6
0-19|0.6|0.7|0.6|222|Mortality|34051259|Black|Male|Other|2005-2009|0.6|0.7|0.7
0-19|0.4|0.8|0.6|41|Mortality|6769408|Black|Male|Other|2006|0.4|0.8|0.6
0-19|0.5|0.9|0.7|45|Mortality|6818048|Black|Male|Other|2007|0.5|0.9|0.7
0-19|0.5|0.9|0.7|46|Mortality|6853996|Black|Male|Other|2008|0.5|0.9|0.7
0-19|0.5|0.9|0.7|47|Mortality|6871696|Black|Male|Other|2009|0.5|0.9|0.7
0-19|0.2|0.4|0.3|17|Mortality|6562662|Black|Male|Soft Tissue|1999|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6621172|Black|Male|Soft Tissue|2000|~|~|~
0-19|0.2|0.4|0.3|18|Mortality|6657073|Black|Male|Soft Tissue|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|19|Mortality|6678156|Black|Male|Soft Tissue|2002|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|6690871|Black|Male|Soft Tissue|2003|~|~|~
0-19|0.1|0.4|0.3|17|Mortality|6713091|Black|Male|Soft Tissue|2004|0.1|0.4|0.3
0-19|~|~|~|~|Mortality|6738111|Black|Male|Soft Tissue|2005|~|~|~
0-19|0.2|0.3|0.2|72|Mortality|34051259|Black|Male|Soft Tissue|2005-2009|0.2|0.3|0.2
0-19|~|~|~|~|Mortality|6769408|Black|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|6818048|Black|Male|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|6853996|Black|Male|Soft Tissue|2008|~|~|~
0-19|0.1|0.4|0.2|17|Mortality|6871696|Black|Male|Soft Tissue|2009|0.1|0.4|0.2
0-19|0.2|0.4|0.3|37|Mortality|12938519|Black|Male and Female|Acute Lymphocytic|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|36|Mortality|13045322|Black|Male and Female|Acute Lymphocytic|2000|0.2|0.4|0.3
0-19|0.3|0.5|0.3|45|Mortality|13103861|Black|Male and Female|Acute Lymphocytic|2001|0.3|0.5|0.3
0-19|0.2|0.3|0.2|31|Mortality|13143335|Black|Male and Female|Acute Lymphocytic|2002|0.2|0.3|0.2
0-19|0.1|0.3|0.2|28|Mortality|13173148|Black|Male and Female|Acute Lymphocytic|2003|0.1|0.3|0.2
0-19|0.1|0.2|0.2|20|Mortality|13218982|Black|Male and Female|Acute Lymphocytic|2004|0.1|0.2|0.2
0-19|0.1|0.3|0.2|28|Mortality|13268491|Black|Male and Female|Acute Lymphocytic|2005|0.1|0.3|0.2
0-19|0.2|0.3|0.2|144|Mortality|67038552|Black|Male and Female|Acute Lymphocytic|2005-2009|0.2|0.3|0.2
0-19|0.1|0.3|0.2|29|Mortality|13329648|Black|Male and Female|Acute Lymphocytic|2006|0.1|0.3|0.2
0-19|0.2|0.3|0.2|31|Mortality|13422681|Black|Male and Female|Acute Lymphocytic|2007|0.2|0.3|0.2
0-19|0.2|0.4|0.3|34|Mortality|13492740|Black|Male and Female|Acute Lymphocytic|2008|0.2|0.4|0.3
0-19|0.1|0.2|0.2|22|Mortality|13524992|Black|Male and Female|Acute Lymphocytic|2009|0.1|0.2|0.2
0-19|0.2|0.4|0.3|36|Mortality|12938519|Black|Male and Female|Acute Myeloid|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13045322|Black|Male and Female|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|33|Mortality|13103861|Black|Male and Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|37|Mortality|13143335|Black|Male and Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|13173148|Black|Male and Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.3|0.5|0.4|48|Mortality|13218982|Black|Male and Female|Acute Myeloid|2004|0.3|0.5|0.4
0-19|0.2|0.4|0.3|37|Mortality|13268491|Black|Male and Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.3|182|Mortality|67038552|Black|Male and Female|Acute Myeloid|2005-2009|0.2|0.3|0.3
0-19|0.2|0.4|0.3|36|Mortality|13329648|Black|Male and Female|Acute Myeloid|2006|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13422681|Black|Male and Female|Acute Myeloid|2007|0.2|0.4|0.3
0-19|0.2|0.4|0.3|37|Mortality|13492740|Black|Male and Female|Acute Myeloid|2008|0.2|0.4|0.3
0-19|0.2|0.3|0.2|32|Mortality|13524992|Black|Male and Female|Acute Myeloid|2009|0.2|0.3|0.2
0-19|2.7|3.3|3.0|382|Mortality|12938519|Black|Male and Female|All Cancer Sites Combined|1999|2.7|3.3|3.0
0-19|2.6|3.1|2.8|367|Mortality|13045322|Black|Male and Female|All Cancer Sites Combined|2000|2.5|3.1|2.8
0-19|2.4|2.9|2.6|343|Mortality|13103861|Black|Male and Female|All Cancer Sites Combined|2001|2.3|2.9|2.6
0-19|2.6|3.2|2.9|373|Mortality|13143335|Black|Male and Female|All Cancer Sites Combined|2002|2.6|3.1|2.8
0-19|2.2|2.8|2.5|331|Mortality|13173148|Black|Male and Female|All Cancer Sites Combined|2003|2.2|2.8|2.5
0-19|2.5|3.1|2.8|368|Mortality|13218982|Black|Male and Female|All Cancer Sites Combined|2004|2.5|3.1|2.8
0-19|2.4|2.9|2.6|349|Mortality|13268491|Black|Male and Female|All Cancer Sites Combined|2005|2.4|2.9|2.6
0-19|2.3|2.6|2.5|1647|Mortality|67038552|Black|Male and Female|All Cancer Sites Combined|2005-2009|2.3|2.6|2.5
0-19|2.2|2.7|2.4|326|Mortality|13329648|Black|Male and Female|All Cancer Sites Combined|2006|2.2|2.7|2.4
0-19|2.1|2.6|2.3|313|Mortality|13422681|Black|Male and Female|All Cancer Sites Combined|2007|2.1|2.6|2.3
0-19|2.2|2.8|2.5|336|Mortality|13492740|Black|Male and Female|All Cancer Sites Combined|2008|2.2|2.8|2.5
0-19|2.1|2.6|2.4|323|Mortality|13524992|Black|Male and Female|All Cancer Sites Combined|2009|2.1|2.7|2.4
0-19|0.2|0.3|0.2|29|Mortality|12938519|Black|Male and Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.4|0.3|32|Mortality|13045322|Black|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.1|0.3|0.2|23|Mortality|13103861|Black|Male and Female|Bones and Joints|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|23|Mortality|13143335|Black|Male and Female|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13173148|Black|Male and Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.2|0.4|0.3|35|Mortality|13218982|Black|Male and Female|Bones and Joints|2004|0.2|0.4|0.3
0-19|0.1|0.3|0.2|29|Mortality|13268491|Black|Male and Female|Bones and Joints|2005|0.1|0.3|0.2
0-19|0.2|0.2|0.2|125|Mortality|67038552|Black|Male and Female|Bones and Joints|2005-2009|0.2|0.2|0.2
0-19|0.1|0.3|0.2|27|Mortality|13329648|Black|Male and Female|Bones and Joints|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13422681|Black|Male and Female|Bones and Joints|2007|0.1|0.2|0.2
0-19|0.1|0.2|0.2|21|Mortality|13492740|Black|Male and Female|Bones and Joints|2008|0.1|0.2|0.2
0-19|0.1|0.3|0.2|27|Mortality|13524992|Black|Male and Female|Bones and Joints|2009|0.1|0.3|0.2
0-19|0.6|0.9|0.7|93|Mortality|12938519|Black|Male and Female|Brain and Other Nervous System|1999|0.6|0.9|0.7
0-19|0.5|0.8|0.7|88|Mortality|13045322|Black|Male and Female|Brain and Other Nervous System|2000|0.5|0.8|0.7
0-19|0.4|0.6|0.5|67|Mortality|13103861|Black|Male and Female|Brain and Other Nervous System|2001|0.4|0.6|0.5
0-19|0.6|0.9|0.8|100|Mortality|13143335|Black|Male and Female|Brain and Other Nervous System|2002|0.6|0.9|0.8
0-19|0.5|0.8|0.6|84|Mortality|13173148|Black|Male and Female|Brain and Other Nervous System|2003|0.5|0.8|0.6
0-19|0.5|0.8|0.6|85|Mortality|13218982|Black|Male and Female|Brain and Other Nervous System|2004|0.5|0.8|0.6
0-19|0.5|0.8|0.6|80|Mortality|13268491|Black|Male and Female|Brain and Other Nervous System|2005|0.5|0.8|0.6
0-19|0.5|0.6|0.6|374|Mortality|67038552|Black|Male and Female|Brain and Other Nervous System|2005-2009|0.5|0.6|0.6
0-19|0.5|0.8|0.6|82|Mortality|13329648|Black|Male and Female|Brain and Other Nervous System|2006|0.5|0.8|0.6
0-19|0.4|0.6|0.5|61|Mortality|13422681|Black|Male and Female|Brain and Other Nervous System|2007|0.3|0.6|0.5
0-19|0.4|0.7|0.6|74|Mortality|13492740|Black|Male and Female|Brain and Other Nervous System|2008|0.4|0.7|0.5
0-19|0.5|0.7|0.6|77|Mortality|13524992|Black|Male and Female|Brain and Other Nervous System|2009|0.4|0.7|0.6
0-19|~|~|~|~|Mortality|12938519|Black|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13045322|Black|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|13103861|Black|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|13143335|Black|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|13173148|Black|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|13218982|Black|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|13268491|Black|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.0|0.0|19|Mortality|67038552|Black|Male and Female|Hodgkin Lymphoma|2005-2009|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|13329648|Black|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|13422681|Black|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|13492740|Black|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|13524992|Black|Male and Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|12938519|Black|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|0.1|0.2|0.1|16|Mortality|13045322|Black|Male and Female|Kidney and Renal Pelvis|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.2|21|Mortality|13103861|Black|Male and Female|Kidney and Renal Pelvis|2001|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|13143335|Black|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|13173148|Black|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|13218982|Black|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|13268491|Black|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.1|0.1|0.1|64|Mortality|67038552|Black|Male and Female|Kidney and Renal Pelvis|2005-2009|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|13329648|Black|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|13422681|Black|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|13492740|Black|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|13524992|Black|Male and Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.7|1.0|0.8|104|Mortality|12938519|Black|Male and Female|Leukemia|1999|0.7|1.0|0.8
0-19|0.6|0.9|0.8|100|Mortality|13045322|Black|Male and Female|Leukemia|2000|0.6|0.9|0.8
0-19|0.7|1.0|0.8|105|Mortality|13103861|Black|Male and Female|Leukemia|2001|0.7|1.0|0.8
0-19|0.6|0.9|0.7|91|Mortality|13143335|Black|Male and Female|Leukemia|2002|0.6|0.9|0.7
0-19|0.5|0.8|0.6|85|Mortality|13173148|Black|Male and Female|Leukemia|2003|0.5|0.8|0.6
0-19|0.6|0.9|0.7|97|Mortality|13218982|Black|Male and Female|Leukemia|2004|0.6|0.9|0.7
0-19|0.6|0.9|0.7|100|Mortality|13268491|Black|Male and Female|Leukemia|2005|0.6|0.9|0.8
0-19|0.6|0.7|0.7|449|Mortality|67038552|Black|Male and Female|Leukemia|2005-2009|0.6|0.7|0.7
0-19|0.5|0.8|0.7|90|Mortality|13329648|Black|Male and Female|Leukemia|2006|0.5|0.8|0.7
0-19|0.6|0.8|0.7|93|Mortality|13422681|Black|Male and Female|Leukemia|2007|0.6|0.8|0.7
0-19|0.6|0.9|0.7|102|Mortality|13492740|Black|Male and Female|Leukemia|2008|0.6|0.9|0.8
0-19|0.4|0.6|0.5|64|Mortality|13524992|Black|Male and Female|Leukemia|2009|0.4|0.6|0.5
0-19|0.1|0.3|0.2|26|Mortality|12938519|Black|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.3|0.2
0-19|0.1|0.2|0.1|16|Mortality|13045322|Black|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.3|0.2|21|Mortality|13103861|Black|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.3|0.2|23|Mortality|13143335|Black|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.3|0.2
0-19|0.1|0.2|0.2|21|Mortality|13173148|Black|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.1|17|Mortality|13218982|Black|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.2|0.1|17|Mortality|13268491|Black|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.2|0.1|83|Mortality|67038552|Black|Male and Female|Non-Hodgkin Lymphoma|2005-2009|0.1|0.2|0.1
0-19|0.1|0.2|0.1|19|Mortality|13329648|Black|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|13422681|Black|Male and Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|13492740|Black|Male and Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|0.1|0.2|0.1|17|Mortality|13524992|Black|Male and Female|Non-Hodgkin Lymphoma|2009|0.1|0.2|0.1
0-19|0.5|0.8|0.6|79|Mortality|12938519|Black|Male and Female|Other|1999|0.5|0.8|0.6
0-19|0.5|0.8|0.7|88|Mortality|13045322|Black|Male and Female|Other|2000|0.5|0.8|0.7
0-19|0.4|0.7|0.6|73|Mortality|13103861|Black|Male and Female|Other|2001|0.4|0.7|0.6
0-19|0.6|0.9|0.7|94|Mortality|13143335|Black|Male and Female|Other|2002|0.6|0.9|0.7
0-19|0.5|0.8|0.6|84|Mortality|13173148|Black|Male and Female|Other|2003|0.5|0.8|0.6
0-19|0.5|0.8|0.6|85|Mortality|13218982|Black|Male and Female|Other|2004|0.5|0.8|0.6
0-19|0.5|0.8|0.6|83|Mortality|13268491|Black|Male and Female|Other|2005|0.5|0.8|0.6
0-19|0.5|0.7|0.6|399|Mortality|67038552|Black|Male and Female|Other|2005-2009|0.5|0.7|0.6
0-19|0.4|0.7|0.5|69|Mortality|13329648|Black|Male and Female|Other|2006|0.4|0.7|0.5
0-19|0.5|0.7|0.6|81|Mortality|13422681|Black|Male and Female|Other|2007|0.5|0.8|0.6
0-19|0.4|0.7|0.6|76|Mortality|13492740|Black|Male and Female|Other|2008|0.4|0.7|0.6
0-19|0.5|0.8|0.6|90|Mortality|13524992|Black|Male and Female|Other|2009|0.5|0.8|0.7
0-19|0.2|0.4|0.3|32|Mortality|12938519|Black|Male and Female|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.3|0.2|21|Mortality|13045322|Black|Male and Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.3|0.2|28|Mortality|13103861|Black|Male and Female|Soft Tissue|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|29|Mortality|13143335|Black|Male and Female|Soft Tissue|2002|0.1|0.3|0.2
0-19|0.1|0.3|0.2|24|Mortality|13173148|Black|Male and Female|Soft Tissue|2003|0.1|0.3|0.2
0-19|0.2|0.4|0.3|37|Mortality|13218982|Black|Male and Female|Soft Tissue|2004|0.2|0.4|0.3
0-19|0.1|0.3|0.2|23|Mortality|13268491|Black|Male and Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.2|0.2|0.2|134|Mortality|67038552|Black|Male and Female|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.1|0.3|0.2|25|Mortality|13329648|Black|Male and Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|22|Mortality|13422681|Black|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.1|0.3|0.2|30|Mortality|13492740|Black|Male and Female|Soft Tissue|2008|0.2|0.3|0.2
0-19|0.2|0.4|0.3|34|Mortality|13524992|Black|Male and Female|Soft Tissue|2009|0.2|0.4|0.3
0-19|0.4|0.7|0.5|32|Mortality|6382096|Hispanic|Female|Acute Lymphocytic|1999|0.3|0.7|0.5
0-19|0.4|0.7|0.5|34|Mortality|6671580|Hispanic|Female|Acute Lymphocytic|2000|0.4|0.7|0.5
0-19|0.4|0.8|0.6|40|Mortality|6904307|Hispanic|Female|Acute Lymphocytic|2001|0.4|0.8|0.6
0-19|0.5|0.9|0.6|44|Mortality|7134087|Hispanic|Female|Acute Lymphocytic|2002|0.4|0.8|0.6
0-19|0.3|0.7|0.5|35|Mortality|7365360|Hispanic|Female|Acute Lymphocytic|2003|0.3|0.7|0.5
0-19|0.4|0.8|0.6|41|Mortality|7606752|Hispanic|Female|Acute Lymphocytic|2004|0.4|0.7|0.5
0-19|0.3|0.5|0.4|28|Mortality|7859967|Hispanic|Female|Acute Lymphocytic|2005|0.2|0.5|0.4
0-19|0.4|0.5|0.4|178|Mortality|42053234|Hispanic|Female|Acute Lymphocytic|2005-2009|0.4|0.5|0.4
0-19|0.2|0.5|0.4|28|Mortality|8132294|Hispanic|Female|Acute Lymphocytic|2006|0.2|0.5|0.3
0-19|0.4|0.7|0.5|44|Mortality|8418953|Hispanic|Female|Acute Lymphocytic|2007|0.4|0.7|0.5
0-19|0.4|0.7|0.5|42|Mortality|8692766|Hispanic|Female|Acute Lymphocytic|2008|0.3|0.7|0.5
0-19|0.3|0.6|0.4|36|Mortality|8949254|Hispanic|Female|Acute Lymphocytic|2009|0.3|0.6|0.4
0-19|0.2|0.5|0.3|19|Mortality|6382096|Hispanic|Female|Acute Myeloid|1999|0.2|0.5|0.3
0-19|0.1|0.4|0.2|16|Mortality|6671580|Hispanic|Female|Acute Myeloid|2000|0.1|0.4|0.2
0-19|0.2|0.4|0.3|20|Mortality|6904307|Hispanic|Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|19|Mortality|7134087|Hispanic|Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|21|Mortality|7365360|Hispanic|Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Acute Myeloid|2004|~|~|~
0-19|0.2|0.5|0.3|23|Mortality|7859967|Hispanic|Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.3|108|Mortality|42053234|Hispanic|Female|Acute Myeloid|2005-2009|0.2|0.3|0.3
0-19|0.1|0.4|0.2|19|Mortality|8132294|Hispanic|Female|Acute Myeloid|2006|0.1|0.4|0.2
0-19|0.1|0.3|0.2|17|Mortality|8418953|Hispanic|Female|Acute Myeloid|2007|0.1|0.3|0.2
0-19|0.2|0.4|0.3|24|Mortality|8692766|Hispanic|Female|Acute Myeloid|2008|0.2|0.4|0.3
0-19|0.2|0.4|0.3|25|Mortality|8949254|Hispanic|Female|Acute Myeloid|2009|0.2|0.4|0.3
0-19|2.2|3.1|2.6|166|Mortality|6382096|Hispanic|Female|All Cancer Sites Combined|1999|2.2|3.0|2.6
0-19|2.1|2.9|2.5|165|Mortality|6671580|Hispanic|Female|All Cancer Sites Combined|2000|2.1|2.9|2.5
0-19|2.3|3.1|2.7|185|Mortality|6904307|Hispanic|Female|All Cancer Sites Combined|2001|2.3|3.1|2.7
0-19|2.3|3.1|2.6|187|Mortality|7134087|Hispanic|Female|All Cancer Sites Combined|2002|2.3|3.0|2.6
0-19|2.0|2.8|2.4|174|Mortality|7365360|Hispanic|Female|All Cancer Sites Combined|2003|2.0|2.7|2.4
0-19|2.2|2.9|2.5|189|Mortality|7606752|Hispanic|Female|All Cancer Sites Combined|2004|2.1|2.9|2.5
0-19|2.1|2.8|2.4|186|Mortality|7859967|Hispanic|Female|All Cancer Sites Combined|2005|2.0|2.7|2.4
0-19|2.3|2.6|2.5|1014|Mortality|42053234|Hispanic|Female|All Cancer Sites Combined|2005-2009|2.3|2.6|2.4
0-19|2.0|2.6|2.3|180|Mortality|8132294|Hispanic|Female|All Cancer Sites Combined|2006|1.9|2.6|2.2
0-19|2.2|2.9|2.5|208|Mortality|8418953|Hispanic|Female|All Cancer Sites Combined|2007|2.1|2.8|2.5
0-19|2.2|2.9|2.6|218|Mortality|8692766|Hispanic|Female|All Cancer Sites Combined|2008|2.2|2.9|2.5
0-19|2.2|2.9|2.5|222|Mortality|8949254|Hispanic|Female|All Cancer Sites Combined|2009|2.2|2.8|2.5
0-19|0.2|0.5|0.3|19|Mortality|6382096|Hispanic|Female|Bones and Joints|1999|0.2|0.5|0.3
0-19|0.2|0.5|0.3|18|Mortality|6671580|Hispanic|Female|Bones and Joints|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|17|Mortality|6904307|Hispanic|Female|Bones and Joints|2001|0.1|0.4|0.2
0-19|0.1|0.4|0.2|16|Mortality|7134087|Hispanic|Female|Bones and Joints|2002|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Bones and Joints|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Bones and Joints|2004|~|~|~
0-19|0.1|0.4|0.2|17|Mortality|7859967|Hispanic|Female|Bones and Joints|2005|0.1|0.3|0.2
0-19|0.2|0.3|0.2|82|Mortality|42053234|Hispanic|Female|Bones and Joints|2005-2009|0.2|0.2|0.2
0-19|0.1|0.3|0.2|16|Mortality|8132294|Hispanic|Female|Bones and Joints|2006|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Bones and Joints|2007|~|~|~
0-19|0.2|0.4|0.3|23|Mortality|8692766|Hispanic|Female|Bones and Joints|2008|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|8949254|Hispanic|Female|Bones and Joints|2009|~|~|~
0-19|0.5|0.9|0.6|42|Mortality|6382096|Hispanic|Female|Brain and Other Nervous System|1999|0.5|0.9|0.7
0-19|0.4|0.8|0.6|39|Mortality|6671580|Hispanic|Female|Brain and Other Nervous System|2000|0.4|0.8|0.6
0-19|0.4|0.8|0.6|39|Mortality|6904307|Hispanic|Female|Brain and Other Nervous System|2001|0.4|0.8|0.6
0-19|0.4|0.7|0.5|38|Mortality|7134087|Hispanic|Female|Brain and Other Nervous System|2002|0.4|0.7|0.5
0-19|0.4|0.8|0.6|46|Mortality|7365360|Hispanic|Female|Brain and Other Nervous System|2003|0.5|0.8|0.6
0-19|0.5|0.9|0.7|54|Mortality|7606752|Hispanic|Female|Brain and Other Nervous System|2004|0.5|0.9|0.7
0-19|0.5|0.9|0.7|56|Mortality|7859967|Hispanic|Female|Brain and Other Nervous System|2005|0.5|0.9|0.7
0-19|0.5|0.7|0.6|248|Mortality|42053234|Hispanic|Female|Brain and Other Nervous System|2005-2009|0.5|0.7|0.6
0-19|0.4|0.7|0.5|41|Mortality|8132294|Hispanic|Female|Brain and Other Nervous System|2006|0.4|0.7|0.5
0-19|0.4|0.7|0.5|44|Mortality|8418953|Hispanic|Female|Brain and Other Nervous System|2007|0.4|0.7|0.5
0-19|0.4|0.7|0.5|47|Mortality|8692766|Hispanic|Female|Brain and Other Nervous System|2008|0.4|0.7|0.5
0-19|0.5|0.9|0.7|60|Mortality|8949254|Hispanic|Female|Brain and Other Nervous System|2009|0.5|0.9|0.7
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6671580|Hispanic|Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6904307|Hispanic|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7134087|Hispanic|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|7859967|Hispanic|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|42053234|Hispanic|Female|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|8132294|Hispanic|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|8692766|Hispanic|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|8949254|Hispanic|Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|6671580|Hispanic|Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|6904307|Hispanic|Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|7134087|Hispanic|Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|7859967|Hispanic|Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.0|0.1|0.1|24|Mortality|42053234|Hispanic|Female|Kidney and Renal Pelvis|2005-2009|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|8132294|Hispanic|Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|8692766|Hispanic|Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|8949254|Hispanic|Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.8|1.4|1.1|67|Mortality|6382096|Hispanic|Female|Leukemia|1999|0.8|1.3|1.0
0-19|0.7|1.2|1.0|63|Mortality|6671580|Hispanic|Female|Leukemia|2000|0.7|1.2|0.9
0-19|0.9|1.5|1.2|81|Mortality|6904307|Hispanic|Female|Leukemia|2001|0.9|1.5|1.2
0-19|0.8|1.3|1.0|73|Mortality|7134087|Hispanic|Female|Leukemia|2002|0.8|1.3|1.0
0-19|0.7|1.1|0.9|67|Mortality|7365360|Hispanic|Female|Leukemia|2003|0.7|1.2|0.9
0-19|0.7|1.2|0.9|71|Mortality|7606752|Hispanic|Female|Leukemia|2004|0.7|1.2|0.9
0-19|0.6|1.1|0.8|62|Mortality|7859967|Hispanic|Female|Leukemia|2005|0.6|1.0|0.8
0-19|0.8|1.0|0.9|370|Mortality|42053234|Hispanic|Female|Leukemia|2005-2009|0.8|1.0|0.9
0-19|0.6|1.0|0.8|63|Mortality|8132294|Hispanic|Female|Leukemia|2006|0.6|1.0|0.8
0-19|0.8|1.2|1.0|80|Mortality|8418953|Hispanic|Female|Leukemia|2007|0.8|1.2|1.0
0-19|0.8|1.3|1.0|85|Mortality|8692766|Hispanic|Female|Leukemia|2008|0.8|1.2|1.0
0-19|0.7|1.1|0.9|80|Mortality|8949254|Hispanic|Female|Leukemia|2009|0.7|1.1|0.9
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|6671580|Hispanic|Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|6904307|Hispanic|Female|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7134087|Hispanic|Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|7859967|Hispanic|Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.1|0.1|0.1|33|Mortality|42053234|Hispanic|Female|Non-Hodgkin Lymphoma|2005-2009|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|8132294|Hispanic|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|8692766|Hispanic|Female|Non-Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|8949254|Hispanic|Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|0.2|0.5|0.3|23|Mortality|6382096|Hispanic|Female|Other|1999|0.2|0.5|0.4
0-19|0.2|0.6|0.4|25|Mortality|6671580|Hispanic|Female|Other|2000|0.2|0.6|0.4
0-19|0.2|0.5|0.3|21|Mortality|6904307|Hispanic|Female|Other|2001|0.2|0.5|0.3
0-19|0.3|0.7|0.5|35|Mortality|7134087|Hispanic|Female|Other|2002|0.3|0.7|0.5
0-19|0.2|0.4|0.3|22|Mortality|7365360|Hispanic|Female|Other|2003|0.2|0.5|0.3
0-19|0.3|0.6|0.4|30|Mortality|7606752|Hispanic|Female|Other|2004|0.3|0.6|0.4
0-19|0.2|0.5|0.3|26|Mortality|7859967|Hispanic|Female|Other|2005|0.2|0.5|0.3
0-19|0.3|0.5|0.4|171|Mortality|42053234|Hispanic|Female|Other|2005-2009|0.3|0.5|0.4
0-19|0.3|0.5|0.4|31|Mortality|8132294|Hispanic|Female|Other|2006|0.3|0.5|0.4
0-19|0.3|0.7|0.5|42|Mortality|8418953|Hispanic|Female|Other|2007|0.4|0.7|0.5
0-19|0.3|0.6|0.4|36|Mortality|8692766|Hispanic|Female|Other|2008|0.3|0.6|0.4
0-19|0.3|0.6|0.4|36|Mortality|8949254|Hispanic|Female|Other|2009|0.3|0.6|0.4
0-19|~|~|~|~|Mortality|6382096|Hispanic|Female|Soft Tissue|1999|~|~|~
0-19|~|~|~|~|Mortality|6671580|Hispanic|Female|Soft Tissue|2000|~|~|~
0-19|~|~|~|~|Mortality|6904307|Hispanic|Female|Soft Tissue|2001|~|~|~
0-19|~|~|~|~|Mortality|7134087|Hispanic|Female|Soft Tissue|2002|~|~|~
0-19|~|~|~|~|Mortality|7365360|Hispanic|Female|Soft Tissue|2003|~|~|~
0-19|~|~|~|~|Mortality|7606752|Hispanic|Female|Soft Tissue|2004|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|7859967|Hispanic|Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.2|0.2|0.2|81|Mortality|42053234|Hispanic|Female|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.1|0.4|0.2|18|Mortality|8132294|Hispanic|Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|8418953|Hispanic|Female|Soft Tissue|2007|~|~|~
0-19|~|~|~|~|Mortality|8692766|Hispanic|Female|Soft Tissue|2008|~|~|~
0-19|0.1|0.3|0.2|19|Mortality|8949254|Hispanic|Female|Soft Tissue|2009|0.1|0.3|0.2
0-19|0.4|0.7|0.5|34|Mortality|6802550|Hispanic|Male|Acute Lymphocytic|1999|0.3|0.7|0.5
0-19|0.6|1.0|0.8|55|Mortality|7110264|Hispanic|Male|Acute Lymphocytic|2000|0.6|1.0|0.8
0-19|0.6|1.1|0.8|59|Mortality|7341536|Hispanic|Male|Acute Lymphocytic|2001|0.6|1.0|0.8
0-19|0.5|0.9|0.7|47|Mortality|7563793|Hispanic|Male|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.7|1.1|0.8|65|Mortality|7785714|Hispanic|Male|Acute Lymphocytic|2003|0.6|1.1|0.8
0-19|0.6|1.0|0.8|58|Mortality|8024129|Hispanic|Male|Acute Lymphocytic|2004|0.5|0.9|0.7
0-19|0.5|0.9|0.7|56|Mortality|8283812|Hispanic|Male|Acute Lymphocytic|2005|0.5|0.9|0.7
0-19|0.5|0.6|0.6|239|Mortality|44270660|Hispanic|Male|Acute Lymphocytic|2005-2009|0.5|0.6|0.5
0-19|0.4|0.7|0.5|44|Mortality|8563877|Hispanic|Male|Acute Lymphocytic|2006|0.4|0.7|0.5
0-19|0.4|0.8|0.6|49|Mortality|8863218|Hispanic|Male|Acute Lymphocytic|2007|0.4|0.7|0.6
0-19|0.3|0.6|0.5|42|Mortality|9146469|Hispanic|Male|Acute Lymphocytic|2008|0.3|0.6|0.5
0-19|0.4|0.7|0.5|48|Mortality|9413284|Hispanic|Male|Acute Lymphocytic|2009|0.4|0.7|0.5
0-19|0.2|0.5|0.4|24|Mortality|6802550|Hispanic|Male|Acute Myeloid|1999|0.2|0.5|0.4
0-19|0.2|0.5|0.3|23|Mortality|7110264|Hispanic|Male|Acute Myeloid|2000|0.2|0.5|0.3
0-19|0.2|0.5|0.3|23|Mortality|7341536|Hispanic|Male|Acute Myeloid|2001|0.2|0.5|0.3
0-19|0.2|0.5|0.3|26|Mortality|7563793|Hispanic|Male|Acute Myeloid|2002|0.2|0.5|0.3
0-19|0.2|0.4|0.3|20|Mortality|7785714|Hispanic|Male|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.5|0.3|26|Mortality|8024129|Hispanic|Male|Acute Myeloid|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|20|Mortality|8283812|Hispanic|Male|Acute Myeloid|2005|0.1|0.4|0.2
0-19|0.2|0.3|0.2|103|Mortality|44270660|Hispanic|Male|Acute Myeloid|2005-2009|0.2|0.3|0.2
0-19|0.1|0.3|0.2|18|Mortality|8563877|Hispanic|Male|Acute Myeloid|2006|0.1|0.3|0.2
0-19|0.1|0.4|0.2|20|Mortality|8863218|Hispanic|Male|Acute Myeloid|2007|0.1|0.3|0.2
0-19|0.1|0.3|0.2|16|Mortality|9146469|Hispanic|Male|Acute Myeloid|2008|0.1|0.3|0.2
0-19|0.2|0.4|0.3|29|Mortality|9413284|Hispanic|Male|Acute Myeloid|2009|0.2|0.4|0.3
0-19|2.5|3.3|2.8|192|Mortality|6802550|Hispanic|Male|All Cancer Sites Combined|1999|2.4|3.3|2.8
0-19|3.1|4.0|3.5|247|Mortality|7110264|Hispanic|Male|All Cancer Sites Combined|2000|3.1|3.9|3.5
0-19|2.8|3.7|3.2|233|Mortality|7341536|Hispanic|Male|All Cancer Sites Combined|2001|2.8|3.6|3.2
0-19|2.8|3.6|3.2|234|Mortality|7563793|Hispanic|Male|All Cancer Sites Combined|2002|2.7|3.5|3.1
0-19|3.2|4.1|3.6|278|Mortality|7785714|Hispanic|Male|All Cancer Sites Combined|2003|3.2|4.0|3.6
0-19|2.8|3.7|3.2|248|Mortality|8024129|Hispanic|Male|All Cancer Sites Combined|2004|2.7|3.5|3.1
0-19|2.7|3.5|3.1|246|Mortality|8283812|Hispanic|Male|All Cancer Sites Combined|2005|2.6|3.4|3.0
0-19|2.7|3.0|2.8|1213|Mortality|44270660|Hispanic|Male|All Cancer Sites Combined|2005-2009|2.6|2.9|2.7
0-19|2.3|3.1|2.7|226|Mortality|8563877|Hispanic|Male|All Cancer Sites Combined|2006|2.3|3.0|2.6
0-19|2.5|3.3|2.9|245|Mortality|8863218|Hispanic|Male|All Cancer Sites Combined|2007|2.4|3.1|2.8
0-19|2.5|3.2|2.9|255|Mortality|9146469|Hispanic|Male|All Cancer Sites Combined|2008|2.5|3.2|2.8
0-19|2.3|3.0|2.6|241|Mortality|9413284|Hispanic|Male|All Cancer Sites Combined|2009|2.2|2.9|2.6
0-19|0.2|0.5|0.3|21|Mortality|6802550|Hispanic|Male|Bones and Joints|1999|0.2|0.5|0.3
0-19|0.2|0.5|0.3|22|Mortality|7110264|Hispanic|Male|Bones and Joints|2000|0.2|0.5|0.3
0-19|0.2|0.4|0.3|18|Mortality|7341536|Hispanic|Male|Bones and Joints|2001|0.1|0.4|0.2
0-19|0.1|0.4|0.2|16|Mortality|7563793|Hispanic|Male|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.2|0.4|0.3|19|Mortality|7785714|Hispanic|Male|Bones and Joints|2003|0.1|0.4|0.2
0-19|0.2|0.5|0.3|25|Mortality|8024129|Hispanic|Male|Bones and Joints|2004|0.2|0.5|0.3
0-19|0.2|0.4|0.3|21|Mortality|8283812|Hispanic|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.3|103|Mortality|44270660|Hispanic|Male|Bones and Joints|2005-2009|0.2|0.3|0.2
0-19|0.2|0.4|0.3|20|Mortality|8563877|Hispanic|Male|Bones and Joints|2006|0.1|0.4|0.2
0-19|0.1|0.4|0.2|19|Mortality|8863218|Hispanic|Male|Bones and Joints|2007|0.1|0.3|0.2
0-19|0.2|0.4|0.3|22|Mortality|9146469|Hispanic|Male|Bones and Joints|2008|0.2|0.4|0.2
0-19|0.2|0.4|0.3|21|Mortality|9413284|Hispanic|Male|Bones and Joints|2009|0.1|0.3|0.2
0-19|0.4|0.8|0.6|39|Mortality|6802550|Hispanic|Male|Brain and Other Nervous System|1999|0.4|0.8|0.6
0-19|0.7|1.1|0.9|61|Mortality|7110264|Hispanic|Male|Brain and Other Nervous System|2000|0.7|1.1|0.9
0-19|0.4|0.7|0.5|40|Mortality|7341536|Hispanic|Male|Brain and Other Nervous System|2001|0.4|0.7|0.5
0-19|0.5|0.9|0.7|52|Mortality|7563793|Hispanic|Male|Brain and Other Nervous System|2002|0.5|0.9|0.7
0-19|0.6|1.0|0.7|57|Mortality|7785714|Hispanic|Male|Brain and Other Nervous System|2003|0.6|0.9|0.7
0-19|0.5|0.8|0.6|48|Mortality|8024129|Hispanic|Male|Brain and Other Nervous System|2004|0.4|0.8|0.6
0-19|0.4|0.7|0.6|45|Mortality|8283812|Hispanic|Male|Brain and Other Nervous System|2005|0.4|0.7|0.5
0-19|0.5|0.7|0.6|264|Mortality|44270660|Hispanic|Male|Brain and Other Nervous System|2005-2009|0.5|0.7|0.6
0-19|0.4|0.8|0.6|51|Mortality|8563877|Hispanic|Male|Brain and Other Nervous System|2006|0.4|0.8|0.6
0-19|0.4|0.7|0.6|50|Mortality|8863218|Hispanic|Male|Brain and Other Nervous System|2007|0.4|0.7|0.6
0-19|0.5|0.8|0.7|59|Mortality|9146469|Hispanic|Male|Brain and Other Nervous System|2008|0.5|0.8|0.6
0-19|0.5|0.8|0.6|59|Mortality|9413284|Hispanic|Male|Brain and Other Nervous System|2009|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|7110264|Hispanic|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|7341536|Hispanic|Male|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7563793|Hispanic|Male|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7785714|Hispanic|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|8024129|Hispanic|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|8283812|Hispanic|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|~|~|~|~|Mortality|44270660|Hispanic|Male|Hodgkin Lymphoma|2005-2009|~|~|~
0-19|~|~|~|~|Mortality|8563877|Hispanic|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8863218|Hispanic|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|9146469|Hispanic|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|9413284|Hispanic|Male|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|7110264|Hispanic|Male|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|7341536|Hispanic|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|7563793|Hispanic|Male|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|7785714|Hispanic|Male|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|8024129|Hispanic|Male|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|8283812|Hispanic|Male|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.0|0.1|0.0|16|Mortality|44270660|Hispanic|Male|Kidney and Renal Pelvis|2005-2009|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|8563877|Hispanic|Male|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|8863218|Hispanic|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|9146469|Hispanic|Male|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|9413284|Hispanic|Male|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.9|1.4|1.1|74|Mortality|6802550|Hispanic|Male|Leukemia|1999|0.9|1.4|1.1
0-19|1.1|1.6|1.3|92|Mortality|7110264|Hispanic|Male|Leukemia|2000|1.0|1.6|1.3
0-19|1.2|1.8|1.5|106|Mortality|7341536|Hispanic|Male|Leukemia|2001|1.2|1.7|1.4
0-19|1.0|1.5|1.3|91|Mortality|7563793|Hispanic|Male|Leukemia|2002|1.0|1.5|1.2
0-19|1.1|1.7|1.4|105|Mortality|7785714|Hispanic|Male|Leukemia|2003|1.1|1.6|1.3
0-19|1.2|1.8|1.5|112|Mortality|8024129|Hispanic|Male|Leukemia|2004|1.1|1.7|1.4
0-19|1.1|1.6|1.3|103|Mortality|8283812|Hispanic|Male|Leukemia|2005|1.0|1.5|1.2
0-19|1.0|1.2|1.1|450|Mortality|44270660|Hispanic|Male|Leukemia|2005-2009|0.9|1.1|1.0
0-19|0.7|1.2|0.9|77|Mortality|8563877|Hispanic|Male|Leukemia|2006|0.7|1.1|0.9
0-19|0.9|1.3|1.1|92|Mortality|8863218|Hispanic|Male|Leukemia|2007|0.8|1.3|1.0
0-19|0.7|1.2|0.9|84|Mortality|9146469|Hispanic|Male|Leukemia|2008|0.7|1.1|0.9
0-19|0.8|1.3|1.0|94|Mortality|9413284|Hispanic|Male|Leukemia|2009|0.8|1.2|1.0
0-19|~|~|~|~|Mortality|6802550|Hispanic|Male|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|7110264|Hispanic|Male|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|7341536|Hispanic|Male|Non-Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|7563793|Hispanic|Male|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|7785714|Hispanic|Male|Non-Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|8024129|Hispanic|Male|Non-Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|8283812|Hispanic|Male|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.1|0.2|0.1|55|Mortality|44270660|Hispanic|Male|Non-Hodgkin Lymphoma|2005-2009|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|8563877|Hispanic|Male|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|8863218|Hispanic|Male|Non-Hodgkin Lymphoma|2007|~|~|~
0-19|0.1|0.3|0.2|16|Mortality|9146469|Hispanic|Male|Non-Hodgkin Lymphoma|2008|0.1|0.3|0.2
0-19|~|~|~|~|Mortality|9413284|Hispanic|Male|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|0.3|0.6|0.4|29|Mortality|6802550|Hispanic|Male|Other|1999|0.3|0.6|0.4
0-19|0.5|0.9|0.7|49|Mortality|7110264|Hispanic|Male|Other|2000|0.5|0.9|0.7
0-19|0.3|0.6|0.4|31|Mortality|7341536|Hispanic|Male|Other|2001|0.3|0.6|0.4
0-19|0.4|0.8|0.6|46|Mortality|7563793|Hispanic|Male|Other|2002|0.4|0.8|0.6
0-19|0.5|0.9|0.7|54|Mortality|7785714|Hispanic|Male|Other|2003|0.5|0.9|0.7
0-19|0.2|0.5|0.4|28|Mortality|8024129|Hispanic|Male|Other|2004|0.2|0.5|0.3
0-19|0.4|0.8|0.6|48|Mortality|8283812|Hispanic|Male|Other|2005|0.4|0.8|0.6
0-19|0.5|0.6|0.5|235|Mortality|44270660|Hispanic|Male|Other|2005-2009|0.5|0.6|0.5
0-19|0.4|0.7|0.5|46|Mortality|8563877|Hispanic|Male|Other|2006|0.4|0.7|0.5
0-19|0.5|0.8|0.6|54|Mortality|8863218|Hispanic|Male|Other|2007|0.5|0.8|0.6
0-19|0.4|0.7|0.5|47|Mortality|9146469|Hispanic|Male|Other|2008|0.4|0.7|0.5
0-19|0.3|0.6|0.4|40|Mortality|9413284|Hispanic|Male|Other|2009|0.3|0.6|0.4
0-19|0.1|0.4|0.2|16|Mortality|6802550|Hispanic|Male|Soft Tissue|1999|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7110264|Hispanic|Male|Soft Tissue|2000|~|~|~
0-19|0.1|0.4|0.2|16|Mortality|7341536|Hispanic|Male|Soft Tissue|2001|0.1|0.4|0.2
0-19|~|~|~|~|Mortality|7563793|Hispanic|Male|Soft Tissue|2002|~|~|~
0-19|0.2|0.4|0.3|21|Mortality|7785714|Hispanic|Male|Soft Tissue|2003|0.2|0.4|0.3
0-19|~|~|~|~|Mortality|8024129|Hispanic|Male|Soft Tissue|2004|~|~|~
0-19|~|~|~|~|Mortality|8283812|Hispanic|Male|Soft Tissue|2005|~|~|~
0-19|0.1|0.2|0.2|76|Mortality|44270660|Hispanic|Male|Soft Tissue|2005-2009|0.1|0.2|0.2
0-19|~|~|~|~|Mortality|8563877|Hispanic|Male|Soft Tissue|2006|~|~|~
0-19|~|~|~|~|Mortality|8863218|Hispanic|Male|Soft Tissue|2007|~|~|~
0-19|0.1|0.4|0.2|19|Mortality|9146469|Hispanic|Male|Soft Tissue|2008|0.1|0.3|0.2
0-19|0.1|0.3|0.2|16|Mortality|9413284|Hispanic|Male|Soft Tissue|2009|0.1|0.3|0.2
0-19|0.4|0.7|0.5|66|Mortality|13184646|Hispanic|Male and Female|Acute Lymphocytic|1999|0.4|0.6|0.5
0-19|0.5|0.8|0.7|89|Mortality|13781844|Hispanic|Male and Female|Acute Lymphocytic|2000|0.5|0.8|0.6
0-19|0.6|0.9|0.7|99|Mortality|14245843|Hispanic|Male and Female|Acute Lymphocytic|2001|0.6|0.8|0.7
0-19|0.5|0.8|0.6|91|Mortality|14697880|Hispanic|Male and Female|Acute Lymphocytic|2002|0.5|0.8|0.6
0-19|0.5|0.8|0.7|100|Mortality|15151074|Hispanic|Male and Female|Acute Lymphocytic|2003|0.5|0.8|0.7
0-19|0.5|0.8|0.7|99|Mortality|15630881|Hispanic|Male and Female|Acute Lymphocytic|2004|0.5|0.8|0.6
0-19|0.4|0.7|0.5|84|Mortality|16143779|Hispanic|Male and Female|Acute Lymphocytic|2005|0.4|0.6|0.5
0-19|0.5|0.6|0.5|417|Mortality|86323894|Hispanic|Male and Female|Acute Lymphocytic|2005-2009|0.4|0.5|0.5
0-19|0.4|0.6|0.5|72|Mortality|16696171|Hispanic|Male and Female|Acute Lymphocytic|2006|0.3|0.5|0.4
0-19|0.5|0.7|0.6|93|Mortality|17282171|Hispanic|Male and Female|Acute Lymphocytic|2007|0.4|0.7|0.5
0-19|0.4|0.6|0.5|84|Mortality|17839235|Hispanic|Male and Female|Acute Lymphocytic|2008|0.4|0.6|0.5
0-19|0.4|0.6|0.5|84|Mortality|18362538|Hispanic|Male and Female|Acute Lymphocytic|2009|0.4|0.6|0.5
0-19|0.2|0.4|0.3|43|Mortality|13184646|Hispanic|Male and Female|Acute Myeloid|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|39|Mortality|13781844|Hispanic|Male and Female|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|43|Mortality|14245843|Hispanic|Male and Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.4|0.3|45|Mortality|14697880|Hispanic|Male and Female|Acute Myeloid|2002|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|15151074|Hispanic|Male and Female|Acute Myeloid|2003|0.2|0.4|0.3
0-19|0.2|0.4|0.3|41|Mortality|15630881|Hispanic|Male and Female|Acute Myeloid|2004|0.2|0.4|0.3
0-19|0.2|0.4|0.3|43|Mortality|16143779|Hispanic|Male and Female|Acute Myeloid|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|211|Mortality|86323894|Hispanic|Male and Female|Acute Myeloid|2005-2009|0.2|0.3|0.2
0-19|0.2|0.3|0.2|37|Mortality|16696171|Hispanic|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|37|Mortality|17282171|Hispanic|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|40|Mortality|17839235|Hispanic|Male and Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|0.2|0.4|0.3|54|Mortality|18362538|Hispanic|Male and Female|Acute Myeloid|2009|0.2|0.4|0.3
0-19|2.5|3.0|2.7|358|Mortality|13184646|Hispanic|Male and Female|All Cancer Sites Combined|1999|2.4|3.0|2.7
0-19|2.8|3.3|3.0|412|Mortality|13781844|Hispanic|Male and Female|All Cancer Sites Combined|2000|2.7|3.3|3.0
0-19|2.7|3.3|3.0|418|Mortality|14245843|Hispanic|Male and Female|All Cancer Sites Combined|2001|2.7|3.2|2.9
0-19|2.6|3.2|2.9|421|Mortality|14697880|Hispanic|Male and Female|All Cancer Sites Combined|2002|2.6|3.2|2.9
0-19|2.8|3.3|3.0|452|Mortality|15151074|Hispanic|Male and Female|All Cancer Sites Combined|2003|2.7|3.3|3.0
0-19|2.6|3.2|2.9|437|Mortality|15630881|Hispanic|Male and Female|All Cancer Sites Combined|2004|2.5|3.1|2.8
0-19|2.5|3.0|2.8|432|Mortality|16143779|Hispanic|Male and Female|All Cancer Sites Combined|2005|2.4|2.9|2.7
0-19|2.5|2.8|2.6|2227|Mortality|86323894|Hispanic|Male and Female|All Cancer Sites Combined|2005-2009|2.5|2.7|2.6
0-19|2.2|2.7|2.5|406|Mortality|16696171|Hispanic|Male and Female|All Cancer Sites Combined|2006|2.2|2.7|2.4
0-19|2.5|3.0|2.7|453|Mortality|17282171|Hispanic|Male and Female|All Cancer Sites Combined|2007|2.4|2.9|2.6
0-19|2.5|3.0|2.7|473|Mortality|17839235|Hispanic|Male and Female|All Cancer Sites Combined|2008|2.4|2.9|2.7
0-19|2.3|2.8|2.6|463|Mortality|18362538|Hispanic|Male and Female|All Cancer Sites Combined|2009|2.3|2.8|2.5
0-19|0.2|0.4|0.3|40|Mortality|13184646|Hispanic|Male and Female|Bones and Joints|1999|0.2|0.4|0.3
0-19|0.2|0.4|0.3|40|Mortality|13781844|Hispanic|Male and Female|Bones and Joints|2000|0.2|0.4|0.3
0-19|0.2|0.4|0.3|35|Mortality|14245843|Hispanic|Male and Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|32|Mortality|14697880|Hispanic|Male and Female|Bones and Joints|2002|0.1|0.3|0.2
0-19|0.2|0.3|0.2|34|Mortality|15151074|Hispanic|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.4|0.3|36|Mortality|15630881|Hispanic|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.4|0.3|38|Mortality|16143779|Hispanic|Male and Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.2|185|Mortality|86323894|Hispanic|Male and Female|Bones and Joints|2005-2009|0.2|0.2|0.2
0-19|0.2|0.3|0.2|36|Mortality|16696171|Hispanic|Male and Female|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.1|0.3|0.2|31|Mortality|17282171|Hispanic|Male and Female|Bones and Joints|2007|0.1|0.3|0.2
0-19|0.2|0.4|0.3|45|Mortality|17839235|Hispanic|Male and Female|Bones and Joints|2008|0.2|0.3|0.3
0-19|0.2|0.3|0.2|35|Mortality|18362538|Hispanic|Male and Female|Bones and Joints|2009|0.1|0.3|0.2
0-19|0.5|0.7|0.6|81|Mortality|13184646|Hispanic|Male and Female|Brain and Other Nervous System|1999|0.5|0.8|0.6
0-19|0.6|0.9|0.7|100|Mortality|13781844|Hispanic|Male and Female|Brain and Other Nervous System|2000|0.6|0.9|0.7
0-19|0.4|0.7|0.6|79|Mortality|14245843|Hispanic|Male and Female|Brain and Other Nervous System|2001|0.4|0.7|0.6
0-19|0.5|0.8|0.6|90|Mortality|14697880|Hispanic|Male and Female|Brain and Other Nervous System|2002|0.5|0.8|0.6
0-19|0.6|0.8|0.7|103|Mortality|15151074|Hispanic|Male and Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.5|0.8|0.7|102|Mortality|15630881|Hispanic|Male and Female|Brain and Other Nervous System|2004|0.5|0.8|0.7
0-19|0.5|0.8|0.6|101|Mortality|16143779|Hispanic|Male and Female|Brain and Other Nervous System|2005|0.5|0.8|0.6
0-19|0.5|0.6|0.6|512|Mortality|86323894|Hispanic|Male and Female|Brain and Other Nervous System|2005-2009|0.5|0.6|0.6
0-19|0.4|0.7|0.5|92|Mortality|16696171|Hispanic|Male and Female|Brain and Other Nervous System|2006|0.4|0.7|0.6
0-19|0.4|0.7|0.5|94|Mortality|17282171|Hispanic|Male and Female|Brain and Other Nervous System|2007|0.4|0.7|0.5
0-19|0.5|0.7|0.6|106|Mortality|17839235|Hispanic|Male and Female|Brain and Other Nervous System|2008|0.5|0.7|0.6
0-19|0.5|0.8|0.6|119|Mortality|18362538|Hispanic|Male and Female|Brain and Other Nervous System|2009|0.5|0.8|0.6
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13781844|Hispanic|Male and Female|Hodgkin Lymphoma|2000|~|~|~
0-19|~|~|~|~|Mortality|14245843|Hispanic|Male and Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|14697880|Hispanic|Male and Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|15151074|Hispanic|Male and Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|15630881|Hispanic|Male and Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|16143779|Hispanic|Male and Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.0|0.0|19|Mortality|86323894|Hispanic|Male and Female|Hodgkin Lymphoma|2005-2009|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|16696171|Hispanic|Male and Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|17282171|Hispanic|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|17839235|Hispanic|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|18362538|Hispanic|Male and Female|Hodgkin Lymphoma|2009|~|~|~
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Kidney and Renal Pelvis|1999|~|~|~
0-19|~|~|~|~|Mortality|13781844|Hispanic|Male and Female|Kidney and Renal Pelvis|2000|~|~|~
0-19|~|~|~|~|Mortality|14245843|Hispanic|Male and Female|Kidney and Renal Pelvis|2001|~|~|~
0-19|~|~|~|~|Mortality|14697880|Hispanic|Male and Female|Kidney and Renal Pelvis|2002|~|~|~
0-19|~|~|~|~|Mortality|15151074|Hispanic|Male and Female|Kidney and Renal Pelvis|2003|~|~|~
0-19|~|~|~|~|Mortality|15630881|Hispanic|Male and Female|Kidney and Renal Pelvis|2004|~|~|~
0-19|~|~|~|~|Mortality|16143779|Hispanic|Male and Female|Kidney and Renal Pelvis|2005|~|~|~
0-19|0.0|0.1|0.0|40|Mortality|86323894|Hispanic|Male and Female|Kidney and Renal Pelvis|2005-2009|0.0|0.1|0.0
0-19|~|~|~|~|Mortality|16696171|Hispanic|Male and Female|Kidney and Renal Pelvis|2006|~|~|~
0-19|~|~|~|~|Mortality|17282171|Hispanic|Male and Female|Kidney and Renal Pelvis|2007|~|~|~
0-19|~|~|~|~|Mortality|17839235|Hispanic|Male and Female|Kidney and Renal Pelvis|2008|~|~|~
0-19|~|~|~|~|Mortality|18362538|Hispanic|Male and Female|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.9|1.3|1.1|141|Mortality|13184646|Hispanic|Male and Female|Leukemia|1999|0.9|1.3|1.1
0-19|1.0|1.3|1.1|155|Mortality|13781844|Hispanic|Male and Female|Leukemia|2000|1.0|1.3|1.1
0-19|1.1|1.5|1.3|187|Mortality|14245843|Hispanic|Male and Female|Leukemia|2001|1.1|1.5|1.3
0-19|1.0|1.3|1.2|164|Mortality|14697880|Hispanic|Male and Female|Leukemia|2002|1.0|1.3|1.1
0-19|1.0|1.3|1.1|172|Mortality|15151074|Hispanic|Male and Female|Leukemia|2003|1.0|1.3|1.1
0-19|1.0|1.4|1.2|183|Mortality|15630881|Hispanic|Male and Female|Leukemia|2004|1.0|1.4|1.2
0-19|0.9|1.2|1.1|165|Mortality|16143779|Hispanic|Male and Female|Leukemia|2005|0.9|1.2|1.0
0-19|0.9|1.1|1.0|820|Mortality|86323894|Hispanic|Male and Female|Leukemia|2005-2009|0.9|1.0|0.9
0-19|0.7|1.0|0.9|140|Mortality|16696171|Hispanic|Male and Female|Leukemia|2006|0.7|1.0|0.8
0-19|0.9|1.2|1.0|172|Mortality|17282171|Hispanic|Male and Female|Leukemia|2007|0.9|1.2|1.0
0-19|0.8|1.1|1.0|169|Mortality|17839235|Hispanic|Male and Female|Leukemia|2008|0.8|1.1|0.9
0-19|0.8|1.1|1.0|174|Mortality|18362538|Hispanic|Male and Female|Leukemia|2009|0.8|1.1|0.9
0-19|~|~|~|~|Mortality|13184646|Hispanic|Male and Female|Non-Hodgkin Lymphoma|1999|~|~|~
0-19|~|~|~|~|Mortality|13781844|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2000|~|~|~
0-19|0.1|0.2|0.1|17|Mortality|14245843|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|14697880|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2002|~|~|~
0-19|0.1|0.2|0.1|20|Mortality|15151074|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.2|0.1|20|Mortality|15630881|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|16143779|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005|~|~|~
0-19|0.1|0.1|0.1|88|Mortality|86323894|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2005-2009|0.1|0.1|0.1
0-19|0.1|0.2|0.1|19|Mortality|16696171|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.1|20|Mortality|17282171|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.1|0.2|0.1|22|Mortality|17839235|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2008|0.1|0.2|0.1
0-19|~|~|~|~|Mortality|18362538|Hispanic|Male and Female|Non-Hodgkin Lymphoma|2009|~|~|~
0-19|0.3|0.5|0.4|52|Mortality|13184646|Hispanic|Male and Female|Other|1999|0.3|0.5|0.4
0-19|0.4|0.7|0.5|74|Mortality|13781844|Hispanic|Male and Female|Other|2000|0.4|0.7|0.5
0-19|0.3|0.5|0.4|52|Mortality|14245843|Hispanic|Male and Female|Other|2001|0.3|0.5|0.4
0-19|0.4|0.7|0.6|81|Mortality|14697880|Hispanic|Male and Female|Other|2002|0.4|0.7|0.6
0-19|0.4|0.6|0.5|76|Mortality|15151074|Hispanic|Male and Female|Other|2003|0.4|0.6|0.5
0-19|0.3|0.5|0.4|58|Mortality|15630881|Hispanic|Male and Female|Other|2004|0.3|0.5|0.4
0-19|0.4|0.6|0.5|74|Mortality|16143779|Hispanic|Male and Female|Other|2005|0.4|0.6|0.5
0-19|0.4|0.5|0.5|406|Mortality|86323894|Hispanic|Male and Female|Other|2005-2009|0.4|0.5|0.5
0-19|0.4|0.6|0.5|77|Mortality|16696171|Hispanic|Male and Female|Other|2006|0.4|0.6|0.5
0-19|0.4|0.7|0.6|96|Mortality|17282171|Hispanic|Male and Female|Other|2007|0.4|0.7|0.6
0-19|0.4|0.6|0.5|83|Mortality|17839235|Hispanic|Male and Female|Other|2008|0.4|0.6|0.5
0-19|0.3|0.5|0.4|76|Mortality|18362538|Hispanic|Male and Female|Other|2009|0.3|0.5|0.4
0-19|0.1|0.3|0.2|24|Mortality|13184646|Hispanic|Male and Female|Soft Tissue|1999|0.1|0.3|0.2
0-19|0.1|0.3|0.2|26|Mortality|13781844|Hispanic|Male and Female|Soft Tissue|2000|0.1|0.3|0.2
0-19|0.2|0.3|0.2|31|Mortality|14245843|Hispanic|Male and Female|Soft Tissue|2001|0.1|0.3|0.2
0-19|0.1|0.3|0.2|27|Mortality|14697880|Hispanic|Male and Female|Soft Tissue|2002|0.1|0.3|0.2
0-19|0.2|0.3|0.2|35|Mortality|15151074|Hispanic|Male and Female|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.1|0.2|0.2|25|Mortality|15630881|Hispanic|Male and Female|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.1|0.3|0.2|30|Mortality|16143779|Hispanic|Male and Female|Soft Tissue|2005|0.1|0.3|0.2
0-19|0.2|0.2|0.2|157|Mortality|86323894|Hispanic|Male and Female|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.1|0.3|0.2|30|Mortality|16696171|Hispanic|Male and Female|Soft Tissue|2006|0.1|0.3|0.2
0-19|0.1|0.2|0.2|28|Mortality|17282171|Hispanic|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.1|0.3|0.2|34|Mortality|17839235|Hispanic|Male and Female|Soft Tissue|2008|0.1|0.3|0.2
0-19|0.1|0.3|0.2|35|Mortality|18362538|Hispanic|Male and Female|Soft Tissue|2009|0.1|0.3|0.2
0-19|0.2|0.4|0.3|92|Mortality|30457609|White|Female|Acute Lymphocytic|1999|0.2|0.4|0.3
0-19|0.3|0.4|0.4|108|Mortality|30592817|White|Female|Acute Lymphocytic|2000|0.3|0.4|0.4
0-19|0.3|0.4|0.3|99|Mortality|30689370|White|Female|Acute Lymphocytic|2001|0.3|0.4|0.3
0-19|0.3|0.4|0.4|115|Mortality|30773483|White|Female|Acute Lymphocytic|2002|0.3|0.4|0.4
0-19|0.3|0.4|0.3|101|Mortality|30859652|White|Female|Acute Lymphocytic|2003|0.3|0.4|0.3
0-19|0.3|0.4|0.3|103|Mortality|30966595|White|Female|Acute Lymphocytic|2004|0.3|0.4|0.3
0-19|0.2|0.3|0.3|84|Mortality|31023899|White|Female|Acute Lymphocytic|2005|0.2|0.3|0.3
0-19|0.3|0.3|0.3|458|Mortality|156040675|White|Female|Acute Lymphocytic|2005-2009|0.3|0.3|0.3
0-19|0.2|0.4|0.3|96|Mortality|31103287|White|Female|Acute Lymphocytic|2006|0.3|0.4|0.3
0-19|0.3|0.4|0.3|106|Mortality|31233583|White|Female|Acute Lymphocytic|2007|0.3|0.4|0.3
0-19|0.2|0.4|0.3|92|Mortality|31316144|White|Female|Acute Lymphocytic|2008|0.2|0.4|0.3
0-19|0.2|0.3|0.3|80|Mortality|31363762|White|Female|Acute Lymphocytic|2009|0.2|0.3|0.3
0-19|0.2|0.3|0.3|83|Mortality|30457609|White|Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|76|Mortality|30592817|White|Female|Acute Myeloid|2000|0.2|0.3|0.2
0-19|0.2|0.4|0.3|94|Mortality|30689370|White|Female|Acute Myeloid|2001|0.2|0.4|0.3
0-19|0.2|0.3|0.2|76|Mortality|30773483|White|Female|Acute Myeloid|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|67|Mortality|30859652|White|Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|69|Mortality|30966595|White|Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|78|Mortality|31023899|White|Female|Acute Myeloid|2005|0.2|0.3|0.3
0-19|0.2|0.2|0.2|330|Mortality|156040675|White|Female|Acute Myeloid|2005-2009|0.2|0.2|0.2
0-19|0.2|0.3|0.2|67|Mortality|31103287|White|Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|62|Mortality|31233583|White|Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|71|Mortality|31316144|White|Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|0.1|0.2|0.2|52|Mortality|31363762|White|Female|Acute Myeloid|2009|0.1|0.2|0.2
0-19|2.3|2.7|2.5|760|Mortality|30457609|White|Female|All Cancer Sites Combined|1999|2.3|2.7|2.5
0-19|2.3|2.7|2.5|767|Mortality|30592817|White|Female|All Cancer Sites Combined|2000|2.3|2.7|2.5
0-19|2.4|2.8|2.6|803|Mortality|30689370|White|Female|All Cancer Sites Combined|2001|2.4|2.8|2.6
0-19|2.3|2.7|2.5|776|Mortality|30773483|White|Female|All Cancer Sites Combined|2002|2.3|2.7|2.5
0-19|2.3|2.6|2.4|756|Mortality|30859652|White|Female|All Cancer Sites Combined|2003|2.3|2.6|2.4
0-19|2.3|2.6|2.4|753|Mortality|30966595|White|Female|All Cancer Sites Combined|2004|2.3|2.6|2.4
0-19|2.2|2.6|2.4|741|Mortality|31023899|White|Female|All Cancer Sites Combined|2005|2.2|2.6|2.4
0-19|2.2|2.4|2.3|3566|Mortality|156040675|White|Female|All Cancer Sites Combined|2005-2009|2.2|2.4|2.3
0-19|2.0|2.3|2.2|676|Mortality|31103287|White|Female|All Cancer Sites Combined|2006|2.0|2.3|2.2
0-19|2.2|2.6|2.4|753|Mortality|31233583|White|Female|All Cancer Sites Combined|2007|2.2|2.6|2.4
0-19|2.1|2.5|2.3|726|Mortality|31316144|White|Female|All Cancer Sites Combined|2008|2.2|2.5|2.3
0-19|2.0|2.3|2.1|670|Mortality|31363762|White|Female|All Cancer Sites Combined|2009|2.0|2.3|2.1
0-19|0.2|0.3|0.2|74|Mortality|30457609|White|Female|Bones and Joints|1999|0.2|0.3|0.2
0-19|0.2|0.3|0.2|62|Mortality|30592817|White|Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|64|Mortality|30689370|White|Female|Bones and Joints|2001|0.2|0.3|0.2
0-19|0.2|0.3|0.2|72|Mortality|30773483|White|Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.1|0.2|0.2|53|Mortality|30859652|White|Female|Bones and Joints|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|55|Mortality|30966595|White|Female|Bones and Joints|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|77|Mortality|31023899|White|Female|Bones and Joints|2005|0.2|0.3|0.2
0-19|0.2|0.2|0.2|348|Mortality|156040675|White|Female|Bones and Joints|2005-2009|0.2|0.2|0.2
0-19|0.1|0.2|0.2|58|Mortality|31103287|White|Female|Bones and Joints|2006|0.1|0.2|0.2
0-19|0.2|0.3|0.2|68|Mortality|31233583|White|Female|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|77|Mortality|31316144|White|Female|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|68|Mortality|31363762|White|Female|Bones and Joints|2009|0.2|0.3|0.2
0-19|0.6|0.8|0.7|201|Mortality|30457609|White|Female|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.5|0.7|0.6|189|Mortality|30592817|White|Female|Brain and Other Nervous System|2000|0.5|0.7|0.6
0-19|0.6|0.8|0.7|209|Mortality|30689370|White|Female|Brain and Other Nervous System|2001|0.6|0.8|0.7
0-19|0.5|0.7|0.6|191|Mortality|30773483|White|Female|Brain and Other Nervous System|2002|0.5|0.7|0.6
0-19|0.6|0.8|0.7|220|Mortality|30859652|White|Female|Brain and Other Nervous System|2003|0.6|0.8|0.7
0-19|0.6|0.7|0.6|199|Mortality|30966595|White|Female|Brain and Other Nervous System|2004|0.6|0.7|0.6
0-19|0.6|0.8|0.7|204|Mortality|31023899|White|Female|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.6|979|Mortality|156040675|White|Female|Brain and Other Nervous System|2005-2009|0.6|0.7|0.6
0-19|0.5|0.7|0.6|177|Mortality|31103287|White|Female|Brain and Other Nervous System|2006|0.5|0.7|0.6
0-19|0.6|0.8|0.7|215|Mortality|31233583|White|Female|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|0.5|0.7|0.6|197|Mortality|31316144|White|Female|Brain and Other Nervous System|2008|0.5|0.7|0.6
0-19|0.5|0.7|0.6|186|Mortality|31363762|White|Female|Brain and Other Nervous System|2009|0.5|0.7|0.6
0-19|~|~|~|~|Mortality|30457609|White|Female|Hodgkin Lymphoma|1999|~|~|~
0-19|0.0|0.1|0.1|16|Mortality|30592817|White|Female|Hodgkin Lymphoma|2000|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|30689370|White|Female|Hodgkin Lymphoma|2001|~|~|~
0-19|~|~|~|~|Mortality|30773483|White|Female|Hodgkin Lymphoma|2002|~|~|~
0-19|~|~|~|~|Mortality|30859652|White|Female|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|30966595|White|Female|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|31023899|White|Female|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.0|0.0|31|Mortality|156040675|White|Female|Hodgkin Lymphoma|2005-2009|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|31103287|White|Female|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|31233583|White|Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|31316144|White|Female|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|31363762|White|Female|Hodgkin Lymphoma|2009|~|~|~
0-19|0.0|0.1|0.1|20|Mortality|30457609|White|Female|Kidney and Renal Pelvis|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.1|18|Mortality|30592817|White|Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.1|0.1|0.1|29|Mortality|30689370|White|Female|Kidney and Renal Pelvis|2001|0.1|0.1|0.1
0-19|0.1|0.1|0.1|24|Mortality|30773483|White|Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|29|Mortality|30859652|White|Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|27|Mortality|30966595|White|Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|25|Mortality|31023899|White|Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.1|0.1|0.1|104|Mortality|156040675|White|Female|Kidney and Renal Pelvis|2005-2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|31103287|White|Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|31233583|White|Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|18|Mortality|31316144|White|Female|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.1|19|Mortality|31363762|White|Female|Kidney and Renal Pelvis|2009|0.0|0.1|0.1
0-19|0.7|0.9|0.8|238|Mortality|30457609|White|Female|Leukemia|1999|0.7|0.9|0.8
0-19|0.7|0.9|0.8|253|Mortality|30592817|White|Female|Leukemia|2000|0.7|0.9|0.8
0-19|0.8|1.0|0.9|265|Mortality|30689370|White|Female|Leukemia|2001|0.8|1.0|0.9
0-19|0.7|0.9|0.8|236|Mortality|30773483|White|Female|Leukemia|2002|0.7|0.9|0.8
0-19|0.6|0.8|0.7|227|Mortality|30859652|White|Female|Leukemia|2003|0.6|0.8|0.7
0-19|0.6|0.8|0.7|222|Mortality|30966595|White|Female|Leukemia|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|206|Mortality|31023899|White|Female|Leukemia|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.7|1046|Mortality|156040675|White|Female|Leukemia|2005-2009|0.6|0.7|0.7
0-19|0.6|0.8|0.7|216|Mortality|31103287|White|Female|Leukemia|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|220|Mortality|31233583|White|Female|Leukemia|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|221|Mortality|31316144|White|Female|Leukemia|2008|0.6|0.8|0.7
0-19|0.5|0.7|0.6|183|Mortality|31363762|White|Female|Leukemia|2009|0.5|0.7|0.6
0-19|0.0|0.1|0.1|22|Mortality|30457609|White|Female|Non-Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.1|0.1|0.1|24|Mortality|30592817|White|Female|Non-Hodgkin Lymphoma|2000|0.1|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|30689370|White|Female|Non-Hodgkin Lymphoma|2001|0.0|0.1|0.1
0-19|0.1|0.1|0.1|27|Mortality|30773483|White|Female|Non-Hodgkin Lymphoma|2002|0.1|0.1|0.1
0-19|0.1|0.1|0.1|26|Mortality|30859652|White|Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|25|Mortality|30966595|White|Female|Non-Hodgkin Lymphoma|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|22|Mortality|31023899|White|Female|Non-Hodgkin Lymphoma|2005|0.0|0.1|0.1
0-19|0.1|0.1|0.1|98|Mortality|156040675|White|Female|Non-Hodgkin Lymphoma|2005-2009|0.1|0.1|0.1
0-19|~|~|~|~|Mortality|31103287|White|Female|Non-Hodgkin Lymphoma|2006|~|~|~
0-19|0.0|0.1|0.1|23|Mortality|31233583|White|Female|Non-Hodgkin Lymphoma|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|17|Mortality|31316144|White|Female|Non-Hodgkin Lymphoma|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.1|23|Mortality|31363762|White|Female|Non-Hodgkin Lymphoma|2009|0.0|0.1|0.1
0-19|0.4|0.6|0.5|149|Mortality|30457609|White|Female|Other|1999|0.4|0.6|0.5
0-19|0.4|0.6|0.5|151|Mortality|30592817|White|Female|Other|2000|0.4|0.6|0.5
0-19|0.4|0.6|0.5|154|Mortality|30689370|White|Female|Other|2001|0.4|0.6|0.5
0-19|0.4|0.6|0.5|158|Mortality|30773483|White|Female|Other|2002|0.4|0.6|0.5
0-19|0.4|0.5|0.5|141|Mortality|30859652|White|Female|Other|2003|0.4|0.5|0.5
0-19|0.4|0.6|0.5|157|Mortality|30966595|White|Female|Other|2004|0.4|0.6|0.5
0-19|0.3|0.5|0.4|128|Mortality|31023899|White|Female|Other|2005|0.3|0.5|0.4
0-19|0.4|0.5|0.4|668|Mortality|156040675|White|Female|Other|2005-2009|0.4|0.5|0.4
0-19|0.4|0.5|0.5|142|Mortality|31103287|White|Female|Other|2006|0.4|0.5|0.5
0-19|0.4|0.5|0.5|143|Mortality|31233583|White|Female|Other|2007|0.4|0.5|0.5
0-19|0.4|0.5|0.4|134|Mortality|31316144|White|Female|Other|2008|0.4|0.5|0.4
0-19|0.3|0.5|0.4|121|Mortality|31363762|White|Female|Other|2009|0.3|0.5|0.4
0-19|0.1|0.2|0.1|43|Mortality|30457609|White|Female|Soft Tissue|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.2|54|Mortality|30592817|White|Female|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.1|0.2|0.2|50|Mortality|30689370|White|Female|Soft Tissue|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|59|Mortality|30773483|White|Female|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.2|51|Mortality|30859652|White|Female|Soft Tissue|2003|0.1|0.2|0.2
0-19|0.1|0.2|0.2|58|Mortality|30966595|White|Female|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.2|0.3|0.2|73|Mortality|31023899|White|Female|Soft Tissue|2005|0.2|0.3|0.2
0-19|0.2|0.2|0.2|292|Mortality|156040675|White|Female|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.1|0.2|0.1|44|Mortality|31103287|White|Female|Soft Tissue|2006|0.1|0.2|0.1
0-19|0.1|0.2|0.2|55|Mortality|31233583|White|Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.1|0.2|0.2|56|Mortality|31316144|White|Female|Soft Tissue|2008|0.1|0.2|0.2
0-19|0.2|0.3|0.2|64|Mortality|31363762|White|Female|Soft Tissue|2009|0.2|0.3|0.2
0-19|0.4|0.5|0.4|144|Mortality|32187349|White|Male|Acute Lymphocytic|1999|0.4|0.5|0.4
0-19|0.5|0.6|0.5|176|Mortality|32335465|White|Male|Acute Lymphocytic|2000|0.5|0.6|0.5
0-19|0.4|0.6|0.5|154|Mortality|32449078|White|Male|Acute Lymphocytic|2001|0.4|0.6|0.5
0-19|0.4|0.6|0.5|158|Mortality|32522098|White|Male|Acute Lymphocytic|2002|0.4|0.6|0.5
0-19|0.5|0.6|0.6|180|Mortality|32578661|White|Male|Acute Lymphocytic|2003|0.5|0.6|0.6
0-19|0.4|0.5|0.5|151|Mortality|32666378|White|Male|Acute Lymphocytic|2004|0.4|0.5|0.5
0-19|0.4|0.5|0.4|146|Mortality|32710351|White|Male|Acute Lymphocytic|2005|0.4|0.5|0.4
0-19|0.4|0.4|0.4|655|Mortality|164397378|White|Male|Acute Lymphocytic|2005-2009|0.4|0.4|0.4
0-19|0.3|0.5|0.4|129|Mortality|32781426|White|Male|Acute Lymphocytic|2006|0.3|0.5|0.4
0-19|0.4|0.5|0.4|142|Mortality|32907095|White|Male|Acute Lymphocytic|2007|0.4|0.5|0.4
0-19|0.3|0.4|0.3|113|Mortality|32980214|White|Male|Acute Lymphocytic|2008|0.3|0.4|0.3
0-19|0.3|0.5|0.4|125|Mortality|33018292|White|Male|Acute Lymphocytic|2009|0.3|0.5|0.4
0-19|0.2|0.3|0.2|75|Mortality|32187349|White|Male|Acute Myeloid|1999|0.2|0.3|0.2
0-19|0.2|0.4|0.3|95|Mortality|32335465|White|Male|Acute Myeloid|2000|0.2|0.4|0.3
0-19|0.2|0.3|0.3|89|Mortality|32449078|White|Male|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|86|Mortality|32522098|White|Male|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.3|84|Mortality|32578661|White|Male|Acute Myeloid|2003|0.2|0.3|0.3
0-19|0.2|0.3|0.3|86|Mortality|32666378|White|Male|Acute Myeloid|2004|0.2|0.3|0.3
0-19|0.2|0.3|0.2|80|Mortality|32710351|White|Male|Acute Myeloid|2005|0.2|0.3|0.2
0-19|0.2|0.3|0.2|397|Mortality|164397378|White|Male|Acute Myeloid|2005-2009|0.2|0.3|0.2
0-19|0.2|0.3|0.3|84|Mortality|32781426|White|Male|Acute Myeloid|2006|0.2|0.3|0.3
0-19|0.2|0.3|0.2|80|Mortality|32907095|White|Male|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|67|Mortality|32980214|White|Male|Acute Myeloid|2008|0.2|0.3|0.2
0-19|0.2|0.3|0.3|86|Mortality|33018292|White|Male|Acute Myeloid|2009|0.2|0.3|0.3
0-19|2.9|3.3|3.1|994|Mortality|32187349|White|Male|All Cancer Sites Combined|1999|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1032|Mortality|32335465|White|Male|All Cancer Sites Combined|2000|3.0|3.4|3.2
0-19|2.8|3.2|3.0|971|Mortality|32449078|White|Male|All Cancer Sites Combined|2001|2.8|3.2|3.0
0-19|2.9|3.3|3.1|1006|Mortality|32522098|White|Male|All Cancer Sites Combined|2002|2.9|3.3|3.1
0-19|3.0|3.4|3.2|1041|Mortality|32578661|White|Male|All Cancer Sites Combined|2003|3.0|3.4|3.2
0-19|2.9|3.2|3.0|995|Mortality|32666378|White|Male|All Cancer Sites Combined|2004|2.9|3.2|3.0
0-19|2.8|3.2|3.0|993|Mortality|32710351|White|Male|All Cancer Sites Combined|2005|2.8|3.2|3.0
0-19|2.7|2.8|2.8|4550|Mortality|164397378|White|Male|All Cancer Sites Combined|2005-2009|2.7|2.8|2.8
0-19|2.6|3.0|2.8|925|Mortality|32781426|White|Male|All Cancer Sites Combined|2006|2.6|3.0|2.8
0-19|2.5|2.9|2.7|896|Mortality|32907095|White|Male|All Cancer Sites Combined|2007|2.5|2.9|2.7
0-19|2.5|2.8|2.7|884|Mortality|32980214|White|Male|All Cancer Sites Combined|2008|2.5|2.9|2.7
0-19|2.4|2.8|2.6|852|Mortality|33018292|White|Male|All Cancer Sites Combined|2009|2.4|2.8|2.6
0-19|0.2|0.4|0.3|94|Mortality|32187349|White|Male|Bones and Joints|1999|0.2|0.4|0.3
0-19|0.2|0.3|0.3|82|Mortality|32335465|White|Male|Bones and Joints|2000|0.2|0.3|0.3
0-19|0.2|0.4|0.3|95|Mortality|32449078|White|Male|Bones and Joints|2001|0.2|0.4|0.3
0-19|0.2|0.3|0.2|79|Mortality|32522098|White|Male|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.3|0.4|0.3|103|Mortality|32578661|White|Male|Bones and Joints|2003|0.3|0.4|0.3
0-19|0.2|0.3|0.3|92|Mortality|32666378|White|Male|Bones and Joints|2004|0.2|0.3|0.3
0-19|0.2|0.4|0.3|98|Mortality|32710351|White|Male|Bones and Joints|2005|0.2|0.4|0.3
0-19|0.2|0.3|0.2|405|Mortality|164397378|White|Male|Bones and Joints|2005-2009|0.2|0.3|0.2
0-19|0.2|0.3|0.2|80|Mortality|32781426|White|Male|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|77|Mortality|32907095|White|Male|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|77|Mortality|32980214|White|Male|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|73|Mortality|33018292|White|Male|Bones and Joints|2009|0.2|0.3|0.2
0-19|0.6|0.8|0.7|230|Mortality|32187349|White|Male|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.7|0.9|0.8|248|Mortality|32335465|White|Male|Brain and Other Nervous System|2000|0.7|0.9|0.8
0-19|0.6|0.8|0.7|219|Mortality|32449078|White|Male|Brain and Other Nervous System|2001|0.6|0.8|0.7
0-19|0.7|0.9|0.8|249|Mortality|32522098|White|Male|Brain and Other Nervous System|2002|0.7|0.9|0.8
0-19|0.7|0.9|0.8|250|Mortality|32578661|White|Male|Brain and Other Nervous System|2003|0.7|0.9|0.8
0-19|0.7|0.8|0.7|241|Mortality|32666378|White|Male|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|234|Mortality|32710351|White|Male|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.7|0.8|0.7|1159|Mortality|164397378|White|Male|Brain and Other Nervous System|2005-2009|0.7|0.7|0.7
0-19|0.6|0.8|0.7|238|Mortality|32781426|White|Male|Brain and Other Nervous System|2006|0.6|0.8|0.7
0-19|0.6|0.8|0.7|224|Mortality|32907095|White|Male|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|0.6|0.8|0.7|236|Mortality|32980214|White|Male|Brain and Other Nervous System|2008|0.6|0.8|0.7
0-19|0.6|0.8|0.7|227|Mortality|33018292|White|Male|Brain and Other Nervous System|2009|0.6|0.8|0.7
0-19|0.0|0.1|0.1|21|Mortality|32187349|White|Male|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32335465|White|Male|Hodgkin Lymphoma|2000|~|~|~
0-19|0.0|0.1|0.0|16|Mortality|32449078|White|Male|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.1|17|Mortality|32522098|White|Male|Hodgkin Lymphoma|2002|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32578661|White|Male|Hodgkin Lymphoma|2003|~|~|~
0-19|~|~|~|~|Mortality|32666378|White|Male|Hodgkin Lymphoma|2004|~|~|~
0-19|~|~|~|~|Mortality|32710351|White|Male|Hodgkin Lymphoma|2005|~|~|~
0-19|0.0|0.0|0.0|45|Mortality|164397378|White|Male|Hodgkin Lymphoma|2005-2009|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|32781426|White|Male|Hodgkin Lymphoma|2006|~|~|~
0-19|~|~|~|~|Mortality|32907095|White|Male|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|32980214|White|Male|Hodgkin Lymphoma|2008|~|~|~
0-19|~|~|~|~|Mortality|33018292|White|Male|Hodgkin Lymphoma|2009|~|~|~
0-19|0.0|0.1|0.1|24|Mortality|32187349|White|Male|Kidney and Renal Pelvis|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.1|17|Mortality|32335465|White|Male|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32449078|White|Male|Kidney and Renal Pelvis|2001|~|~|~
0-19|0.0|0.1|0.1|17|Mortality|32522098|White|Male|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.0|0.1|0.1|24|Mortality|32578661|White|Male|Kidney and Renal Pelvis|2003|0.0|0.1|0.1
0-19|0.0|0.1|0.1|21|Mortality|32666378|White|Male|Kidney and Renal Pelvis|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.1|20|Mortality|32710351|White|Male|Kidney and Renal Pelvis|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|82|Mortality|164397378|White|Male|Kidney and Renal Pelvis|2005-2009|0.0|0.1|0.0
0-19|0.0|0.1|0.1|20|Mortality|32781426|White|Male|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|32907095|White|Male|Kidney and Renal Pelvis|2007|~|~|~
0-19|0.0|0.1|0.1|18|Mortality|32980214|White|Male|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|~|~|~|~|Mortality|33018292|White|Male|Kidney and Renal Pelvis|2009|~|~|~
0-19|0.8|1.0|0.9|296|Mortality|32187349|White|Male|Leukemia|1999|0.8|1.0|0.9
0-19|0.9|1.2|1.1|343|Mortality|32335465|White|Male|Leukemia|2000|1.0|1.2|1.1
0-19|0.9|1.1|1.0|321|Mortality|32449078|White|Male|Leukemia|2001|0.9|1.1|1.0
0-19|0.8|1.1|0.9|310|Mortality|32522098|White|Male|Leukemia|2002|0.9|1.1|1.0
0-19|0.9|1.1|1.0|335|Mortality|32578661|White|Male|Leukemia|2003|0.9|1.1|1.0
0-19|0.8|1.1|0.9|310|Mortality|32666378|White|Male|Leukemia|2004|0.8|1.1|0.9
0-19|0.8|1.0|0.9|302|Mortality|32710351|White|Male|Leukemia|2005|0.8|1.0|0.9
0-19|0.8|0.9|0.8|1398|Mortality|164397378|White|Male|Leukemia|2005-2009|0.8|0.9|0.9
0-19|0.8|1.0|0.9|284|Mortality|32781426|White|Male|Leukemia|2006|0.8|1.0|0.9
0-19|0.8|1.0|0.9|289|Mortality|32907095|White|Male|Leukemia|2007|0.8|1.0|0.9
0-19|0.7|0.8|0.7|247|Mortality|32980214|White|Male|Leukemia|2008|0.7|0.8|0.7
0-19|0.7|0.9|0.8|276|Mortality|33018292|White|Male|Leukemia|2009|0.7|0.9|0.8
0-19|0.1|0.2|0.2|53|Mortality|32187349|White|Male|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.2
0-19|0.2|0.3|0.2|66|Mortality|32335465|White|Male|Non-Hodgkin Lymphoma|2000|0.2|0.3|0.2
0-19|0.1|0.2|0.2|56|Mortality|32449078|White|Male|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.2
0-19|0.1|0.2|0.2|61|Mortality|32522098|White|Male|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.2
0-19|0.1|0.2|0.1|48|Mortality|32578661|White|Male|Non-Hodgkin Lymphoma|2003|0.1|0.2|0.1
0-19|0.1|0.2|0.2|54|Mortality|32666378|White|Male|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|61|Mortality|32710351|White|Male|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.2
0-19|0.1|0.2|0.1|247|Mortality|164397378|White|Male|Non-Hodgkin Lymphoma|2005-2009|0.1|0.2|0.2
0-19|0.1|0.2|0.2|54|Mortality|32781426|White|Male|Non-Hodgkin Lymphoma|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.1|45|Mortality|32907095|White|Male|Non-Hodgkin Lymphoma|2007|0.1|0.2|0.1
0-19|0.1|0.2|0.2|55|Mortality|32980214|White|Male|Non-Hodgkin Lymphoma|2008|0.1|0.2|0.2
0-19|0.1|0.1|0.1|32|Mortality|33018292|White|Male|Non-Hodgkin Lymphoma|2009|0.1|0.1|0.1
0-19|0.5|0.7|0.6|203|Mortality|32187349|White|Male|Other|1999|0.5|0.7|0.6
0-19|0.6|0.7|0.6|208|Mortality|32335465|White|Male|Other|2000|0.6|0.7|0.6
0-19|0.5|0.7|0.6|187|Mortality|32449078|White|Male|Other|2001|0.5|0.7|0.6
0-19|0.6|0.8|0.7|214|Mortality|32522098|White|Male|Other|2002|0.6|0.8|0.7
0-19|0.5|0.7|0.6|200|Mortality|32578661|White|Male|Other|2003|0.5|0.7|0.6
0-19|0.5|0.7|0.6|205|Mortality|32666378|White|Male|Other|2004|0.5|0.7|0.6
0-19|0.5|0.7|0.6|208|Mortality|32710351|White|Male|Other|2005|0.6|0.7|0.6
0-19|0.5|0.6|0.5|903|Mortality|164397378|White|Male|Other|2005-2009|0.5|0.6|0.5
0-19|0.4|0.6|0.5|168|Mortality|32781426|White|Male|Other|2006|0.4|0.6|0.5
0-19|0.5|0.7|0.6|190|Mortality|32907095|White|Male|Other|2007|0.5|0.7|0.6
0-19|0.5|0.6|0.5|176|Mortality|32980214|White|Male|Other|2008|0.5|0.6|0.5
0-19|0.4|0.6|0.5|161|Mortality|33018292|White|Male|Other|2009|0.4|0.6|0.5
0-19|0.2|0.3|0.2|73|Mortality|32187349|White|Male|Soft Tissue|1999|0.2|0.3|0.2
0-19|0.1|0.2|0.2|62|Mortality|32335465|White|Male|Soft Tissue|2000|0.1|0.2|0.2
0-19|0.2|0.3|0.2|65|Mortality|32449078|White|Male|Soft Tissue|2001|0.2|0.3|0.2
0-19|0.1|0.2|0.2|59|Mortality|32522098|White|Male|Soft Tissue|2002|0.1|0.2|0.2
0-19|0.2|0.3|0.2|70|Mortality|32578661|White|Male|Soft Tissue|2003|0.2|0.3|0.2
0-19|0.1|0.2|0.2|62|Mortality|32666378|White|Male|Soft Tissue|2004|0.1|0.2|0.2
0-19|0.1|0.2|0.2|57|Mortality|32710351|White|Male|Soft Tissue|2005|0.1|0.2|0.2
0-19|0.2|0.2|0.2|311|Mortality|164397378|White|Male|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.2|0.3|0.2|67|Mortality|32781426|White|Male|Soft Tissue|2006|0.2|0.3|0.2
0-19|0.1|0.2|0.2|57|Mortality|32907095|White|Male|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.3|0.2|71|Mortality|32980214|White|Male|Soft Tissue|2008|0.2|0.3|0.2
0-19|0.1|0.2|0.2|59|Mortality|33018292|White|Male|Soft Tissue|2009|0.1|0.2|0.2
0-19|0.3|0.4|0.4|236|Mortality|62644958|White|Male and Female|Acute Lymphocytic|1999|0.3|0.4|0.4
0-19|0.4|0.5|0.5|284|Mortality|62928282|White|Male and Female|Acute Lymphocytic|2000|0.4|0.5|0.5
0-19|0.4|0.5|0.4|253|Mortality|63138448|White|Male and Female|Acute Lymphocytic|2001|0.4|0.5|0.4
0-19|0.4|0.5|0.4|273|Mortality|63295581|White|Male and Female|Acute Lymphocytic|2002|0.4|0.5|0.4
0-19|0.4|0.5|0.4|281|Mortality|63438313|White|Male and Female|Acute Lymphocytic|2003|0.4|0.5|0.4
0-19|0.4|0.5|0.4|254|Mortality|63632973|White|Male and Female|Acute Lymphocytic|2004|0.4|0.5|0.4
0-19|0.3|0.4|0.4|230|Mortality|63734250|White|Male and Female|Acute Lymphocytic|2005|0.3|0.4|0.4
0-19|0.3|0.4|0.3|1113|Mortality|320438053|White|Male and Female|Acute Lymphocytic|2005-2009|0.3|0.4|0.3
0-19|0.3|0.4|0.4|225|Mortality|63884713|White|Male and Female|Acute Lymphocytic|2006|0.3|0.4|0.4
0-19|0.3|0.4|0.4|248|Mortality|64140678|White|Male and Female|Acute Lymphocytic|2007|0.3|0.4|0.4
0-19|0.3|0.4|0.3|205|Mortality|64296358|White|Male and Female|Acute Lymphocytic|2008|0.3|0.4|0.3
0-19|0.3|0.4|0.3|205|Mortality|64382054|White|Male and Female|Acute Lymphocytic|2009|0.3|0.4|0.3
0-19|0.2|0.3|0.3|158|Mortality|62644958|White|Male and Female|Acute Myeloid|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.3|171|Mortality|62928282|White|Male and Female|Acute Myeloid|2000|0.2|0.3|0.3
0-19|0.2|0.3|0.3|183|Mortality|63138448|White|Male and Female|Acute Myeloid|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.3|162|Mortality|63295581|White|Male and Female|Acute Myeloid|2002|0.2|0.3|0.3
0-19|0.2|0.3|0.2|151|Mortality|63438313|White|Male and Female|Acute Myeloid|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|155|Mortality|63632973|White|Male and Female|Acute Myeloid|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.2|158|Mortality|63734250|White|Male and Female|Acute Myeloid|2005|0.2|0.3|0.2
0-19|0.2|0.2|0.2|727|Mortality|320438053|White|Male and Female|Acute Myeloid|2005-2009|0.2|0.2|0.2
0-19|0.2|0.3|0.2|151|Mortality|63884713|White|Male and Female|Acute Myeloid|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|142|Mortality|64140678|White|Male and Female|Acute Myeloid|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|138|Mortality|64296358|White|Male and Female|Acute Myeloid|2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|138|Mortality|64382054|White|Male and Female|Acute Myeloid|2009|0.2|0.3|0.2
0-19|2.7|2.9|2.8|1754|Mortality|62644958|White|Male and Female|All Cancer Sites Combined|1999|2.7|2.9|2.8
0-19|2.7|3.0|2.9|1799|Mortality|62928282|White|Male and Female|All Cancer Sites Combined|2000|2.7|3.0|2.9
0-19|2.7|2.9|2.8|1774|Mortality|63138448|White|Male and Female|All Cancer Sites Combined|2001|2.7|2.9|2.8
0-19|2.7|2.9|2.8|1782|Mortality|63295581|White|Male and Female|All Cancer Sites Combined|2002|2.7|2.9|2.8
0-19|2.7|3.0|2.8|1797|Mortality|63438313|White|Male and Female|All Cancer Sites Combined|2003|2.7|3.0|2.8
0-19|2.6|2.9|2.7|1748|Mortality|63632973|White|Male and Female|All Cancer Sites Combined|2004|2.6|2.9|2.7
0-19|2.6|2.8|2.7|1734|Mortality|63734250|White|Male and Female|All Cancer Sites Combined|2005|2.6|2.9|2.7
0-19|2.5|2.6|2.5|8116|Mortality|320438053|White|Male and Female|All Cancer Sites Combined|2005-2009|2.5|2.6|2.5
0-19|2.4|2.6|2.5|1601|Mortality|63884713|White|Male and Female|All Cancer Sites Combined|2006|2.4|2.6|2.5
0-19|2.4|2.7|2.6|1649|Mortality|64140678|White|Male and Female|All Cancer Sites Combined|2007|2.4|2.7|2.6
0-19|2.4|2.6|2.5|1610|Mortality|64296358|White|Male and Female|All Cancer Sites Combined|2008|2.4|2.6|2.5
0-19|2.2|2.5|2.4|1522|Mortality|64382054|White|Male and Female|All Cancer Sites Combined|2009|2.2|2.5|2.4
0-19|0.2|0.3|0.3|168|Mortality|62644958|White|Male and Female|Bones and Joints|1999|0.2|0.3|0.3
0-19|0.2|0.3|0.2|144|Mortality|62928282|White|Male and Female|Bones and Joints|2000|0.2|0.3|0.2
0-19|0.2|0.3|0.2|159|Mortality|63138448|White|Male and Female|Bones and Joints|2001|0.2|0.3|0.3
0-19|0.2|0.3|0.2|151|Mortality|63295581|White|Male and Female|Bones and Joints|2002|0.2|0.3|0.2
0-19|0.2|0.3|0.2|156|Mortality|63438313|White|Male and Female|Bones and Joints|2003|0.2|0.3|0.2
0-19|0.2|0.3|0.2|147|Mortality|63632973|White|Male and Female|Bones and Joints|2004|0.2|0.3|0.2
0-19|0.2|0.3|0.3|175|Mortality|63734250|White|Male and Female|Bones and Joints|2005|0.2|0.3|0.3
0-19|0.2|0.3|0.2|753|Mortality|320438053|White|Male and Female|Bones and Joints|2005-2009|0.2|0.3|0.2
0-19|0.2|0.3|0.2|138|Mortality|63884713|White|Male and Female|Bones and Joints|2006|0.2|0.3|0.2
0-19|0.2|0.3|0.2|145|Mortality|64140678|White|Male and Female|Bones and Joints|2007|0.2|0.3|0.2
0-19|0.2|0.3|0.2|154|Mortality|64296358|White|Male and Female|Bones and Joints|2008|0.2|0.3|0.2
0-19|0.2|0.3|0.2|141|Mortality|64382054|White|Male and Female|Bones and Joints|2009|0.2|0.3|0.2
0-19|0.6|0.8|0.7|431|Mortality|62644958|White|Male and Female|Brain and Other Nervous System|1999|0.6|0.8|0.7
0-19|0.6|0.8|0.7|437|Mortality|62928282|White|Male and Female|Brain and Other Nervous System|2000|0.6|0.8|0.7
0-19|0.6|0.7|0.7|428|Mortality|63138448|White|Male and Female|Brain and Other Nervous System|2001|0.6|0.7|0.7
0-19|0.6|0.8|0.7|440|Mortality|63295581|White|Male and Female|Brain and Other Nervous System|2002|0.6|0.8|0.7
0-19|0.7|0.8|0.7|470|Mortality|63438313|White|Male and Female|Brain and Other Nervous System|2003|0.7|0.8|0.7
0-19|0.6|0.8|0.7|440|Mortality|63632973|White|Male and Female|Brain and Other Nervous System|2004|0.6|0.8|0.7
0-19|0.6|0.8|0.7|438|Mortality|63734250|White|Male and Female|Brain and Other Nervous System|2005|0.6|0.8|0.7
0-19|0.6|0.7|0.7|2138|Mortality|320438053|White|Male and Female|Brain and Other Nervous System|2005-2009|0.6|0.7|0.7
0-19|0.6|0.7|0.7|415|Mortality|63884713|White|Male and Female|Brain and Other Nervous System|2006|0.6|0.7|0.6
0-19|0.6|0.8|0.7|439|Mortality|64140678|White|Male and Female|Brain and Other Nervous System|2007|0.6|0.8|0.7
0-19|0.6|0.7|0.7|433|Mortality|64296358|White|Male and Female|Brain and Other Nervous System|2008|0.6|0.7|0.7
0-19|0.6|0.7|0.6|413|Mortality|64382054|White|Male and Female|Brain and Other Nervous System|2009|0.6|0.7|0.6
0-19|0.0|0.1|0.1|34|Mortality|62644958|White|Male and Female|Hodgkin Lymphoma|1999|0.0|0.1|0.1
0-19|0.0|0.1|0.0|22|Mortality|62928282|White|Male and Female|Hodgkin Lymphoma|2000|0.0|0.1|0.0
0-19|0.0|0.1|0.0|26|Mortality|63138448|White|Male and Female|Hodgkin Lymphoma|2001|0.0|0.1|0.0
0-19|0.0|0.1|0.0|26|Mortality|63295581|White|Male and Female|Hodgkin Lymphoma|2002|0.0|0.1|0.0
0-19|0.0|0.0|0.0|20|Mortality|63438313|White|Male and Female|Hodgkin Lymphoma|2003|0.0|0.0|0.0
0-19|0.0|0.0|0.0|20|Mortality|63632973|White|Male and Female|Hodgkin Lymphoma|2004|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|63734250|White|Male and Female|Hodgkin Lymphoma|2005|0.0|0.0|0.0
0-19|0.0|0.0|0.0|76|Mortality|320438053|White|Male and Female|Hodgkin Lymphoma|2005-2009|0.0|0.0|0.0
0-19|0.0|0.0|0.0|19|Mortality|63884713|White|Male and Female|Hodgkin Lymphoma|2006|0.0|0.0|0.0
0-19|~|~|~|~|Mortality|64140678|White|Male and Female|Hodgkin Lymphoma|2007|~|~|~
0-19|~|~|~|~|Mortality|64296358|White|Male and Female|Hodgkin Lymphoma|2008|~|~|~
0-19|0.0|0.0|0.0|16|Mortality|64382054|White|Male and Female|Hodgkin Lymphoma|2009|0.0|0.0|0.0
0-19|0.1|0.1|0.1|44|Mortality|62644958|White|Male and Female|Kidney and Renal Pelvis|1999|0.1|0.1|0.1
0-19|0.0|0.1|0.1|35|Mortality|62928282|White|Male and Female|Kidney and Renal Pelvis|2000|0.0|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63138448|White|Male and Female|Kidney and Renal Pelvis|2001|0.0|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63295581|White|Male and Female|Kidney and Renal Pelvis|2002|0.0|0.1|0.1
0-19|0.1|0.1|0.1|53|Mortality|63438313|White|Male and Female|Kidney and Renal Pelvis|2003|0.1|0.1|0.1
0-19|0.1|0.1|0.1|48|Mortality|63632973|White|Male and Female|Kidney and Renal Pelvis|2004|0.1|0.1|0.1
0-19|0.1|0.1|0.1|45|Mortality|63734250|White|Male and Female|Kidney and Renal Pelvis|2005|0.1|0.1|0.1
0-19|0.1|0.1|0.1|186|Mortality|320438053|White|Male and Female|Kidney and Renal Pelvis|2005-2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|41|Mortality|63884713|White|Male and Female|Kidney and Renal Pelvis|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|31|Mortality|64140678|White|Male and Female|Kidney and Renal Pelvis|2007|0.0|0.1|0.0
0-19|0.0|0.1|0.1|36|Mortality|64296358|White|Male and Female|Kidney and Renal Pelvis|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.1|33|Mortality|64382054|White|Male and Female|Kidney and Renal Pelvis|2009|0.0|0.1|0.1
0-19|0.8|0.9|0.9|534|Mortality|62644958|White|Male and Female|Leukemia|1999|0.8|0.9|0.9
0-19|0.9|1.0|0.9|596|Mortality|62928282|White|Male and Female|Leukemia|2000|0.9|1.0|0.9
0-19|0.9|1.0|0.9|586|Mortality|63138448|White|Male and Female|Leukemia|2001|0.9|1.0|0.9
0-19|0.8|0.9|0.9|546|Mortality|63295581|White|Male and Female|Leukemia|2002|0.8|0.9|0.9
0-19|0.8|1.0|0.9|562|Mortality|63438313|White|Male and Female|Leukemia|2003|0.8|1.0|0.9
0-19|0.8|0.9|0.8|532|Mortality|63632973|White|Male and Female|Leukemia|2004|0.8|0.9|0.8
0-19|0.7|0.9|0.8|508|Mortality|63734250|White|Male and Female|Leukemia|2005|0.7|0.9|0.8
0-19|0.7|0.8|0.8|2444|Mortality|320438053|White|Male and Female|Leukemia|2005-2009|0.7|0.8|0.8
0-19|0.7|0.8|0.8|500|Mortality|63884713|White|Male and Female|Leukemia|2006|0.7|0.9|0.8
0-19|0.7|0.9|0.8|509|Mortality|64140678|White|Male and Female|Leukemia|2007|0.7|0.9|0.8
0-19|0.7|0.8|0.7|468|Mortality|64296358|White|Male and Female|Leukemia|2008|0.7|0.8|0.7
0-19|0.6|0.8|0.7|459|Mortality|64382054|White|Male and Female|Leukemia|2009|0.6|0.8|0.7
0-19|0.1|0.2|0.1|75|Mortality|62644958|White|Male and Female|Non-Hodgkin Lymphoma|1999|0.1|0.2|0.1
0-19|0.1|0.2|0.1|90|Mortality|62928282|White|Male and Female|Non-Hodgkin Lymphoma|2000|0.1|0.2|0.1
0-19|0.1|0.2|0.1|78|Mortality|63138448|White|Male and Female|Non-Hodgkin Lymphoma|2001|0.1|0.2|0.1
0-19|0.1|0.2|0.1|88|Mortality|63295581|White|Male and Female|Non-Hodgkin Lymphoma|2002|0.1|0.2|0.1
0-19|0.1|0.1|0.1|74|Mortality|63438313|White|Male and Female|Non-Hodgkin Lymphoma|2003|0.1|0.1|0.1
0-19|0.1|0.2|0.1|79|Mortality|63632973|White|Male and Female|Non-Hodgkin Lymphoma|2004|0.1|0.2|0.1
0-19|0.1|0.2|0.1|83|Mortality|63734250|White|Male and Female|Non-Hodgkin Lymphoma|2005|0.1|0.2|0.1
0-19|0.1|0.1|0.1|345|Mortality|320438053|White|Male and Female|Non-Hodgkin Lymphoma|2005-2009|0.1|0.1|0.1
0-19|0.1|0.1|0.1|67|Mortality|63884713|White|Male and Female|Non-Hodgkin Lymphoma|2006|0.1|0.1|0.1
0-19|0.1|0.1|0.1|68|Mortality|64140678|White|Male and Female|Non-Hodgkin Lymphoma|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|72|Mortality|64296358|White|Male and Female|Non-Hodgkin Lymphoma|2008|0.1|0.1|0.1
0-19|0.1|0.1|0.1|55|Mortality|64382054|White|Male and Female|Non-Hodgkin Lymphoma|2009|0.1|0.1|0.1
0-19|0.5|0.6|0.6|352|Mortality|62644958|White|Male and Female|Other|1999|0.5|0.6|0.6
0-19|0.5|0.6|0.6|359|Mortality|62928282|White|Male and Female|Other|2000|0.5|0.6|0.6
0-19|0.5|0.6|0.5|341|Mortality|63138448|White|Male and Female|Other|2001|0.5|0.6|0.5
0-19|0.5|0.7|0.6|372|Mortality|63295581|White|Male and Female|Other|2002|0.5|0.7|0.6
0-19|0.5|0.6|0.5|341|Mortality|63438313|White|Male and Female|Other|2003|0.5|0.6|0.5
0-19|0.5|0.6|0.6|362|Mortality|63632973|White|Male and Female|Other|2004|0.5|0.6|0.6
0-19|0.5|0.6|0.5|336|Mortality|63734250|White|Male and Female|Other|2005|0.5|0.6|0.5
0-19|0.5|0.5|0.5|1571|Mortality|320438053|White|Male and Female|Other|2005-2009|0.5|0.5|0.5
0-19|0.4|0.5|0.5|310|Mortality|63884713|White|Male and Female|Other|2006|0.4|0.5|0.5
0-19|0.5|0.6|0.5|333|Mortality|64140678|White|Male and Female|Other|2007|0.5|0.6|0.5
0-19|0.4|0.5|0.5|310|Mortality|64296358|White|Male and Female|Other|2008|0.4|0.5|0.5
0-19|0.4|0.5|0.4|282|Mortality|64382054|White|Male and Female|Other|2009|0.4|0.5|0.4
0-19|0.2|0.2|0.2|116|Mortality|62644958|White|Male and Female|Soft Tissue|1999|0.2|0.2|0.2
0-19|0.2|0.2|0.2|116|Mortality|62928282|White|Male and Female|Soft Tissue|2000|0.2|0.2|0.2
0-19|0.1|0.2|0.2|115|Mortality|63138448|White|Male and Female|Soft Tissue|2001|0.2|0.2|0.2
0-19|0.2|0.2|0.2|118|Mortality|63295581|White|Male and Female|Soft Tissue|2002|0.2|0.2|0.2
0-19|0.2|0.2|0.2|121|Mortality|63438313|White|Male and Female|Soft Tissue|2003|0.2|0.2|0.2
0-19|0.2|0.2|0.2|120|Mortality|63632973|White|Male and Female|Soft Tissue|2004|0.2|0.2|0.2
0-19|0.2|0.2|0.2|130|Mortality|63734250|White|Male and Female|Soft Tissue|2005|0.2|0.2|0.2
0-19|0.2|0.2|0.2|603|Mortality|320438053|White|Male and Female|Soft Tissue|2005-2009|0.2|0.2|0.2
0-19|0.1|0.2|0.2|111|Mortality|63884713|White|Male and Female|Soft Tissue|2006|0.1|0.2|0.2
0-19|0.1|0.2|0.2|112|Mortality|64140678|White|Male and Female|Soft Tissue|2007|0.1|0.2|0.2
0-19|0.2|0.2|0.2|127|Mortality|64296358|White|Male and Female|Soft Tissue|2008|0.2|0.2|0.2
0-19|0.2|0.2|0.2|123|Mortality|64382054|White|Male and Female|Soft Tissue|2009|0.2|0.2|0.2
